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ABSTRACT 
  
Modulation of blood-surface interactions to increase the thrombo-resistance of a 
synthetic biomaterial is a vital aspect in the design of haemocompatible surfaces. 
Recent work suggests that chemical and physical properties of a surface 
fundamentally influence the biological responses of adsorbed proteins and platelets. 
A non-haemocompatible material surface may ubiquitously adsorb specific plasma 
proteins that form a proteinacious layer which mediates the adhesion and activation 
of platelets and the clotting cascade, and consequently the formation of blood clots. 
This will ultimately lead to the rejection of the material and subsequently, the 
implanted medical device. 
 
Currently the preferential adsorption of specific proteins, their exact interaction and 
the effect of physical and spatial cues from the nano-environment in platelet 
adhesion, spreading and its subsequent activation still remain unclear. Apart from 
surface chemistry and wetability of the surface, variation in the nano-structure of 
biomaterials, structural differences between different proteins, the various forces 
involved and their combinatorial effect, and the dynamic nature of each protein (their 
ability to exist and co-exist in various conformations depending on the surrounding 
nano-environment) prevents us from acknowledging a general description of the 
interplay between proteins and biomaterials. Thus the purpose of this study is to 
investigate the effect of plasma protein adsorption and subsequent platelet 
interactions on the smooth and nano-patterned commercially used biomaterials such 
as: hydrogenated amorphous carbon (a-C:H), tetrahedral amorphous carbon (ta-C) 
and titania (TiO2) surfaces. Protein interactions were investigated using a 
combination of atomic force microscopy (AFM), quartz crystal microbalance with 
dissipation (QCM-D), enzyme-linked immunosorbant assay (ELISA) and 
fluorescence microscopy, while platelet interactions were examined using scanning 
electron microscopy (SEM), AFM, QCM, ELISA, fluorescence microscopy and flow 
cytometry, in-vitro. 
 
   vi 
Results have shown a-C:H and ta-C surfaces exhibited increased affinity to 
fibrinogen than TiO2 surfaces, while facilitating similar levels of platelet attachment. 
Differences in platelet attachment between protein pre-coated surfaces showed the 
necessary role of fibrinogen in platelet adhesion. The a-C:H coated surfaces resulted 
in decreased cellular spreading when compared with ta-C and TiO2 coated surfaces, 
while same level of platelet activation was detected indicating that platelets could 
exist in their activated state without spreading. When platelet interactions on nano-
patterned surfaces were compared against smooth surfaces, nano-rough a-C:H and ta-
C surfaces presented with increased levels of platelet attachment as well as its 
spreading when compared with TiO2, while similar levels of platelet activation was 
detected amongst the smooth and the rough substrates. Furthermore, excessive 
platelet adhesion and spreading were noted on fibrinogen pre-coated nano-patterned 
and flat surfaces when compared to albumin and plasma pre-coated surfaces, with 
minimal changes in activation levels on each platelet. Increased levels of platelet 
adhesion and spreading were positively correlated with increased fibrinogen 
adsorption, reinforcing the crucial role of fibrinogen in platelet binding but also its 
possible role in platelet spreading.  
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1   INTRODUCTION 
 
Cardiovascular disease (CVD) has become the leading killer of men and women with 
mortality and morbidity rates of approximately 17 million people each year [1]. 
Apart from an ageing popular, with average life expectancy of 80+ years and 
increasing [2], increases in the prevalence of cigarette smoking, stress, obesity and 
decreases in participation in physical activity have been shown to exacerbate this 
epidemic over the last few decades [3]. Almost 3.5 million Australians have been 
reported to suffer from long-term cardiovascular diseases, with over 500,000 deaths 
attributed to this cause each year [3]. Invasive treatments for cardiovascular diseases 
have been shown to reduce the quality of life for many and are a significant 
socioeconomic burden on our economy [4].  
 
Almost all cardiovascular devices and cardiovascular disease related procedures, 
either short-term or long-term, require significant anticoagulation, at high cost and 
with considerable risk to the patient [5]. In Australia, approximately $5.9 billion 
dollars are spent each year in health care expenditure, of which, approximately $3 
billion dollars been spent on hospitalisation, $1.6 billion on prescriptions and over 
$1.1 billion on medical services such as implants, and post-operative care [3]. In 
terms of the world market for medical devices, cardiovascular devices were 
forecasted to grow in single digit percentage each year and likely to exceed USD $27 
billion dollars by 2017 [6]. Despite the millions of dollars spent on the research and 
development of cardiovascular implants and blood-compatible materials, the 
formation of blood clots (thrombosis) remains a major problem with blood-
contacting devices. Even after six decades, a truly blood compatible 
(haemocompatibile) biomaterial is yet to be identified [5].  
 
The design of haemocompatible biomaterials is complicated by our poor 
understanding of not only the individual blood–material interactions that contribute 
to platelet adhesion and contact activation, but also the consequences of their 
interplay to coagulation as a whole. From what is understood, blood contacting 
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devices such as catheters, blood vessel grafts, vascular stents, artificial heart valves, 
circulatory support devices, various extracorporeal tubings, hemodialysis, 
hemapheresis and oxygenator membranes perform in a corrosive bio-environment 
due to the metabolic activity of the cells and fluids in our body, which, for 
biomaterials with a low wear resistance, causes the release of metal ions and wear 
debris. Platelets play a crucial role by recognizing and adhering to the surface of the 
foreign implant and its wear debris, signalling additional platelets and forming a 
haemostatic plug as part of the coagulation cascade. This response is initiated by the 
rapid adsorption of plasma proteins, such as the fibrinogen, followed by its adhesion 
and activation. Therefore studying the interplay between platelets and the biomaterial 
surface is necessary to overcome thrombogensis-related device failure - especially 
when considering the potential of surface modifications such as diamond like carbon 
(DLC) or titania (TiO2) coatings, which can greatly influence these interactions.  
 
Inorganic coatings such as diamond-like carbon (DLC) and titania (TiO2), because of 
their excellent mechanical properties and smooth surface finishing have gained 
popularity for their use as an effective surface modification on implantable devices. 
Both materials’ have been shown to improve haemocompatibility without affecting 
the mechanical and physical properties of the underlying bulk material. Despite the 
excellent response to blood proteins and cells in vitro and in vivo, unexpected 
negative results from various clinical studies significantly affect their potential as a 
passivating coating for cardiovascular applications. A better understanding of the 
material science in relation to their interaction with blood proteins and cellular 
components is needed. At present, no consistent relationship has been established 
between the materials’ physical and chemical structure, and its haemocompatibility. 
The exact mechanism behind the preferential adsorption of fibrinogen and albumin 
during blood interaction, or the complex and synergistic interactions between 
platelets and plasma proteins on such surfaces are still not fully understood.  
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Aims  
 
The overall purpose of this study was to investigate the role of plasma proteins, 
surface chemistry and nano-patterned surface on the haemocompatibility of 
biomaterial surfaces, and to enhance the overall understanding of haemostatic 
responses on biomaterial surfaces.  
 
The specific aim of this study was investigated by: 
1. Characterising TiO2, a-C:H, ta-C surface coatings with varying nano-
topographies;  
2. Investigating the adsorption of serum protein and, platelet adhesion and 
aggregation on surfaces pre-coated with serum proteins; and, 
3. Analysing the activation of platelets and clot formation on protein pre-coated 
surfaces 
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2   LITERATURE REVIEW 
 
 
2.1 The Cardiovascular System 
 
The cardiovascular system, also known as the circulatory system, is mainly 
composed of the heart, blood and blood vessels, and, plays an important role in 
sustaining life by maintaining homeostasis. The cardiovascular system aids behaves 
as a transport system by circulating O2 (oxygenated), CO2 (deoxygenated), heat, 
metabolic wastes, nutrients, electrolytes and regulatory hormones within the body. 
These materials are carried by blood in its dissolved as well as its suspended state. 
The flow of blood is continually directed by the vasculature as well as chemical and 
topographical cues released within the vascular walls  [7]. A schematic of the human 
circulatory system is shown in Figure 2.1. 
 
 
2.1.1 Blood Vasculature 
 
Blood vessels are conduits forming two vascular loops called the systemic and 
pulmonary circulation.  Each loop forms a closed-system with a continuum of 
different blood vessels that begin and end with the heart. Pulmonary circulation 
carries blood between the heart and the lungs and the systemic circulation carries 
blood between the heart and other body tissues.  
 
Arteries rapidly distribute blood from the heart to various organs by expanding the 
arterial wall elastically. When the heart relaxes, the elastin fibres tighten causing the 
wall passively recoil and consequently forcing excess blood within the arteries 
downstream. The collagen fibres in the arterial connective tissue provide strength 
against high inter-luminal pressure caused by pumping of the heart. Arteries 
sequentially diverge into smaller arteries and once reaching an organ the smaller 
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arteries branch into numerous arterioles to supply oxygenated blood within the organ 
tissues. Arterioles provide high resistance against blood flow. Due to their 
significantly smaller radius, a major drop in mean arterial pressure occurs when 
blood flows from small arteries to arterioles. Arterioles branch further to form the 
smallest vessels, called capillaries, where all exchanges are made with surrounding 
cells via diffusion. 
 
Figure 2.1 Schematic diagram of the circulatory system [8]  
 
 
Capillaries have 1µm thin walls with a lumen which is approximately 7µm thick, 
enough to facilitate one red blood cell to pass through at a time. Extensive capillary 
branching reduces blood flow rate and increases the available surface area for heat, 
metabolite and nutrient exchange with the nearest cell. Pores on capillary walls are 
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filled with water to permit water soluble material exchange. Branched capillaries 
reconverge to form venules and eventually merge into small veins. Smaller veins 
reunite to form large veins which carry deoxygenated blood from the organs back to 
the heart. Venules and veins have little tone (thin smooth muscle layer) and 
resistance. Veins especially, have large luminal diameter with little luminal elastin 
and hence are often called capacitance vessels. They act as storage reservoirs, 
constantly distending to accommodate higher blood volume without recoil.  
Sequentially located, one-way venous valves counteract gravitational effects by 
preventing back flow of blood. Movement from skeletal muscles greatly facilitates 
passage of blood through the veins back to the heart. A schematic cross-section of 
arteries and veins is shown in Figure 2.2. 
 
Typically, the blood vessel wall is composed of three layers: intima, media and 
adventitia, except for the capillaries, which consist of a single layer of endothelial 
cells. The outermost layer of arteries and veins are called the tunica adventitia. It is 
made up of collagen and elastic fibres which form the connective tissue of the vessel 
wall. The intermediate layer, called the tunica media, is composed of smooth muscle 
and elastic fibres, and inner layer of the arteries and veins are called the tunica 
intima. In arteries, the intima layer is made up of smooth endothelium lined with an 
elastic membrane that is covered by elastic tissues. Veins, on the other hand, do not 
contain this elastic membrane lining. The innermost layer of tunica intima is 
composed of endothelial cells. Endothelial cells are simple squamous epithelial cells 
that act as a semi permeable membrane between and tissue and blood in the lumen.  
These cells are regulated by hormones and growth factors which circulate in blood 
and are involved in vascular regulation by releasing vasoconstrictors and 
vasodilators, secretion of immune-regulatory and neuro-regulatory factors to sustain 
haemostasis, differentiation and proliferation of cell mediated and humoral response 
immune cells, as well as induction of inflammatory response by activating 
leukocytes at site of tissue injury or infection, and,  blood clot formation by 
angiogenesis, coagulation and vasculogenesis  [9].  
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Figure 2.2 Schematic cross-sectional diagram showing the structural layers of 
arteries and veins [10] 
 
 
2.1.2 Blood and Its Composition 
 
Almost 8% of our total body weight is represented by blood. Women approximately 
carry 5 litres of blood while men carry over 5.5 litres. Blood is composed of three 
types of specialised cells; erythrocytes (red blood cells), leukocytes (white blood 
cells) and platelets (thrombocytes), all differentiated from haemocytoblast cells, as 
shown in Figure 2.3. These blood cells are suspended in a pool of complex liquid, 
called plasma. In fact over 99% of the cells in plasma are erythrocytes. The average 
packed cell volume, also known as ‘haemocrit’ of blood, consists of 45% 
erythrocytes (5 billion red blood cells per 1mm blood volume), 55% blood plasma 
and less than 1% of platelets and leukocytes.  
 
The major role of blood is to maintain homeostasis. This is done by transporting 
materials to and from cells, distributing oxygen to cells for energy synthesis, pH 
balance, removing excess heat from the body, defending the body against pathogens 
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and foreign material by providing immunity, initiating haemostatic response and 
consequently surface induced-thrombosis during vascular damage. 
 
 
Figure 2.3 Differentiation of haematopoietic stem cells showing the three types of 
blood cells: red blood cells, white blood cells and platelets [11] 
 
Haemostasis is a process that involves the minimisation of blood loss and the control 
of haemorrhage to avoid total exanguination [12, 13].  Under normal physiological 
conditions, the endothelial layer of the vessel wall behaves as a thrombo-resistant 
surface, promoting anti-thrombotic activities which allow the blood remain in its 
fluidic state [14, 15]. However, when the walls of the vasculature are damaged, blood 
circulating within the vessel walls becomes exposed to cells and sub-endothelial 
extra cellular matrix (ECM) within the wall causing an immediate and rapid 
haemostatic response as well as an inflammatory response. The haemostatic response 
involves two simultaneously occurring, yet distinctive, stages; 
 The contraction of smooth muscle cells with the blood vessels, known as, 
primary haemostasis 
 The adhesion and activation of blood platelets as well as the coagulation of 
plasma proteins, known as the secondary haemostasis 
Chapter 2: Literature Review   9 
Implantation of a cardiovascular device represents the introduction of a foreign 
material, with properties different to that of the endothelium. Even after vascular 
healing, the interaction between blood and the blood-contacting surface of the 
biomaterial triggers a series of complex and interlinked events (Figure 2.4).  
 
 
Figure 2.4 Overview of blood biomaterial interactions [16] 
 
This includes: protein adsorption, platelet and leukocyte activation/adhesion, and the 
activation of complement and coagulation system (Figure 2.5); all of which are 
mechanisms of a thrombotic response to the biomaterial.  
 
The following subsections explain the interaction between plasma proteins, blood 
platelets and white blood cells to produce the observed thrombosis during vascular 
injury as well as during blood-biomaterial interactions. 
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Figure 2.5 Typical response of blood to biomaterial surfaces [17] 
 
 
2.1.3 White Blood Cells 
 
White blood cells, or leukocytes primarily function to defend the human body by 
providing an immune barrier against pathogens and other foreign materials [18]. The 
inflammatory response is initiated almost immediately after platelet activation and 
also aids in the removal of damaged cells [19, 20].  
 
The five main types of leukocytes include; neutrophils, eosinophils, basophils, 
monocytes, and, B- and T- lymphocytes. Lymphocytes provide targeted defence 
against pathogens. B-lymphocytes produce antibodies against a specific pathogen 
causing antibody-mediated destruction while T-lymphocytes produce destructive 
chemicals and chemotaxis against infected or aberrant cell, inducing a cell mediated 
immune response. Eosinophils respond during allergic reactions and attack parasitic 
worms. Basophils release two chemicals, heparin and histamine. Heparin dissolves 
fat content in blood and prevents blood coagulation. Histamine is involved in 
increasing blood flow by causing vasodilatation and smooth muscle contraction in 
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response to allergic reactions. Neutrophils are the most leukocytes and they represent 
40–60% (3–5 x 106 neutrophils/ml) of the total leukocyte count in blood, while, 
monocytes represent 5% with a concentration of 0.2–1 x 106 monocytes/ml. 
Neutrophils have a half-life between 8-20hours and behave as phagocytes by 
engulfing bacteria and debris. On the other hand, monocytes, with half lives of 2-4 
days, migrate into tissues where they maturate and differentiate into macrophages 
before ingest foreign material and debris, in a similar manner to neutrophils [21]. 
Together, leukocytes and their derivates with the help of certain plasma proteins 
make up the immune system.  
 
The two main cell types involved with inflammatory response with cardiovascular 
devices are neutrophils and monocytes. These cells are known to further contribute to 
localised thrombogenesis [22]. When an inflammatory response triggered by 
stimulants such as cytokines, neutrophils take on a more active role and increase 
their lifespan by three-fold [23], while, monocytes increase their life span and 
deposit onto the damaged blood vessel for a short time before differentiating into 
macrophages. Both, monocytes and neutrophils, have been shown to activate by pro-
inflammatory mediators such as platelet activating factors and cytokines, 
complement proteins, adhesion, spreading and activation of blood platelets as well as 
β-thromboglobulin and platelet derived growth factors (PDGF) release by platelets, 
adhesion of other cells, as well as bacteria and their products [24-26].  
 
Several studies looking at inflammatory response from angioplasty [27], 
haemodialysis [28], and cardiopulmonary bypass [29] have shown that leukocyte 
activation causes a change in  the expression of membrane receptors such as CD11b, 
synthesis and expression of tissue factor, release of inflammatory mediators such as 
tissue necrotic factor (TNF), release of granular contents (degranulation) and 
cytokines, production of arachidonic acid metabolites, such as leukotriene B4 and 
platelet activating factor on neutrophils and/or monocytes [30]. Large biomaterial 
surfaces cannot be engulfed by leukocytes as such adherent neutrophils and 
monocytes undergo a frustrated phagocytosis whereby they release oxidants such as 
O2− and H2O2 and increase their adhesive capacity on endothelial cells and other 
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surfaces by interacting more favourably with adhesive molecules such as L-selectins, 
immunoglobulins and integrins [21, 27, 31]. When adhering on endothelial cells, 
leukocytes roll onto endothelial cells by latching onto the cell’s L-selectin molecules. 
This inevitably reduces their speed and the leukocytes become activated due to local 
stimulation and additional interaction between leukocyte receptors and cellular 
ligands. Over-expression and functional changes of leukocytes CD11 receptors 
occur, further increasing the leukocytes adhesive properties to not only endothelial 
cells but also blood platelets. Platelets adhered on biomaterial surfaces have been 
known to mediate leukocyte adhesion via the interaction between platelet receptors 
P-selectin and αIIbβ3 with leukocyte receptors PSGL-1 and CD11b, respectively [32, 
33]. Surface chemistry, surface topography as well as surface adsorbed proteins such 
as fibrinogen on the blood-contacting biomaterial have been shown to modulate the 
level of leukocyte adhesion and their activation [34, 35]. Several in vivo studies have 
shown neutrophil and monocyte adhesion on vascular grafts, stents, oxygenators, and 
haemodialysis membranes [34, 36-38].  
 
 
2.1.4 Blood Platelets 
 
Platelets are involved in blood clot formation to minimise blood loss and are known 
to be the primary cells involved in haemostasis. Under normal physiological 
conditions, circulating platelets remain in their ‘rested’ or ‘inactivated’ state while 
interacting with the thrombo-resistant endothelial lining of the vessel wall [39]. The 
endothelial cells release anti-coagulants such as prostacyclin and nitric oxide, as well 
as convert activation inducers such as adenosine diphosphate (ADP) into adenosine 
monophosphate (AMP) to maintain platelets in their inactive state [14, 15, 40].  
 
In non-haemostatic conditions, platelets preserve the integrity of the vasculature by 
responding to minimal stimulation. They become activated upon contact with 
thrombogenic surfaces like: injured endothelium, sub-endothelium and artificial 
surfaces forming a haemostatic plug. The signalling pathway of circulating platelets 
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allows for their rapid capture at site of thrombogenic surface followed by a 
thrombotic response to arrest uncontrollable blood loss.  
 
During vascular injury, damage to blood vessels exposes agonisits such as: sub-
endothelial collagen, microfibrils and von Willebrand factor, to platelets and other 
blood elements, as shown in Figure 2.6. In addition to these agonists, thrombin, 
produced downstream of the coagulation cascade, also effectively activates platelet 
response.   
 
 
Figure 2.6 Platelet plug formation during haemostasis [41] 
 
However, in the presence of blood-contacting artificial surfaces, platelet response is 
initiated by the interaction of extracellular stimulus such as: plasma proteins that 
rapidly adsorb on the platelet surface; exposed collagen from injury to surrounding 
tissues; molecules derived from: consequent inflammatory response, such as 
leukocytes, or, circulating activated platelets, such as platelet activating factor. This 
blood-biomaterial interaction also involves the coupling of the agonist to specific 
receptors on the platelet plasma membrane for platelet activation [22, 42].  
 
Activated platelets adhere to sub-endothelial components, biomaterial surface and to 
each other, forming “white” thrombus. As such, the activation of platelets can be 
described in three steps: adhesion of platelets to collagen fibrils of the sub-
endothelium or artificial surfaces; spreading and aggregation of platelets via 
autocatalytic signalling; activation of platelets and formation of a thrombus clot, 
although platelet spreading, aggregation and activation has been shown to occur 
simultaneously [43]. The three steps occur through interactions between extracellular 
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proteins and receptors on the platelet surface membrane [15]. The thrombus aims to 
effectively seal the haemorrhaging vessel. In depth review of platelet adhesion and 
their subsequent activation is detailed in the following sub-sections.  
 
 
2.1.4.1 Platelet Biology 
 
Platelets are colourless, outer-edge cell fragments shed from megakaryocytes (bone 
marrow cells, precursor to erythrocytic and leukocytic cell lines) and have a life span 
of 8-12 days before being removed and phagocytosed by macrophages. Platelets are 
vesicles containing megakaryotic cytoplasm surrounded by plasma membrane. 
Typically one thousand platelets are secreted from each megakaryocyte under the 
stimuli of thrombopoietin hormone. Spleen stores approximately 1/3rd of circulating 
platelets in blood filled pockets and releases during splenic contraction during 
sympathetic neuronal stimuli.  
 
Resting platelets follow a discoid a-nuclear structure. They are 2-4µm in diameter 
and 1µm thick. Platelets are considered the smaller blood cells and they circulate the 
blood in concentrations of 2-3 x 108 cells per millilitre of blood. Platelets lack nuclei 
and thus do not store DNA. However, platelets contain RNA which gets transcribed 
during platelet activation, and, cytosolic enzymes and organelles for energy 
generation and, to synthesise and secrete chemicals from its secretory granules [44]. 
Actin and myosin proteins exist in high concentration within platelets to facilitate 
platelet contraction.  
 
The bi-lamellar plasma membrane of the platelet is a multiple-channel, surface-
connected canalicular system, which not only increases the surface area of the 
platelet but also tunnels granular secretory contents outside of platelets [42]. The 
plasma membrane skeleton, comprised of crosslinked short-actin filaments connected 
to plasma membrane via actin binding molecules, preserve the structural integrity of 
the plasma membrane by stabilising the lipid bilayer. Sodium and calcium ATPase 
pumps on the plasma membrane regulate ionic homeostasis by facilitating the 
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exchange of molecules to and from the ECM. Platelet receptors are located on the 
glycocalyx, an outer coating on the exterior surface plasma membrane [39, 45]. They 
serve as activating and inhibitory agents and are composed of glycoproteins (GP) 
such as: GPIaIIa, GP Ib, GP IIbIIIa and GP IV.  The receptors are connected to the 
membrane’s phospholipid bilayer made up of negatively charged 
phosphatidylinositol and phosphatidylserine residues. The negatively charged outer 
surface of the platelets have been suspected to minimise attachment between 
circulating platelets [45]. 
 
The intra-cytoplasmic tail of each receptor is in close contact with the actin and 
actin-binding contractile systems within the platelet cytoplasmic skeleton (also 
known as: platelet cytoskeleton). The platelet cytoskeleton not only maintains the 
rounded shape of the resting platelets, but also facilitates morphological changes 
within platelets during activation [46]. Actin exists in two forms: in its monomeric 
state (G-actin) and its polymerised state (F-actin) and constitutes to 15-20% of 
platelets total protein content. These actin filaments with association to proteins such 
as tropomysin, α-actinin and actin binding protein, make up a platelet’s cytoskeleton. 
During platelet activation G-actin molecules polymerise causing an increase in the 
total F-actin concentrations from 30-40% to 60-70% [47, 48]. This causes platelets to 
change their morphology from a discoid shape to its spread form, with extended 
filopodia [47, 48]. Microtubular network in conjunction with the canal system forms 
the membrane complex that are involved in localising enzymes involved in the 
synthesis of prostaglandins and sequestering calcium ions [42]. The microtubular coil 
beneath platelet membrane, formed by tubulin proteins and  short actin filaments 
(microfilaments), also sustain the discoid shape of an unstimulated platelet [49, 50]. 
During platelet activation, the microtubules disassemble then reassemble. The actin 
binding, myosin, molecules cross-link with actin filaments creating sufficient tension 
to centralise the granules within platelets [51].  
 
The platelet’s cytoplasm consists of numerous organelles such as: mitochondriae, 
glycogen, and peroxisomes; and granules such as: α- and dense granules and 
lysosomes. The α and dense granules are the two main types of granular components 
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in promoting immediate haemostatic response and they play an important role in 
storing growth factors, enzymes, receptors and mediators necessary for platelet 
function and their activity. During platelet stimulation these granules release all of 
their secretory contents. The more predominant α- granule is involved in the storage 
of platelet membrane receptors such as GPIb and GPIIb/IIIa. Apart from this, 
proteins such as platelet factor 4, β-thrombomodulin, platelet derived growth factors 
(PDGF), fibrinogen, fibronectin, thrombospondin, plasminogen activator inhibitor 1, 
von Willebrand factor, and other cytokines are also stored in α-granules [52, 53]. 
These proteins behave as pro-inflammatory mediators, receptor-ligand signalling and 
exert chemotactic responses during vascular injury [54]. On the other hand, dense 
bodies contain serotonin, adenosine diphosphate (ADP), adenosine triphosphate 
(ATP), magnesium and calcium, all of whom behave as pro-aggregation factors 
involved in the activation of platelets [42]. Lysosomes are primarily involved in the 
lysis of thrombus clots [55]. They contain enzymes such as: elastase [56], 
collagenase [57] and heparanase [58]; and are released upon stimulation from 
stronger agonists such as: collagen from ECM and thrombin from the blood plasma 
[54, 59].  
 
 
2.1.4.2 Platelet receptors 
 
The activity of platelets during haemostasis is dictated by platelet-membrane 
adhesive receptors. There are several different types of adhesive receptors on the 
membrane surface, of which most of them belong to the immunoglobulin (IgG) 
superfamily, integrins, cadherins and selectins. However, the most predominant 
family of receptors are known as the integrins [60]. Integrins have a primary role of 
mediating interactions between platelets; and between platelets and ECM and/or 
plasma proteins during the adhesion and activation process. This is carried out via 
inside-out integrin signalling from inside of platelets to the ECM and plasma protein 
ligands, as well as outside-in signalling [60]. The most important receptors involved 
during biomaterial related haemostasis and their respective ligands for binding are 
shown Figure 2.7. 
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Resting platelets have been found to express integrins: α2β1 (GPIa/IIa), α5β1 
(GPIc/IIa), α6β1 (GPIc’/IIa), αvβ3 (vitronectin receptor), and αIIbβ3 (GPIIb/IIIa) on its 
surface, where each integrin can bind to more than one ligand [61-64]. Of all the 
platelet receptors, GP Ib and αIIbβ3 integrins are predominantly and constitutively 
expressed with the highest densities on platelets.  
  
 
Figure 2.7 Platelet receptors involved in platelet biomaterial interactions [22] 
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During platelet activation, such as with blood vessel injury or due to biomaterial 
surfaces; the conformation of the resting integrin changes from its inactive state to its 
activated state.  The control of change in conformational state from a low to high 
affinity state occurs within a short time frame, depending on their ligand-binding 
properties [64, 65] and can be characterised into inside-out and outside-in signalling 
[66, 67]. This is shown in Figure 2.8. 
 
Inside-out signalling increases the binding affinity of integrins located outside the 
platelet membrane to bind to extracellular ligands. It involves the transfer of signal 
from an activator from the inside of an activated platelet, to the outside to ultimately 
control the adhesion strength and binding affinity between the integrins and, ECM 
proteins for the adhesion and aggregation of platelets. However, outside-in signalling 
is applicable for integrins that behave like traditional signalling receptors, where 
binding between integrins to their extracellular ligands causes a conformational 
change within the integrin leading to integrin clustering [68]. Often, inside-out 
signalling leads to outside-in signalling and vice versa.  
 
 
Figure 2.8 Inside-out and outside-in platelet integrin signalling [69] 
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For example: activation of platelet integrins may increase ligand binding, may  
generate outside-in signalling of other integrins; while, ligand binding caused by 
outside-in signalling may induce inside-out signalling of integrins [68]. 
 
 
2.1.4.2.1 GP Ib  
 
GP Ib, also known as CD42, are leucine-rich glycoprotein receptors from the 
immunoglobulin super family. These receptors are generally complexed with GP IX. 
There are approximately 25,000 receptors present on the surface of circulating  
platelets [70, 71] and they appear as long molecules that are easily susceptible to 
conformational change upon shear stress caused by flowing blood. GP Ib indirectly 
mediates platelet interaction to collagen by binding to von Willebrand factor [72]. 
Under static conditions, GP Ib will not bind plasma von Willebrand factor without 
the presence of antibiotics such as: ristocetin; or, toxins such as: botrocetin snake 
venom is present. Shear stress induces the required conformational change within 
von Willebrand factor to increase it affinity to GP Ib receptors for receptor-ligand 
binding [22]. However, in the presence of biomaterial surfaces, GP Ib has been 
shown to bind to von Willebrand factor proteins adsorbed onto biomaterial surfaces 
both: under static and shear flow. 
 
 
2.1.4.2.2 GP  IIb/IIIa   
 
GPIIbIIIa (CD41/CD61) is a symmetrical, heterodimeric, transmembrane molecule 
primarily known to bind to fibrinogen, although not exclusively, to enhance platelet 
activation. GPIIbIIIa have also been known to bind to von Willebrand factor and 
fibronectin to induce platelet spreading; and mediate platelet adhesion on biomaterial 
surfaces by  preferentially binding to immobilised fibrinogen [73], in a similar 
manner to von Willebrand factor binding to GPIb. These receptors belong to the 
integrin family, where it is known as αIIbβ3. There are over 40,000-80,000 αIIbβ3 
complexes on the surface of each platelet, and an additional 20,000-40,000 integrins 
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positioned in the α-granules and the canal system of the plasma membrane [70]. 
During activation, inside-out signalling triggers the release of stored integrins, where 
they get translocated to the platelet membrane to enhance the adhesiveness of 
platelets. Agonists such as thrombin, ADP and TxA2 are potent activators of αIIbβ3 
integrins [74, 75]. 
 
The αIIbβ3 receptors are made of two components; an α (GPIIb) subunit and β 
(GPIIIa) subunit, each produced from different genes [76]. The extracellular α-
subunit is composed of a 125kDa extracellular heavy chain molecule and a 22kDa 
light chain molecule that protrudes into the cell membrane. The β-subunit consists of 
one single 95kDa chain that also traverses the cell membrane, similar to the α-light 
chain [75]. The NH2 extracellular terminal on α- and β- subunits form a 3-D binding 
pocket for fibrinogen, and other ligands such as; von Willebrand factor, fibronectin 
and viteronectin [75]. The stability of the integrin structure is sustained by the 
pairing of their cystine rich residues via disulfide bonds [76]. During activation the 
Ca2+, Mg2+, and Mn2+ divalent cations on the extracellular α-domain behave as co-
factors for integrin binding [77]. Fibrinogen uses the calcium dependent pathway 
when binding to the αIIb subunit of αIIbβ3 complex via its RGD sequence located in 
fibrinogen’s Aα and a 12 amino acid sequence located at the carboxyl terminus of its 
γ chain [42]. While, von Willebrand factor, thrombospondin, fibronectin and 
vitronectin adhesive glycoproteins bind to activated αIIbβ3 receptors via their RGD 
tract [78].  
 
Resting platelets express αIIbβ3 receptors in their inactive form. The conformation of 
the inactive receptors present their low-affinity binding site to tightly regulate their 
adhesion to fibrinogen, however, upon platelet activation, a rapid conformational 
change occurs within the receptor exposing the receptor’s high affinity binding site 
for soluble-fibrinogen [79]. Activation of the integrins increases their adhesive 
capacity, and thus facilitates aggregation of platelets by cross-linking with αIIbβ3 
receptors on adjacent platelets, as well as, Mac-1 receptors on leukocytes by 
fibrinogen.  
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2.1.4.2.3 GP Ia/IIa 
 
GPIa/IIa (also known as α2β1, VLA2, CD49b/CD29) expressed on platelet membrane 
directly mediates the first contact of platelets to collagen and is a major receptor for 
collagen exposed from the subendothelial basement membrane [80-85]. Like αIIbβ3, 
α2β1 is also a heterodimeric molecule, part of the integrin family. While, α2β1 
integrins have been implicated with primary interactions between collagen and 
platelets, they need to work in concert with GPIV (CD36) and GPVI receptors to 
sufficiently induce collagen dependent platelet activation [69, 86-93]. This is carried 
out by promoting a conformational change within αIIbβ3 receptors for platelet 
aggregation. 
 
The α2β1 complex is composed of an α2 subunit of molecular weight 150 kDa and a  
β1 subunit of molecular weight 130 kDa [94]. The I domain within the α2 subunit 
(amino acids 140-349) is homologous to the A domain of von Willebrand factor, and 
it plays an important role in binding to collagen [94, 95]. Collagen is a long, 
insoluble, fibrillar-protein [82], that bind to the α2-I domain via divalent cations 
located in the metal ion-dependent adhesion site (MIDAS) [94, 95]. The α2β1 
integrin, even at its low affinity state have been shown to mediate platelet adhesion 
to collagen, by binding to collagen’s Gly-Phe-Hyp-Gly-Glu-Arg (GFOGER) peptide 
sequence. Binding of GFOGER site on collagen to the α2-I domain in collagen have led 
to the activation of α2β1 complex to its high affinity state[96]. This enhances the 
receptors adhesive properties to collagen proteins, resulting in platelet activation 
[80].  
 
 
2.1.4.2.4 P-selectin 
 
P-selectin (also known as CD62P, and previously known as PADGEM and GMP-
140) is a member of the selectin family, along with L-selectin, E-selectin adhesive 
proteins [97, 98]. P-selectin is a single-chain transmembrane glycoprotein, rich in 
cystine residues with many N-linked oligosaccharide chains. It has a mass of 
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approximately 140kDa and shares common structural features with the selectin 
family: an N-terminal, extracellular calcium-dependent lectin domain (approximately 
120 amino acid residues), a transmembrane domain, discrete complement regulatory-
like repeated units (2 repeats for for L-selectins, 6 repeats for E-selectins and 9 
repeats for P-selectins), epidermal growth factor (EGF) like domain and an 
intracellular cytoplasmic tail [99]. However, they are distributed differently on 
different cells.  
 
P-selectin is located on the membrane of the α-granules of platelets. On activation, P-
selectin is translocated and expressed on the membrane surface of activated platelets 
for a period of up to 1-4 hours (depending on the level of stimulus) before they are 
shed into blood plasma [100]. P-selectin receptors bind to mucin-like glycoprotein 
ligand for P-selectin (PSGL-1), commonly found on neutrophils, natural killer cells, 
monocytes and T-lymplocytes [101]. As such P-selectin is known for playing an 
important role in mediating the adhesion between activated platelets and neutrophils, 
monocytes and some lymphocytes. Furthermore, thrombin behaves as a potent 
agonist for increased surface expression of P-selectin on stimulated platelets [100]. 
As P-selectin expression on membrane surface only occurs on stimulated and 
activated platelets, the detection of P-selectin (CD62P) on the membranes of 
adsorbed platelets is considered as an indication of end stage activation. Furthermore, 
P-selectin is also found on the membrane of Weibel-Palade body of endotheial cells 
[102]. Upon endotheial stimulation, the endothelial P-selectins mobilise to the cell 
surface to facilitate possible interactions between activated platelets and endothelial 
cells.  
 
 
2.1.5 Platelet Interactions 
 
Platelet adhesion on implanted biomaterial surface or an injured vessel wall is known 
to be the primary and most important step in the sequence of events leading to the 
spreading and activation of platelets to form a haemostatic plug (thrombosis). The 
adhesion of platelets is a complex process involving platelet surface integrins and 
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exposed ECM proteins, as well as intracellular signalling processes which lead to 
activation and aggregation of platelets [103]. Furthermore, haemostatic interactions 
are further exacerbated by hydrodynamic conditions such as: shear rates and stress 
[104]. Platelets are susceptible to integrin activation when they are circulating at high 
shear rates, or velocity, however, there is time limited contact between the adhering 
surface and platelet integrins, decreasing the efficiency of platelet adhesion [105, 
106]. This causes the detachment of adhered platelets increasing the likelihood of 
embolisation of platelet clots [105, 106]. 
 
 
2.1.5.1 Platelet adhesion and activation 
 
During a thrombotic event, platelets adhere to and consequently spread when 
exposed to sub-endothelial collagen microfilaments of the vascular endothelial cell 
lining or adsorbed plasma proteins on biomaterial surfaces. In the event of a blood 
vessel injury, collagen directly binds to platelets via collagen receptors, α2β1 and 
GPVI. GPVI receptors especially have been shown to generate a strongest activating 
signal. However, during high shear conditions, platelet adhesion is initiated by: 
fibrinogen, fibronectin and the most commonly occurring, collagen bound 
multimeric- von Willebrand factor. This occurs via αIIbβ3, α2β1, GPIcIIa and GPIb 
platelet receptors [72]. Once platelets adhere to collagen, the probability of GPVI 
signalling mediated by collagen becomes greater with increased GPVI clustering 
[107].  Clustering of GPVI glycoprotein causes the phosphorylation of Fc receptor γ 
chain in GPVI by tyrosine kinases of the Src family [108] . Spleen tyrosine kinases 
identifies and activates in response to phosphotyrosine residues (PLCγ2) inducing 
the activation of PLCγ2. Phosphotyrosine residues further converts 
phosphatidylinositol (PI)-4, 5 P2 to 1,4,5- IP3and diacyl glycerol complex, opening 
calcium (Ca2+) channels [109]. This causes a rapid store operated calcium entry 
increasing Ca2+ concentrations in the cytoplasm. 
 
When blood is in contact with artificial biomaterials, platelet receptors recognise and 
bind to plasma proteins such as: fibrinogen, fibronectin, vitronectin, 
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immunoglobulins and von Willebrand factor [110-115]. However, of these proteins, 
fibrinogen has been shown to play a fundamental role in the adhesion process, while, 
fibronectin, von Willebrand factor and immunoglobulins have been shown to provide 
only a supporting role leasing to the activation of platelets [116-119]. Adsorbed 
fibrinogen binds to and activates platelet receptor integrin αIIbβ3 by changing the 
conformation of the β-integrins. This change causes a shift in the integrin from their 
low affinity into their high affinity state by inside-out signalling [120]. However, 
αIIbβ3 receptors in their low-affinity state have also been shown to bind to surface 
adsorbed fibrinogen [121]. The adhesion of platelets and their subsequent 
aggregation on biomaterial surfaces is shown in a schematic diagram in Figure 2.9.  
 
Platelet spreading and subsequent activation on the site of vascular injury or 
biomaterial surface occurs as a result of tight binding of platelets to the surface when 
multiple focal contacts form with fibrinogen and other surface adsorbed proteins 
[122]. Fibrinogen, von Willebrand factor and fibronectin binds to αIIbβ3 integrins 
[123]. Adhesive proteins contain a RGD sequence at their cell recognition site, which 
behave as a switch for spreading. However, in the absence of fibrinogen, when von 
Willebrand factor binds to αIIbβ3, the integrin recognises the RGD sequence in von 
Willebrand factor and platelet spreading is initiated [42]. During activation, when the 
α granular membrane fuses with the plasma membrane, αIIbβ3 receptors from the α-
granules along with any remaining αIIbβ3 intra-platelet receptors from the canaliculli 
system present themselves to the cell surface. Platelet aggregation occurs when 
fibrinogen, due to its symmetrical structure, acts as a bridge to connect activated 
αIIbβ3 receptors of adjacent platelets.   
 
Hillary et al [124] showed phosphorylation of the cytoplasmic domain of the GPIIIa 
subunit of the αIIbβ3 receptor complex was necessary to activate the receptor prior to 
fibrinogen binding. Protein kinase C [125], and increased intracellular calcium ion 
levels provokes αIIbβ3 activation. However, protein kinase C activation can cause 
other integrin activation, aggregation and secretion independently of calcium (Ca2+) 
ions [126].  
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Figure 2.9 Platelet adhesion and aggregation on biomaterial surfaces [127] 
 
Nitric oxide and prostacyclin (PGI2) released from damaged endothelium elevates 
intracellular cyclic adenosine mono-phosphate (c-AMP) levels [128, 129]. C-AMP 
and cyclic guanosine mono-phosphate (c-GMP), governed by protein kinase C, 
down-regulates receptor exposure by phosphorylating threonine and serine residues 
of an intermediating regulatory protein. Following fibrinogen binding, a sequence of 
tyrosin phosphorylation of intracellular proteins, initiated by the β subunit [130] of 
the activated receptor, causes cytoskeletal rearrangements in platelets for filopodia 
development [92, 131, 132]. ADP released from the dense granules binds to P2Y1 
and P2Y12 receptors on platelets causing intracellular calcium ion mobilisation, which 
initiates a change in platelet morphology [133, 134] as shown in Figure 2.10. ADP 
also binds to P2X1, an ATP gated channel, opening the channel to facilitate the influx 
of extracellular calcium across the membrane [135]. Increase in calcium ion levels to 
1µM activates Rap 1B (Ras family member) molecules [136], which further activates 
αIIbβ3 integrins [137]. Thrombospondin binds to GPIV inducing the stabilisation of 
fibrinogen bridges [138].  
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The aggregation reaction causes thromboxane-2 (TxA2) synthesis. Furthermore, ADP 
released from dense granules, and thrombospondin released from α-granules of 
platelets enhances platelet aggregation. Agonists such as TxA2 (by binding to TP 
receptors on platelets) and ADP (by binding to PAR1 and PAR4 receptors on 
platelets) along with the sequence of events following thrombin activation potentiate 
the growth of thrombus by forming a layered platelet plug. The above mentioned 
agonists signal via G-protein coupled receptors on the platelet surface facilitating the 
detachment of α and β subunits [139]. The dissociated subunits interact with platelet 
enzymes, adenyl cyclise, causing calcium ion release.  
 
 
Figure 2.10 Morphological changes in platelets during activation. Image shows 
platelets in their rested state, various stages of shape change with filopodial 
extrusions and completely spread stage. [140] 
 
During high shear stress conditions, such as during circulation through micro-vessels 
or stenoic arteries, aggregation is also mediated by von Willebrand factor and its 
interaction with GPIb. Following a series of events, upon binding, intracellular 
calcium ions increase causing conformational change in αIIbβ3 integrins activating the 
receptor for von Willebrand factor binding [141]. Downstream of fibrinogen bridge 
formation, extracellular to intracellular cell signalling occurs. Proteins such as talin, 
myosin, tyrosine kinases (spleen tyrosine kinase and Src) and C1B1 bind with the 
αIIbβ3 cytoplasmic domains causing the phosphorylation of the β3 strand of the 
integrin [142]. Furthermore, binding of fibrinogen to this integrin causes an increase 
in Src activity causing an increase in integrin activation for thrombus. von 
Willebrand factor have been shown to bind to and activate GPIb, as well as, 
aggregate platelets by forming inter-platelet bridges by binding to adjacent αIIbβ3 
integrins [138]. However, during low shear-shear stress conditions, fibrinogen, 
fibronectin and other platelet activators play an vital role in platelet aggregation [130, 
143]. Clot stabilisation is controlled by adhesion molecules such as: junctional 
adhesion molecule A and C, which mediate the signalling process and attachment 
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between platelets and between platelets and leukocytes [144, 145]. Other adhesion 
molecules expressed on activated platelets include endothelial cell specific adhesion 
molecule (ESAM) [146], CD 226 [147], and, signalling lymphocyte activation 
molecule [148] and CD84 [149]. Receptor-ligand binding induces Rap1B integrin 
activation and signalling [142]. 
 
 
Structural changes during platelet activation 
 
During platelet activation, platelets transition from their discoid shape to a spherical 
figure with extensive and pointed pseudopodia, by depolymerisation of microtubular 
bundles and polymerisation of actin monomers to actin filaments. The actin filaments 
cause surface of platelets to contract and form indents with bulky protrusions 
alongside. Actin monomers, in its resting state are bound to ADP. During activation, 
ATP becomes available for actin to assemble into ATP-bound monomers with two 
pointed ends, one low affinity actin binding end and one high affinity fast growing 
end [42]. Actin filaments form local adhesion sites with the plasma membrane by 
anchoring to transmembrane integrin molecules such as: αIIbβ3 [150] and one none 
non-integrin molecule GPIbIX. Stability of the focal adhesion point is regulated by a 
protein called RHO (member of the RAS family) [151]. Thrombin activation 
eventuates the activation RHO [152] and consequently, the activated RHO further 
activates kinases, which phosphorylate myosin light chain kinase, regulating actin 
dependent cytoskeletal shape [153-155]. Thrombin activates platelets in two way; 
first by signalling via PAR1 and followed by Par4 platelet receptors or by binding to 
GP1bα integrins [156-159]. In general, shape change can be either induced by many 
agonists such as: thrombin, TxA2, vasopressin, platelet activating factor, U44069 and 
ADP via calcium independent pathways.  
 
Microtubules and microfilaments within platelets re-assemble to form a central ring 
enclosing all the organelles. The granules are contracted towards the surface where 
its secretory contents are extruded.  The membranes of granules fuse with the 
membrane complex releasing P-selectin (GMP-140, PADGEM – granular membrane 
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protein) into the plasma membrane. α-granules require high concentrations of an 
agonist, similar to lysosomal granule, which requires high concentrations of collagen 
or powerful activating agents like thrombin, to release their granular particles. Dense 
granule, on the other hand, can easily secrete its contents. Apart from these three 
granules, during activation and aggregation, when activated by agonists such as 
thrombin and collagen, platelets synthesise and release thromboxane (TX)A2 and 
platelet activating factor to create a positive feedback loop. Immobilised calcium ion 
in platelets activates phospholipase A2 [160], which in turn modulates phospholipids 
in plasma membrane into arachidonate acid which in-turn forms TxA2 by an enzyme 
called cyclooxygenase [161]. Due to its short half-life (30seconds), TxA2 
immediately crosses the membrane barrier activating surrounding platelets. 
 
Di-acyl glycerol (a component of phospholipase C, which activates protein kinase C 
to release Ca2+ ions from dense tubular system) mediates the fusion of granular 
membrane to plasma membrane [109, 162]. Interaction of actin filaments with 
myosin heads facilitates contraction within platelets for granular centralization and 
secretion.  ADP and collagen induces the phosphorylation of myosin molecule and 
the subsequent contractile movement between actin and myosin, while tropomyosin 
and caldesmon proteins in platelets regulate this process.  
 
 
 
2.1.6 Coagulation Cascade 
 
The coagulation of blood involves the transference of blood from its liquid state to a 
gel-like texture triggered by a chain reaction involving, platelets and coagulation 
factors.  While platelets immediately establish a thrombus seal, called the primary 
hemostasis; soluble-coagulation factors (or clothing factors) from the blood plasma 
respond in a cascade of complex and sequential proteolytic (enzymatic) reactions, 
which results in formation of a fibrin-dependant blood clot. This is shown in Figure 
2.11. 
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Initiation of fibrin-dependant clotting occurs either by endothelial surface-mediated 
reactions, or through tissue factor (TF) expression by cells, leading to the formation 
of Factor Xa. The tissue factor dependent clotting follows the extrinsic pathway, 
while the negatively charged surface-mediated clotting occurs via the intrinsic 
pathway. The common pathway refers to the series of events that follow downstream 
of thrombin formation to produce fibrin clot. Essentially thrombin cleaves fibrinogen 
to fibrin allowing fibrin monomers subsequent polymerisation which strengthens the 
platelet plug.  
 
 
Figure 2.11 Simplified version of the coagulation cascade. [22, 163] 
 
 
The activation of the clotting factor occurs as an inactive factor becomes 
enzymatically active upon contacting a surface or after being proteolytically cleaved 
by other enzymes. Once activated, the newly activate enzyme then activates another 
inactive precursor factor, until Factor XIII is activated by thrombin. Fibrinogen then 
crosslinks to form and stabilise the fibrin clot into an insoluble fibrin gel. The fibrin 
chain holds the loosely aggregated platelets, and can be degraded via fibrinolysis 
[164]. Occurring simultaneously, the fibrin clot reinforces and stabilises the initial 
platelet plug, inducing a more efficient secondary hemostasis.  
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With the exclusion of thrombin and fibrin, the newly formed enzymes have low 
activity until they bind to membrane receptors of the activated platelet or to enzyme-
specific protein co-factors. This cascading reaction process is mediated by the 
presence of plasma inhibitors and active proteases. 
 
 
2.1.6.1 The Extrinsic Pathway 
 
Tissue factor, usually absent from blood-contacting cells but expressed on damaged 
non-vascular cells at the site of injury [165], binds to the inactive plasma Factor VII 
and activates  this vitamin K-dependent factor. In specific, monocytes [166-168] and 
leukocytes (because of monocytes) [169], in the presence of a blood contacting 
biomaterial have been shown to express tissue factors. Under normal conditions, 
approximately 1% of available Factor VII circulates in plasma in their activated state 
(Factor VIIa) [170]. Upon exposure to tissue factor, Factor VII and VIIa form tissue 
factor:VII and tissue factor:VIIa extrinsic tenase complexes with tissue factor, 
respectively. Factor VII assembles on the phosphylipid surface of the cell membrane 
via calcium binding. Prothrombinase enzyme cleaves prothrombin to thrombin. Once 
bound, the tissue factor:VIIa complexes (aswell as Factors IXa, Xa, XIIa and 
thrombin [171, 172]) activate the inactive Factor VII in remaining tissue factor:VII 
complexes forming a self-amplifying, auto-catalytic feedback loop [173]. In addition, 
tissue factor:VIIa complexes either readily activates Factor X [174], or, activates 
Factor IX, by proteolysis, which then causes Factor IXa to convert Factor X to its 
activated state (Factor Xa) under the presence of cofactor Factor VIII. The extrinsic 
pathway is highlighted in red, in Figure 2.12.  
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Figure 2.12 A comprehensive diagram of the coagulation cascade [16] 
 
 
2.1.6.2 Intrinsic Pathway 
 
The intrinsic pathway (highlighted in blue in Figure 2.12) is initiated by contact 
activation of Factor XII, by latching its heavy chain, to a negatively charged surface. 
Factor XIIa automatically activates circulating Factor XII and converts Factor XI 
into Factor XIa, dimeric serine protease. Factor XIIa also activates prekallikrein into 
kallikrein and cleaves the light chain of high molecular weight kininogen to carry out 
its pro-coagulant activity. This liberates Factor XIa from its activating surface. 
Kallikrein reciprocates by activating Factor XII and converts high molecular weight 
kinogen to bradykinin. The cleaved high molecular weight kinogen, or bradykinin, 
binds readily to prekallikrein to form kallikrein. This allows for a potent association 
between the inflammatory and coagulation pathways, facilitating the conversion of 
Factor X to Factor Xa by Factor XIa. 
 
Collagen present in the sub-endothelium after vessel injury has been known to 
initiate the above mentioned sequence of intrinsic reactions [175]. However, the 
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significance of the intrinsic pathway to blood coagulation on artificial biomaterials 
remains speculative, as the occurrence of negatively charged surfaces in vitro and in 
vivo is limited. In fact previous studies have shown that that deficiencies in high 
molecular weight kinogen, prekallikrein and Factor XII, have not shown any 
abnormal bleeding in in vivo models [176-178]. 
 
 
2.1.6.3 The Common Pathway 
 
The common pathway, as the name suggests, applies to both the intrinsic and 
extrinsic coagulation pathway. Activated Factor X converts vitamin K-dependent 
prothrombin to its activated state, thrombin by cleaving the Gla portion of the N-
terminal of prothrombin. Thrombin, like Factor VII, requires calcium to bind to the 
platelet phospholipid membrane. Thrombin interacts with Factors V, VIII, XI, 
platelet receptors and proteins S and C to mediate the synthesis and breakdown of 
thrombin enzymes. Factor Xa along with calcium, Activated Factor V, released from 
platelets α-granule, along with phospholipids form a prothrombinase complex that 
increases the rate of thrombin production by 300,000 fold. 
 
Thrombin binds to fibrinogen’s central domain and cleaves fibrinopeptides A and B 
to form fibrin monomer. Fibrin monomers attach to one another side to side, half 
way along the length of the protein to form long, thin fibrin monomer strands. Heavy 
crosslinking of Factor XIIIa provides strength for mesh-like formation and against 
plasmin degradation. Platelet plug formed from primary haemostasis is fastened by 
the fibrin mesh, encapsulating and occluding the ruptured vessel wall. The fibrin 
strands bind to platelet receptor glycoproteins as well as adhesion protein such as 
thrombospondin, von Willebrand factor and fibronectin. Adhesive proteins act as 
bridges between fibrin mesh and platelets, platelets and sub-endothelial matrix, and, 
collagen and plasma proteins. Fibrinogen links to actin filaments in intracellular 
platelets via αIIbβ3 receptors reducing the retraction of blood clots and increases the 
available passageway for blood in the vessel lumen.  
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The size and extent of thrombus formation is limited by several factors such as; shear 
forces, activated protein C and other plasma inhibitors (namely C1 and AIII and 
tissue factor pathway inhibitor). Shear forces generated by the rapid flow of blood 
tear away weakly formed platelet clots, while, activated protein C, created by 
thrombin-thrombomodulin complex formed on endothelial surface, inhibits the 
function of Factors V and VII and plasma inhibitors.  Both conditions work 
synergistically to limit the function of soluble pro-coagulant molecules such as 
Factor Xa and thrombin. Several inhibitors can interfere with these clotting reactions 
(shown in Figure 2.12). C1 (serpin protease) and AIII (anti-thrombin) and tissue 
factor pathway inhibitor inhibit the clotting cascade activity by limiting the function 
of Factors Xa, XIa, XIIa and IXa; and heparin, inhibits thrombin, and Factors Xa, 
IXa and Xia, by accelerating their interactions with AIII.  
 
 
2.1.7 Plasma proteins 
 
Proteins present in blood plasma, known as: serum proteins or, plasma proteins, are 
either involved with the maintenance of osmotic pressure of blood; aid in the 
transport of hormones, vitamins, metals and lipids in the circulatory system; and 
behave as enzymes, complement components, protease inhibitors and kinin 
precursors. Apart from this, the adhesion and activation of platelets, activation of the 
coagulation cascade and the regulation of immunological mechanisms are also 
mediated by plasma proteins. Over 100 different plasma proteins have been 
identified with their concentrations in plasma ranging between 35-50 mg/mL for 
serum albumin to only 0-5 pg/mL for interleukin 6 [179].  
 
On blood contacting biomaterials, plasma proteins readily and rapidly adsorb onto 
the surface within seconds to generate a biologically active surface for haemostatic 
response [180, 181]. Blood cells arriving at the biomaterial surface primarily interact 
with the surface adsorbed plasma proteins rather than directly with the material itself, 
as such, understanding the initial adsorption of proteins onto a biomaterial surface is 
key in determining the biomcompatibility and haemocompatibility of the implanted 
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biomaterial. Fibrinogen, fibronectin, vitronectin, immunoglobulins and von 
Willebrand factor are naturally soluble plasma proteins found to be potential 
mediators of platelet adhesion and aggregation. And of these proteins, fibrinogen has 
been found to be the key protein in the adhesion process, while, fibronectin, von 
Willebrand factor and immunoglobulins merely play a supporting role. Apart from 
platelet activating proteins; other proteins such as: the highly adsorbing albumin, as 
well as Hageman factor, high molecular weight kinogen (HWMK), and factor VIII/ 
von Willebrand factor complex, which adsorb at less concentrations also readily 
adhere onto biomaterial surfaces [182]. 
 
The type of protein adsorbed and the dynamics behind protein adsorption is dictated 
by chemical and physical properties of the biomaterial surface. Thermodynamically, 
it has been shown that the adsorption of proteins may only occur if there is a 
decrease in Gibbs free energy (G): 
 
ΔadsG=ΔadsH-TΔadsS <0                                              eq 1 
 
where 
H=enthalpy 
S=entropy  
T=temperature 
Δads = overall change in the characteristic function of adsorption 
 
This decrease is generally attributed from an increase in system entropy caused by 
the interactions between charged groups at the surface-blood interface and 
conformational changes in the structure of the adsorbed protein. Not all proteins are 
indefinitely bound to the surface after adsorption. Proteins have been shown to de-
attach and re-attach changing the composition of proteins over time, known as the 
Vroman effect phenomena [183, 184]. The Vroman effect also states that the 
adsorbed proteins form a monolayer covering on the surface and the thickness of the 
adsorbed protein monolayer has been found to range between 2-10 nm, depending on 
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the size and shape of the protein [185]. Shear flow have not been shown to affect the 
adsorption process, even at high shear rates such as: 2700 s-1 [186]. The surface 
properties of the biomaterial determine the selectivity of the proteins adsorbed on the 
surface where the concentrations of the adsorbed proteins may be 1000- fold higher 
than normally found in blood [187, 188]. It has been found that maximum protein 
adsorption is achieved when surfaces and proteins possess opposite net charges with 
a pH between the isoelectric points (pI) of the surface and the protein [187]. The 
biological activity of plasma proteins has been shown to change upon adsorption due 
to tertiary and secondary conformational changes within the protein structure [188]. 
 
 
2.1.7.1 Fibrinogen 
 
Fibrinogen (Fg) is an trinodal [189], elongated extracellular protein and makes up 2-
3% of plasma proteins. It has a molecular weight of Mw = 340 kDa and appears as a 
rod like structure with dimensions 45 × 9 × 6 nm. Fibrinogen has 3 subdomains (E, D 
and α-C), with a central globular domain attached to two elongated domains 
positioned distal to one another [190]. Furthermore, firbinogen is a negatively 
charged protein at physiological pH (pI 5.5) because of its D and E domains. These 
two domains are the most surface active domains involved in surface and platelet 
binding. The α-C domain on the other hand, is positively charged and acts as a 
pioneer in the surface binding process, although, it does not bind to the surface [191, 
192].  
 
Fibrinogen is found in blood in concentrations of 3mg/ml and is known for its pivotal 
involvement in the adhesion of platelets. Stanford, Munoz and Vroman [193] in 1983 
showed platelets adhere onto biomaterial surfaces pre-adsorbed with plasma proteins 
primarily via surface-bound fibrinogen. Fibrinogen is an adhesive protein that 
interacts strongly with biomaterial surfaces irrespective of the electrostatic charge on 
the surface [117, 194, 195]. Fibrinogen adsorbs onto biomaterials almost 
immediately upon contact, causing its spreading, denaturation, or, unfolding of its 
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tertiary structure. This conformational transformation causes tight binding of 
fibrinogen to the biomaterial surface allowing for increased platelet interaction [196].  
 
Tsai et al [116] deduced that apart from fibrinogen, vitronectin, fibronectin and von 
Willebrand factor can also induce platelet adhesion, although, surface-bound 
fibrinogen was the major plasma protein involved in platelet adhesion. Even at small 
concentrations fibrinogen has been shown to elicit a full-scale platelet attachment 
[197], while, fibronectin, only at 10x its physiological concentration or greater can 
mediate the same response [198]. Fibrinogen proteins bind to platelets via activated 
their αIIbβ3 integrins on the platelet surface, although binding of fibrinogen to inactive 
αIIbβ3 integrins have also been reported [120, 199, 200]. Fibrinogen binding to 
agonist-stimulated platelets results in platelet aggregation, by cross-linking adjacent 
activated platelets. Unstimulated platelets do not allow for fibrinogen related 
aggregation because of tightly regulated constraints placed by actin or actin-
associated proteins located within the platelet sub-membrane [201]. Turnover of 
actin filaments upon platelet stimulation have been shown to facilitate αIIbβ3 platelet 
receptor binding to fibrinogen.  
 
The γ chain of the carboxyl (C)-terminal dodecapeptide sequences located at amino 
actid resides 400-411 in fibrinogen, known as the platelet binding domain, have been 
implicated as the major site of platelet attachment [202]. The γ-chain sequences are 
located at distal ends of the protein and either: bind to the overlapping sites in αIIbβ3 
integrins, or, to two distinct sites, where the binding of one site causes a 
conformational change in the integrin, precluding the binding of the other peptide 
[203, 204]. The tri-peptide Arg-Gly-Asp (RGD) sequences in fibrinogen, also 
adheres to platelets, in a similar manner to vitronectin, fibronectin and von 
Willebrand factor, although, it does so at a much lesser extent [199, 200].  
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2.1.7.2 Albumin 
  
Albumin is a relatively large, globular, extracellular protein with dimensions; 8 × 8.7 
× 6 nm, and molecular weight of Mw = 65 kD. It has an abundance of 60-70% in the 
plasma [205]. It is a main constituent of blood plasma serving the transport of 
metabolites and regulates osmotic pressure [206]. Albumin is a negatively charged 
protein (pI 4.9) and is composed of three homologous domains comprising a total of 
585 amino acids. Each of its domains consists of two sub-domains stabilised by 17 
disulfide bridges [207].  
 
Albumin readily adsorbs on biomaterial surfaces, irrespective of electrostatic 
interactions because of its low conformational stability [208]. In 1969 Salzman and 
colleagues [209, 210] stumbled upon the role of human serum albumin in decreasing 
the affinity for platelet binding onto biocompatible surfaces by showing the 
preferential adhesion of albumin on heparinised surfaces, by competing with 
fibrinogen for surface binding-sites, reducing the total concentration of fibrinogen 
proteins adsorbed on the surfaces. Since it was known that platelets requires a protein 
co-factor (such as fibrinogen) to adsorb onto biomaterials to promote platelet 
activation, they proposed that albumin may play a possible role in minimising 
platelet attachment [209]. For this reason albumin has been utilised as a possible 
thrombo-resistant coating for several haemocompatible applications.  
 
In fact, albumin is often used to coat vascular grafts to passivate surfaces from 
platelet and leukocyte attachment and activation, although, albumin has been 
implicated with mediating monocyte attachment on biomaterial surfaces [205, 211-
213]. It has been shown that albumin proteins do not possess the adhesive sequences 
necessary to mediate the adhesion of platelets to biomaterial surfaces [214, 215]. 
Nimeri and colleagues [216] in 1998 analysed the degree of neutrophil activation on 
immunoglobulin (IgG) and albumin protein-coated surfaces. Results showed that 
when compared with IgG, albumin coated surfaces exhibited decreased neutrophil 
response showing decreased cell spreading and lack of reactive species production, 
necessary for neutrophil activation. Furthermore, it was found that neutrophil 
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attachment occurred more slowly on albumin-adsorbed surfaces. Another study by 
Renner and colleagues [217] looked at patterns of competitive protein adsorption 
between fibronectin and albumin. Albumin was shown to have a higher binding 
affinity to the surface than fibronectin, although, the binding affinity of albumin to 
the surface can be owed to the surface chemistry of the material. Similar results were 
found when Fibrinogen was displaced with albumin [218]. 
 
 
2.2 Blood-compatible Surfaces 
 
Blood contacting implants perform in a corrosive bio-environment due to the 
metabolic activity of the cells and fluids in our body, which, for biomaterials with a 
low wear resistance, causes the release of metal ions and wear debris. This results in 
cellular and tissue damage, infections and thrombus generation, leading to adverse 
medical conditions and failure of the implant. The bio-surfaces of devices such as: 
catheters, blood vessel grafts, vascular stents, artificial heart valves, circulatory 
support devices, various extracorporeal tubings, hemodialysis, hemapheresis and 
oxygenator membranes; that are in direct contact with streaming blood are selected 
with biomaterials that exhibit good mechanical properties, stability, tribological 
properties, biocompatibility, and most importantly: haemocompatibility.  
 
Despite over several decades of progress in understanding the interplay between 
blood and biomaterial surfaces [5, 219, 220], the development of a non-
thrombogenic surface still remains an ongoing task.  Insufficient hemocompatibility 
impacts patient mortality by impairing the functionality and the safety of the device 
[5]. Thrombotic occlusion of blood vessels, resulting in emboli and proliferative 
processes in the vessel wall has been attributed to the adhesion and activation of 
haemostatic (blood coagulation and platelets), and immune systems [221]. At 
present, thrombotic event has been suppressed by consuming prophylactic anti-
coagulant medication (heparin, warfarin, etc). Though it is not ideal, such 
medications need to be chronically administered to prevent adverse conditions, or 
patient morbidity. 
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The interactions between blood and biomaterial surfaces are initiated by the physical 
and chemical properties of the foreign material. Efforts have therefore been directed 
towards modulating biomaterial surfaces by: altering the physiochemical and 
topographical characteristics; to control the composition of the layer of plasma 
proteins that is invariably adsorbed upon blood contact, and consequently, 
interactions with haemostatic (platelets and coagulation cascade and the complement 
system) blood components [5]. This has an added advantage of improving the 
biomaterial’s haemocompatibility whilst retaining the advantageous mechanical and 
physical properties of the underlying bulk substrate. Therefore, surface modifications 
such as: the implementation of thin surface coatings, and nano-topographical changes 
to the bulk substrate, which can vastly influence these haemostatic responses will be 
discussed in the following subsections. 
 
. 
2.2.1 Surface Modification 
 
Modification to an implant surface by the addition of thin film coatings can vastly 
influence a biomaterial surface’s interaction with blood is an ideal means of 
improving the biomaterial’s haemocompatibility without affecting the bulk 
material’s mechanical and physical properties. Presently researched surface 
modifications can be categorised into 5 groups: inorganic and organic surface 
coatings; as well as, functionalisation of surfaces using: bioactive and passivating 
molecules, and the endothelialisation of biomaterial surfaces.  
 
Organic coatings have already been employed in several commercially available 
blood-contacting devices. Polymers such as polyethersulfone and cellulose are the 
principle materials used in haemodialysis, while polysiloxane and polypropylene are 
used in oxygenator membranes [222-224]. DacronTM, knitted polyester, and 
expanded polytetrafluorethylene foils (GoreTexTM) are widely used in vascular 
grafts; and polytetrafluorethylene, polyethylene, polyvinylchloride, polyurethanes 
and polysiloxane and PEBAXTM (a polyether block amide) are used in catheters 
[222-224]. While, the surfaces of these polymers can be used to easily modify 
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biomaterial surfaces, they have been shown to undergo hydrolytic degradation, in 
vivo, adversely triggering the systemic immune response [225, 226]. 
 
Another approach used to minimise thrombotic events caused by biomaterial 
surfaces is by passivating the blood-contacting devices such as: dialysis membranes, 
stents and stent grafts with inert long-chained hydrophilic molecules such as: 
polyethylene oxide (PEO), polyethylene glycol (PEG) and tetraethylene glycol 
dimethyl ether (tetraglyme) [22, 227-231]. These functionalised molecules have been 
implanted on biomaterial surfaces by methods such as: physisorption, covalent 
bonding and block integration [232]. Results show that the above mentioned 
modified surfaces have been found to reduce coagulation activation, blood platelet 
adhesion and complement activation [229]. Apart from functionalised molecules, 
inert bio-molecules such as albumin have also been used to passivate bio-surfaces 
[233, 234]. Albumin is found in high concentrations in blood plasma. It can be used 
to mask the biomaterial surface from clot formation as it lacks the biological 
sequences necessary for platelet receptor adhesion. However, because of changed to 
the protein upon surface adsorption, and the physiological degradation of the protein 
from sterilisation or over time due to a limited shelf life, limits the potential of 
albumin [233, 234]. Furthermore, albumin is derived from humans and as such may 
pose a major risk of the transmission of infectious diseases to patients. 
 
Opposite to surface passivation, bioactive coatings using immobilisation of 
functionalised molecules and biomolecules such as: sulfated mucopolysaccharide 
heparin (to mimic the anti-coagulant, heparin sulphate),    have been used in tubing’s 
and oxygenator membranes, dialysis membranes, vascular stents, stent grafts, bypass 
grafts, and ventricular assist devices [235-238]. Bioactive coatings aim to mimic 
active anticoagulant mechanisms performed by the anti-coagulant enzymes in blood 
and endothelial cells of the vascular lining. This method is still at its infancy, as 
targeting complex receptors using appropriate bioactive ligands that are immobilised, 
oriented and presented at high concentrations is a complex process that is still not 
completely understood. The immobilised bio-molecules like heparin-sulphate are 
highly susceptible to degradation caused by normal physiological processes of 
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proteolytic enzymes (inactivation by protamine sulphate) which can quickly 
deactivate the surface modification [239-242]. Apart from this, technological issues 
such as: limited shelf life and limited sterilisability are impending problems that 
haven’t been addressed [239, 241]. Sulfated pentasaccharides have been recently 
studied as a replacement for the long-chain heparin [243]. While, these structures are 
more resistant against enzymatic degradation than the whole heparin molecule, the 
affinity of the immobilised molecule heparin-binding ligands did not lead to a 
heparin-like activity in complex blood [243]. Other molecules such as: hirudin 
covalently immobilised to DarconTM for vascular grafts) [244, 245] and benzamidine 
(immobilised on polyoctadecene alt maleic anhydride, PO-MA) [246] have been 
used as a direct inhibitor of thrombin. While, these surfaces have shown decreased 
fibrin formation and cell adhesion onto the surfaces when compared with compared 
with the non-coated surfaces, the modification has not come to clinical application 
because of the high expenses involved and a possible degradation of the molecule in 
vivo [221]. As an alternative to the inhibition of the coagulation cascade, the active 
inhibition of platelet activation and aggregation through using drug eluting coatings 
have also been studied. Abciximab [247] and dipyridamol [248], an antagonist to 
platelet integrin αIIbβ3, and ADP, respectively, as well as the release of nitric oxide 
from surface coatings. While these surfaces have been shown to reduce platelet 
adhesion and aggregation; cytotoxic effects to the surrounding tissue and blood were 
also reported [249].  
 
Endothelialisation of biomaterial surfaces is another form of surface modification to 
produce a permanently active haemocompatible coating [221]. Typically, autologous 
endothelial cells are harvested and cultivated, in vitro, on immobilised ECM on 
biomaterial surfaces, followed by their implantation [250]. The ECM provides the 
peptide sequences and framework for endothelial cell binding and growth, although, 
the matrix alone exhibit highly thrombogenic cues for platelet adhesion and 
activation [251]. As such, a complete coverage by cells is necessary prior to contact 
with blood [251]. As an alternative, surfaces were immobilised with antibodies 
specific for endothelial cells, to allow the favourable binding of the cells to the 
biomaterial surface upon implantation. An example of which is the sustained release 
of vascular endothelial growth factor VEGF [252]. While VEFG was employed to 
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stimulate endothelialisation from cells within the body, the rapid degradation of the 
factor, in vivo, as well as limitations associated with implant sterilisation were 
limiting causes for further investigation [253].  
 
Commercially available vascular stents or mechanical heart valves already employ 
haemocompatible inorganic ceramic coatings such as: nitrides, metal oxides like 
titanium oxide, and carbon based inorganic coatings like hydrogenated amorphous 
carbon (a-C:H, diamond-like carbon DLC) [254]. Inorganic coatings behave as 
passive, corrosion resistant coatings and have been shown to exhibit high inertness, 
mechanical and chemical stability. DLC coatings are presently being used in 
artificial heart valves [255, 256] and on vascular stents [257]. DLC offers several 
advantages over other materials as they highly inert, very smooth, present low 
friction and minimal wear. DLC’s hydrophobic nature allows for an increased 
adsorption of albumin proteins and enhanced adhesion of blood platelets. Apart from 
DLC; titanium oxides and titanium nitrides were also widely investigated. Titanium 
has a tendency to readily form a native oxide layer. This oxide layer is only a few 
nano-meters in thickness and has thus far exhibited low haemocompatibility [258]. 
Studies have shown, increasing the coating thickness to a few hundred nano-meters, 
using deposition techniques such as FAD [259], have greatly improved the surface’s 
haemocompatibility [260-262]. Titanium oxide coatings have been demonstrated to 
adsorb lower concentrations of fibrinogen on the surface, suppress the activation of 
the coagulation cascade and reduce blood platelet adhesion when compared with 
non-coated titanium films [263]. Haemocompatibility of titanium oxide [264, 265], 
oxynitride [266] and nitinol [261] surfaces have also been demonstrated under shear 
flow in vivo [267]. Amorphous silicon carbide (a-SiC:H) with similar properties to 
titanium oxide has also been commercially used as a coating on vascular stents and 
heart valves [268, 269]. Whilst commercially used inorganic biomaterial coatings 
have shown to reduce the severity of haemostatic responses, they have not 
completely suppressed the activation of coagulation factors and platelet interactions.  
 
Apart from the addition of a thin film coating, changing a material’s nano-
topography has also been shown to vastly influence blood proteins adsorption and 
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platelet interactions on biomaterial surfaces. The interaction between blood and 
topography involve different mechanisms depending on the typical feature size of the 
topography. As such, evaluating the interaction of blood with surface topography 
requires a strict control on the chemistry at the material's interface. Many surface 
modification techniques such as: chemical treatment, lithographic techniques, 
glancing angle deposition and self-directed assembly of nanoparticles using block 
co-polymer techniques; have been employed to improve biomaterial’s 
haemocompatibility. Nano-topographical changes have resulted in the formation of 
particles, pores, pits, and grooves, though it is still unclear to what extent such 
surface nano-topographies influence blood interactions. A review of surface nano-
patterning techniques and the influence of nano-patterns on platelet interaction is 
detailed in Section 2.2.1.4. 
 
 
2.2.1.1 Diamond-Like Carbon (DLC) surface coatings 
 
Carbon (C) is a fundamental element existent in all organic molecules and it can 
exist in three different hybridisation states sp1 (carbon-based polymers), sp2 
(graphitic) and sp3 (diamond-like) [270]. This allows carbon to co-exist in a variety 
of crystalline and disordered-amorphous phases [270, 271]. Diamond has 100% sp3 
carbon bond configuration with four valence electrons positioned in a symmetrical 
orbital structure. Each valence electron forms strong covalent σ bonds with adjacent 
atoms and it is these strong bonds that are responsible for diamond’s excellent 
hardness, electrical resistivity, chemical inertness, and wear properties [270]. 
Graphite exhibits sp2 hybridisation of its carbon atoms presenting strong anisotropic 
properties in one direction because of strong intra-layer covalent bonds (three of the 
four valence electrons exhibit strong σ bonding, similar to diamond), while, the 
perpendicular direction (between layers) only possesses weak van der Waals forces 
from weak π bonding between the fourth electron and adjacent atoms. The sp2 
hybridisation results in low hardness, electrical resistivity, and high wear rate, 
combined with low friction [272] 
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Diamond-like carbon (DLC) is a class of materials with diamond-like and graphite-
like properties. It resembles a metastable form of amorphous carbon with varying 
atomic bond structures depending upon their: hydrogen content (up to 40%); the 
proportion of sp3; and sp2 hybridisation states [273]. The ratio of the three factors 
allows DLC to exhibit range of characteristics resembling a mix of graphite-like and 
diamond-like properties such as: high mechanical hardness, chemical inertness, low 
friction coefficient, low wear resistance, corrosion resistance, optical and infrared-
transparency, semiconductor-like properties because of its wide band gap, and 
excellent smoothness because its amorphous nature (no grain boundaries) [273-282]. 
As such, DLC can be applied as a thin film coating and can adhere well to metallic 
and non-metallic biomaterials [270, 283, 284]. Over the past two decades DLC has 
emerged as a potential material because the above mentioned properties of DLC 
match the criteria required for a good biomaterial for its application in the 
cardiovascular field, as well as other fields such as: dentistry, orthopaedic and 
optometry [285].  
 
In the cardiovascular field, the main causes of implant failure within the body has 
been due to a lack of compatibility between the surface of the biomaterial and blood, 
as well as, wear particle formation from constant delamination of the implant surface 
under shear stress [286]. Both adverse conditions ultimately lead to the formation of 
thrombus clots which can eventuate into patient death. A haemocompatible, low 
friction, smooth, biocompatible coating, with excellent tribological properties such as 
DLC, would reduce these problems.  
 
 
2.2.1.1.1 Chemical and mechanical properties 
 
DLC exists as amorphous carbon with a disordered network of sp3 and sp2 
coordinated bonds, as well as hydrogenated alloys. Amorphous carbon (a-C) films 
have high sp2, while, coatings with high concentrations of sp3 bonds are referred to 
as tetrahedral amorphous carbon (ta-C) [274, 287]. Amorphous carbon coatings with 
high concentrations of hydrogen atoms are known as hydrogenated amourphous-
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carbon (a-C:H) [274]. The surface characteristics of each coating vary considerably 
with varying compositions of hydrogen, sp2 and sp3 bonding [286]. An adaptation of 
Robertson’s [270] ternary phase diagram, shown in Figure 2.13, illustrates the 
various forms of DLC and their respective deposition techniques. The sp2 corner of 
the ternary diagram represents materials of graphitic nature while the materials of a 
diamond-like nature lie near the sp3 corner. The limits of the triangle are defined by 
hydrocarbon polymers (H-C polymers). Any point beyond this line, deposition of 
carbon will not allow for interconnected networks, instead only the formation of 
carbon molecules is possible.  
 
Figure 2.13 Ternary phase diagram showing the various forms of DLC and their 
respective deposition techniques [288]. 
 
The mechanical and physical properties of the various DLC films, as shown in 
Figure 2.14, can be produced by modulating the deposition parameters of various 
coating technologies [278, 286]. In general, DLC films are formed by bombarding 
high energy carbon or hydrocarbon radical species with impact energies ranging 
from 50 to several hundred electron volts. A number of techniques have been 
employed to synthesise DLC films namely: ion beam deposition (IBD), radio 
frequency plasma enhanced chemical vapour deposition (r.f.-PECVD), filtered 
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cathodic vacuum arc (FCVA), ion plating, plasma immersion ion implantation and 
deposition (PIIID), magnetron sputtering, ion beam sputtering, pulsed laser 
deposition, and mass selected ion beam deposition [289-297]. It has been shown that 
the coating technology and carbon substrates determine the hydrogen content of 
DLC, while, the impact energy dictates the propensity of the sp3 fractions, and 
consequently the type of DLC film produced [298, 299]. Furthermore, when 
compared with diamond, these coatings can be fabricated in an economical manner 
for mass productions. 
 
 
Figure 2.14 A comparison of the mechanical properties of various DLC films [270] 
 
In comparison to the various forms of DLC, a-C:H and ta-C are the most commonly 
used coatings applications in biomedical field, and as such a-C:H and ta-C will be the 
primary focus in the following subsections. Unlike diamond, DLC coatings have 
superior smoothness and can be deposited at room temperature [300, 301], however 
they exhibit high intrinsic stresses and thermal stability (not application for ta-C), 
increasing their likelihood to delaminate off the underlying substrate. When 
compared with a-C:H; ta-C thin films, because of its inherently high sp3 (diamond-
like) fractions, exhibited higher density, increased elastic modulus (300 GPa for a-
C:H and 757 GPa for ta-C) and hardness values [270]. Addition of hydrogen atoms, 
as found in a-C:H, reduces the ratio of sp3/sp2 bonds and consequently exhibits 
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reduced hardness values and co-efficient of friction. A-C:H surfaces have been 
reported to achieve a co-efficient of friction of 0.05 [302], while ta-C surfaces exhibit 
co-efficient of friction between 0.1-0.15 [303]. In terms of surface characteristics, 
DLC has an inherently low surface energy. Amorphous carbon coatings have surface 
energies close to 40-54 mNm-1 with contact angles between 55-70º in water [304, 
305].  
 
Wear rates determine the degree of spallation or delamination of the coating. 
Biomaterial coatings with high wear rates would be ideal for cardiovascular 
applications, as it enables the substrate to withstand high shear rates with minimal 
delamination within the vascular walls. Ta-C surface have been shown to exhibit 
wear rates close to 10-9 mm3N-1m-1, while, a-C:H surfaces have shown wear rates 
between 10-6 and 10-7 mm3N-1m-1 [306]. Further, wear rates are inversely 
proportional to stress, young’s modulus and hardness; so a thicker layer of DLC 
coating should ideally increase the wear properties of DLC films. However, the 
adhesion strength between the coating and substrate have been reported to be higher 
with thin films suggesting that thin films are more wear resistant than thick films 
[270].  
 
DLC coatings in blood and medical applications pose an attractive prospect because 
they possess excellent haemocompatibility, wear properties, low co-efficient of 
friction, smooth finish and they provide desirable surface modifications to commonly 
used biomaterials. DLC, as thin films, have been used as a protective layer for: 
optical windows, magnetic storage disks, machinery and car parts, cutting tools, cold 
extrusion dies, micro-electromechanical devices (MEMs), etc [270, 300, 301, 303, 
307, 308]. Apart from this, in the biomedical field, DLC films are of particular 
interest as a protective coating for implants. The excellent wear resistance, non 
leaching properties and good sterilisation compatibility makes DLC ideal for several 
biomedical applications including: orthopaedic implants, surgical tools, contact 
lenses, dental implants, mechanical heart valves, ventricular assist devices, vascular 
stents, guidewires etc due to its excellent biocompatibility [254-256, 286, 308-311].  
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2.2.1.1.2 Biocompatibility 
 
Ratner [312] defines biocompatibility as “the ability of a material to locally trigger 
and guide normal wound healing, reconstruction, and/or tissue integration with only 
low degrees of inflammatory reaction” and surface compatibility as “the chemical, 
biological and physical appropriateness of an implant surface to the host tissues” 
[312]. Therefore, by investigating the interaction between cells and biomaterial 
surfaces; or, proteins and biomaterial surfaces, the biocompatibility of an implant 
material could be estimated. 
 
The biocompatibility and surface of DLC coatings were investigated extensively 
since the early 90’s through several cell culture techniques and in vivo studies 
analysing the tissue-biomaterial interface and the bio-tolerance of DLC films after 
long term implantation [281, 313, 314]. Macrophage and monocytic cells play a 
dominant role the in inflammation and interaction with implanted materials and as 
such the activation of these cells has been used as an important determinant in 
evaluating the immunological response of a biomaterial. When compared with 
polyurethane-coated, and uncoated 316-L stainless steel; ta-C coated substrates 
presented decreased spreading of macrophages and decreased inflammatory activity 
[315]. 
 
To evaluate the integration of the implant with the biological environment, the 
contact and growth of tissue specific cells such as: osteoblasts, fibroblasts, 
endothelial cells; were monitored for their adhesion, spreading and proliferation on 
the implant surface. Human fibroblasts and osteoblast-like cells did not show any 
cytotoxic effects when exposed to DLC films [316-318]. In fact, DLC coatings also 
showed promising results as a haemocompatible material [319-321]. Thompson et al 
[281] and Evans et al [314] studied the influence of a-C:H surfaces in activating 
mouse macrophage and mouse fibroblast cells. The results showed that fibroblast 
cells grew the thin films with no inflammation or toxicological effects, in vitro. 
Similar results were obtained from other studies looking at fibroblast and 
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macrophage response on a-C:H and ta-C films produced using glow discharge and 
various PECVD methods [316, 317, 322-324].  
 
A study looking at the incorporation of titanium (Ti) ions into a-C:H films, prepared 
by using a magnetron sputtering, on the activity of osteoblast, and osteoclast cells 
showed that the addition of Ti ions increased bone cell proliferation and minimised 
activity of osteoclast-like cell [323]. The incorporation of calcium oxide (CaO) in a-
C:H coatings, prepared using plasma decomposition of gaseous carbon precursors, 
showed improved biological acceptance of mouse fibroblasts to the doped thin films 
[325]. The influence of inductively coupled PECVD a-C:H and ta-C in glial and 
fibroblast cells for neuro-prosthetic implants in vitro was also investigated [326].  
 
Several in vivo studies were also carried out to analyse the influence of various 
conditions in the physiological environment on the biocompatibility of DLC 
surfaces.  A study conducted by Mohanty et al [318] looked at the tissue response of 
a-C:H-coated titanium substrates after its implantation in skeletal muscles of rabbit 
for 1 year. The results showed no cytotoxic or adverse immunological response, and 
the surfaces did not present any delamination of the film. A 52 week study 
investigating fibrous tissue formation and phagocytic response on a-C:H-coated 
orthopaedic pins and screws in guinea pigs showed the formation of thin connective-
tissue capsules by fibrocytes and collagen fibers in the subcutaneous layer [313]. 
Apart from this, bone and muscular apposition was also noticed, with no phagocytic 
reaction and corrosion products in the walls of the capsule. Another study looking at 
the implantation of a-C:H-coated CoCr cylinders in trans-cortical sites of sheep and 
intramuscular location of rats also showed no significant toxicological response 
because of the a-C:H coated implant [310]. All these studies indicate that DLC 
coatings are quite biocompatible and do not activate any inflammatory reaction in 
vivo. This provokes a growing interest in DLC as a protective coating for 
orthopaedics, cardiovascular, and dental application [327].  
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2.2.1.2 Titania (TiO2) surface coatings 
 
In the biomedical field, titanium and titanium based alloys have been widely utilised 
for their excellent corrosion-resistance and biocompatibility [328]. Although, 
titanium’s remarkable corrosion resistance has been widely attributed to the 
naturally-forming, passive oxide film on the surface of titanium [329-331]. This 
oxide layer forms spontaneously in air, water or other electrolytic solutions, and 
reforms upon surface damage. The thin native oxide film has thickness of 5-6 nm 
[332] and primarily consists of amorphous titanium dioxide (TiO2), while the 
presence of Ti3O, Ti2O, Ti3O2, TiO, Ti2O3, Ti3O5 also have been reported [333-337]. 
Titanium can exist in many different states because the solubility of oxygen is 
relatively high in titanium. As such the ratio of oxygen to titanium gradually 
changes, along with its physical properties, until the oxide layer reaches its stable 
form, TiO2. This protective and highly stable, passive TiO2 film is, in effect, the 
surface that will interact with the in vivo environment and is therefore of huge 
importance when considering cell-surface interactions. The bulk titanium will 
seldom play a role in blood-surface, or, tissue-surface interactions during the initial 
acceptance of the implant in vivo. As such there is a growing interest in TiO2 for its 
use as a surface coating in biomedical applications.  
 
The ratio of concentrations between oxygen and titanium ions at the interface 
between TiO2 and the bulk titanium, regresses from 2:1 (oxygen: titanium) to a 
much lower ratio in the bulk material. The most external layer of the interface has 
titanium ions bonded to chemisorbed water and weak, physisorbed hydroxide anions 
on the surface. Further, exposure time and environmental factors such as: humidity, 
pollutants/contaminants (especially hydrocarbons) and air quality influence the 
penetration of hydrocarbons and metal-organic compounds (alkoxides or 
carboxylates) into titanium [338]. While TiO2 has gained much interest, protein 
studies from in vivo experimentation have shown that the harsh chemical 
environment within the human body tends to accelerate the corrosion process 
affecting the use of titanium in long term biomedical applications [339-341]. The 
titanium dioxide layer formed on titanium surfaces is soluble in pH 3-12 and as such 
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can readily dissolute in vivo. The Ti ion binds its four positive charges with negative 
charges found in physiology (e.g. oxygen), to form Ti(OH)4 (aq). The reactive 
oxygen species interacts with cation Ti(OH)3
+, found in normal physiological 
conditions to form an electro-neutral species. The neutral hydrolysis of Ti suppresses 
the affinity of Ti ions to organic molecules within the body, and as such does not 
cause a toxic chemical response in vivo  [339]. While the corrosion product of Ti 
does not behave as a chemical burden, the wear particles have been shown to induce 
thrombotic events within the body [342]. 
 
Crystalline TiO2 films, produced in a similar manner to DLC using titanium-based 
reactive species, have been shown to improve the stability of TiO2 in vivo [343].  The 
thickness of the thin film can be increased from several nano-meters to 200nm, 
increasing its corrosion resistant properties [344]. As such the following sections will 
focus on crystalline TiO2 in terms of its chemical, mechanical and tissue compatible 
properties. 
 
 
2.2.1.2.1 Chemical and mechanical properties 
 
Crystalline TiO2 exists in three different phases: rutile and anatase, and brookite. The 
rutile and anastase phase follows a tetragonal structure (rutile: a = b = 4.584 Å, c = 
2.953 Å; and, anatase: a = b = 3.782 Å, c = 9.502 Å), as shown in Figure 2.15, while 
the bookite phase follow an orthorhombic/rhombohedral structure (a = 5.436 Å, b = 
9.166 Å, c = 5.135 Å) [345-347]. The rutile and anatase crystals are formed by one 
titanium atom surrounded by six oxygen atoms. The differences between the two 
crystal structures are the assembly pattern of the tetrahedral chains, also known as 
distortion pattern [347]. In the rutile structure, the cubic lattice is symmetrical and is 
stretched beyond a cubic shape, while, the tetrahedral shape in anastase is 
significantly distorted, making the structure more asymmetrical. In effect, the 
specific distortion pattern of each phase determine its electronic band structures, 
surface structure, bulk diffusion, surface transfer capability and redox potentials 
[347]. Because of its structure, the rutile phase has the highest refractive index and 
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behaves more thermodynamically stable than the others. This is because rutile and 
anastase crystal structure is denser and more closely packed than brookite and 
amorphous TiO2, hence providing fewer paths for ion diffusion and release. Because 
of its low thermodynamic stability, brookite and amorphous phases of TiO2 are less 
studied in experimental investigations.  
 
Figure 2.15 Bulk crystal structures of rutile and anastase forms of TiO2 [348] 
  
TiO2 films have been synthesised from a variety of techniques, some include: the 
sol–gel process [349], chemical vapour deposition [350], evaporation [351], reactive 
sputtering techniques [352, 353], ion beam assisted process [354], atomic layer 
deposition [355], pulse laser deposition [356], cathodic arc deposition and filtered arc 
deposition (FAD) [259, 357]. Of the techniques mentioned, FACVD has recently 
been of interest and is used in this study, because this method allows for deposition 
of crystalline TiO2 at room temperature and the technique can be modulated to 
produce higher propensities of the highly stable, rutile and anastase phase. The 
samples substrates used in this project were anastase TiO2 coatings prepared with 
FACVD deposition technique. 
 
Rutile and anastase TiO2 thin films behave as good insulators and can prevent the 
influx of anion impurities such as: chlorine, phosphates and fluorine, from the 
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environment. TiO2 can naturally bind with acids and bases (amphoteric) because of 
the intermediate hydroxyl group, Ti(OH)3
+, formed by titanium ions after exposure to 
an aqueous environment [341]. The crystalline oxide layer has been shown to exhibit 
a hydroxylated layer similar to what is expected on naturally occurring, amorphous 
TiO2 [358, 359]. TiO2 has a near neutral pH of 6 and in physiological conditions 
have been shown to carry no charge [360, 361]. Because of their attraction to water 
and water-soluble molecules, these films are highly polar, and consequently display 
high surface energies and hydrophilic properties [362]. This enables TiO2 surface to 
interact favourably with passivating proteins such as: albumin, and exhibit good 
biocompatibility for cell adhesion. The refractive index of rutile TiO2 films is higher 
than anastase because the rutile structure has a higher density than anastase. TiO2 
films used in this study were produced by Bendavid et al [357] using FACVD 
method. The coatings were reported to exhibit refractive index values of 2.62, in 
between the values obtained for amorphous and rutile films (2.56 and 2.72, 
respectively). The hardness was shown to be between 11.6 and 18.5 GPa, with elastic 
modulus between 140 and 225 GPa, and compressive stress within 0.7 and 2.6 GPa 
[357]. An increase in the density of the deposited films (>3.85 g/cm3) was strongly 
correlated with enhanced optical and mechanical properties. However, this is 
ultimately dependent on the energy of the titanium ions  and the substrate bias [357]. 
 
TiO2’s chemical and physical properties make it pliable to many different 
commercial applications. As an n-type semiconducting material, semiconductor 
grade TiO2, because of their photoswitchable surface wettability, high photocatalytic 
activity, bistable electrical resistance states, strong oxidising properties and high 
electron drift mobility properties have been commercially used as antifogging, self-
cleaning and disinfecting coatings on medical devices, food preparation surfaces and 
building materials [363-365].  
 
In its powder form, TiO2 is the most widely used white pigment in products such as: 
paints, coatings, plastics, paper, inks, fibres, food and cosmetics. The degree of 
opacity necessary for a material to confer to the host matrix is determined by its 
refractive index and its brightness [363]. Because TiO2 has a high refractive index 
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and high brightness, it can be used to produce the technical effect of a whitening 
agent, at very low concentrations. TiO2 is considered non-toxic and as such is often 
used in the food and drug industry as an intense white pigment for confectionary, 
baked goods, cheeses, icings, toppings, toothpaste, food supplements and 
pharmaceuticals [366].  
 
 
2.2.1.2.2 Biocompatibility  
 
The biocompatibility and surface of TiO2 coatings were investigated extensively 
through several cell culture techniques and in vivo studies analysing the tissue-
biomaterial interface and the bio-tolerance of TiO2 films for orthopaedic 
applications. The activation of macrophage and monocytic cell lines are determinants 
of the immunological response of a biomaterial. An in vitro investigation conducted 
by Valles et al [343] showed, TiO2 surfaces exhibited suppressed macrophage 
response when compared with titanium. This indicates TiO2 is tolerated by the body 
and does not induce any immunological response.  
 
Crystalline TiO2 were found to be less bio-reactive than commercially pure titanium. 
A study conducted by Li et al [367] investigated the bioactivity of TiO2 films by 
measuring its ability to induce apatite deposition using stimulated body fluids (SBF), 
in vitro. Results showed that TiO2 was able to grow apatite on its surface by exposing 
its negatively charged TiO- groups to calcium ions in SBF via an ion exchange 
process. This property has been attributed to the biocompatibility of TiO2 coatings. 
Wu et al [368] analysed the bioactive properties of TiO2 in vivo. Results showed that 
when compared with amorphous TiO2, crystalline TiO2 showed greater bioactivity. 
This shows the potential of TiO2 as a bioactive coating for inert bulk substrates for its 
application in the orthopaedic industry.  
 
TiO2 is a relatively hydrophilic surface and as such have been implicated with 
increased adsorption of serum proteins. As, glycoprotein and fibronectin mediate and 
promote the spreading and adhesion of cells on biomaterials; the adsorption of such 
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proteins were investigated. A study conducted by Ellingsen [369] in 1991 showed 
serum proteins, such as fibronectin, readily adsorb onto titania surfaces. In the 
orthopaedic industry, the adsorption of proteins onto an implant is essentially the first 
step to osseo-integrating a biomaterial surface with bone for long term implantation. 
TiO2 surfaces synthesised at low concentrations, with increased thickness, have been 
shown to induce increased protein adsorption. Furthermore, this study was able to 
show proteins bind to TiO2 in a similar manner to calcium binding from SBF. Similar 
to plasma protein adsorption on hydroxyapatite surfaces, calcium uptake on TiO2 
surfaces has been correlated with increased adsorption of albumin and 
glycosaminoglycans [332]. TiO2 with increased surface thickness have also been 
shown to provide a haemocompatible response by adsorbing a higher ratio of 
albumin to fibrinogen. Sunny et al [344] showed a seven fold increase in albumin 
adsorption, when compared with fibrinogen, on TiO2 coatings of thickness 200nm. 
This ratio was found to be significantly lower at lower coating thickness.  
 
To evaluate the integration of the implant with the biological environment, the 
contact and growth of tissue specific cells such as: osteoblasts, fibroblasts, 
endothelial cells; were monitored for their adhesion, spreading and proliferation in 
vitro and in vivo. Apart from fibronectin, other cell adhesion molecules such as 
vitronectin, have also been shown to adsorb at high concentrations, along with the 
binding of osteoblast cells for bone apposition [370]. Several studies have shown that 
TiO2 exhibits increased osseointegration properties, when compared with titanium 
surfaces by increasing the adhesion and proliferation of osteoblast cells [371, 372]. 
As a biomaterial, TiO2 have also been shown to be beneficial for endothelial cells, 
encouraging more ECM secretion and functions, while inhibiting VSMC growth 
[373, 374]. Similar results have been found in other studies involving endothelial 
cells and vascular smooth muscle cells [375]. Apart from osteoblasts and VSMC, 
TiO2 have also been shown to promote fibroblast adhesion and growth [376], 
reinforcing the biocompatible, non-cytotoxic properties of TiO2 surfaces.  
The above mentioned studies essentially show the biocompatibility and bioactive 
properties of TiO2 films by promoting tissue specific cell growth without any 
toxicological or immunological effect. The influence of blood and blood cells on 
TiO2 will be detailed in the following subsections.  
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2.2.1.3 Haemocompatibility  
 
Haemocompatibility is defined as the tolerance of blood and its components to 
blood-contacting surfaces. Since, blood is the first bodily fluid that contacts artificial 
surfaces the haemocompatibility of a biomaterial is of great importance. It is 
important to fabricate biomaterial surfaces such that when a biomaterial comes in 
contact with blood, it does not activate blood platelets or the coagulation system to 
induce thrombosis. Upon blood contact, plasma proteins, especially: albumin and 
fibrinogen, from the blood rapidly adsorb onto the surface. The ratio of adsorbed 
albumin and fibrinogen determines the haemocompatibility of the biomaterial, as the 
adsorption of  albumin reduced the adhesion, spreading and activation of platelets, 
while adsorption of fibrinogen promotes platelet adhesion and activation [327]. The 
haemolysis ratio characterised by the release of haemoglobin into the plasma from 
ruptured blood cell is also good indication of biocompatibility. A low haemolysis 
ratio is indicative of a more haemocompatible material. Furthermore, the effect of the 
coagulation cascade on a-C:H surfaces was measured using  the clotting times. The 
activated partial pro-thrombin time (APTT) measures the ability of the biomaterial to 
retard blood coagulation via the intrinsic (tissue factor dependent) pathway, and as 
such governs the influence of synthetic biomaterials on coagulation time.  
 
 
2.2.1.3.1 DLC 
 
DLC surfaces have been reported as extremely haemocompatible surfaces, where 
their blood compatibility has attributed to low surface energy, effective work 
function and smooth surface finish. A study conducted by Yu et al [321] investigated 
anticoagulant properties of ta-C films  deposited by FVAD method. It was shown 
when compared with isotropic pyrolytic carbon (LTI carbon), ta-C surfaces exhibited 
lower haemolysis ratio and platelet adhesion, while presenting similar levels of 
albumin and fibrinogen adsorption as LTI. Reduced platelet adhesion with similar 
levels of protein adsorption between the two surfaces was attributed to the varying 
Fermi energies between the two surfaces. Nurdin et al [319] found that it was not the 
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work function of the surfaces, but surface energies of a-C:H that was responsible for 
the drastically reduced activation of platelets and complement convertase.  
 
Yang et al [320], by comparing PECVD a-C:H surfaces coated under low substrate 
bias with 316-L steel, proposed that the smoothness of the biomaterial coating and its 
inherent low co-efficient of friction was responsible for the increased 
haemocompatibility of a-C:H surfaces.  Jones et al [263] reaffirmed the significance 
of surface energy in haemocompatibility by using scanning electron microscopy 
(SEM), to show low surface energy a-C:H films produced on titanium substrates via 
PECVD using an TiC-TiN interlayer did not present any platelet spreading or 
aggregation, when compared with high surface energy substrates coated with the 
interlayer only.  
 
To analyse the influence of surface chemistry on haemocompatibility, several studies 
looked into doping various elements into DLC to improve its blood-compatibility in 
vitro. In 2005, Kwok et al [377] doped phosphorous (P) ions into a-C:H films 
deposited via PIIID. The introduction of P-ions reduced the contact angle of a-C:H 
films to 16.9° and increased the surface adsorption of albumin proteins. 
Incorporating Si ions into PECVD deposited a-C:H films  reduced the overall platelet 
attachment on the surface [282, 378]. This positive response was implicated with the 
lowered surface energy of a-C:H surfaces from the addition of Si ions. The addition 
of F ions to a-C:H and ta-C surfaces presented similar results of reduced platelet 
adhesion and activation [379] reinforcing the role of surface energy in platelet 
adhesion.  
 
Apart from surface chemistry, the influence of deposition methods on platelet 
interactions was also investigated. In 2003, Yang et al [320] showed that films 
deposited at a lower substrate bias (−75 V) than normal (−900 V) reduced platelet 
adhesion and its subsequent activation. Furthermore, it was shown that a reduced 
bias elongated the overall APTT clotting times when compared with stainless steel. 
Logothetidis et al [380] evaluated the influence of hydrogen content and substrate 
bias on the haemocompatibility of a-C:H and ta-C films using spectroscopic 
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ellipsometry. Results showed that the albumin/fibrinogen ratio for a-C:H surfaces 
with increased hydrogen content, lower refractive index and positive substrate bias 
was higher, suggesting that a-C:H films with surface chemistries more polymeric in 
nature exhibited better haemocompatibility. Contrastingly, a study conducted by Ma 
et al [271] showed that the albumin/fibrinogen ratio was found to be inversely 
proportional to the hydrogen content, where an increase in hydrogen content 
decreases the overall surface adsorption of albumin and fibrinogen proteins and 
decreases the overall albumin/fibrinogen ratio.  
 
Changing the ratio of sp3 and sp2 hybridization fractions was also shown to modulate 
surface haemocompatibility of DLC films. Leng et al [381], using ta-C films 
deposited using pulse laser, showed  an increase in sp2 to sp3 ratio correlated with 
reduced platelet attachment. Similarly, Chen et al [382] used PIIID coated a-C:H to 
show the same. However, Logothetidis et al [380] showed increasing the sp3 fraction  
of a-C films decreased the overall platelet attachment.  
 
An in vitro study conducted by Gutensohn et al [383] evaluated the expression of 
platelet activation factors, CD62-P and CD63, on DLC coated stainless steel arterial 
stents. The results, when compared with uncoated stainless steel stents, showed a 
decrease in antigen expression on DLC surfaces. This was attributed to the 
suppression of ion leaching from the stainless steel by DLC coating. DLC was also 
found to reduce platelet adhesion under shear flow [384, 385].  
 
Haemocompatibility of DLC films were also evaluated in terms of the surface 
wettability and the surface energy.  Reducing the surface energy of DLC films by 
doping with P-ions have shown a preferential adsorption of albumin proteins and 
weak adsorption of other plasma proteins [377]. Huang et al [267] showed that blood 
compatibility improved on hydrophilic surfaces, by increasing albumin uptake on 
DLC surfaces. However, Leech et al [386], while investigating the thrombogenic 
response of hydrophilic coated catheters in dogs, by measuring the amount of clot 
formation, observed that the hydrophilic coatings were as thrombogenic as the 
uncoated stainless steel catheters. Similarly, Jones et al [387] showed titanium-based 
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hydrophilic surfaces presented enhanced fibrinogen adsorption and platelet 
spreading, and related DLC’s haemocompatibility to its low surface energy, 
hydrophobicity, and smooth surface finish. Another study, evaluating the influence 
of  silicon, when doped with a-C:H, in promoting haemocompatibility found silicon 
ions lowered the surface energy, and increased the hydrophobicity, of a-C:H surfaces 
and consequently presented decreased platelet adhesion [378]. However, Saito et al 
[379] showed that increasing a-C:H’s hydrophobicity by incorporating fluorine 
atoms, increased the number of platelets attached onto a biomaterial surface as well 
as their spreading. 
 
Though, a-C:H and ta-C films did not show any cytotoxic effects in vitro and in vivo, 
its response to blood during clinical evaluation ultimately dictate its 
haemocompatibility. DLC films in recent years have been used to coat stents, 
guidewires, heart valves and left ventricular assist devices. The application of stents, 
to keep the vasculature open to prevent its occlusion, has been largely limited by 
restenosis, occlusion, and stent-associated thrombosis. Arterial stents have been 
shown to leach metal ions such as: Ni, Cr, Mo, and Mn; into the blood, increasing the 
overall thrombogenicity of the implant [388]. However, DLC coating also reduced 
platelet activation and thrombogenicity to a significant extent [389]. A study 
conducted by Bartorelli et al [389] demonstrated the effect of PVD-deposited DLC 
coating in CarbostentTM (Sorin, Saluggia, Italy) in reducing restenosis. 165 DLC-
coated stents were implanted into 110 patients for 129 lesions, and clinical success 
was noted in all cases. There was no development of stent-related thrombosis after 
30 days after implantation. Similarly, another study conducted by Antoniucci et al 
[390] evaluated the influence of CarbostentTM in a clinical study consisting of 112 
patients for 6 months. Angiographic results showed less than 11% restenosis rate 
amongst 108 patients, showing that CarbostentTM significantly suppressed thrombus 
formation. Similarly, Schaefer et al [391] implanted a DLC-coated nitinol stent for 
endovascular treatment of superficial femoral artery occlusive disease. The results 
obtained 12 months after intervention showed 100% pretency rate, reinforcing the 
beneficial role of DLC. However, a clinical trial conducted in 2004 did not show any 
appreciable difference between DLC coated and uncoated stents. Haase et al [392] 
compared CarbostentTM with non-DLC coated bare metal stents to find that 
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CarbostentTM does not provide any clinical advantage (18% restenosis rate) when 
compared with uncoated stainless steel stents (and 21% restenosis rate) with similar 
design and structure.  
 
Apart from Sorin (manufacturer of CarbostentTM), other companies such: as Plasma 
Chem (BioDiamondTM; Mainz, Germany), Phytis (Diamond FlexTM; Dreieich, 
Germany) and Bekaert (DylynTM; Kortrijk, Belgium) also have come forward to use 
DLC coatings in medical implants.  Plasma chem’s Biodiamond is nanocomposite 
multilayer-coated stent with a DLC intermediate layer coating the inside and outside 
of their stainless steel 316-L stent. Airoldi et al [393] investigated the influence of a-
C:H coating on Biodiamond’s and Diamond Flex’s 316-L stainless steel vascular 
stents,  for the treatment of coronary artery disease amongst 347 patients (502 
lesions). The thrombotic effects of DLC were evaluated through angiographic tests 
against uncoated 316- stainless steel stents, after 6 months of implantation. Results 
showed that the binary restenosis for a-C:H stents were 31.8% and 35.9% for 
stainless steel stents, while the major adverse cardiac effect was 30.5% for a-C:H 
coated stainless steel stents and 32.7% for uncoated one. This again prooves no 
appreciable difference between DLC coated and uncoated stents. 
 
Despite the excellent in vitro and in vivo biocompatibility and haemocompatibity 
results of DLC surfaces, the unexpected negative results from various clinical tests 
significantly affect the cardiovascular applications of DLC coatings [393]. The exact 
mechanism behind the preferential adsorption of fibrinogen and albumin during 
DLC-blood interaction, or the interactions between platelets and plasma proteins on 
DLC films is still not fully understood. A better understanding of the material 
science and the interaction of blood components with the biomaterial surface is 
therefore still needs to be addressed. 
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2.2.1.3.2 TiO2  
 
TiO2 coatings, like DLC, have been studied as very haemocompatible materials, 
where the haemocompatibility of the coating has been correlated to its thickness and 
structure of the oxide layer. Sunny et al [344] highlighted the importance of the 
thickness of the coated layer by reporting a seven fold increase in ratio of albumin to 
fibrinogen adsorption to 200nm. Preferential adsorption of albumin over fibrinogen 
has been attributed to a reduction in the adhesion and activation of platelets.  The 
thickness of the oxide layer has also been implicated with the suppression of the 
coagulation cascade. Huang et al [264] showed that when the thickness of the TiO2 
layer was increased from 10nm to 250nm, APTT clotting time was increased by a 
factor of 1.5. However, when the thickness of the oxide layer was increased by pre-
treating the bulk substrate with hydrogen peroxide (H2O2) prior to oxide coating, an 
increased adsorption of fibrinogen and high molecular weight kininogen proteins was 
observed. Since these proteins activate platelet response, severe activation of 
platelets and the clotting cascade was noted on treated TiO2 surfaces.  
 
Along with surface thickness, the crystal structures of the coating also have shown to 
have an impact on the degree of plasma adsorption. TiO2 surfaces with greater 
crystallinity, such as rutile surfaces, were found to induce less platelet adherence and 
activation in comparison to amorphous oxide surfaces; whilst, the opposite effect 
was observed on the clotting cascade, rutile surfaces exhibiting increased coagulation 
cascade activation [394]. McAlarney et al [395] showed complement C3 adsorption 
on crystalline TiO2 surfaces increased with increasing thickness. Spontaneous 
activation of the C3 proteins on the TiO2 may lead to the consequent activation of the 
coagulation cascade and as such can greatly aid in the formation of thrombus clots. 
 
Several theories have been proposed to understand the mechanism by which changes 
in the thickness, structure and chemical composition of TiO2 impact the surface’s 
haemocompatibility. Surface charge of TiO2 is proposed to be a significant 
contributor to reduced plasma protein adsorption and subsequent platelet activation. 
The hydroxide groups formed on TiO2 surfaces upon contact with water is thought to 
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behave as positively charged species in the acidic biological condition caused by the 
implantation process. The positive surface charge has been proposed to inhibit the 
adsorption of positively charged plasma proteins like fibrinogen, and facilitate the 
adsorption of negatively charged proteins like the anti-thrombotic albumin, to 
promote the overall haemocompatibility of the surface.  
 
Another hypothesis is that the low surface energy and the semiconductor nature of 
TiO2 are the underlying factors behind TiO2‘s haemocompatibility. Low surface 
energy, increased by the increased atomic density of the crystal structure; have been 
shown to decrease fibrinogen uptake on the surface [396], while, surfaces with high 
surface energies and hence low wettability (like LITC), cause plasma fibrinogen to 
irreversibly bind onto the solid surface to lower the overall surface-interfacial 
tension. Decreased fibrinogen adsorption on TiO2 surfaces has been attributed to 
weak interactions between the surface and the protein. Crystalline TiO2 has been 
reported to have a electronic band gap of 3.2eV, while fibrinogen’s electronic band 
gap is 1.8 [397, 398]. Since the conduction and valence bands of fibrinogen lie 
within TiO2’s band gap, the inhibition of electrons transferred from fibrinogen to the 
crystalline oxide layer has been linked with decreased fibrinogen adsorption [399, 
400]. A higher band gap on crystalline surfaces is correlated with the degree of 
crystallinity. As rutile and anastase TiO2 surfaces exhibit increased crystallinity when 
compared with amorphous oxide, they have been attributed with an increased band 
gap. 
 
In an effort to understand the influence of surface chemistry and surface charge on 
the adhesion of plasma proteins, numerous studies have analysed the effect of doping 
TiO2 with either tantalum, chromium or phosphorus ions to produce n-type 
semiconductors. Doping the surface with cations such as tantalum, chromium and 
phosphorous; have shown to reduce fibrinogen adsorption, the activation of the 
clotting cascade, and platelet adhesion [394, 396]. This has been attributed to the 
positive charge of the surface formed by the influx of positive cations from the 
doping process. However this was only true for samples that had not undergone 
tempering. Samples that were tempered during phosphorous ion implantation showed 
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lower protein adsorption, platelet adhesion and activation, and lower clotting cascade 
activation; while, chromium ion-implanted surfaces exhibited low fibrinogen 
adsorption, and significantly increased levels of platelet adhesion and activation, and 
coagulation cascade activation. This suggests that the theory that n-type 
semiconductors prevent electron transfer from fibrinogen may not extend to proteins 
involved in the clotting cascade, and that clotting activation on ion-implanted oxide 
are reduced through other mechanisms such as lower interfacial energy or surface 
chemistry [394]. Furthermore, enhanced haemocompatibility from phosphorous ions 
have been attributed to platelet membranes enriched with phosphorous-based 
molecules which recognises the phosphorous ions on the oxide coating, reducing 
their overall adhesion and activation.  
 
Whilst, the physical, chemical and biological properties of TiO2 coatings render it a 
promising biomaterial for its use in the cardiovascular industry, the various studies 
into the interactions of the TiO2 surface layer with blood proteins such as fibrinogen, 
platelets and the coagulation cascade have only highlighted the some aspects of its 
haemocompatibility. Further investigation of the material science and its dynamic 
and synergistic interaction with blood components is still necessary to better 
understand its haemocompatibility.   
 
 
2.2.1.4 Surface nano-patterning 
 
The various strategies described thus far are based on modifying surface chemistry to 
achieve favourable biological interactions. However, it is becoming increasingly 
evident that apart from the chemical composition of the surface, surface topography 
also influences biological response [401]. In specific, patterning the topography of a 
biomaterial surface with nanoscale features, to create a nano-topographical surface, 
is known to play a significant role in modulating interactions at the bio-interface. It 
has been hypothesised that the geometrical and chemical features of the nano-
patterns may control the interactions between proteins and cells at the bio-interface. 
Nano-patterns may mimic the structure of natural extracellular matrix (ECM) in 
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which cells reside and function, and as such, tailoring the topographical cues can be 
influential in controlling cellular interactions on implant surface. Though it is still 
unclear just to what extent, several studies have shown topographical features such as 
nano-particles, nano-pores, nano-pits, or nano-grooves have modified the surface 
interactions of proteins such as: fibrinogen, fibronectin, viteronectin and lysozymes; 
and cells such as: osteoblast, osteoclast, fibroblast, endothelial, macrophage and stem 
cells [402-412]. Therefore, a detailed understanding of the dynamic physiochemical 
interactions between proteins, cells and nano-patterned surfaces at the bio-interface is 
fundamental for improvements in areas in such as cell culture technology, biosensing 
and medical device development [413]. As for the cardiovascular field, 
understanding the optimum nano-topography or range of nano-topographies which 
can greatly enhance surface haemocompatibility will aid in synthesis of non-
thrombogenic biomaterials.  
 
To investigate platelet adhesion and protein adsorption on nano-topographical 
surfaces, it is necessary to fabricate 2-dimensional surfaces with well-defined nano-
topographies that are highly reproducible with uniform nanostructures and 
homogenous surface chemistry. The nano-patterned surfaces should be cheap to 
fabricate and that too within a short period of time, especially when considering 
certain studies that require numerous samples, with large surface areas [413]. 
Furthermore, the fabrication method needs to be translatable for high throughput 
volume and the fabricated nano-topographies should be transferable onto 3-
dimensional biomaterials for future commercial and clinical applications [413]. At 
present, 2-D fabrication methods are at their infancy and the use of 2-D nano-
structures on 3-D biomaterials still remains a challenging task.  
 
 
2.2.1.4.1 Surface nano-patterning techniques 
 
Several strategies have gained considerable interest in the recent years for the 
fabrication of 2-D structures. Some include electron beam lithography (e-beam), 
chemical etching, glancing angle deposition, self-assembly nano-patterning, polymer 
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de-mixing and block co-polymers.  Apart from e-beam lithography, the above 
mentioned synthesis techniques have been used to produce surface nano-
topographies that are to some degree parallel, but not periodic. E-beam lithography 
has been appointed as the preferred technique to produce regular arrays of nano-
patterns.  
 
Electron beam lithography has been used as a gold standard in producing high 
resolution, ordered arrays of nano-topographies, however, it is mainly used to 
fabricate masters for parallel replication processes such as photolithography and 
nano-imprint lithography (NIL) [414]. The resolution of nano-particles is limited by 
the wavelength of the light source used for exposure of the coated resist at the wafer 
[413, 414]. Wavelengths down to approximately 10 nm are currently being explored 
to produce nano-features with dimensions in the sub-20nm and sub-10nm range 
[415, 416]. E-beam lithography is a very expensive and a time consuming process 
that is limited to the fabrication of nano-topographies on small surface areas. As 
such, alternative fabrication processes are being developed as a means to produce 
low-cost, highly-reproducible nano-topographies.  
 
Chemical modifications such as chemical etching and oxidation have been used to 
create nano-roughness with irregular topographies. Columnar structures can be 
produced using techniques like reactive-ion etching; whilst nano-patterns can be 
fabricated using controlled chemical oxidative patterning and alkaline modifications 
of metals [417-419]. By changing the solution or the concentration of the solution, as 
well as exposure time and substrate type, it is possible to modulate the roughness of 
the surface [420]. However, etching causes localised changes to surface chemistry, 
rendering it difficult to distinguish between changes in surface chemistry and 
topography as topographical changes for biological interactions [421, 422]. 
 
Glancing angle deposition technique is a physical vapour deposition (PVD) 
technique in which the particle flux is deposited on the surface from an oblique (or, 
glancing) incidence to create thin films that are anisotropic, porous and highly 
structured [423].  Growth of the thin film is dominated by atomic-shadowing, 
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wherein nucleation sites on the substrate evolve into a tilted columnar 
microstructure.  By changing process parameters including substrate tilt angles, 
adatom diffusion, collimated vapour flux and the sample rotation speed, it is possible 
to fabricate thin coatings with a variety of exotic nano-structures [424]. It is also 
possible to create glancing angle deposition thin films composed of multiple 
materials and different hetero-structures [425].  
 
Self-assembly nano-patterning involves the controlled assembly of colloidal nano-
particles either by electrostatic interactions or by a simple close packing of the 
particles [426]. The assembly of colloidal particles have been optimised to produce 
hexagonally closed-packed arrays, covering domains up to 100 μm2 [413]. Self-
assembly of colloidal particles, through electrostatic assembly, has been optimised to 
produce large areas with uniform structures. These methods offer several advantages 
such as reproducibility, reliability, ease of production within a quick time-frame; 
however, aggregation of the colloidal particles with particle diameters less than 40 
nm has been reported. 
 
Polymer de-mixing involves the spontaneous phase separation of two immiscible 
thin spin-cast polymer blends to create nanotopographical morphologies [427, 428]. 
This technique is relatively simple means of producing nano-features onto polymer 
substrates in a controlled manner. The size, structure and pitch of the nano-features is 
dependent on the immiscibility of the two polymers chosen, their molecular weight, 
the specific solvent used and the thickness of the spin-coated film [429-431].  
 
Block co-polymer is similar to polymer de-mixing in that it too is a phase separation 
technique used for the production of nano-patterned thin spin-cast surface coatings 
[432-434]. The polymer chains, or blocks, are selected to covalently attach to each 
other, and because of their immiscibility, phase separation will take place [434]. The 
polymers organise themselves into laterally ordered, periodic arrays of self 
assembled features, for the addition of metallic salts. The original block co-polymers 
are etched away after the films are exposed to metal salts, resulting in a pattern of 
metal nano-structures on the surface replicating the pattern of the phase-separated 
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block co-polymer features. The size and pitch between the nano-patterns can be 
varied in relation to to the size of the domains on the co-polymer chains [435, 436]. 
Block co-polymer allows for nano-patterning with features of dimensions below 
10nm [437]. Whilst block co-polymer allows for pseudo-regular nano-patterns, the 
lack large-scale ordered and symmetrical array may influence biological response 
such as platelet adhesion and their spreading. 
 
 
2.2.1.4.2 Influence of nano-topography on blood compatibility 
 
While, DLC’s haemocompatibility has been attributed to its smooth surface finish, in 
recent years, it has been shown that platelet adhesion and the adsorption of 
fibrinogen can in fact be minimised to levels lower than on the corresponding smooth 
surfaces by carefully optimising the surface nano-topography in the nanometer to 
sub-micrometer range [438]. Chen et al [439] proposed that roughness should be 
catagorised into three groups:  
 Greater than 2 μm; 
 Between 2 μm and 50 nm; and 
  Less than 50 nm 
It was hypothesised that creating a roughness greater than 2 μm will allow for nano-
patterns with dimensions greater than the diameter of a resting platelet, and, 
consequently will result in an overall increase in surface contact area, which may 
promote platelet-surface adhesion, and hence thrombogenic response. Nano-pillars or 
nano-grooves fabricated to produce a roughness value between 2 μm and 50 nm will 
mimic the dimension of proteins; and will effectively reduce the contact area for 
platelet adhesion by only allowing platelets to interact on the apical side of the nano-
topographic surface, suppressing their adhesion and consequently their activation. 
They prescribed that nano-patterns within this range will be optimum to create a 
thrombo-resistant surface, as surface structures that are less than 50 nm high might 
exhibit little influence on platelet interactions. It was suggested that nano-structures 
less than 50 nm will create nano-features that are smaller than the average size of 
filopods exhibited on activated platelets and may not recognisable by platelets. 
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Consequently, platelets may respond in a similar way as they would on smooth 
surfaces exhibiting their influence based on other dominating factors. Furthermore, it 
was proposed that a more propitious response can be created by optimising both: the 
surface roughness and surface chemistry; and using them in combination [16].   
 
A study conducted Sun et al [438] investigated platelet interactions on fluorinated 
polycarbonate urethane (FPCU) nano-patterned with carbon nanotube arrays 
(ACNT) of diameter 39.7nm and length 20µm. The results showed that when 
compared to a flat FPCU surfaces, the nano-patterned surfaces suppressed platelet 
adhesion, when compared with the flat substrates. Platelet activation studies using 
fluorescence microscopy presented minimal platelet activation on the nano-patterned 
surfaces. Furthermore, it was found that ACNT nano-tubes decreased the overall 
surface wettability, and consequently lowered the surface free energy of FPCU. This 
was in corroboration with Chen’s [439] hypothesis. Another study conducted by 
Milner et al [440] investigated the influence of polyether(urethane urea) (PUU) 
surfaces nano-patterned with 700 nm and 400 nm square pillars on platelet adhesion 
under low shear stress. Results showed that the nano-patterned surfaces reduced 
platelet adhesion from a pool of plasma proteins. Again, no significant changes in 
platelet activation was observed on the nano-patterned surfaces, suggesting that 
although the pillars lead to an increase of the total surface area, the actual contact 
area between platelets and surface was limited to the top of the nano-patterns. Since, 
increased hydrophobicity of a biomaterial has already been attributed with decreased 
platelet adhesion; it was unclear just to what level of influence the nano-patterned 
structure exhibited on lowering the adhesion and activation of platelets.  
 
Minelli et al [441] nano-patterned polymethylmethacrylate (PMMA) surfaces using 
polymer de-mixing to produce nano features of size 27, 50, 60, 150 and 1240 nm and 
height 3, 4, 10, 50 and 120 nm, respectively. Von Willebrand factor, albumin and 
fibrinogen adsorption and platelet adhesion was investigated on these nano-patterned 
surfaces and the results were compared with the flat substrates. The findings showed 
that the adsorption of albumin and von Willebrand factor increased with increasing 
surface roughness, while, fibrinogen adsorption decreased. SEM images of platelet 
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adhesion showed that platelets (from a solution of plasma proteins) adhered more 
strongly, displaying spreading and platelet-platelet aggregation, as the size of the 
nano-features increased. These results contradict Chen’s [439] hypothesis as the 
largest nano-feature was significantly less than 2µm, and surfaces with nano-
patternes less than 50nm showed decreased platelet adhesion than surfaces with 
nano-patterns between the range 50nm and 2µm. Similar to Minelli’s finding, Kubo 
et al [442] showed, using titanium surfaces with 100nm nano-pits, a two fold 
increase in albumin adsorption on nano-pattered surfaces.  
 
Sutherland et al [408] found an increase in platelet adhesion on fibrinogen pre-
adsorbed nano-pitted TiO2 substrates (nano-pit dimension: 40nm wide and 10nm 
deep), when compared with fibrinogen pre-adsorbed flat surfaces. This suggested 
that nano-pits were responsible for increased adsorption of fibrinogen and 
conformational changes within the protein for platelet binding. Furthermore, when 
comparing platelet adhesion on the bare surfaces, it was noticed that nano-pits 
suppressed platelet adhesion, reinforcing the significant role of surface topography in 
protein adsorption and conformation, as well as the influence of fibrinogen in platelet 
adhesion. It was also interesting to note, while Minelli reported an increase in platelet 
adhesion with increasing roughness on PMMA surfaces, Sutherland was able to 
show a decrease in platelet adhesion on increasing roughness of TiO2 surfaces.   
 
Dolatshahi-Pirouz et al [423], reported atomic force microscopy (AFM) studies 
which revealed that fibrinogen conformation on nano-rough platinum surfaces (RMS 
of 9nm) exhibited an unfolding of the protein structure as compared to the fibrinogen 
conformation on platinum surfaces with a mean roughness of 1.5nm. It was found 
that nano-patterns with roughness in the same order as proteins were found to not 
exert any influence on the protein’s conformation, while surfaces with dimensions 
greater than or less than the dimensions of proteins influence the conformation of the 
protein upon adsorption [413].  However, it is was specific to the protein adsorbed 
and the surface chemistry of the biomaterial [413]. 
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Furthermore, apart from the size, the spatial arrangements of nano-features are also 
important factors that contribute in modulating biological response. Curtis et al [443] 
compared the effect of cell adhesion on the regularity of nano-structures. The study 
found that regular nano-structures (60-150nm, formed using electron beam 
lithography), promoted cellular adhesion when compared with irregular/pseudo-
regular nano-patterns. Similarly, Koh et al [444] was able to show, using platelets, 
that platelet adhesion and activation on irregularly arranged multi-walled carbon 
nano-tube (MWNT)-polylactic-co-glycolic-acid (PLGA) was significantly reduced 
when compared with the flat substrates and regularly arranged carbon nano-tubes. 
 
While a synergistic combination of surface topography and surface chemistry is 
necessary to better influence platelet interactions, a clear understanding of how 
surface chemistry and topography relate to interfacial properties and biological 
interactions and the degree of influence nano-patterns play on platelet adhesion and 
activation is still poorly understood.  
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3 MATERIALS AND METHODS 
 
In physiological conditions, surface influenced platelet response to clot formation is 
the result of a complex biological system involving the adsorption of proteins, 
platelet receptor-ligand binding and signal transduction. Protein ad sorption mediates 
the platelet interactions and consequent responses on biomaterial surfaces, while, 
surface topography of the underlying substrate have been shown to influence the 
concentration and conformation of the adsorbed proteins.  
A number of experimental investigations with increasing complexity were tested to 
relay the interplay between platelets, plasma proteins, such as albumin and 
fibrinogen, and haemocompatibile biomaterial coatings. Techniques employed for 
such an investigation include; x-ray spectroscopy (XPS), atomic force microscopy 
(AFM), scanning electron microscopy (SEM), focused ion beam (FIB), enzyme 
linked immuno-sorbant assay (ELISA), fluorescence microscopy, flow cytometry 
and quartz crystal microbalance with dissipation technology (QCM-D). A 
combination of techniques was employed to overcome the limitations of each method 
[445]. Further, the topography of the flat surfaces were modified, using the block co-
polymer technique, to produce pseudo-regular nano-patterns, and their ability to 
influence protein adsorption and platelet attachment and activation was also 
analysed.  
Surface coatings analysed in this project include; amorphous-hydrogenated diamond 
like carbon (a-C:H), tetrahedral amorphous carbon (ta-C) and titania (TiO2) on ultra 
flat silicon wafers. Where necessary, the results derived from these experiments were 
compared with two types of control surfaces; flat and nano-patterned silicon (Si) 
wafers, as well as tissue culture polystyrene (TCPS).  
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3.1 Material Processing and Surface Characterisation 
 
In this study hydrogenous amorphous carbon (a-C:H), hydrogen free-tetrahedral 
amorphous carbon (ta-C) and titania (TiO2) were coated on either; nano-patterned or 
unpatterned semiconductor grade silicon (1 0 0) wafer disks and quartz crystal 
microbalance (QCM) sensors. These surfaces were characterised using X-ray 
photoelectron spectroscopy (XPS), atomic force microscopy (AFM), scanning 
electron microscopy (SEM), and focused ion beam (FIB) measurements. Smooth and 
patterned si-wafer discs were used as control. All buffers and solutions used were 
degassed and filtered using 0.2µm Millipore filter. 
 
 
3.1.1 Surface Preparation 
 
 
3.1.1.1 Initial preparation 
 
Ultra-flat silicon wafers, purchased from Silicon Wafers Enterprises LLC, CA, USA, 
were coated with a-C:H and ta-C diamond like carbon, and TiO2 at CSIRO Material 
Science and Engineering (NSW, Australia). 4” single crystal circular silicon wafers 
(1 0 0) with resistivity 0.008-0.020 ohms and thickness of 0.5-0.55 mm were cut into 
15 mm diameter discs using a diamond coated hole-saw with a water based coolant. 
The samples were pre-cut into 15 mm diameter discs with 0.5 mm tolerance to 
comfortably fit into 12-well culture plates for in-vitro experiments.  
 
The surfaces were pre-treated ultrasonically with acetone followed by ethanol for 5 
mins each to clean the surfaces prior to coating. QCM sensor crystals (purchased 
from ATA scientific, NSW, Australia) were cleaned using de-ionised water, followed 
by; Hellmanex III (2% - Sigma Aldrich), de-ionised water and ethanol (80% v/v) for 
5 minutes each. The samples were then dried using Nitrogen (N2) gas and sterilised 
in an UV/Ozone chamber for 15mins to remove all organic and in-organic substances 
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prior to coating. A few discs QCM-D sensors were retained as controls with 
unaltered surface topography. 
 
 
3.1.1.2 Surface nano-patterning 
 
Present nano-fabrication techniques facilitate the production of nano-features within 
the size range required for nano-sized proteins and micro-sized platelets to recognise 
and interact with the surface. The exact nano-structure design and size of nano-
particles employed was identified after carefully evaluating present literature on the 
range of nano-patterning techniques available to create specific roughness values and 
the beneficial effects of such nano-patterns on influencing biological interactions. 
The following describes the method employed to develop nano-patterned surfaces, 
through block co-polymer technique, used for this study. 
 
Si wafer samples were kindly patterned with gold (Au) particles at NRC National 
Institute for Nanotechnology (AB, Canada) using a specific block co-polymer 
colloidal deposition technique with polystyrene (PS) and polyvinylpyridine (PVP).  
 
Typically, silicon wafers were cleaned using the RCA method [446] before being 
spun coated with a solution of 1% polystyrene- polyvinylpyridine (PS-P4VP, 12k-
3.2k) block co-polymer in toluene for 20 seconds at 3800 rpm. The block co-polymer 
films were then soaked in a solution containing gold salts (1.2% HClaq v/v with 
200mM KAuCl4) for 3 hours. The films were etched with oxygen plasma for 30 
seconds before drying with nitrogen gas. The metal ions bind to PVP exposing the 
PS and excess PVP to the reactive oxygen ions. The plasma removes the polymer 
film and reduces the Au ions to form a pseudo-regular Au nano-structure pattern on 
the silicon surface [435, 436].    
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3.1.1.3 Surface coating 
 
Nano-patterned and flat (un-patterned) substrates were vapour coated with either 
hydrogenated amorphous diamond like carbon (a-C:H), tetrahedral amorphous 
carbon (ta-C) or titania (TiO2) coating. 
 
 
3.1.1.3.1 Hydrogenated-Amorphous Carbon (a-C:H) deposition 
 
Commercially available a-C:H was coated onto the specimens using a chemical 
vapour deposition technique called RF Plasma Enhanced Chemical Vapour 
Deposition (RF-PECVD) to synthesise quality coatings at low temperatures. The 
deposition system consisted of a plasma reactor equipped with rotary and turbo 
molecular pumps with controlled gas supply and pumping system, in a manner 
described elsewhere [447]. A base pressure of 1x10-3 Pa was attained in the chamber 
prior to deposition. The diamond like carbon (DLC) films were deposited onto 
silicon wafers and QCM sensor chips, both flat and nano-patterned. Acetylene 
(C2H2), CF4 and argon (Ar), were used as process gases. The gases were introduced 
into the system through a gas distributor using mass flow controllers. The total 
pressure was set independently of the gas flow by adjusting a throttle valve. Prior to 
deposition, the substrates was sputter cleaned in-situ for 15 seconds in argon plasma 
operated at 3.3 Pa with the argon flow rate set at 10 sccm at 200 W RF power. The 
flow rate of C2H2 was kept constant at 60 sccm. The deposition pressure was set at 
6.6 Pa at an rf power of 200 W for 10 seconds.  
 
 
3.1.1.3.2 Tetrahedral Amorphous Carbon (ta-C) deposition 
 
Hydrogen-free tetrahedral amorphous carbon (ta-C) was deposited on silicon wafers 
and silica QCM-sensors using a physical vapour deposition technique called the 
Filtered Cathodic Vacuum Arc (FCVA). The system employed is described in detail 
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elsewhere [448]. The arc source was operated at DC arc current of 60 A, producing a 
positive carbon ion current of 200 mA, (measured at the exit of the arc source), with 
a shutter of 140 mm in diameter. The cathode used for producing the arc was high 
purity graphite (99.9%). A DC substrate bias voltage of −100 V was applied to the 
substrate. The deposition was performed at room temperature and the deposition rate 
was 50 nm/min.  
 
 
3.1.1.3.3 Titania (TiO2) deposition  
 
Crystalline, anastase, titanium dioxide (titania, TiO2) was deposited onto nano-
patterned and flat, silicon and silica QCM substrates using a physical vapour 
deposition technique called the filtered arc cathodic vacuum arc deposition 
(FACVD) system, described in detail elsewhere [357]. The thin films were deposited 
from the plasma discharged from the titanium electrode (cathode) of the cathodic arc 
to the substrate. This occurs in vacuum at a low voltage, high current setting. The 
base pressure of the system was reduced to 2x10– 4 Pa prior to coating. The sample 
substrates were subjected to the following deposition conditions: 120A dc arc 
current; 12sccm O2 gas flow rate; 0.35Pa chamber pressure; 200mA measured 
titanium ion arc beam current with an area of 8 cm2 biased  at  -100 V at the substrate 
position, -50V substrate bias and a deposition time of 15 sec. The deposition process 
was conducted at room temperature as the intrinsic energy of the depositing metal is 
sufficiently high to facilitate self-densification of the titania film on the substrate 
surface.  
 
 
3.1.1.4 Surface cleaning 
 
Samples were cleaned and sterilised in a reliable and repeatable manner to avoid any 
contamination such as particle residues and debris on the surfaces prior to each 
experiment.  
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To validate the cleaning methods, the surfaces were incubated in a solution of either 
fibrinogen proteins or platelet suspension prior to cleaning. An ELISA was then 
carried out to detect any remaining fibrinogen residues adsorbed on the surface and 
fluorescence microscopy was used to detect un-washed platelets using an actin stain. 
Results from these experiments did not detect any protein or platelets, even at trace 
concentrations, validating the cleaning procedure (data not shown).  
 
 
3.1.1.4.1 Flat discs 
 
The flat substrates were cleaned prior to and in-between all experiments via the 
following method; wiped and ultrasonically washed in degassed de-ionised water 
prior to Decon 90 (2% solution v/v - Sigma Aldrich), de-ionised water and ethanol 
(80% v/v) for 20 minutes each. The samples were then transferred to an acetone bath 
for 10mins followed by ultrasonic cleaning with ethanol 80% (v/v) and 100% (v/v) 
before being dried with N2 gas and sterilised in an UV/Ozone chamber for 15 
minutes. 
 
 
3.1.1.4.2 Flat QCM-sensors 
 
QCM sensor crystals were cleaned prior to and in-between experiments via the 
following method; wiped and soaked in degassed de-ionised water, Decon 90 (2% 
solution v/v - Sigma Aldrich), de-ionised water again and ethanol 80% (v/v) for 20 
minutes each. The samples were then dried using N2 gas and sterilised in an 
UV/Ozone chamber for 15minutes.  
 
Delamination of the ta-C films were noted during the cleaning process as such only 
silica, TiO2 and a-C:H crystals were used for further experimentation. 
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3.1.1.4.3 Nano-patterned discs 
 
The patterned substrates were cleaned prior to experiments via the following method; 
soaked in degassed de-ionised water, Decon 90 (2% solution v/v - Sigma Aldrich), 
de-ionised water again and ethanol 80% (v/v) for 5 minutes each before gently 
drying with N2 gas.  
 
 
3.1.2 Surface Characterisation 
 
Surface characterisation is essential step in the experimental process as it verifies the 
integrity of a substrate by allowing the detection of flaws and errors developed 
during the patterning and coating processes. Prior to in-vitro analysis, the substrates 
were evaluated through a series of stringent surface characterisation techniques such 
as; x-ray photoelectron spectroscopy (XPS), scanning electron microscopy (SEM), 
focused ion beam (FIB) analysis and atomic force microscopy (AFM). 
 
 
3.1.2.1 X-ray Photoelectron Spectroscopy (XPS) 
 
The surface composition of the flat substrate materials were analysed using the 
SAGE 150 XPS system. 
 
 
3.1.2.2 Scanning Electron Microscopy (SEM) 
 
The overall topographical characteristics of the nano-patterned and un-patterned 
(flat) surfaces were studied using scanning electron microscopy (SEM). Sterilised 
samples were stored in a desiccator before mounting on brass SEM stage holders for 
analysis, using carbon double-sided tape and silver paint (high purity silver paint, 
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SPI). Once mounted, samples were sputter coated for two minutes with platinum 
(15nm thick coating) using the Balzers SCD040 sputtering system before examining 
with SEM (Zeiss Ultra Plus, ACMM, University of Sydney, Australia). The samples 
were sputter coated to make their surface more conductive and therefore less 
susceptible to the accumulation of surface charge. Then the samples were attached to 
0 degree angled SEM stages and were imaged under ultra high vacuum (1x10-5 Pa) 
conditions at an accelerating voltage of 10 keV using an InLens detector.  
 
 
Focused Ion Beam (FIB) microscopy 
 
Subsections of each sample was visualised using Zeiss Auriga FIB-SEM (ACMM, 
University of Sydney, Australia) in ultra high vacuum with accelerating voltage of 
10keV. Three sections were imaged per sample with a scan area of 2 µm x 2 µm. The 
FIB-SEM system uses a combination of a FIB and electron beam and secondary ion 
and secondary electron detectors. Gallium ions from a liquid ion source were field 
emitted on the sample surface at high beam currents of 50 pA, 30 KV, to mill 
through the surface. 
 
 
3.1.2.3 Atomic Force Microscopy (AFM) 
 
Surface topography and the overall nano-roughness of samples were analysed in air 
using Multimode NanoScope IIIa AFM (Dimensions 3100, Digital Instruments Inc, 
ANSTO) in low voltage tapping mode at 296K with a tip diameter of 10nm, scan rate 
of 1hz and scan area of 0.5µm x 0.5µm or 1µm x 1µm. Commercial available Si3N4 
cantilevers were used and the force and resonant tip frequency parameters were 
adjusted continually to obtain the best images. 5 spots were scanned for each sample 
and the surface root mean square (RMS) roughness was calculated: 
 
 ∑(Zi−Zaverage)/N                                                       eq 2 
where 
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 Zaverage is the average of the Z height values within a given area 
Zi is the individual Z-value and N is the number of pixels within the given area 
 
Image processing and pore size analysis was performed using Nanoscope off-line 
software (Veeco Corp. Santa Barbara, USA). 
 
 
 
3.2 Protein Studies 
 
During blood contact, all biomaterial surfaces presently used in diagnostic and 
treatment methods exhibit some level of thrombogenic tendencies and as such can 
influence the delicate balance between unstopped bleeding and thrombosis in the 
haemostatic system. The artificial surface activates both, the blood cells (red blood 
cells, white blood cells and platelets) as well as the enzyme mediated coagulation 
cascade by exhibiting a similar surface to that found at the site of vascular injury. 
This involves the rapid adsorption of blood plasma proteins on the biomaterial 
surfaces to generate a biologically active monolayer which subsequently mediates 
the adhesion and activation of platelets.  
 
Apart from surface hydrophobicity, conformational changes in the protein structure, 
caused by the isoelectric charge (pI) difference between the surface and specific 
plasma proteins, have also been implicated as a potential driving mechanism which 
dictates protein adsorption.  
 
As such, plasma protein adsorption and the conformation of adsorbed proteins along 
with the kinetics behind protein adsorption was studied. Specifically, fibrinogen 
protein (Fg), well known for its intricate role in platelet adhesion and aggregation, 
was extensively studied and the results were compared against that of albumin 
(BSA), the most abundant plasma proteins that is often used to passivate biomaterial 
surfaces. SDS-PAGE, Western Blotting and Coomassie Stain were used to 
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characterise fibrinogen. Protein studies were carried out using a combination of 
ELISA, fluorescence microscopy, AFM and QCM-D. 
 
Further, the ability of a material’s chemistry to enhance fibrinogen’s activity and 
prolong clotting times were analysed via a series of clotting cascade experiments.  
 
 
3.2.1 Protein Preparation and Characterisation 
 
Fibrinogen (Fg, from human plasma, >95% clottable protein, lyophilised, AbCam, 
Australia) was identified Western blotting and its molecular weight characterised 
using SDS-PAGE. Both fibrinogen and albumin (BSA - >96% purity, lyophilised, 
Sigma Aldrich, Australia) were diluted in Dulbecco’s Phosphate buffered Saline 
(DPBS), pH 7.4, unless stated otherwise. These proteins were biotinylated for single 
and competitive protein adsorption studies on silicon, a-C:H, TiO2 and ta-C coated 
surfaces. Where applicable, the TCPS well plates were pre-coated with either 0.1% 
(w/v) albumin (BSA) or 0.1%(w/v) casein proteins.  
 
The efficiency of the biotinylation technique was analysed using ELISA and the 
concentration of each biotinylated protein was quantified using Coomassie Blue 
protein assay. Coomassie Blue protein assay was also used to quantify stock 
concentrations of non-biotinylated fibrinogen and albumin solutions used in the 
following experiments. 
 
 
3.2.1.1 Sodium Dodecyl Sulphate Polyacrelamide Gel Electrophoresis (SDS-
PAGE) 
 
The molecular weight of fibrinogen was determined using SDS-PAGE, where 
proteins were separated by their molecular weight using electrophoresis. Fibrinogen 
was prepared at a concentration of 50µg/ml in Dulbecco’s phosphate buffered saline 
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(DPBS) (Sigma-Aldrich, Australia), pH 7.4. Unfractionated fibrinogen samples 
(250µg/ml) were loaded onto the gel in a reduced and non-reduced form. In the non-
reduced sample, the protein solution was mixed with sample buffer (0.5M Tris HCl, 
10% (w/v) SDS, 50% (v/v) glycerol and 0.05% (w/v) Bromophenol Blue, pH 6.8), at 
a ratio of 7:2, in MilliQ water and stored at room temperature for 20 minutes. The 
reduced samples were heated in 10mM of dithiothreitol (DTT), a reducing agent, for 
5 minutes in a 95 ºC waterbath before diluting in sample buffer (SB). 10 µl of 
samples were loaded along with a standard and electrophoresed on 3-8% Tris-acetate 
SDS-PAGE gels (Invitrogen, Sydney, Australia) using aTris-acetate SDS running 
buffer (50mM Tricine, 50mM Tris Base, 0.1% (w/v) SDS, pH 8.24) at 160 V for 60 
minutes. The gels were transferred into the fixing solution (40% v/v methanol : 10% 
v/v acetic acid : 50% v/v MilliQ water) for 10 minutes prior to being stained in 
diluted solution of Simply Safe Coomassie Blue G250 dye over night.  
 
Electrophoretic patterns under non-reducing conditions by Coomassie Blue staining 
showed one broad band at 340 kDa, and under reducing conditions shows its three 
subunits Aα-, Bβ- and γ-chains at 65, 55 and 47 kDa respectively (data not shown). 
Molecular weight standard used was within the range of 10-250 kDa. 
 
 
3.2.1.2 Western blotting 
 
After electrophoresis, the samples were transferred to a polyvinylidene difluoride 
(PVDF) membrane (Millipore, Sydney, Australia) using NuPage Transfer buffer with 
10% (v/v) methanol, pH 7.2 for 60 minutes in a semi dry blotter at 300 mA and 20 V. 
The membranes were removed and blocked for 1 hour using 1% (w/v) BSA in Tris-
buffered saline (20mM Tris Base, 136mM NaCl, pH 7.6) with 0.1% (v/v) Tween 20 
(TBST) solution at room temperature. This was followed by incubation with 2 µg/ml 
primary antibody, monoclonal anti-human fibrinogen antibody (clone 2C2-G7, 
AbCam, Australia) diluted in 1% (w/v) BSA/TBST for 2 hours at room temperature. 
Later the membranes were rinsed with TBST and incubated with horseradish 
peroxidise-conjugated secondary antibodies for 60 minutes at room temperature. 
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After rinsing thrice in TBST and twice using TBS the membranes were placed in the 
chemiluminescence reagent for 2 minutes (Quantum Scientific, Cat# 34095) before 
being placed between two transparent overhead sheets and developed onto X-ray 
film. Western blot and SDS-PAGE gel electrophoresis results together identified the 
proteins as fibrinogen and of high purity (data not shown).  
 
 
3.2.1.3 Biotin labelling of fibrinogen and albumin 
 
Protein adsorption onto biomaterial surfaces were analysed using biotin-labelled 
fibrinogen and albumin in both, single and multi-protein solutions. EZ-link NHS-
Biotin (Pierce Biotechnology) was diluted in dimethylsulfoxide (DMSO), resulting 
in a final concentration of 10mM biotin, which was added to each protein solution, 
5mg/ml albumin (BSA) and 5mg/ml fibrinogen in DPBS.  The solutions were 
incubated in the dark for 2 hours before separating the biotinylated proteins from 
excess biotin. Biotinylated fibrinogen was separated using centrifuging while 
biotinylated albumin (BSA) was separated using dialysis.  
 
The fibrinogen solution was transferred to 10 kDa microcon (BD Diagnostics) and 
centrifuged for 15 minutes at 13000 rpm. Following a washing step with DPBS, the 
solution was centrifuged for 15 minutes and washed again. The previous step was 
repeated over six times before aliquoting the solution in vials.  
 
Albumin (BSA) solution on the other hand was dialysed. After incubating in the dark 
for 2 hours, the solution was transferred into dialysis tubes before completely 
immersing the tubes in excess DPBS buffer at 4ºC for 2 hours with constant stirring. 
The previous step was repeated again before removing the tubes from buffer and 
storing it inside a bed of dry sucrose at 4 ºC. The solution was dialysed overnight 
before relieving the contents of the tubes into aliquots.  
 
The relative intensity of labelled proteins were analysed using ELISA where 
streptavidin horse-radish peroxidase (SA-HRP, GE Healthcare Life Sciences, 1:500 
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dilution in DPBS containing 0.1% casein)  was used as the primary antibody. 2,2’-
Azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt (ABTS, Sigma) 
containing hydrogen peroxide, a colorimetric substrate, was added to the wells and 
incubated for 30 minutes at room temperature. The absorbance was measured using a 
plate reader at a wavelength of 405 nm.  
 
The concentration of the aliquoted proteins was measured using Coomassie Blue 
protein assay while the number of biotin molecules bound to each protein was 
measured using the Avidin-HABA assay, in a manner described elsewhere [449-
451]. 
 
 
3.2.1.4 Coomassie blue protein assay  
 
Exact concentrations of proteins in solution were quantified using a colourimetric 
Coomassie blue protein assay. Triplicates of 10 µl of each biotinylated and non-
biotinylated fibrinogen and albumin stock solution in DPBS were pipetted into 
96well plates along with the pre-calibrated albumin (BSA, Sigma Aldrich, Australia) 
standard solution in dilutions of 0, 0.1, 0.25, 0.75 and 1 mg/ml. 300 µl of Coomassie 
Plus reagent was added to each well. The well plate was mixed on a shaker for 5 
mins before measuring the absorbance at 595 nm wavelength using a plate reader. 
The concentration values were used to titrate the protein solutions 500 µg/ml stock 
solutions and 50 µg/ml albumin or fibrinogen working solutions.  
 
 
3.2.2 Protein Adsorption 
 
The adsorption of proteins and the relative conformation on the flat surfaces were 
evaluated using a combination of ELISA, fluorescence microscopy, AFM and QCM 
while the concentration and conformation of fibrinogen and plasma proteins after 
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adhering to nano-patterned surfaces were evaluated using fluorescence microscopy 
and AFM.  
 
Investigations were carried on sterilised flat (non-patterned, smooth) and nano-
patterned a-C:H, Ta-C and TiO2 coated –silicon wafers. Since the composition of 
adsorbed proteins change over time by a phenomenon known as the Vroman’s effect, 
samples were incubated in protein solutions for a period of 60 minutes to allow 
stabilisation of the adsorbed proteins as well as to ensure its complete coverage on 
the biomaterial surfaces. All experiments were carried out on 12 well plates, unless 
stated otherwise and all solutions used were degassed and filtered using Millipore 0.2 
µm Millipore filter. 
 
 
3.2.2.1 Enzyme Linked Immuno-Sorbent Assay (ELISA) 
 
 
3.2.2.1.1 Simple and complex studies 
 
The adsorption of fibrinogen (Fg) and albumin (BSA) in single and complex 
solutions onto flat silicon, TiO2, a-C:H and ta-C coated silicon wafers were analysed 
using biotinylated proteins (preparatory method detailed in Section 0). Samples, in 
triplicate, were placed in 0.1% (w/v) casein (diluted in DPBS) pre-coated well plates 
(60 minutes at 37 ºC). These samples were incubated for 60 minutes at 37 ºC in one 
of four conditions: 
 
 a simple solution containing 50 µg/ml biotin labelled albumin (BSA); 
 a simple solution containing 50 µg/ml biotin labelled fibrinogen (Fg);  
 a complex solution composed of 500nµg/ml biotinylated albumin (BSA) and 
50nµg/ml non-biotinylated fibrinogen; or, 
 a complex solution composed of 500nµg/ml non biotinylated albumin (BSA) 
and 50 µg/ml biotinylated fibrinogen (Fg) 
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The physiological ratio of albumin (BSA) and fibrinogen (Fg) proteins found in 
blood serum is approximately 10:1 for healthy blood [452, 453] and as such albumin 
and fibrinogen in the complex solution were mixed in the ratio 10:1. Bovine albumin 
was used instead of human albumin as BSA is homologous in structure to human 
albumin and serve the same function in the two species. TCPS well plates pre-coated 
with 0.1% (w/v) casein proteins were used as negative controls while non-casein pre-
coated well plates were used as positive controls. After an hour of incubation, the flat 
substrates were washed thrice in DPBS, incubated with 0.1% (w/v) casein block for 
60 minutes at 37ºC, washed twice in DPBS-T (DPBS with 0.01% (v/v) Tween) 
before incubating in biotin-binding SA-HRP (dilution 1:500 in 0.1% (w/v) casein) 
for 30 minutes at room temperature. The samples were washed four times in DPBS-T 
before loading each well with excess ABTS in hydrogen peroxide and incubating in 
room temperature for 30minutes. 100µl duplicates from each well were transferred 
into a 96 high binding well plate before measuring the concentration of fibrinogen 
and albumin was measured as arbitrary absorbance values using a plate reader at 
405nm wavelength. 
 
The average number of biotin attached to each fibrinogen and albumin molecule, as 
calculated from HABA avidin assay, was used to quantify the number proteins 
attached to each surface. 
 
 
3.2.2.1.2 Conformation of adsorbed fibrinogen measured using ELISA 
 
The orientation of adsorbed fibrinogen in simple and complex solution was evaluated 
by measuring the availability of platelet binding region, fibrinogen A alpha chain, 
and gamma chain for antibody binding.  Flat silicon, TiO2, a-C:H and ta-C substrates, 
in triplicate, were placed in 0.1% (w/v) albumin (BSA) pre-coated well plates and 
incubated for 60 minutes at 37ºC in two different fibrinogen containing solutions: a 
simple solution containing only 50µg/ml fibrinogen (Fg); and  a multi protein 
solution containing 500µg/ml albumin (BSA) and 50µg/ml fibrinogen (Fg).  
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The albumin and fibrinogen from the complex solution were mixed in the ratio 10:1. 
Albumin (BSA) pre-coated polystyrene well plates were used as negative controls 
while non-albumin (BSA) coated well plates were used as positive controls. After an 
hour of incubation, the samples were washed in DPBS, incubated with 0.1% (w/v) 
albumin(BSA) block for 60 minutes at 37ºC, washed twice in DPBS-T (DPBS with 
0.01% v/v Tween) before incubating in primary antibodies. The antibodies used were 
mouse monoclonal anti-human fibrinogen antibody (2C2-G7 -Bioscientific, Australia 
for Cederlane) ,mouse monoclonal anti-human fibrinogen A alpha chain antibody 
(alpha chain binding FgA antibody – 1/1000 dilution in 0.1% w/v BSA, AbCam, 
Australia), and rabbit monoclonal anti-fibrinogen gamma chain antibody (gamma 
chain binding antibody– 3/1000 dilution in 0.1% w/v BSA, AbCam, Australia).  The 
wells were washed twice in DPBS and incubated at room temperature with 
secondary antibodies; biotinylated anti-mouse IGg antibody (binds to FgA and 2C2-
G7 primary antibodies) and biotinylated anti-rabbit antibody IGg (binds to Fg-
gamma antibody.  
 
The secondary antibodies were diluted in the ratio of 1:1000 in 0.1% w/v BSA and 
were purchased from GE Healthcare (Buckinghamshire, U.K.).  After an hour of 
incubation, the samples were washed twice in DPBS-T and loaded with SA-HRP 
(dilution 1:500 in 0.1% w/v casein) for 30 minutes at room temperature. Wells were 
then washed four times in DPBS-T before the colour substrate ABTS with hydrogen 
peroxide was incubated for 30minutes in room temperature. 100µl duplicates from 
each well were transferred into a 96 high binding well plate and the absorbance were 
read using a plate reader at 405nm wavelength. 
 
 
3.2.2.2 Fluorescence Microscopy 
 
In this experiment, the concentration and conformation of adsorbed fibrinogen on flat 
and nano-patterned substrates from solutions of only fibrinogen proteins and plasma 
was determined using fluorescence microscopy.  
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Flat silicon, TiO2, a-C:H and ta-C substrates, in triplicate, were placed in 0.1% (w/v) 
albumin (BSA) pre-coated well plates and incubated for 60 minutes at 37ºC with 
either 50µg/ml fibrinogen (Fg) solution or diluted plasma (ratio 1:10, in DPBS), 
while nano-patterned TiO2, a-C:H and ta-C substrates, in triplicate, were incubated 
with only 50µg/ml fibrinogen (Fg) solution. After an hour of incubation, the samples 
were washed in DPBS, incubated with 0.1% (w/v) albumin (BSA) block for 60 
minutes at 37ºC, washed twice in DPBS-T (DPBS with 0.01% v/v Tween) before 
incubating in mouse monoclonal anti-human fibrinogen primary antibody (2C2-G7 - 
Bioscientific, Australia for Cederlane).  
 
After an hour of incubation the wells were washed twice in DPBS and incubated at 
room temperature with Alexa Fluor 488 tagged anti-mouse IGg secondary antibody 
for 60 minutes at 37ºC. Following a quick washing step with DPBS with 0.5% (v/v) 
Tween 20, the test samples were stored in DPBS prior to visualising at 500x 
magnification with fluorescence microscope (Zeiss Axioskop Mot Mat 2, Australia). 
The distribution of the protein across the surface and the total intensity from each 
image, measured as total number of positive pixels was estimated using ImageJ. 
 
 
3.2.2.3 AFM  
 
The conformation of adsorbed fibrinogen and serum proteins on flat and nano-
patterned surfaces were visualised using AFM. In short, flat and nano-patterned 
silicon, TiO2, a-C:H and ta-C substrates, in triplicate, were placed in 0.1% (w/v) 
albumin (BSA) pre-coated well plates and incubated for 60 minutes at 37ºC, with 
50µg/ml fibrinogen (Fg) solution and diluted plasma (ratio 1:10, in DPBS). After an 
hour of incubation, the samples were washed in DPBS and samples were measured 
in liquid mode using Catalyst AFM (Bruker Bioscope Catalyst, BMIF, UNSW) in 
low voltage tapping mode at 296K with a tip diameter of 2nm, scan rate of 0.3Hz and 
scan area of 1µm x 1µm. Commercially available Si3N4 cantilevers were used and 
the force and resonant tip frequency parameters were adjusted continually to obtain 
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the best images. Image processing and surface topography analysis was performed 
using Nanoscope off-line software (Bruker, SA Australia). 
 
 
3.2.2.4 Quartz Crystal Microbalance with Dissipation monitoring (QCM-D) 
 
In this experiment, QCM-D (Q-sense AB, Sweden) was used to measure the amount 
of albumin (BSA), fibrinogen (Fg) and plasma proteins (diluted plasma in ratio 1:10, 
in DPBS) adsorbed onto TiO2 and a-C:H coated silica resonator substrates by 
measuring the frequency (ƒ) and dissipation (D) at the fundamental frequency, 
5MHz, and successive overtones of 15, 25 and 35MHz. A stable overtone was 
selected, which in this case was 15Hz and the corresponding ƒ and D values were 
compared with control silica sensors.  
 
Typically the QCM-D crystals were calibrated in air at 37ºC ± 0.1ºC and loaded with 
DPBS until a stable f and D baseline was established. After washing, the sensors 
were exposed to 50ug/ml fibrinogen and 50ug/ml BSA, or diluted plasma (ratio 1:10, 
in DPBS) for 60 minutes followed by a washing step with DPBS until a stable 
baseline was obtained (approximately three rinses). Silica QCM-D sensors were used 
as negative controls. A minimum of three repeats were recorded for each material 
surface with each protein solution. The Voigt based viscoelastic model assumes that 
the adsorbed layer is of uniform thickness, conserves its shape, and does not flow 
and as such the time-dependent frequency shifts (ƒ) and dissipation values (D) 
obtained for the 3rd (15Hz, n=3), 5th (25Hz, n=5), and 7th (35Hz, n=7) overtone were 
modelled using Voigt models along with their respective dissipation values to obtain 
the mass and the rate change of mass of adsorbed layers.  
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3.2.3 Clotting Cascade Experiments 
 
Coagulation of blood plasma induced by smooth contacting surfaces was measured 
using clot based assays. Citrated plasma was used in all three coagulation assays to 
induce fibrin-dependant clot formation. The time taken to induce clot formation via 
the extrinsic and intrinsic coagulation pathway was measured using the prothrombin 
assay (PT) and activated partial thromboplastin assay (aPTT), respectively. The 
ability of the contacting surfaces to denature fibrinogen, preventing it from forming 
fibrin monomers and consequently delaying fibrin clot formation was measured 
using the thombin time assay (TT).  Contacting surfaces include; a-C:H, TiO2 and 
Ta-C coated Si-surfaces where bare Si-wafer discs and polystyrene tissue culture 
well plates were used as negative and positive control, respectively. Furthermore, a 
heparin dose response standard curve was established to assess the degree of 
anticoagulant activity of each material surface. 
 
 
3.2.3.1 Plasma Purification for Clotting Cascade Experiments 
 
Human blood was collected from healthy donors, under ethics approval from the 
University of New South Wales. Blood was collected into polypropylene tubes 
containing 3.2% trisodium citrate solution, where the ratio of whole blood to sodium 
citrate was 9:1. The whole blood was transferred into 15ml centrifuge tubes and 
centrifuged at 2500 x g for 15minutes. Following centrifugation, the plasma was 
immediately separated from the red blood cells into new polypropylene tubes and 
stored at 4ºC until use. The assays were performed with two hours of collecting 
blood plasma before the plasma was rendered unviable.  
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3.2.3.2 Prothrombin Time (PT) 
 
Blood was collected and prepared according to the directions described in section 
4.2.2.1. Phosphoplastin RL reagent (R2 Diagnostics, Indiana, USA), from rabbit 
brain particles, was pre-warmed at 37ºC for 10 minutes and inverted to form a 
homogenous suspension. Well plates containing triplicate of each surface was 
incubated with 200µl of plasma at 37ºC for 60 seconds followed by 400µl of 
Phosphoplastin RL reagent.  
 
Tissue-culture polystyrene (TCPS) wells were used as positive control and plasma 
clotting times as a function of heparin concentration were used as negative control. 
Heparin (diluted in DPBS) was dissolved in blood plasma in the ratio of 1:9, totalling 
final heparin concentration of 0, 1, 2.5 and 5µg/ml. 200µl duplicates of each heparin-
plasma sample was loaded on TCPS well plates, incubated at 37ºC for 60 seconds 
before loading with reagent. Clotting times were recorded when the first form of 
fibrin formation was observed. 
 
 
3.2.3.3 Activated Partial Thromboplastin Time (aPTT) 
 
Samples were placed in TCPS well plates, as described in Section 0. 200µl of 
citrated plasma was loaded onto each sample and incubated at 37ºC for 60 seconds 
before incubating in 200µl of resuspended Phospholin ES (R2 Diagnostics, Indiana, 
USA), an ellagic acid based reagent from soyabean phospholipids, for 3minutes. 
200µl of 0.025M pre-warmed calcium chloride solution was pippetted to initiate 
clotting. Non-BSA coated polystyrene tissue-culture wells were used as positive 
control. Plasma clotting times as a function of heparin concentration were used as 
negative control in a manner described above. Time taken for clot formation was 
recorded. 
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3.2.3.4 Thrombin Time (TT) 
 
The required concentration of lyophilised human thrombin (Sigma Aldrich, 
Australia) was evaluated by ensuring clot formation falls within the laboratory 
normal range of 16-18 seconds. Thrombin was diluted in 1% (w/v) albumin (BSA) 
solution to form a reagent with final concentration of 10NIH units/ml. 300µl of pre-
warmed citrated plasma, collected in an eppendorf tube, was incubated with equal 
parts of thrombin solution and the time taken for fibrin to coagulate was recorded. 
The thrombin reagent was further diluted until fibrin formation was established 
within the reference range stated above.  
 
Once the necessary dilution was identified, fresh thrombin solution was prepared. 
Triplicate of  samples, placed in TCPS well plates, were loaded with 300µl of 
citrated plasma for 60 seconds at 37ºC before incubating in 300µl of resuspended 
thrombin solution for 2 minutes. TCPS wells with normal plasma were used as 
positive controls and TCPS well plates with plasma diluted in heparin at various 
concentrations were used as negative controls, as described previously in Section 0. 
The clotting times were measured using a stop watch. 
 
 
3.2.4 Platelet Studies 
 
Adsorbed plasma proteins, such as fibrinogen, on artificial surfaces recognise platelet 
adhesion receptors, potentially leading to the subsequent adhesion, spreading, 
aggregation and activation of platelets. In fact, prolonged exposure of biomaterials to 
blood, in vivo, have been known to cause platelet numbers in blood to decrease with 
surface exposure time, all the while increasing the probability of platelet-dependant, 
blood clot formation. Surfaces  inert to platelet adhesion and activation can be 
achieved through surface modifications, such as surface coatings and nano-
patterning, however, it is necessary to understand the influence of such surface 
modifications and their selective adsorption of plasma proteins on platelet 
interactions. 
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In this study, platelet responses to flat and nano-patterned silicon, TiO2, a-C:H and 
ta-C substrates were examined. The volume of platelets, their morphology, spreading 
and aggregation, once adsorbed onto bare surfaces and protein-pre coated surfaces 
were analysed using a combination of fluorescence microscopy, SEM and AFM and 
QCM-D.  
 
Platelets preferentially bind to fibrinogen via platelet integrin αIIbβ3 and as a 
consequence have been known to promote platelet adhesion and activation. The 
extent of other integrins involved in the adhesion process during platelet-biomaterial 
interactions still remains unknown. As such platelet interactions on biomaterial 
surfaces pre-exposed to fibrinogen and plasma proteins in the absence of αIIbβ3 
integrins (using anti-integrin αIIbβ3 antibody) were investigated by fluorescence 
microscopy, AFM and QCM-D. The activation of platelets, by the activation of α2β1 
and αIIbβ3 integrins, and the expression of P-selectin (CD62P) on platelet plasma 
membranes were detected using a combination of ELISA, fluorescent microscopy 
and flow cytometry.  
 
 
3.2.4.1 Platelet and surface preparation for platelet studies 
 
 
3.2.4.1.1 Platelet isolation from human blood 
 
Platelet adhesion assays were conducted using human blood from anonymous 
healthy adult donors, whose details are not provided. Platelets were isolated from 
blood collected from healthy donors in polypropylene tubes containing 3.2% tri-
sodium citrate anticoagulant. Following the transfer of blood into centrifuge tubes, 
red blood cells were separated from platelet rich plasma (PRP) by centrifuging for 20 
minutes at 1000rpm.  The PRP supernatant was carefully transferred into fresh 
centrifuge tubes in which it is centrifuged for a further 10 minutes at 1000rpm to 
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remove any remaining red blood cells. Again, the PRP was transferred to clean 
centrifuge tubes and centrifuged for 10 minutes only this time at a speed of 1600rpm 
causing the platelets pellet in a pool of platelet poor plasma (PPP). The PPP was 
aliquoted and stored at -20ºC for later use. The platelets were resuspended in pre-
warmed Tyrodes buffer (Sigma, supplemented with 10U apyrase, filter sterilised, 
37ºC). The suspension was centrifuged at 1600rpm for a further 10 minutes to re-
pellet the platelets. The supernatant, containing Tyrodes buffer and remaining plasma 
proteins, was discarded.  
 
Platelets were counted in a haemocytometer and diluted in pre-warmed Tyrodes 
buffer to a final concentration of 1x107 platelets/ml. The platelet suspension was 
incubated in a waterbath for 30minutes to settle at a temperature of 37oC before use 
in proceeding experimentation.  
 
Due to the inviability of the platelets within the Tyrodes solution, it is possible only 
to store the suspension formed by this procedure for up to 5 hours after the blood was 
first collected from the donor before biological interactions (from further 
experimentations) become null.   
 
 
3.2.4.1.2 Pre-incubating platelet solutions with integrin αIIbβ3 antibody 
 
For experiments analysing the influence of integrin αIIbβ3 in promoting platelet 
adhesion, platelets (prepared as described in Section 3.2.4.1.1) were pre-exposed to 
anti-αIIbβ3 F(ab) fragment antibody (1 μg/ml, ReoPro, Abciximab, Eli Lily, Sydney, 
Australia) for 60 minutes at 37ºC, 5% CO2 before being loaded into wells. 
 
 
3.2.4.1.3 Pre-coating surfaces with protein solutions 
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Typically, tissue culture polystyrene (TCPS) well plates, pre-incubated with 0.1% 
(w/v) BSA for 60 minutes at 37ºC, were seeded with sterilised surfaces (detailed in 
Section 3.1.1.4), in triplicate, before loading with one of three solutions; 50µg/ml 
albumin (BSA), 50µg/ml fibrinogen (Fg) and pre-warmed plasma (diluted in DPBS, 
ratio 1:10) for 60 minutes at 37ºC. The well plates were washed twice in DPBS and 
incubated with block protein, 0.1% (w/v) BSA, for 30 minutes at 37ºC. The block 
step is performed to reduce background staining of the substrates. Again, the wells 
were washed twice in DPBS before commencing the incubation of platelets. Bare 
substrates, without any protein coat, were compared with the protein-precoated 
substrates to analyse the combinatorial effect of surface chemistry and the adsorption 
of specific plasma proteins in modulating platelet interactions.   
 
 
3.2.4.2 Platelet adhesion studies 
 
 
3.2.4.2.1 Fluorescence Microscopy 
 
Fluorescence microscopy was used to visualise platelet adhesion on nano-patterned 
and flat silicon, TiO2, a-C:H and ta-C surfaces by staining the actin monomers found 
in the adhered platelet cytoplasm using Rhodamine-Phallodin.  
Bare and protein pre-coated surfaces were prepared in a manner detailed in Section 
3.2.4.1.3. Platelets (1 × 107 platelets/ml in Tyrodes buffer containing Apyrase, 
Section 3.2.4.1.1) were incubated for 1 h at 37°C, either alone or in combination with 
anti-human glycoprotein GPIIb-IIIa receptor (integrin αIIbβ3) F(ab) fragment 
antibody (1 μg/ml, Abciximab, Eli Lily, Sydney, Australia), in a manner described in 
Section 3.2.4.1.2. Bare and protein pre-coated nano-patterned surfaces, on the other 
hand, were incubated only with platelets in Tyrodes solution for 60 minutes at 37ºC. 
Any unbound platelets from the well plates were removed from washing with DPBS 
following the removal of platelet suspension from wells. The platelets were fixed 
with fixing solution (4% v/v Paraformaldehyde and 1% w/v sucrose) for 15 minutes 
at room temperature and washed with DPBS buffer. The surfaces were permeabilised 
Chapter 3: Materials and Methods   95 
at 4ºC for 5minutes using permeabilising solution and blocked with 1% (w/v) 
albumin (BSA)/TBS solution for 5 minutes at 37ºC. Rhodamine-Phallodin (1/100 
dilution in 1% w/v BSA/TBS, Invitrogen Corporation), a staining solution, was used 
to stain the actin filaments of the permeabilised platelets over 60 minutes at 37ºC.  
 
Following a quick washing step with DPBS with 0.5% (v/v) Tween 20 (PBST), the 
test samples were stored in DPBS prior to visualising at 500x magnification with 
fluorescence microscope (Zeiss Axioskop Mot Mat 2, Australia). Microscope images 
were analysed for cell number and circularity by using the automated detection of 
cell outline feature in ImageJ (version 1.44p, NIH). TCPS well plates were used as 
controls. 
 
 
3.2.4.2.2 SEM  
 
Platelet morphology on flat and nano-patterned protein pre-coated substrates was 
also visualised using SEM. Bare and protein pre-coated flat and nano-patterned 
surfaces, prepared according to Section 3.2.4.1.3, were incubated with platelet 
solution (1 × 107 platelets/ml in Tyrodes buffer containing Apyrase, Section 
3.2.4.1.1) for 1 h at 37°C. The well plates were washed twice with DPBS and soaked 
in a diluted glutaraldehyde fixative (2.5% (v/v) in DPBS) for 60 minutes at room 
temperature before another washing step. Once the adhered platelets were fixed, the 
well plates were dehydrated in a series of graded ethanol washes (50%, 60% and 
70% v/v ethanol diluted in MilliQ water) for 10 minutes each. The well plates were 
then incubated overnight  at 4ºC, in fresh 70% ethanol solution before dehydrating in 
90% (v/v) and 95% (v/v) ethanol for 10 minutes each followed by two rises in 100% 
ethanol for 10 minutes, changing solution in between. Any remaining moisture and 
ethanol residues in the biological specimens were removed by drying the test 
samples in a critical point drier (CPD). The samples were mounted on stubs, before 
being sputter coated and imaged using SEM ( described in Section 3.1.2.2). 
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3.2.4.2.3 AFM 
 
AFM allows for precise high resolution imaging of platelets at the nanometer scale 
by probing the surface nano-topology with a mechanical cantilever. In this 
experiment, AFM was used to show topographical images of platelets exposed to flat 
and nano-patterned fibrinogen coated a-C:H substrates.  
 
Typically, sterilised flat and nano-patterned a-C:H surfaces (from Section 3.1.1.4) 
loaded in albumin (BSA) pre-coated TCPS well platelets, were incubated with 
50µg/ml fibrinogen (Fg) for 60 minutes at 37ºC. The well plates were washed and 
incubated with block protein, 0.1% (w/v) BSA, for 30 minutes at 37ºC before being 
washed again (detailed in Section 3.2.4.1.3). The fibrinogen pre-coated flat a-C:H 
substrates were then seeded with platelets (1 × 107 platelets/ml in Tyrodes buffer 
containing Apyrase, Section 3.2.4.1.1) for 1 h at 37°C, either alone or in combination 
with anti-human glycoprotein GPIIb-IIIa receptor (integrin αIIbβ3) F(ab) fragment 
antibody (1 μg/ml, Abciximab, Eli Lily, Sydney, Australia, Section3.2.4.1.2), while 
fibrinogen pre-coated nano-patterned surfaces were incubated only with platelets in 
Tyrodes solution for 60 minutes at 37ºC. Any unbound platelets from the well plates 
were removed from washing with DPBS following the removal of platelet 
suspension from wells. The platelets were fixed with 1:1 ratio Methanol : Ethanol 
solution for 5minutes at 4ºC before storing in DPBS for AFM imaging. 
 
 
3.2.4.2.4 QCM-D  
 
Real-time analysis of platelet interactions on bare and protein pre-coated flat surfaces 
was carried out using a single cell, open chamber QCM-D at 5% CO2 and 37 ± 0.1 
ºC. Silica, TiO2 and a-C:H coated QCM sensors were exposed to DPBS until a stable 
ƒ and D measurements were established. The QCM crystals were then incubated with 
one of four solutions; DPBS, 50µg/ml albumin (BSA), 50µg/ml fibrinogen (Fg) and 
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diluted plasma (ration 1:10, in DPBS) for 60 minutes and then rinsed with DPBS, 
again until a consistent ƒ and D values were attained (approximately 3 rinses). The 
surfaces were blocked with 0.1% (w/v) BSA (this step was omitted in sensors 
incubated in DPBS so that platelet interactions on bare surfaces can be analysed) for 
30 minutes and washed again with DPBS before incubating with platelet solution. 
Platelets (1 × 107 platelets/ml in Tyrodes buffer containing Apyrase, Section 
3.2.4.1.1) were incubated for 1 h, either alone or in combination with anti-human 
glycoprotein GPIIb-IIIa receptor (integrin αIIbβ3) F(ab) fragment antibody (1 μg/ml, 
Abciximab, Eli Lily, Sydney, Australia). After incubation, the samples were again 
washed with DPBS and any changes in ƒ and D measurements during platelet 
incubation were recorded.  
 
 
3.2.4.3 Platelet activation studies 
 
 
3.2.4.3.1 ELISA 
 
ELISA was used to measure the presence of activated plasma membrane integrins on 
platelets adsorbed on bare and protein pre-coated flat surfaces by probing for α2β1 
and αIIbβ3 integrins using specific anti-integrin antibodies. Bare and protein pre-
coated flat, prepared according to Section 3.2.4.1.3, were incubated with platelet 
solution (1 × 107 platelets/ml in Tyrodes buffer containing Apyrase, Section 
3.2.4.1.1) for 1 h at 37°C, 5% CO2. Again the wells were washed in DPBS twice and 
fixed with 1:1 ratio methanol : ethanol solution for 5 minutes at 4ºC. Upon fixing, the 
platelets were incubated with either:  
 mouse monoclonal anti-α2β1 (3 µg/ml, clone BHA2.1, Millipore, Sydney, 
Australia) primary antibody; or, 
 mouse monoclonal anti-human glycoprotein GPIIb–IIIa receptor (integrin 
αIIbβ3) F(ab) fragment antibody (Abciximab – Reopro, 3µg/ml, Eli Lily, 
Australia) 
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for 2 hours at room temperature without agitation. Following a washing step with 
PBS-T, secondary antibodies, biotinylated anti-mouse antibody (1:1000 in 0.1% w/v 
BSA, GE Healthcare Buckinghamshire, U.K.) and polyclonal goat anti-human Ig 
F(ab) fragment peroxidase conjugated secondary antibody (1:2000, Thermo Fisher 
Scientific, Australia), respectively, were added to each well and incubated for 1 hour 
at 37ºC. The samples were washed once more in PBS-T before incubating for 
30minutes at room temperature with SA-HRP colorimetric agent (1:500 dilution in 
0.1% w/v BSA). After subsequent washing step, ABTS (with hydrogen peroxide) 
colorimetric substrate was added and incubated over night at room temperature. 
Duplicates of 100µl from each well plate was transferred into a 96 high binding 
ELISA well plates before measuring absorbance at 405nm wavelength using a plate 
reader.  Results from each test sample were compared against polystyrene well 
platelets, as control. 50µg/ml collagen precoated on TCPS well plates were used as 
positive control when measuring integrin α2β1 activation on platelet membrane.  
 
 
3.2.4.3.2 Fluorescence microscopy 
 
Fluorescence microscopy was used to visualise the localisation of activated αIIbβ3 
integrins and the expression of P-selectin (CD62P) receptors on surface adsorbed 
platelets. Bare and protein pre-coated flat and nano-patterned surfaces, prepared 
according to Section 3.2.4.1.3, were incubated with platelet solution (1 × 107 
platelets/ml in Tyrodes buffer containing Apyrase, Section 3.2.4.1.1) for 1 h at 37°C. 
Unbound platelets remaining in suspension after incubating on bare and protein-pre-
coated surfaces were collected into flow cytometry glass vials for following 
experiments using flow cytometer.  
 
The surface bound platelets washed in TBS and fixed, with fixing solution (4% v/v 
Paraformaldehyde and 1% w/v sucrose) for 15 minutes at room temperature. The 
samples were washed again in TBS before permeabilising the platelet membrane at 
4ºC for 5minutes using permeabilising solution. The samples were then blocked with 
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1% (w/v) albumin (BSA)/TBS solution for 5 minutes at 37ºC before being integrin 
and actin staining. 
 
Nano-patterned surfaces were dual labelled with either green staining anti-integrin 
αIIbβ3 and red staining Rhodamine-Phallodin, or, green staining anti-integrin αIIbβ3 
and red staining anti-CD62P antibodies. The methods are described below in detail: 
 For anti-integrin αIIbβ3 and actin staining - samples were incubated with 
mouse monoclonal anti-human glycoprotein GPIIb–IIIa receptor (integrin 
αIIbβ3) F(ab) fragment antibody (Abciximab – Reopro, 3µg/ml diluted in 1% 
(w/v) BSA/TBST, Eli Lily, Australia) for 60 minutes at 37ºC followed by 
quick wash in TBST. Then the samples incubated with goat polyclonal FITC 
conjugated F(ab) specific secondary Anti-Human IgG (1:16 dilution, Sigma 
Aldrich, MO, USA) antibody for 60 minutes at 37ºC. Following a quick 
washing step using TBST the surface adsorbed platelets were stained with 
Rhodamine-Phallodin for 60 minutes at 37ºC.  
 For anti-integrin αIIbβ3 and CD62P staining – surface adsorbed platelets were 
incubated for for 60 minutes at 37ºC with mouse monoclonal anti-human 
glycoprotein GPIIb–IIIa receptor (integrin αIIbβ3) F(ab) fragment antibody 
followed by quick wash in TBST. Then a cocktail containing goat polyclonal 
FITC conjugated F(ab) specific Anti-Human IgG (1:16 dilution, Sigma 
Aldrich, MO, USA) secondary antibody and mouse monoclonal RPE 
conjugated anti-human CD62P (P-selectin) antibody (1:100 dilution, 
eBiosciences, San Diego, CA, USA) were loaded onto the platelet adsorbed 
surfaces for 60 minutes at 37ºC.  
Flat surfaces were dual labelled with green staining anti-integrin αIIbβ3 and red 
staining anti-CD62P antibodies using the method below: 
 Surfaces were incubated with mouse monoclonal anti-human glycoprotein 
GPIIb–IIIa receptor (integrin αIIbβ3) F(ab) fragment antibody for for 60 
minutes at 37ºC. Following a quick wash with TBST the samples were 
incubated with both; goat polyclonal FITC conjugated F(ab) specific Anti-
Human IgG and mouse monoclonal RPE conjugated anti-human CD62P (P-
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selectin) antibody for 60 minutes at 37ºC using the dilutions mentioned 
above.  
 
After dual labelling the samples were washed with 0.5% PBST, before storing the 
samples in DPBS for visualisation under fluorescent microscopy at 500x 
magnification. Microscope images were analysed for localisation of activated 
integrins and cytoskeletal arrangements. 
 
 
3.2.4.3.3 Flow-cytometry 
 
Activation αIIbβ3 and P-selectin integrins on un-bound platelets in the presence 
varying surface chemistries and pre-coated proteins were analysed using flow 
cytometry. Platelet suspension retrieved from each flat and nano-patterned test 
surfaces, either; bare or protein pre-coated, from fluorescence microscopy 
experimentation (as described in Section 3.2.4.3.2) was collected and 100µl from 
each test surface was pipetted into 2 glass Flow Cytometer Vials. 
 
The vials were either: 
 Incubated with 1/100 dilution of Fluorescein isothiocyanate (FITC) 
conjugated anti-CD62P (clone 9E1, Bio-Scientific Pty. Ltd., Australia), 
vortexed and incubated for 20 minutes at 37ºC; or,  
 Incubated with 1/32 dilution of mouse monoclonal anti-human glycoprotein 
GPIIb–IIIa receptor (integrin αIIbβ3) F(ab) fragment antibody, vortexed and 
incubated for 60 minutes at 37ºC. The platelets in the vials were pelleted by 
centrifuging at 1000rpm for 3 minutes, the supernatant containing un-bound, 
excess antibodies were discarded. The vials were washed in PBST and 
pelleted again by centrifuging at 1000rpm for 3 minutes to remove any 
remaining free antibodies. After the washing step the samples were incubated 
with goat polyclonal FITC conjugated F(ab) specific Anti-Human IgG for 60 
minutes at 37ºC before following another round of centrifuging, washing and 
centrifuging.  
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The supernatant from the vials were discarded and pellets were resuspended in 1% 
(w/v) Paraformaldehyde in Tyrodes Buffer for 20minutes at 4ºC. The samples were 
re-centrifuged for 3 minutes at 1000rpm, before being resuspended in pre-warmed 
(37ºC) DPBS. The FITC fluorescence intensity of 10,000 platelets was analysed 
using the FL-1 channel in Flow Cytometer. 
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4   MATERIAL CHARACTERISATION AND 
PROTEIN ADSORPTION 
 
4.1   Introduction    
       
The characterisation of a material plays a crucial role in validating its structure and 
integrity, and consequently aids in accurately analysing the results of its biological 
interactions. In this study a-C:H, TiO2, Ta-C coated flat and nano-patterned 
substrates were characterised based on their surface chemistry and topography using 
a combination of x-ray photo electron spectroscopy (XPS), scanning electron 
microscopy (SEM), focused ion beam (FIB) and atomic force microscopy (AFM). 
The sample substrates were then subjected to a rigorous sterilisation procedure, prior 
to being introduced into 12-well TCPS plates for serum protein adsorption.  The 
concentration and conformation of the adsorbed fibrinogen were examined using a 
combination of ELISA, QCM-D, fluorescence microscopy and AFM.   
 
 
4.2 Material characterisation 
 
4.2.1 XPS 
 
XPS was used to characterise the surface chemistry of the thin films. Figure 4.1 (a) 
and (b) shows a high resolution image of the valence band XPS signals on TiO2 
coatings. XPS analysis of the TiO2 films presented with characteristic, dominating 
peaks at 458eV and 463.9eV corresponding to the presence of Ti2p (titanium), with 
no evidence of contamination from the coating process. Trace amounts of carbon 
(C1) and oxygen (O1) were also recorded at 285eV and 530eV respectively, 
primarily due to the spontaneous oxide layer formation and the surface adsorption of 
organic (carbon based) molecules from exposure of the oxide layer to the 
atmospheric air.   
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Figure 4.1 X-ray photoelectron spectroscopy graph showing a) full spectrum scan 
and, b) magnified view of Ti2p peaks on TiO2 surface. 
 
 
Figure 4.2 (a) and (b) shows the C1 core level XPS spectra of a-C:H films. The 
dominating C1 (carbon) peaks were noted at 284.6eV. Although XPS does not take 
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into consideration the concentration of hydrogen atoms or the presence of C-H 
bonds, trace amounts of oxygen atoms (O1 peaks) were noted at 532eV. Again, no 
other contaminants were evident from the coating process.  
 
To identify the state of the carbon, the C1 spectrum of the adlayer was compared 
against that of graphite (C with sp2 hybridisation, as indicated by the red curve) and 
microcrystalline diamond particles (C with sp3 hybridisation, as indicated by the 
green curve) with main peaks at 284.4eV and 287.8eV, respectively. Characteristic 
of a-C:H coatings, the C1s value on the thin film is slightly higher than that of 
graphite and significantly lower than that measured for diamond, indicating the film 
contains a mixture of sp2 (graphite-like) and sp3 (diamond-like) bonded matrix. This 
could possibly be due to the electron system of the underlying silicon substrate and 
the coating parameters.  
 
A shallow slope at the high binding energy side (between 285eV and 288eV) of the 
C1 curve is primarily due to the superimposition of the C-O bonds and sp3 bonds 
illustrating the presence of oxygen bound carbon atoms (C-O bonds, as indicated by 
the blue curve) in combination with sp3 fractions. The C-O bonds demonstrate the 
spontaneously absorbed oxide film on the carbon adlayer under atmospheric 
conditions.  
 
Similarly, the C1 peak on Ta-C films, as shown in Figure 4.3 (a) and (b) was again 
indicative of the saturated carbon adlayer on the silicon substrate. Trace oxygen 
levels are attributed to oxide layer formation on the film surface. Furthermore, the 
state of the carbon atoms is akin to that of sp2 clusters, however this could possibly 
be due to a structurally different sp2 overlayer formed during a high voltage bias 
[454]. 
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Figure 4.2 XPS graph displaying a) full spectrum scan and, b) magnified view of C1 
peak on amorphous, hydrogenated diamond like carbon (a-C:H) films. 
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Figure 4.3 XPS image showing a) full spectrum scan and, b) magnified view of C1s 
spectra on Ta-C films. 
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4.2.2 SEM and FIB 
 
SEM and FIB were used to determine the uniformity and the degree of penetration of 
the deposited layer. A thin layer of a-C:H, ta-C and TiO2 film was deposited on ultra 
flat silicon substrates and silica QCM sensors; as such, it was necessary to determine 
the homogeneity, thickness of the coated layer and any morphological features, if 
present. Furthermore, silicon, TiO2, a-C:H and ta-C nano-patterned silicon wafers, 
using gold nano-particles, were also characterised before being analysed for their 
ability to influence protein and platelet interactions.  
 
The morphology of the silicon surfaces, before and after thin film coating, were 
analysed via SEM in Figure 4.4. The images show a 10 µm x 10 µm scan of 
topography on each surface, where SEM confirmed the smooth appearance of the 
four flat surfaces with no distinctive or characteristic features in the micron scale. 
Some pitting due to delamination was evident on the Ta-C surfaces at higher 
magnification (data not shown).  
 
Figure 4.5 shows 10 µm x 10 µm SEM scans of TiO2, a-C:H and Ta-C coated flat 
silica quart crystal microbalance sensors and bare silica QCM sensors. Coated QCM 
sensors also displayed flat and featureless, smooth topography with surface 
morphology influenced by the underlying control test substrate. These images also 
show a complete coverage by the deposited layer with no erroneous regions without 
coating. 
 
The nano-patterned TiO2, a-C:H and ta-C surfaces was also analysed by SEM, as 
shown in Figure 4.6. Their topographies on 10 µm x 10 µm SEM scans were 
compared against their respective control flat surfaces to establish if the level of 
surface roughness was altered through the coating process.  
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 Figure 4.4 Surface topography of a. smooth silicon wafer test substrates and silicon 
discs coated with b. TiO2, c. a-C:H and d. Ta-C, as visualised using SEM. Scan size 
of 10µm x 10µm2 was imaged using an InLens detector (10kV). 
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 Figure 4.5 Surface topography of a. silica QCM crystal, b. TiO2, c. a-C:H and d. 
Ta-C coated sensors, as visualised using SEM. Scan size of 10µm x 10µm2 were 
imaged using an InLens detector (10kV). 
 
Block co-polymer technology, using polystyrene (PS) and polyvinylpyridine (PVP) 
polymers, was employed to carefully create nano-patterns from gold particles on the 
ultra-flat silicon wafers. Figure 4.6(a) and (b) shows the flat surface and its 
morphology before and after nano-patterning. The particles appear as pseudo-regular 
islands with a pseudo-regular pitch. The TiO2, a-C:H and ta-C coated patterned 
silicon wafers present similar morphological features to the patterned silicon 
substrate, as shown in Figure 4.6(d), 4.6(f), 4.6(h)  respectively. The nano-patterns 
appear to vary in their dimension, although less than 100nm in diameter each and the 
coated films follow the morphology of the underlying patterned substrates. 
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Furthermore, individual nano-islands appear to vary in their dimension, although 
keeping within the 40nm diameter threshold. 
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Figure 4.6 Surface topography of nano-patterned silicon substrates b. without any 
coating and that coated with d. TiO2, f. a-C:H and h. Ta-C, as visualised using SEM. 
Topography was created by gold particle arrays in a pseudo-regular fashion using 
the block co-polymer method. Corresponding images of non-patterned test substrates 
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are given in a, c, e, and g, respectively. Scan size of 5µm x 5µm2 were imaged using 
an InLens detector (10kV). 
 
A higher magnification of the deposited a-C:H film by SEM on the nano-patterned 
surface is shown in Figure 4.7. It appears that the coated film envelopes the gold 
nano-particles, encapsulating it to form dome-like coverage. Furthermore, the islands 
tend to coalesce to form small clusters of two or three nano-domes thus increasing its 
overall geometry and decreasing the pitch between adjacent islands. Due to cluster 
formation, the globular islands tend to form irregular shapes, some mimicking the 
general cylindrical conformation of proteins. Such morphological patterns were also 
noted on ta-C and TiO2 surfaces, characteristic of their respective thin film-coating 
process. 
 
 
 
              
 
 
 
 
 
 
 
 
Figure 4.7 A magnified view of nano-patterned a-C:H surface from SEM. Samples 
were imaged using an InLens detector (10kV) at 30K X magnification (above) and 
150K X magnification (below). 
1µm 
200nm 
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The thickness of the deposited film on silicon wafer was determined using FIB. High 
density positively charged gallium ions were bombarded onto the substrate etching 
away to form a cross section of the surface. The etching rate and current were chosen 
to minimise re-deposition of ions. Transmission signals in the form of reflected 
secondary ions from each point were collated to generate the images in Figure 4.8 
and Figure 4.9.  
 
The depth of deposited a-C:H, as measured by FIB, is shown in Figure 4.8. The 
thickness of the coated layer is indicated between the red arrows. The thick base 
layer below the arrows is primarily silicon with a thin native oxide layer. The thin, 
bright adlayer above silicon is an intermediate layer of silicon and carbon (SiC) 
formed rapidly during the coating process when carbon atoms were bombarded onto 
the silicon surface. The slightly thicker layer above SiC is the deposited a-C:H 
followed by a superficial layer of organic compounds adsorbed on the a-C:H surface 
from interacting with the atmosphere.  
 
 
Figure 4.8 Cross-sectional view of a-C:H coated flat silicon substrate, as determined 
by SEM-FIB. Sample was milled using FIB image probe (30KV, 5pA) and scanned 
using InLens detector (10kV) at 53.8º stage tilt. Depth of the deposited layer is 
indicated between the red arrows. Layers between the arrows bottom to top include; 
native oxide on the silicon surface, a-C:H coating and organic layer formed from 
atmospheric conditions, respectively. 
 
200nm 
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Since the samples were imaged at 53.8 degrees the images were corrected for the tilt 
before calibrating for thickness. The deposited a-C:H film formed a uniform 
deposition layer and its depth was homogenous throughout the sample. TiO2 and ta-C 
films were also cross sectioned to show that TiO2 formed the thickest layer followed 
by Ta-C and a-C:H. Table 4.1 summarises the thickness values of the thin films on 
the flat and patterned surfaces. 
 
Table 4.1 Thickness of the thin film coating was calibrated using ImageJ from FIB 
measurements (1.44p, NIH). 
                            THICKNESS (nm) 
 Flat Surface Nano-patterned Surface 
TiO2 130-140nm 30-35nm 
a-C:H 75-85nm 35-40nm 
Ta-C 90-100nm 30-35nm 
 
 
The coating thickness of TiO2, a-C:H and Ta-C on nano-patterned silicon substrates 
are shown in Figure 4.9. The gold particles appear embedded deep within the 
adlayer, adjacent to the silicon base and yet appear more intense than the deposited 
coating. This is indicative of the intrinsic conductive nature of gold. The marginally 
conductive deposited film, on the other hand, is marginally conductive and appeared 
less intense due to its relatively inert properties. Furthermore, it is evident across all 
three coated films that the deposited layer had formed a blanket, completely 
encapsulating the gold particles. It can be inferred that the film penetrated between 
the grooves created between the particles and the surface thus reduced the likelihood 
of sharp edges, and the relative roughness profile created by the gold particles.  
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Figure 4.9 Cross-sectional view of nano-patterned si wafer substrates (a) non-coated 
and coated with (b) TiO2, (c) a-C:H and (d) Ta-C, as determined by SEM-FIB. 
Topography was created by gold particle arrays in a pseudo-regular fashion using 
block co-polymer method. Samples were milled using FIB image probe (30KV, 5pA). 
Images were scanned InLens detector (10kV) at 53.8º stage tilt. Depth of the 
deposited layer, indicated between the red arrows. 
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4.2.3 AFM 
 
Differences in surface nano-topography between the flat, QCM crystals and nano-
patterned substrates were further analysed in air by AFM, in low voltage tapping 
mode. Scan rate of 1Hz and scan area of 0.5µm x 0.5µm or 1µm x 1µm were used. 
Surface nano-topography as well as their respective roughness scale were established 
using AFM. Results are shown in Figure 4.10 to 4.12 for flat, QCM sensors and 
nano-patterned substrates, respectively.  
 
Ultra flat silicon wafers exhibited a stochastic roughness of 0.20nm with a maximum 
z-range of 2.57nm. Ta-c and a-C:H films  followed this profile with RMS values of 
0.36nm and 0.20nm respectively, as shown in Figure 4.10. These values were similar 
to that of the ultra-flat silicon wafer substrate. Furthermore, comparing the three 
surfaces, it is evident that both; a-C:H and ta-C films exhibit morphological features 
influenced by the silicon substrate indicating a uniform deposition of the thin film. 
TiO2, however, presented a much higher roughness of 1.55nm. TiO2 substrates 
displayed some peaks (convex summits), distributed randomly with irregular pitch. 
The dome like peaks range between 40-100 nm in diameter with an average height of 
10.45nm, as deduced from the roughness profile on the right.   
 
Silica QCM crystals displayed a roughness of 1.09nm and like the si-wafers, the a-
C:H coatings on QCM crystals appeared homogenous with morphological features 
similar to the substrate. Ta-C however displayed several regions of sharp peaks 
increasing the overall the RMS value. This may partially be due to some level of 
delamination caused by the weak bonds between the silica and the carbon adlayer. 
TiO2 films presented several peaks localised throughout the surface defined with a 
rounded geometry. 
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 Figure 4.10 AFM topographical image (left; scan size 500 x 500nm2) and line scans 
(right) of a. silicon, and, b. TiO2, c. a-C:H and d. ta-C deposited on ultra flat silicon 
wafers. The lighter regions are height variations observed from the coating 
procedure. The vertical scale range is 50nm. 
 
The islands appear flattened (maximum z-height of 13.7nm), some adjoining with 
neighbouring domains thereby reducing its overall undulations and causing a 
roughness value similar to the silica sensor. A comparison of the surface roughness 
(RMS) is shown in Table 4.2 for flat surfaces and QCM sensors. 
 
Table 4.2 Comparison of root mean square (RMS) roughness value (measured in nm) 
of both flat substrates and flat QCM crystals. 
 
 Smooth Surface QCM Sensor 
Silicon/Silica 0.203 ± 0.027 1.085 ± 0.14 
TiO2 1.554 ± 0.062 1.514 ± 0.063 
a-C:H 0.36 ± 0.031 1.166 ± 0.114 
Ta-C 0.204 ± 0.031 2.254 ± 0.545 
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Figure 4.11 AFM topographical image (scan size 500 x 500nm2; scale range 50nm) 
and corresponding line scans of a. silica b. TiO2, c. a-C:H and d. ta-C deposited on 
QCM crystals. 
 
A clear difference between the patterned and flat substrates was exhibited when the 
average nano-roughness was raised from 1nm to 5-10nm range. The nano-patterned 
surfaces, as shown in Figure 4.12, presented with an increased number of peaks with 
greater height differences (z-range) thereby increasing the overall RMS value of the 
silicon wafer to 5.25nm, as shown in Table 4.3. From Figure 4.12, it was evident the 
z-range between nano-particles varied significantly, with some gold particles 
aggregating leading to large height differences. For this reason some sporadic peaks 
that formed because of the fabrication process were disregarded during the roughness 
calculation.  
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Figure 4.12 AFM topographical image (scan size 1µm x 1µm2) of a. uncoated SiO2, 
and, c. TiO2, e. a-C:H and g. Ta-C deposited nano-patterned surfaces. 
Corresponding topographies of their flat surfaces are compared in images b, d, f, 
and h, respectively. The vertical scale range is 50nm. 
 
A comparison of the four surfaces showed TiO2 followed a similar morphology to 
the silicon surface while ta-C and a-C:H displayed a greater roughness value. Ta-C 
surfaces showed minor levels of delamination creating large height differences 
between peaks. The average peak depth (z-range) calculated between the silicon, 
TiO2, a-C:H and ta-C surfaces were  26, 27.55, 37.90 and 32.02nm, respectively, 
consequently increasing the overall surface area by 9.43, 10.98, 14.6 and 11.12%, 
respectively. These results are tabulated in Table 4.3. 
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Table 4.3 Comparison of root mean square (RMS) roughness value (measured in nm) 
of nano-patterned surfaces. 
 
Nano-patterned Surfaces RMS (nm) Increase in Surface Area (%) (3s.f.) 
Si 5.247 ± 0.342 9.43 
TiO2 5.458 ± 0.238 10.9 
a-C:H 6.943 ± 0.289 14.6 
Ta-C 5.031 ± 0.723 11.2 
 
Roughness profile images deduced from the line scans in Figure 4.13 were used to 
estimate the pitch between neighbouring peaks and the diameter of nano-particles. 
TiO2, a-C:H and Ta-C displayed pitch of 50-150, 70-160= and 50-200nm, 
respectively and diameter between 21-60, 28-55 and 33-60nm, respectively. While 
TiO2 surfaces show similar number of peaks as the silicon surface, a-C:H and ta-C 
films caused aggregation between adjacent gold nano-particles raising the overall 
island diameter from 25-30nm to significantly higher values. This in combination 
with the thicker layer of a-C:H formed on the gold particles may explain their 
elevated roughness values when compared to the nano-patterned control.  
 
 
 
a 
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Figure 4.13 Line plot of a. TiO2, b. a-C:H and c. Ta-C deposited nano-patterned 
surfaces. The vertical scale range is 50nm. 
 
 
4.3 Protein adsorption studies on flat surfaces 
 
Most implantable biomaterial surfaces come in contact with blood causing a 
sequence of interactions initiated by the rapid adsorption of plasma proteins that 
change in conformation to form a proteinacious adlayer that mediates the adhesion 
and activation of platelets and the clotting cascade. This may consequently lead to 
c 
b 
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the formation of blood clots (thrombus). As such, it is important to understand the 
adsorption of specific proteins, their exact interaction, and the mechanisms of 
unfolding at the solid-liquid interface. Fibrinogen, due to its abundance in blood 
plasma and its major role in platelet attachment, was chosen as the serum protein. 
Furthermore, the effect of nano-features on fibrinogen attachment was analysed. 
 
In this study, flat surfaces, examined in section 4.1, were investigated using a 
combination of ELISA, AFM in liquid mode, fluorescence microscopy and QCM-D 
measurements for their adsorbed concentration and conformation. Fibrinogen 
attachment on nano-patterned surfaces was examined using fluorescence microscopy 
and AFM. QCM-D was used to further analyse the kinetics of protein attachment. 
The results obtained were compared to bare surfaces, from Section 4.2, as well as 
surfaces pre-coated with albumin (BSA) and/or diluted plasma proteins (ratio 1:10, 
in DPBS buffer). 
 
 
4.3.1 ELISA 
 
Fibrinogen is an abundant soluble extracellular matrix protein available in blood at 
concentration of 3mg/ml and shows a high affinity to adsorb onto most surfaces.  
Fibrinogen along with other serum proteins, such as fibronectin and von Willebrand 
factor, mediate platelet adhesion and aggregation via direct interaction with platelet 
receptors. Surface bound fibrinogen molecules have been known to change in 
conformation to perform its implicated role in mediating adhesion of platelets to 
synthetic surface by binding its RGDS site on the Aα chain and a non-RGD 
dodecapeptide sequence in the γ-chain on fibrinogen to αIIbβ3 integrin on platelets. 
Albumin on the other hand, is a negatively charged protein that readily adsorbs onto 
most materials and has been known to reduce platelet adhesion to the surface. 
Consequently, a higher albumin to fibrinogen ratio has often been correlated to good 
haemocompatibility of biomaterials by reducing the likelihood of thrombus 
generation. As such, adsorption of fibrinogen in a simple solution and in solution 
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with excess albumin was analysed using ELISA along with its adsorbed 
conformation.  
 
 
4.3.1.1 Adsorption studies 
 
A comparison of albumin and fibrinogen (Fg) protein adsorption on flat silicon, 
TiO2, a-C:H and ta-C surfaces in a simple solution of the individual protein were 
studied. These results were compared against complex solutions containing both 
proteins: either biotinylated fibrinogen (Fg); or, biotinylated albumin (BSA), in a 
ratio of 1:10 (Fg:BSA, fibrinogen to albumin), as found in physiological conditions. 
The bound biotinylated proteins were exposed to streptavidin horseradish peroxidise 
(SA-HRP) label, prior to being assayed using ABTS, a colorimetric dye at 405nm 
wavelength.  
 
The HABA-avidin assay was performed to determine the quantity of biotin 
molecules per mole of protein. It was found that 27 biotin molecules on average 
attach to a fibrinogen (Fg) protein and 4 biotin molecules per albumin (BSA) protein 
(data not shown). Accordingly, the absorbance values for fibrinogen and albumin 
were corrected by a factor of 27 and 4, respectively, to provide relative 
concentrations of attached proteins, as shown in Figure 4.14.  
 
The general trend observed in Figure 4.14(a) is that surfaces show a higher affinity to 
albumin than fibrinogen, except on silicon (Si) surfaces where the adsorption ratio 
relatively equal. On silicon (Si) and TiO2, the relative concentration of albumin 
adsorption varied marginally. 
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Figure 4.14 Absorbance detected for biotinylated fibrinogen (Fg) and albumin (BSA) 
binding to flat substrates as determined by ELISA. The results show a comparison 
between biotinylated fibrinogen (Fg) and albumin (BSA) adsorption from a. an 
individual and b. competitive solution (10:1 ratio of BSA:Fg). Error bars SD (n=3) 
 
0
0.02
0.04
0.06
0.08
0.1
0.12
0.14
0.16
Si TiO2 a-C:H Ta-C
A
rb
it
ra
ry
 u
n
it
s
 (
A
rb
)
Individual Solution
BSA Fg
0
0.02
0.04
0.06
0.08
0.1
0.12
0.14
0.16
Si TiO2 a-C:H Ta-C
A
rb
it
ra
ry
 u
n
it
s
 (
A
rb
)
Complex Solution
BSA Fg
a 
b 
Chapter 4: Material Characterization and Protein Adsorption  130 
Both surfaces exhibited less albumin adsorption than ta-C and when compared to a-
C:H, ta-C films facilitated  twice as many proteins. The difference in adsorbed 
fibrinogen on silicon (Si), TiO2 and a-C:H was minimal and was proven as 
statistically insignificant (P<0.05), while ta-C surfaces supported less fibrinogen than 
the other substrates. Furthermore, albumin is a small globular molecule, of molecular 
weight 67ka, than the long cylindrical shaped fibrinogen (340kDa) and so should 
ideally accommodate a higher quantity of protein on the substrate than fibrinogen. 
However, this was not the case. Similar amounts of both proteins were adsorbed 
indicating a conformational change within fibrinogen facilitating more protein 
attachment. Similarly a conformational change within albumin may also have 
occurred to facilitate a two-fold difference in adhesion on ta-C surfaces.   
 
When compared to single protein solutions, the amount of protein attachment was 
significantly lower in a competitive solution for both albumin and fibrinogen (Figure 
4.14 (b)). Increased adsorption of fibrinogen over albumin was a trend noticed on 
both; a-C”H and ta-C surfaces. In general, albumin’s affinity for the surface 
considerably decreased, in the presence of fibrinogen even though its concentration 
is 10 fold greater than fibrinogen. In terms of albumin adsorption; no statistically 
significant difference is noticed between the four substrates, while, fibrinogen 
facilitated a marked difference. Ta-C and a-C:H exhibited higher levels of bound-
fibrinogen with ta-C facilitating the highest amount of protein. Silicon and TiO2 both 
adsorbed comparable amounts of fibrinogen. 
 
Binding affinity of fibrinogen (Fg) in the presence of albumin (BSA), and vice versa, 
was evaluated by computing their adsorption from a solution of both proteins 
described earlier, as a percentage of their absorbance from a simple solution of their 
own molecules (single-protein). The results are shown in Figure 4.15.  
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Figure 4.15 Amount of albumin (BSA) and fibrinogen (Fg) adsorbed from a complex 
solution containing both proteins (in ratio 10:1, respectively), as a percentage 
relative to their adsorption from their single solution. Error bars SD (n=3) 
 
In the presence of fibrinogen, only 40.8% (3s.f.) of the albumin calculated from the 
single protein studies is shown to be adsorbed on silicon indicating a 59.2% (3s.f.) 
decrease in albumin adsorption. Similarly, when competitively interacting 
fibrinogen, TiO2 and a-C:H showed a 65.6 and 67.5% (3s.f.) decrease in albumin 
binding with ta-C displaying a significant loss of 85.1% inadvertently indicating the 
greater influence of fibrinogen in the presence of ta-C in decreasing albumin’s 
binding affinity.  Albumin has also shown to reduce fibrinogen’s binding affinity on 
the four samples. By competitively binding to the surface, albumin reduces 
fibrinogen adsorption by 62.5% (3s.f.) on silicon (Si), 65% (3s.f.) on TiO2, 40% 
(3s.f.) on a-C:H and 11.5% (3s.f.) on ta-C surfaces  leaving 37.5, 35, 61 and 88% 
(3s.f.), respectively, adsorbed.  
 
These data indicate that the substrate-binding affinity of albumin and fibrinogen was 
greatly reduced in the presence of each other. Furthermore, fibrinogen has a higher 
binding affinity to the surface than albumin on TiO2, a-C:H and ta-C surfaces, where 
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it interacts strongly with ta-C surfaces limiting albumin’s influence in this dynamic 
process. Albumin poses a greater influence on fibrinogen in the presence of silicon, 
followed by TiO2. The results not only reinforce the significant role surface 
chemistry plays in protein adsorption but also in the dynamic interactions between 
proteins. 
 
Previous studies have often evaluated the haemocompatibility of a biomaterial 
surface by measuring its albumin to fibrinogen binding ratio. As such, the total 
amount of adsorbed albumin (BSA) was divided by the amount of adsorbed 
fibrinogen (Fg) from its simple solution to produce a binding ratio and this ratio was 
compared with the ratio of adsorbed albumin (BSA) and fibrinogen (Fg) fractions 
from the complex solution. The results are shown in Figure 4.16. 
 
 
Figure 4.16 Albumin to fibrinogen binding ratio, as calculated from ELISA, for both 
single and complex protein solution. Error bars: SD (n=3) 
 
Observing the ratio values from single protein solutions; Ta-C followed by a-C:H 
appear to be the most haemocompatible substrates, however, this is not the case 
when comparing the values from complex solution. The ratio was significantly 
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decreased, suggesting that both; a-C:H and ta-C surfaces show a high affinity for 
fibrinogen, thereby preferentially adsorbing fibrinogen over albumin, even when 
albumin was present at a 10 fold concentration. The relative adsorption ratios on 
silicon and TiO2 remain unchanged between the single and complex solution, again 
suggesting that the binding affinity of fibrinogen remains unaltered in the presence of 
albumin and vice versa.  
 
 
4.3.1.2 Conformation studies 
 
Fibrinogen conformation was determined by measuring the relative concentrations of 
antibody binding to specific epitopes on the protein’s surface in an ELISA assay. 
Antibodies used in this study are specific to the alpha chain (fg-alpha monoclonal 
antibody), gamma chain (fg-gamma mAB) and platelet binding region (2C2-G7 
mAB) on fibrinogen, as shown in Figure 4.17. Fibrinogen coated, 
fibrinogen/albumin (Fg:BSA, diluted in ratio 1:10, fibrinogen to albumin) and 
diluted plasma (ratio 1:10, in DPBS) pre-coated flat substrates were used and the 
results were compared with TCPS control substrates.  
 
The amount of mAB 2C2-G7 bound to fibrinogen adsorbed on the test substrates 
were evaluated in Figure 4.17(a). Despite the reduction of adsorbed fibrinogen in the 
presence of albumin, as mentioned in section 4.3.1.1, similar values for 2C2-G7 
adsorption was evident between fibrinogen pre-coated and fibrinogen/albumin 
(Fg:BSA) pre-coated substrates. This reinforces the importance of conformation as 
well as concentration in determining the likelihood of platelet binding.  Furthermore, 
when compared with fibrinogen and fibrinogen/albumin (Fg:BSA) coated surfaces, 
there is significantly less binding of 2C2-G7 on substrates pre-coated with plasma. 
Between the five plasma coated surfaces; TCPS exhibited the highest reading, 
indicating a greater exposure of its RGDS site on the Aα chain and a non-RGD 
dodecapeptide sequence in the γ-chain for platelet adhesion. 
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Figure 4.17 Concentration of monoclonal antibody a. 2C2-G7 b. Fg-α and c. fg-γ 
adhesion to fibrinogen coated test samples, as determined by ELISA. Comparison of 
the volume of adsorbed human fibrinogen and its relative conformation in the 
presence of other proteins are evaluated using single, complex (Fg:BSA) and plasma 
protein solution (1:10 dilution in DPBS) containing fibrinogen. Silicon (Si), TiO2, a-
C:H and ta-C surfaces were compared with control TCPS polystyrene substrates. 
Error bars: SD (n=3). 
 
Also small amounts of 2C2-G7 were present on plasma coated a-C:H and ta-C 
surfaces. The significant difference in 2C2-G7 quantity between the three different 
protein coated surfaces suggest one or more of the following notions; either a limited 
amount of protein is absorbed from plasma due to the presence of other plasma 
protein of high binding affinity, or, the presence of larger molecules adjacent to the 
protein may sterically hinder the antibody binding site, or, a shift in protein 
conformation upon adsorption be the cause of protein denaturing, decreasing the 
exposure of its platelet binding region. 
 
The relative absorbance from the presence of fg-alpha antibody is evaluated in 
Figure 4.17(b). Plasma pre-coated TCPS, like in Figure 4.17(a), presented elevated 
levels of antibody, while minimal absorbance is recorded for silicon (Si), TiO2, a-
C:H and ta-C surfaces, indicating that fibrinogen adhesion on TCPS surface may be 
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
Fg Fg:BSA (1:10) Plasma (1:10)
A
b
s
o
rb
a
n
c
e
 (
A
b
s
)
Si TiO2 a-C:H Ta-C TCPS
c Fibrinogen γ chain 
Chapter 4: Material Characterization and Protein Adsorption  136 
significantly greater than the other substrates or the binding region appears more 
pronounced in the presence of TCPS. In general, TCPS displayed elevated levels in 
all three protein conditions. Unlike with 2C2-G7 where the exposure of the epitope is 
because of the dynamic interaction between fibrinogen and other proteins, these 
results indicate that the exposure of fg-alpha domain is primarily dependent on TCPS 
surface chemistry and possibly, although not necessarily, due to fibrinogen’s 
interaction with other proteins. It is also interesting to note that apart from the 
obvious TCPS, silicon (Si) and a-C:H pre-coated with fibrinogen also displayed a 
slightly higher level of alpha chain epitope. There is no significant difference 
between silicon, TiO2, a-C:H and ta-C surfaces pre-coated with Fg:BSA (P<0.05) 
although, overall the four substrates exhibited increased adsorption on fibrinogen 
pre-coated surfaces when compared with pre-coated Fg:BSA, implicating the 
possible role of albumin in altering the orientation of fibrinogen and possibly 
masking its fg-alpha antibody binding epitope.  
 
The test substrates including the control TCPS displayed no appreciable difference in 
fg-gamma binding. When compared with fibrinogen pre-coated, Fg:BSA coated 
samples showed reduced adsorption, where TiO2, a-C:H and ta-C surfaces did not 
show values above background. Silicon (Si) and TCPS surfaces showed slightly 
higher than background values indicating a conformational change in fibrinogen 
protein exposing its fg-gamma epitope for antibody binding. Akin to fg-alpha, no 
absorbance was recorded on all plasma pre-coated surfaces, except TCPS. 
Comparison of the three protein coated surfaces suggest that fibrinogen underwent 
conformational change upon interacting with other serum proteins such as albumin, 
inhibiting its exposure of the fg-gamma domain. 
 
These data establish that dynamic interactions between plasma proteins as well as 
fibrinogen’s adsorption on biomaterial surfaces play an important role in determining 
the protein’s conformation. While denaturing of some regions of the protein is 
dependent on the surface, others may be due to other biological interactions. It is a 
combination of both aspects that induce complete unfolding of the protein on a 
biomaterial surface.  
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4.3.2 Fluorescence microscopy 
 
Fluorescence microscopy was used as an alternative technique to ELISA to 
characterise fibrinogen concentration adsorbed on test substrates using a 
fluorescently tagged anti-protein antibody. Fibrinogen and plasma protein pre-coated 
test substrates were incubated with 2C2-G7 monoclonal antibody. The antibody was 
fluorescently labelled using anti-mouse alexa fluorophore 488 conjugated antibody, a 
green fluorophore, and visualised by Zeiss Axioskop microscope at 500x 
magnification. The total intensity from each image, measured as total number of 
positive pixels, was estimated using ImageJ and distribution of the protein across the 
material surface was imaged. Test substrates include flat and nano-patterned silicon, 
TiO2, a-C:H and ta-C. The images taken of protein coated flat substrates are shown 
in Figure 4.18. The surfaces generally presented homogenously distributed 
fluorescent tags with sporadic dots of localised high fluorophore densities. The dots 
may be caused by regions of highly aggregated proteins or regions where fibrinogen 
molecules posses a highly regulated conformation, exposing its 2C2-G7 binding 
region. Furthermore, control substrates (bare surfaces without any proteins) that were 
directly incubated with the fluorescent tag also displayed high intensity dots (data not 
shown). However, these dots were more rarely noticed. This may possible be from 
surface imperfections causing non-specific interactions between the antibody and the 
substrate.  
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Figure 4.18 Fluorescence microscope images showing the distribution of fibrinogen 
on the various surfaces using alexa fluorophore 488 tagged 2C2-G7mAB antibody 
bound to fibrinogen proteins from fibrinogen and plasma (dilution 1:10) pre-coated 
flat substrates. Samples were imaged by Zeiss Axioskop (Mot Mat 2, Australia) 
fluorescent microscope and analysed using ImageJ (v.1.44p, NIH). Scale bar: 10µm. 
 
Quantity and distribution of proteins across the various protein coated surfaces was 
difficult to discern. As such each surface was sampled for their total integrated 
density of positive pixels and graphed, as shown in Figure 4.19. Further, the results 
were corrected for false positive readings from non-specific fluorophore-surface 
interactions.   
 
Results from Figure 4.19 are analogous to Figure 4.17(a) from Section 4.3.1.2, with 
minor variances. Similar amount of 2C2-G7 bound fibrinogen was detected on 
silicon (Si), TiO2, a-C:H and ta-C fibrinogen (Fg) pre-coated surfaces, where silicon 
displayed the most and ta-C with the least amount of 2C2-G7 antibodies. The amount 
of 2C2-G7 bound fibrinogen present on plasma pre-coated surfaces were 
significantly less, of which differences between TiO2, a-C:H and ta-C can be 
considered statistically insignificant (P<0.05). Plasma pre-coated silicon displayed 
the highest amount of 2C2-G7, contradicting data from Figure 4.17(a). Again, minor 
differences between the two graphs are expected due to difference in sensitivities 
between the two techniques.   
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Figure 4.19 Concentration of 2C2-G7mAB on fibrinogen and plasma pre-coated flat 
surfaces. The amount of antibody detected was measured from the total number of 
positive pixels from fluorescent images and displayed as arbitrary values using 
ImageJ (p1.44p, NIH). 
 
Apart from surface chemistry and competitive interactions, surface characteristics, 
such as nano-features, have been known to influence the quantity and conformation 
of protein adsorption, subsequently affect the adhesion, spreading and activation of 
platelets and ultimately the formation of blood clots. As such, the influence of nano-
patterns on fibrinogen adsorption and its conformation was investigated in Figure 
4.20 using 2C2-G7mAB on fibrinogen pre-coated flat and nano-patterned substrates.  
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Figure 4.20 Relative level of 2C2-G7 antibody detected on flat and nano-patterned 
surfaces pre-coated with fibrinogen. The amount of antibody present was measured 
from the total number of positive pixels from fluorescent images and displayed as 
arbitrary values using ImageJ (p1.44p, NIH). 
 
Protein adsorption on flat surfaces followed a trend similar to that described in 
Figure 4.19. When compared with flat surfaces, the nano-patterned surfaces 
exhibited higher level of antibody reactives and of the four patterned surfaces, a-C:H 
presented the highest amount of 2C2-G7 antibodies. Differences in the amount of 
2C2-G7 monoclonal antibodies attached due to nano-features were tabulated as a 
percentage value of the flat surfaces in Table 4.4. The last column provides an 
estimated value independent of the increase in surface area caused by the nano-
patterns.  
 
Silicon showed the lowest increase in 2C2-G7 binding (30.4%) followed by tiania 
with 37.8% while a-C:H showed the highest increase by 57.7%. As mentioned earlier 
an increase in 2C2-G7mAB can possibly be because of an increase in protein 
concentration as well as an increased likelihood to conform in a particular orientation 
that facilitates 2C2-G7mAB binding. As such, higher 2C2-G7 levels, indicating 
higher levels of platelet binding region available on fibrinogen proteins, could 
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increase the chances of platelet binding and subsequently the haemocompatibility of 
a material. 
 
Table 4.4 Percentage increase in 2C2-G7 antibody adsorbed on fibrinogen coated 
substrates due to presence of nano-patterns. 
 
Nano-patterned 
Substrates 
Increase in 2C2-
G7mAB (%) 
(3s.f.) 
Δ in Surface Area 
(%) - table 4.3 
(3s.f.) 
Δ in 2C2-G7 mAB 
per unit sq (%) 
(3s.f.) 
Silicon 33.2 9.43 30.4 
TiO2 41.9 10.9 37.8 
a-C:H 66.1 14.8 57.7 
Ta-C 56.9 11.1 51.2 
 
As such, it can be hypothesised that nano-patterns with RMS values between 5-10nm 
may greatly alters the haemocompatibility of a material increasing its likelihood of 
platelet activation. When comparing the four surfaces it is evident that apart from 
nano-patterns, surface chemistry also plays a crucial role in protein adsorption and 
conformation. A-C:H supported a higher level of fibrinogen adsorption than silicon 
and TiO2.  
 
 
4.3.3 AFM 
 
The conformation of serum proteins were deduced using AFM under liquid mode 
conditions. The purpose of the study was to analyse changes in nano-topography 
between the flat and nano-patterned surfaces after fibrinogen and plasma adsorption 
using Bioscope Catalyst, Bruker AFM, in low voltage tapping mode. Scan rate of 
1Hz and scan area of 1µm x 1µm was used. Imaging was carried out on protein 
adsorbed silicon, TiO2, a-C:H and ta-C surfaces incubated in DPBS at room 
temperature, atmospheric conditions.  
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The nano-topography of the bare substrates was significantly altered upon the 
adsorption of serum proteins. Figure 4.21 and 
Figure 4.23 provides insight into fibrinogen’s conformation on the four flat surfaces. 
On silicon (Si), fibrinogen formed a thick adlayer layer, with an over roughness 
value of 9.19nm. It mainly consisted of protein aggregates forming a non-uniform 
surface with an undulating topography. Due to high peaks formed by the protein 
aggregates, it is difficult to visualise individual proteins, on the silicon (Si) surface.  
 
Though it is normal to form aggregates, other factors may have also influenced this 
response, such as; a change in temperature from 37 degrees to 25 degrees, causing 
the proteins to change in structure or protein particles adhering to the AFM tip 
causing affecting the characteristics of the tip, namely tip length and overall charge, 
which may ultimately interfere with the scanning process. Furthermore, because of 
the sweeping movement of the AFM tip during the scanning process proteins may 
have delocalised to form clusters with adjacent proteins. Protein translocation, while 
scanning, could have also caused the difference between trace and retrace patterns of 
the tip forming exaggerated peaks with shallow inclination. 
 
Fibrinogen’s conformation on TiO2, a-C:H and ta-C, on the other hand, was clearly 
visualised. Fibrinogen appears to be distributed uniformly across the surfaces with 
fewer regions exhibiting protein clumping. When compared with the bare surface, a 
significant increase in roughness was noticed on the protein-adsorbed films. Side 
profiles along with surface 3-D plots, not only indicate the existence of proteins on 
the surface but also suggest that the proteins present a certain nano-topography 
similar to that of the patterned surfaces, mentioned previously in Section 4.2, which 
may behave as physical cues for cellular and platelet interactions. The roughness 
values of the adlayer on TiO2, a-C:H and ta-C range between 1-3nm suggesting that 
the protein predominantly exists in its stable conformation, aligning flat against the 
surface forming a side on topography. Localised minor peaks may have been caused 
by other protein conformations such as end-on or bent conformation. Furthermore, 
larger regions of elevated peaks are indicative of protein clumping. As such, it is 
evident that a protein’s morphology on a particular surface is not confined to a 
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particular conformation; while they tend to predominantly orient in a particular 
conformation, they may also exist in several other conformations simultaneously.   
 
Fibrinogen’s general structure on TiO2, a-C:H and ta-C surfaces is shown in Figure 
4.21(e), (h) and (k). As can be seen, the side-on oriented protein appears to form 
either a long fibrillar (rod-like) or bent structure. Furthermore, in some images a tri-
nodular structure can be visualised. The exact size of each protein circled in red 
ranged between 45-55nm in length with 5-15nm thickness. The AFM tip used for 
scanning the proteins was approximately 5-10nm in diameter, which larger than the 
width of the protein. This may suggest that the peripheral regions of the tip may have 
inadvertently interacted with adjacent proteins on the surface, exaggerating the 
overall dimensions of the protein. However, the tri-nodular shape and the various 
conformations of the protein evident in the images corroborates with previous studies 
[455, 456]. In contrast to the flat surfaces, the overall RMS value of nano-patterned 
films after protein adsorption is less than the roughness values obtained from 
fibrinogen coated bare surfaces, as shown in Figure 4.22 and Figure 4.23. 
.  
Chapter 4: Material Characterization and Protein Adsorption  146 
 
 
  
c d 
a b 
e 
Chapter 4: Material Characterization and Protein Adsorption  147 
 
 
Figure 4.21 2-dimensional, 1µm2 AFM images of flat a. silicon ; c. TiO2; f. a-C:H; and i. ta-C surfaces incubated with 50µg/ml of fibrinogen 
for 1hour at 37 degrees. Image b; d; g; and j correspond to a to a 1µm2 view of their 3-D height, respectively. A 3X high magnification of the 
protein layers on e. TiO2; h. a-C:H; and k. ta-C is presented on the right with red circles indicating the conformation of fibrinogen protein. 
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Figure 4.22  2-D images of nano-patterned a. silicon (Si), c. TiO2, e. a-C:H and g. ta-C surfaces incubated with 50µg/ml of fibrinogen for 
1hour at 37 degrees. Corresponding 1µm2 3-D height analysis is presented on the right in b, d, f, h, respectively.
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Figure 4.23  1µm2 roughness profiles of flat and nano-patterned silicon (Si), TiO2, a-C:H and ta-C surfaces pre-adsorbed with fibrinogen 
protein, as analysed using AFM. 
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The overall roughness values (RMS) on fibrinogen coated nano-patterned surfaces, 
shown in Figure 4.24, has been decreased to 2-4nm with a-C:H surfaces displaying 
the highest RMS of 3.55nm. Comparing the fibrinogen coated patterned surfaces 
with the bare surfaces, it is evident that the fibrinogen molecules saturate onto the 
concave grooves created by the nano-particles. Therefore, overall z-range of the 
surface nano-topology is smaller and consequently its roughness value is also 
decreased. It was difficult to visualise individual proteins on the nano-patterned 
surfaces when compared with the flat surfaces. However, judging by their 3-D plots 
it is evident that the proteins align themselves against the grooves and slopes 
following the topography of the underlying substrate. 2-D plots of the surfaces show 
fewer peaks than on the bare surfaces, again reinforcing the complete coverage of the 
surface by fibrinogen. This trend was noticed amongst all four surfaces. 
 
 
Figure 4.24 A comparison of roughness values (RMS) between flat and nano-
patterned surfaces in the presence and absence of fibrinogen.  
 
Furthermore, it was interesting to note the random fibrinogen clusters formed on the 
surface. The roughness profiles of the protein adsorbed nano-patterned surfaces in  
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Figure 4.23 showed reduced z-range when compared with the bare surfaces (Figure 
4.12). A reduction in the average z-height could indicate the adhesion of multiple 
layers of protein. However, it is still uncertain whether these proteins are irreversibly 
adsorbed on the grooves or not.  
 
Apart from fibrinogen, the general surface topography upon plasma protein 
adsorption (1/10 dilution in DPBS) was analysed using AFM and results are shown 
in Figure 4.25 and  
Figure 4.27. The flat and nano-patterned plasma pre-coated surfaces were analysed 
for their roughness value and the results were compared with the bare surfaces in 
Figure 4.28.  
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Figure 4.25 2-dimensional, 1µm2 AFM images of flat a. silicon, c. TiO2, f. a-C:H and i. ta-C surfaces incubated with diluted plasma (dilution 
factor 1:10) for 1hour at 37 degrees. Image b, d, f and h correspond to a to a 1µm2 view of their 3-D height, respectively. 
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Flat silicon substrates exhibited the greatest roughness value of 4.04nm upon 
adsorbing plasma-proteins (Figure 4.28). The ultra smooth surface lacks physical 
nano-cues to act as focal adhesion points for the protein to adhere. This may have a 
consequent role in forming a thick protein adlayer, caused by the packing of proteins 
and water along the thickness of the protein coat, which may be necessary for the 
localisation and adhesion of the surface proteins. Furthermore, the protein film may 
be highly viscous affecting the overall adhesion between the tip and the surface. A 
viscous adlayer causes strong tip-protein interaction, increasing the force required to 
detach the tip from the protein adlayer upon scanning. This interferes with the trace-
retrace curves of the surface nano-topography and in-turn exaggerates the z-height 
profile and protein conformation on the adsorbed surfaces. Consequently, the 
adsorbed proteins appear un-stable and delocalised. Roughness profiles on  
Figure 4.27 and 3-D plots in Figure 4.25 of the sample depict this notion.   
 
While ta-C and a-C:H surfaces showed a slight increase in RMS values, TiO2 
exhibited a decrease in roughness. Flat TiO2 surfaces originally exhibited island like 
features on the bare surface with peaks separated by wide grooves. The adsorbed 
plasma appears to have filled the void causing a decrease in the overall surface 
roughness. The smoothening effect of plasma proteins adsorbed on flat surfaces is 
evident on the surface plots shown in Figure 4.25. 
 
While the ultra flat surfaces displayed significant rise in roughness values, the nano-
patterned silicon, TiO2 and ta-C substrates exhibited a smaller RMS value upon 
protein adsorption. Again, this may be due to proteins interacting with the grooves on 
the surface causing a decrease in z-range and consequently the roughness of the 
surface. A-C:h surfaces, on the other hand formed a highly featured surface with 
roughness of 15nm caused by the plasma protein aggregation. The plasma proteins 
on a-C:H surfaces localise on top of the peaks forming well connected protein 
clusters on the surface. 
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Figure 4.26  2-D images of nano-patterned a. silicon, c. TiO2, e. a-C:H and g. ta-C surfaces incubated with diluted plasma (diluted factor 
1:10) for 1hour at 37 degrees. Corresponding 1µm2 3-D height analysis is presented on the right in b, d, f, h, respectively. 
f 
h 
e 
g 
Chapter 4: Material Characterization and Protein Adsorption  159 
 
 Flat Nano-patterned 
S
il
ic
o
n
 
  
T
iO
2
 
  
Chapter 4: Material Characterization and Protein Adsorption  160 
a
-C
:H
 
  
T
a
-C
 
  
 
Figure 4.27  1µm2 roughness profiles of flat and nano-patterned silicon, TiO2, a-C:H and ta-C surfaces pre-adsorbed with diluted plasma 
(dilution factor 1:10), as analysed using AFM. 
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Though AFM graphs provide insight into overall serum protein packing on various 
surface chemistries and topographies, individual protein conformations of the 
adsorbed serum layer were not easily deductible. 
 
 
Figure 4.28 A comparison of roughness values (RMS) between flat and nano-
patterned surfaces in the presence and absence of plasma proteins.  
 
 
4.3.4 QCM-D 
 
QCM-D is a quantitative tool that uses real time analyses to determine the interaction 
between flat QCM crystal coated with silica, TiO2 and a-C:H, and, serum proteins 
such as; fibrinogen (Fg), albumin (BSA) and plasma (diluted in DPBS, 1:10 dilution 
factor). Ta-C surfaces sustained significant delamination of the coated film, from the 
weak bonding between the silica under-layer and the ta-C film, and consequently 
were retired from all further QCM-D experimentations. The acquired frequency (ƒ) 
and dissipation (D) curves were manipulated using Voigt based models to provide 
insight into the conformation, concentration, viscosity and rate of adsorption of 
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irreversibly bound proteins on the surfaces. Each experiment was performed in 
triplicate, although, only one indicative replicate is shown in Figure 4.29, Figure 
4.32(a) and (b), and Figure 4.33.  
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Figure 4.29 Comparison of real time a. albumin, b. fibrinogen and c. plasma (diluted 
1:10 in DPBS) interaction on silica, titania (TiO2) and a-C:H surfaces, as 
determined using QCM-D. The graphs display changes in frequency (Δƒ) and 
dissipation (D) as a function of time for the third overtone (15MHz). 
 
c. Plasma Proteins 
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Figure 4.29 (a), (b) and (c) shows in real time, the changes in frequency (ƒ) and 
energy dissipation (D) obtained for the third overtone (n=15MHz) for  albumin 
(BSA), fibrinogen (Fg) and plasma adsorption, respectively, onto silica, TiO2 and a-
C:H surfaces. A baseline was established by preconditioning the surfaces with 
DPBS. The crystals were incubated for either 30minutes for BSA or 1hr for 
fibrinogen and plasma solutions.  Time t=0min denotes the onset of protein exposure. 
Any unbound proteins were washed away during the post-incubation DPBS rinses 
lasting approximately 10minutes each. The experiments were temperature controlled 
to at 37 ± 0.2ºC and measurements were obtained for 4 different overtones; 5, 15, 25 
and 35MHz. 
 
The protein incubated surfaces showed slight variations in ƒ and D at different 
overtones. The differences in various overtones are caused by frequency dependence 
on the visco-elastic properties of the film [457] where an overtone acts as a function 
of penetration depth of the viscous adlayer (total distance out from the quartz 
crystal). A lower overtone detects properties of the furthest region of the protein 
layer and consequently is the least stable. The negative in the ƒ is indicative of the 
damping effect caused by the adsorbed mass where a more negative ƒ value is 
attributed to increased mass uptake. D values are indicative of the visco-elastic 
properties of the surface where a large increase in dissipative energy is indicative of 
a shift from a stiff, rigid, low viscoelastic surface to a highly viscoelastic surface 
causing the proteins to form a non-rigid bond with the crystal surface. An increase in 
D is also indicative of the amount of energy required to displace the proteins, where 
a higher D value indicates soft adlayer which requires less energy to displace the 
protein [458]. 
 
To allow for a direct comparison of ƒ shifts between protein solutions and various 
surfaces, overtone n=3 (15MHz) was chosen. This overtone exhibited a good 
compromise between stability and sensitivity and as such consistently presents 
smooth curves of frequency and dissipation changes with minimal aberrations. The 
final D value for the third overtone is shown in Figure 4.30(b). 
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Within the first 5 minutes a significant drop in ƒ was observed after which the curve 
plateaued over the remaining incubation period. Minor changes in frequency during 
the washing phases indicate that the majority of the proteins were irreversibly 
adsorbed onto the surfaces.  
 
Since albumin reaches saturation levels much sooner than fibrinogen and plasma; 
surfaces were exposed to albumin for only 30minutes while the other two protein 
solutions were incubated for 60minutes. Comparing ƒ shifts between the three 
proteins solutions it is evident albumin (BSA) exhibited a smaller shift in ƒ and D 
when compared to fibrinogen, corroborating with previous studies [189, 218, 459-
462], while plasma showed the highest change in values.   
 
Amongst the three surfaces, it is evident a-C:H exhibited the highest ƒ shift in the 
presence of all three solutions.  TiO2 surfaces showed similar frequency response 
curves to a-C:H and silica in the presence of albumin and fibrinogen, respectively, 
while exhibiting a concave like ƒ profile during plasma protein adsorption. While 
adsorbing plasma, TiO2 crystals exhibit a sudden drop followed by a slow increase in 
ƒ values. The D values however, slowly increase suggesting that upon contact with 
the surface, the plasma proteins immediately form a densely populated rigid layer 
that slowly increases in viscosity. After the first few minutes, a dynamic interaction 
between the surface and the adlayer causes the replacement of low-affinity bound 
proteins with water molecules, as shown by the steady increase in D values. 
Frequency ƒ curves reached maximum adsorption points sooner on silica surfaces 
while exhibiting the smallest shift in ƒ and D on fibrinogen and albumin. Frequency 
shift associated with plasma protein adsorption did not plateau.  
 
As mentioned above, the adsorbed mass detected by QCM-D is not only attributed to 
protein adsorption but also to the uptake of water coupled to protein. Ideally when 
the D value typically reaches above 1x10-6 the film is said to be too soft to function 
as a fully coupled oscillator of the crystal sensor [463], i.e. a linear relationship 
between ƒ shift and mass uptake cannot be established. Since the changes in D 
exceed this value, it is therefore crucial to use the Voigt model in this regime to 
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better estimate mass adsorption by considering changes in dissipative energy. Mass 
estimates of irreversibly adsorbed protein hydro-dynamically coupled to water 
molecules are shown in Figure 4.30(a) and its corresponding D values on Figure 
4.30(b).  
 
When comparing the three protein solutions it is evident that fibrinogen and plasma 
exhibited saturation mass in the range of 900-1800ng/cm2 and 1300-2800ng/cm2, 
respectively, when compared with albumin (300-900ng/cm2). Between the three 
surfaces, a-C:H sustained the highest mass uptake of 849ngcm2, 1706ng/cm2 and 
2707ng/cm2 on albumin, fibrinogen and plasma, respectively. Silica exhibited the 
lowest mass uptake on albumin and fibrinogen surfaces with, 306ng/cm2 and 
929ng/cm2, respectively, while TiO2 adsorbed the lowest amount on plasma coated 
surfaces with 1328ng/cm2.  
 
Closer analyses of these graphs indicate that on albumin and fibrinogen, the total 
change in dissipation is relatively proportional total increase in mass; this is not the 
case for plasma coated surfaces. Plasma-coated a-C:H surfaces exhibited a lower 
dissipation value than silica while facilitating a greater adsorbed mass which 
suggests a lower concentration of plasma adsorption on silica surfaces rendering the 
adsorbed layer highly viscous. This may be due to the initial stage of plasma clotting 
caused by the coagulation factors in plasma. 
 
Concentration of the adsorbed proteins was calculated by dividing the mass of the 
adsorbed albumin or fibrinogen adlayer on the three surfaces by their respective 
molecular weights of 64.5kDa and 340kDa, respectively. The results are shown in 
Figure 4.31. Although, albumin exhibited a smaller mass uptake its relative protein 
concentration was significantly higher than fibrinogen. This is because fibrinogen is 
relatively larger in size than albumin, and consequently requires fewer molecules for 
complete coverage of the crystal surface. These results corroborate with ELISA 
results from Section 4.3.1.  
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Figure 4.30 Comparison of a. adsorbed mass, as calibrated from the Voigt model 
and b. dissipation detected by the QCM-D of albumin, fibrinogen and diluted plasma 
proteins on silica, TiO2 and a-C:H surfaces. Results were computed from raw data 
for the third overtone (15MHz). Error bars: SD (n=3) 
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Furthermore, these concentration values do not take into consideration the ratio of 
water molecules adsorbed along with the proteins. As the adsorbed mass 
encompasses both water and protein, the exact ratio of water to protein adsorption 
needs to be considered. A study conducted by Hook et al, in 2002 [461] comparing 
mass uptake values between optical waveguide lightmode spectroscopy (OWLS), 
ellipsometry (ELM) and quartz crystal microbalance (QCM-D) demonstrated that 
QCM-D over estimated the mass of albumin uptake by a factor of 1.75 and 
fibrinogen by a factor of 2.8-3.2. Mass values obtained for fibrinogen (Figure 4.30 
(a)) fall within the theoretical monolayer mass estimates, as the theoretical side-on 
monolayer coverage of fibrinogen reported was approximately 140 ng/cm2 while the 
close packed end-on monolayer is 1000 ng/cm2 which can be recalculated to 
approximately 420 and 3000 ng/cm2 respectively for QCM-D measurements. 
Subsequently, the results shown in Figure 4.31 should be corrected by these factors 
to provide a better estimate of the concentration of adsorbed proteins. However, 
while these ratios can be used as a guide to estimate the relative concentration of the 
adsorbed protein they cannot provide exact concentration values. The experiments 
conducted by Hook were primarily on TiO2 surfaces and level of protein hydration 
varies between surface chemistries and consequently the overestimation of mass by 
QCM-D will also differ. 
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Figure 4.31 Concentration of fibrinogen and albumin adsorbed on silica, TiO2 and a-
C:H, as determined using QCM-D. Protein estimates were derived from Voigt 
modelling of frequency and dissipation curves for the third overtone (15MHz). Error 
bars: SD (n=3) 
 
The final dissipation versus frequency ratio provides insight into the viscosity of the 
adsorbed layer and conformational changes in the protein. Figure 4.32(a) and (b) 
shows real time changes in the dissipation to frequency ratio after fibrinogen and 
plasma adsorption on silica, TiO2 and a-C:H surfaces while Figure 4.32(c) shows the 
stable values measured after the DPBS rinses for the third overtone.  
 
ΔD/Δf curves indicate the level of hydration where a higher ratio caused primarily by 
a high dissipation values per unit shift in frequency, is indicative of a more viscous 
layer. After the instantaneous adsorption of proteins upon contact with the surface, 
the dissipation versus frequency plots for silica and a-C:H surfaces interacting with 
fibrinogen and plasma protein solutions exhibited a steady decreases in frequency 
and while increasing in dissipation values, as shown by the black arrows. This 
suggests that throughout the measurement period there is a constant dynamic 
interaction between the adsorbed layer and the supernatant where the proteins 
rearrange on the surface by breaking and forming protein bonds and consequent 
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hydration shells to accommodate more proteins. Unlike silica and a-C:H, fibrinogen 
adsorption on TiO2 appears to be initiated by a rapid adsorption of water molecules 
as well as protein followed by strong dispelling of water molecules from the fluidic 
layer causing a significant decrease in dissipation energy and a small change in 
frequency. The slightly more rigid layer then interacts dynamically with dissolved 
fibrinogen molecules continuously throughout the rest of the measurement period in 
a manner similar to silica and a-C:H surfaces described above. Plasma proteins on 
TiO2, on the other hand, competitively bind into a rigid layer initially followed by the 
detachment of water molecules and weakly bound proteins, possibly due to their low 
affinity to the surface. The removal of weakly bound proteins is explained by the 
drastic increase in frequency values.  
 
  
0
2
4
6
8
10
12
-100 -90 -80 -70 -60 -50 -40
D
n
=
3
, 
F
ib
ri
n
o
g
e
n
(x
1
0
-0
6
)
Δƒn=3, Fibrinogen (Hz)
Silica TiO2 a-C:H
a 
Chapter 4: Material Characterization and Protein Adsorption  172 
 
 
Figure 4.32 Dissipation versus frequency curves (third overtone; n=3) for a. 
fibrinogen, b. plasma and c. final values of dissipation vs frequency ratio for 
fibrinogen and plasma proteins on silica, TiO2 and a-C:H surfaces, as determined by 
QCM-D. Black arrows represent the direction of increasing time. 
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After a few minutes an sudden influx of water molecules and some proteins is 
evidenced by the sharp change in curve shifting to an increase in dissipation values 
with small increase to frequency values. Furthermore, the results in Figure 4.32(c) 
indicate that when compared with plasma, fibrinogen proteins on the three surfaces 
formed a relatively more rigid adlayer. Between the three surfaces it is evident that 
plasma adsorbed on silica surfaces formed a highly viscous adlayer, while a-C:H 
exhibited a more rigid film. Variances in fibrinogen coated surfaces seemed minimal, 
of which TiO2 exhibited a slightly more rigid film. 
 
The kinetics of fibrinogen and plasma adsorption on silica, TiO2 and a-C:H surfaces 
was further investigated by analysing the rate of mass change as a function of 
adsorbed mass, as shown in Figure 4.33.  
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Figure 4.33 Comparison of adsorption rates of a. fibrinogen b. plasma (1:10 
dilution) on silica, TiO2 and a-C:H surfaces, as determined using QCM-D. Mass 
estimates were derived from Voigt modelling of frequency and dissipation curves for 
the third overtone (15MHz). Error bars: SD (n=3) 
 
The gradient of curve is steeper during the initial phases of adsorption suggesting 
that fibrinogen upon contact with the surface is rapidly adsorbed onto all three 
surfaces after which the rate of adsorption decreases and saturates near zero. Rate of 
saturation occurs slowly on silica surfaces. A-C:H surfaces followed by TiO2 
exhibited a higher  initial rate of adsorption than silica surfaces, suggesting that 
fibrinogen shows a higher binding affinity towards a-C:H surfaces. This may also 
explain the increased mass uptake on a-C:H surfaces. Further, rate of mass uptake 
versus mass on all three surfaces followed a concave relationship suggesting that the 
bound fibrinogen rearranged upon adsorption. This corroborates with results from 
Figure 4.32.  While plasma interaction on silica and a-C:H surfaces follow similar 
adsorption curves to the fibrinogen bound surfaces, TiO2 responded differently. After 
the initial rapid adsorption of proteins, plasma adsorbed on TiO2 surfaces desorbed 
from the surfaces at a lower rate than that of the initial rate of adsorption, described 
by decrease in adsorbed mass. Following protein de-attachment and possible changes 
in protein conformation and its arrangement on the surface, the surface continues to 
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adsorb more proteins from solution at a lower adsorption rates subsequently 
saturating above zero. While the maximum rate of adsorption was similar between 
the plasma adsorbed and fibrinogen adsorbed surfaces, the nature of the adsorption 
profile supports the notion that kinetics behind protein adsorption is dependent on 
surface chemistry and the adsorbed proteins.  
 
 
4.4 Summary 
 
When fibrinogen and albumin were in a solution by themselves, ultra-flat test 
substrates, with surface roughness in the sub-nano-meter range, have been shown to 
exhibit a higher affinity to albumin than fibrinogen. However, when albumin was in 
a competitive solution with fibrinogen at physiological concentrations (ratio 10:1, 
albumin to fibrinogen), not only was there a decrease in adsorption of both proteins 
but albumin’s affinity to the test surfaces became less than that of fibrinogen. This 
was especially evident on ta-C and a-C:H surfaces, which displayed increased 
concentrations of fibrinogen adsorption during competitive binding, while the ratio 
of albumin to fibrinogen adsorbed on TiO2 surfaces remained unaltered. This shows 
that the adsorption of selective proteins is implicitly linked to the surface chemistry 
of the biomaterial.  
 
The level of platelet binding region presented on fibrinogen remained unaffected 
even though the concentration of adsorbed fibrinogen decreased in the presence of 
albumin.  By changing the surface nano-topography by adding nano-patterns, the 
overall surface roughness of the test substrates was increased to 5-10nm. This caused 
an increase in the adsorption of fibrinogen proteins and the proteins were found to 
form multiple layers, saturating in the grooves between the peaks formed by the 
nano-patterns. While it was evident that the morphology of adsorbed proteins were 
not confined to a particular conformation or orientation, it was found that the tri-
nodular fibrinogen adsorbed on nano-patterned surfaces predominantly aligning 
themselves against the slope of the nano-patterns, decreasing the overall surface 
roughness, whereas, fibrinogen adsorbed on flat surfaces were shown to align flat 
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against the surface following side on conformation. Furthermore, fibrinogen proteins 
adsorbed on nano-patterned surfaces presented increased the level of platelet binding 
domains, where a-C:H and ta-C exhibited the highest % increase when compared 
with the flat surfaces.  
 
Flat surfaces lacked the physical cues necessary to behave as focal adhesion points 
for plasma proteins other than albumin or fibrinogen to adhere. As such, plasma 
proteins formed a dense and highly viscous adlayer, when compared with the rigid 
albumin and fibrinogen protein coat, which was necessary for the localisation and 
adhesion of other surface tethering proteins. Further, when comparing the kinetics of 
fibrinogen and plasma protein adsorption, it was evident that fibrinogen and other 
plasma proteins adsorbed rapidly on a-C:H surfaces than TiO2 during the initial 
stages of protein adsorption indicating a higher binding affinity between the proteins 
and a-C:H. However, during the latter stages of adsorption it was noticed that the rate 
of protein adhesion decreased to near zero while adsorbed mass continued to increase 
suggesting a dynamic interaction between the surface and fibrinogen and/or plasma 
proteins causing the rearrangement of the proteins upon adsorption.  
 
Denaturing of fibrinogen protein on the adsorbed surfaces and its assumed 
conformation for platelet binding was typically dependent on a combination of 
surface chemistry, surface nano-topography as well as its interaction with other 
plasma proteins. The exposure of fibrinogen α-chain, platelet binding domain and γ-
chain was affected by varying the surface chemistry of the thin film, though not to 
the same extent as pre-coating the substrates with plasma proteins. The presence of 
other plasma proteins can drastically reduce the availability of platelet binding 
domains exposed on fibrinogen adsorbed from plasma, implying a favourable 
interaction between plasma proteins and biomaterial surfaces in reducing the 
exposure of fibrinogen’s platelet binding domain for platelet αIIbβ3 receptor binding. 
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5   PLATELET ADHESION 
 
5.1   Introduction 
 
Platelet adhesion on implanted biomaterial surfaces and their subsequent spreading 
and aggregation are known to be crucial steps in the sequence of events leading to 
the formation of a haemostatic plug and thrombosis.  Platelet membrane receptors 
from the β1 and β3 heterodimeric integrin families such as α2β1 and αIIbβ3 receptors 
have been known to facilitate platelet adhesion on artificial surfaces through surface 
adsorbed proteins. As mentioned earlier, the receptors recognise and bind to adhesive 
plasma proteins such as fibrinogen, fibronectin, vitronectin, immunoglobulins and 
von Willebrand factor von Willebrand factor, to mediate the adhesion process. While 
α2β1 integrins are receptors for collagen [464], αIIbβ3 receptors bind to fibrinogen. 
Fibrinogen plays the prominent role in the adhesion process  by binding its RGD 
tract and γ chain of the carboxyl (C)-terminal to GPIIb/IIIa (αIIbβ3) integrins on the 
platelet surface [121]. This is led by a change in the platelet receptor conformation 
where the β-integrins shift from their low affinity to their high affinity state for 
adhesion and subsequent platelet spreading. Adsorbed fibrinogen, due to a 
conformational change upon adsorption, even at small concentrations of 7ng/cm2 has 
been known to mediate αIIbβ3 receptor adhesion in both; its low and high affinity state 
[116, 117]. Platelet spreading and subsequent activation which occurs as a result of 
tight binding of platelets to the surface occurs as multiple focal contacts form with 
fibrinogen and other surface adsorbed proteins [122].  
 
The haemocompatibility of a material is evaluated by its ability to resist this adhesion 
process and, as such, it is necessary to determine the adhesive properties of silicon, a-
C:H, TiO2, Ta-C coated flat and nano-patterned substrates by detecting the 
concentration and morphological characteristics of adhered platelets as well as the 
kinetics behind platelet adhesion.  
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In this chapter test substrates, pre-coated or devoid of serum proteins, were 
investigated for their role in platelet adhesion and aggregation using a combination 
of fluorescence microscopy, scanning electron microscopy (SEM), atomic force 
microscopy (AFM) and quartz crystal microbalance with dissipation technology 
(QCM-D). Platelet adhesion was further examined to evaluate the morphology of the 
adhered platelets including the degree of platelet spreading, the overall surface 
coverage and level of platelet aggregation.  The sample substrates were initially 
subjected to a rigorous sterilization procedure, prior to being introduced into 12-well 
TCPS plates for platelet adhesion studies and the results obtained were compared 
with that of the bare substrates. 
 
 
5.2 Results and Discussion 
 
 
5.2.1   Morphology and concentration of surface-adhered platelets  
 
Morphological characteristics as well as quantitative analysis on the number of 
adhered platelets are used to elucidate the cells’ health and how well it responds to 
the chemistry and topography of the underlying substrate. As such, platelet 
interactions on the different substrata were visualised using a combination of 
fluorescence microscopy, SEM and AFM.  Platelets were seeded on bare and protein 
pre-coated, flat and nano-patterned silicon, TiO2, a-C:H and ta-C substrates, for 1 
hour at 37ºC. 50µg/ml of albumin (BSA) and fibrinogen (Fg) proteins were used 
along with diluted plasma (diluted in ratio 1:10, in DPBS).  After washing, the 
surface bound platelets were either fixed and permeabilised before staining the actin 
filaments in red with rhodamine-phalloidin fluorescent dye to reveal any cytoskeletal 
developments at 500x magnification using fluorescence microscopy, or, fixed with 
2% glutaraldehyde (in DPBS) before progressively dehydrating in graded ethanol 
baths and sputter coating with platinum for SEM analysis. The influence of fixatives 
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in decreasing the overall nano-resolution of platelet cytoskeleton was further 
elucidated from AFM imaging using model flat and nano-patterned a-C:H surfaces.  
The role of fibrinogen protein and αIIbβ3 integrin in mediating platelet attachment on 
the flat substrates was also evaluated using fluorescence microscopy. Platelet 
solution was pre-incubated with 1µg/ml anti-human integrin αIIbβ3 F(ab) fragment 
antibody prior to seeding on protein pre-coated surfaces. The images were obtained 
using a fluorescence microscope at 500x magnification.  
 
 
5.2.1.1 Flat Surfaces 
 
The results below quantitatively and qualitatively describe the morphology and 
concentration of surface bound platelets adsorbed on flat substrates. Platelet adhesion 
on the flat substrates was investigated to identify the effect of surface chemistry and 
adsorbed proteins on the adhesion process. The extent of its influence was further 
analysed by observing changes in platelet morphology. Figure 5.1 shows the 
morphology of platelets using fluorescence microscopy 60 minutes post seeding. The 
red regions represent the actin filaments of the platelet cytoskeleton. When 
comparing the various surface chemistries, it is evident that TCPS served as the 
positive control, exhibiting a greater concentration of platelet adhesion and spreading 
under all four conditions. The level of platelet attachment and subsequent spreading 
varied drastically between protein pre-coated surfaces rather than surface chemistry, 
and clear and distinct differences in the conformation of individually adsorbed 
platelets were observed. In general, fibrinogen pre-coated and bare test substrates 
supported platelet spreading, while only minor levels of spreading was evident on the 
albumin and plasma surfaces. Albumin coated surfaces like the bare surfaces 
exhibited higher levels of platelet attachment. Albumin is often used to passivate 
blood contacting biomaterials and does not have the necessary peptide sequences for 
platelet integrin binding [215] and as such, platelet interaction on albumin coated 
surfaces, as found on all test substrates, might be the result of non-ligand specific, 
surface-receptor interactions. 
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Figure 5.1 Fluorescence microscopy images showing rhodamine-phalloidin stained 
actin filaments of surface bound platelet cytoskeleton on bare (DPBS) and protein 
pre-coated a. silicon; b. TiO2; c. a-C:H; d. ta-C; and e. TCPS flat surfaces. Protein 
pre-coated surfaces include 50µg/ml albumin (BSA), fibrinogen (Fg) and plasma 
(ratio of dilution 1:10, in DPBS). Samples were imaged at 500x magnification using 
Zeiss Axioskop microscope.  
 
Various stages of platelet spreading were evident on each substrate. Platelet 
diameters ranged from 4-10µm. A greater degree in platelet spreading, as elucidated 
from increased surface coverage by individual platelets, leads to considerable 
thinning of the platelet as it flattens across the surface. This decreases the 
concentration of actin filaments, and consequently the concentration of the dye, 
available per unit square making the spread platelets appear fainter and more difficult 
to visualise. Differences in platelet conformation, once absorbed on surfaces, dictate 
subsequent platelet responses, and as such, techniques such as SEM was utilised to 
produce high resolution images of surface adsorbed platelet morphologies. Further, 
the degree of morphological changes appeared more pronounced in SEM images, 
showing exaggerated levels of platelet spreading and aggregation.  As such only the 
most commonly found platelet conformation, as observed using fluorescence 
microscopy as well as SEM analysis, was imaged for each of the protein-coated 
conditions.   
 
Figure 5.2 shows the most predominant conformation of platelets attached on 
albumin pre-coated silicon, TiO2, a-C:H and ta-C. The adhered platelets followed a 
rounded morphology with no apparent actin-rich pseudopodia or displayed radial 
protrusions containing non-filamentous actin, except for control TCPS (Figure 5.2) 
which supported increased levels of platelet spreading. Filopodia act as probes as 
they navigate through the surfaces for potential tethering sites, and as such, round 
cells, predominantly found on ta-C surfaces, that present no apparent filopodia are 
indicative of weakly adhered cells. 
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Figure 5.2 SEM images of platelets exposed to (a) silicon, (b) TiO2, (c) a-C:H and 
(d) ta-C on pre-coated with albumin (BSA) at 50µg/ml concentration. Samples were 
imaged using an InLens detector (10KV) at 54 degrees stage tilt.  
 
Bare surfaces displayed significant levels of platelet spreading when compared with 
albumin surfaces, as shown in Figure 5.3. Completely spread platelets, as found on 
control silicon surfaces, support increased surface adhesion points and consequently 
appear more strongly bound to the surface. Ta-C exhibited hemisphere shaped 
platelets while the platelets on a-C:H and TiO2 surfaces exhibited spread dendritic 
morphologies with well-developed actin fibres at the leading edge of the cell 
membrane (Figure 5.1). 
 
Similar to bare TiO2 and a-C:H surfaces, fibrinogen coated substrates also presented 
spread platelets with actin rich, stellate shaped filopodia, as shown in Figure 5.4.  
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Figure 5.3 SEM images of platelets exposed to bare (a) silicon, (b) TiO2, (c) a-C:H 
and (d) ta-C surfaces. Samples were imaged using an InLens detector (10KV) at 54 
degrees stage tilt.  
 
 
  
  
Figure 5.4 SEM images of platelets exposed to (a) silicon, (b) TiO2, (c) a-C:H and 
(d) ta-C on pre-coated with fibrinogen (Fg) at 50µg/ml concentration. Samples were 
imaged using an InLens detector (10KV) at 54 degrees stage tilt. 
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Figure 5.5 shows the morphologies of exposed platelets on plasma coated substrates. 
Plasma surfaces exhibited lower concentrations of spread platelets when compared 
with pre-coated fibrinogen. Platelets in the presence of plasma proteins showed well 
defined filopodia and their overreaching as they communicate with adjacent platelets 
was also noted on all substrates. Though platelet inter-communication was evident 
on fibrinogen surfaces as well, it was not presented as often as seen on pre-coated 
plasma. 
  
  
        
Figure 5.5 SEM images of platelets exposed to (a) silicon, (b) TiO2, (c) a-C:H and 
(d) ta-C on pre-coated with diluted plasma (dilution factor 1:10, in DPBS). Samples 
were imaged using an InLens detector (10KV) at 54 degrees stage tilt. 
 
Sporadic regions of platelet aggregation were evident on all surfaces, especially on 
control TCPS and silicon substrates. Some regions displayed multi-stacked and 
extensively spread platelets similar in appearance to secondary clotting as found in in 
vivo. Whilst the level of aggregation was extensive in SEM, possibly due to 
inadvertent platelet membrane activation caused by the gluteraldehyde fixative used 
during the preparation process, fluorescence microscopy also displayed inter-
communication between multiple platelets and possible z-stacking. SEM images 
showing platelet aggregation are provided in Figure 5.6. 
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Figure 5.6 Aggregation of platelets on (a) fibrinogen pre-coated ta-C, and (b) 
plasma pre-coated silicon surfaces as visualised using SEM. Images were taken 
using an InLens detector (10KV) at 54 degrees stage tilt. 
 
Chemical fixatives, utilised in SEM and fluorescence imaging, for platelet adhesion 
studies were applied to immobilise or ‘fix’ sub-cellular components of surface 
adhered platelets by halting cellular metabolism and destroying proteases and 
enzymes which can further affect the platelet’s microstructure and integrity. Whilst 
a 
b 
3µm 
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such fixatives were applied to influence the cell’s preservation against harsh buffers 
and detergents by stabilising the actin filaments and microtubules that preserve the 
platelet’s structure, they have also been known to dramatically reduce the nano-scale 
resolution of its cytoskeletal characteristics as well as initiating unwarranted 
membrane activation shown as increased platelet spreading and aggregation. For this 
reason AFM was utilised to visualise the nano-topographical features of platelets 
attached on model a-C:H substrates, in liquid, under tapping mode. After incubating 
for 60 minutes, a light fixative solution containing equal parts of pre-chilled 
methanol and ethanol was applied for 5mins on the surface attached platelets, prior to 
imaging. A-C:H surfaces were chosen as model substrates as they supported the least 
number of attached platelets, found through fluorescence microscopy analysis, and as 
such is likely to present as the most haemocompatible surface. 
 
Figure 5.7 shows an AFM image representing the morphology of an adhered platelet 
on flat a-C:H substrate. AFM was employed to investigate the morphology of single 
platelets due to its high spatial resolution in the nano-meter scale. While fluorescence 
microscopy can track the localisation of single molecules, they are limited only to the 
visualisation of the labelled parts and electron microscopy requires the samples to be 
fixed and dried which significantly alters the platelet microstructure and the electron 
beam continually ionises the sample and burning away any topographical features 
[465].  
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Figure 5.7 AFM topographical images showing (a) 2D and (b) 3D plots of 
fibrinogen pre-coated a-C:H surfaces seeded with human platelets. Surfaces were 
analysed in tapping mode with scan rate of 0.2Hz, vertical scale range of 1.3µm and 
scan size of 10µm x 10µm2. Measurements we carried out in liquid mode and images 
corrected using Nanoscope analysis. 
 
A coagulating fixative containing equal parts of ethanol and methanol was used as it 
rapidly changes the hydration state of the sub-cellular components without affecting 
the spatial structure of platelet’s surface membrane and its components. The platelets 
a 
b 
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were not imaged live to avoid the risk of creating large deformations and 
consequently tearing of the cell membrane and dislodgement of surface features from 
the normal force as well as the lateral and shear forces exerted by the AFM tip [466-
468]. The active compounds in glutaraldehyde and paraformaldehyde, often used as 
cross-linking fixatives in SEM and fluorescence microscopy, respectively, interact 
with and polymerise the proteins in platelets to form covalent cross groups, changing 
the surface nano-topography and structure of the platelet surface. Glutaraldehyde 
incurs a reducing step that mechanically dislodges delicate actin structures such as; 
filopodia and lamellipodia while paraformaldehyde fails to maintain microtubular 
integrity making it difficult to visualise microtubules upon fixation [465, 469].  
 
The topographical AFM image of platelets on fibrinogen coated a-C:H thin films 
shows a round platelet displaying spreading around the edges as it flattens onto the 
cell surface. There appears to be the formation of a pseudo-nucleus due to the 
accumulation of dense and alpha granules and filopodia protruding from the cell 
periphery. The diameter of the deposited platelet ranged between 8-10µm and the 
height of the platelet was measured at 1.3µm, however, activated platelets have been 
reported to exhibits cell heights as low as 100nm [470]. Furthermore, the filopodia 
extended to a length of 1-2µm, although, previous studies have shown the internal 
actin filaments spanning up to 10µm [471]. Similar sizes of platelets were observed 
in fluorescence microscopy and SEM images, although, on SEM images the 
conformation mostly exhibited by platelets exposed to fibrinogen coated a-C:H 
appeared more spread that what was represented by AFM. This reinforces the need 
for AFM imaging and fluorescence microscopy in analysing surface-platelet 
interactions.  
 
Tapping mode, when applied in liquid with a light fixative, present platelets as 
‘hardened’ structures between the short time intervals due to its inherent visco-elastic 
properties and subsequently renders platelets less susceptible to deformation during 
the high resolution imaging process. This is different to contact mode, because when 
a constant force is applied the lateral forces are significantly larger causing local 
deformations followed by resealing of the cell membrane exposing the underlying 
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sub-membrane structures which inevitably causes platelet restructuring and 
consequent activation and aggregations [465, 468].  
 
Whilst, fluorescence, SEM and AFM images qualitatively prove the level of cell 
adhesion, a quantitative measure better compares the different surfaces and 
subsequent protein coats. As such Figure 5.8 (a) and (b) describes the total 
concentration of platelets attached per square centimetre, and, degree of platelet 
spreading measured as a percentage of total surface area, respectively.  
 
In general, the number of platelets attached on the bare and albumin pre-coated 
silicon, a-C:H and ta-C substrates, as shown in Figure 5.8 (a), was greater than that 
on fibrinogen and plasma surfaces. This was especially evident on fibrinogen 
surfaces which supported the lowest concentration of platelets. This suggests that 
platelet adhesion is not only dependent on ligand-receptor mediated adhesion but 
also through non-specific surface interactions as found on albumin surfaces and 
surfaces devoid of proteins. Further, a decreased concentration of platelets in the 
presence of fibrinogen and plasma proteins implies a favourable interaction between 
the surface and serum proteins in reducing platelet receptor activation for adhesion. 
While this was the case for the above mentioned surfaces, fibrinogen and plasma 
proteins were shown to promote platelet adhesion on TCPS surfaces, and plasma 
proteins alone in promoting platelet attachment on TiO2 surfaces. A-C:H followed by 
ta-C facilitated the least number of platelets on plasma and fibrinogen coated 
surfaces. This establishes the potential role of surface chemistry in dictating specific 
protein adsorption from plasma, its adsorbed conformation and its consequent 
interactions with circulating platelets.  
 
The difference in platelet coverage, shown in Figure 5.8 (b), on TiO2, a-C:H and ta-C 
surfaces was conserved between the various pre-coated surfaces where a-C:H 
followed by ta-C showed the lowest level of platelet spreading.  
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Figure 5.8 Comparison of a. surface bound platelet concentrations, per square 
centimetre, and b. mean surface coverage by the platelets, as percentage value, 
calculated from rhodamine-phalloidin stained fluorescence microscopy images. Flat 
silicon, TiO2, a-C:H, ta-C and TCPS test substrates were pre-coated with albumin 
(BSA), fibrinogen (Fg) and diluted plasma (ratio 1:10, in DPBS) prior to platelet 
incubation. The results were compared with surfaces devoid of proteins (DPBS). 
Error bars: SD (n=3). 
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This was especially evident on fibrinogen and plasma surfaces. Corresponding to its 
increased levels of platelet attachment, TCPS followed by silicon substrates 
exhibited greater levels of platelet spreading on its surfaces. Control TCPS promoted 
significantly increased levels of platelet spreading (62% surface coverage) in the 
presence of plasma proteins indicating that TCPS exhibits the least haemocompatible 
surface chemistry for platelet interaction. 
 
Figure 5.9 (a) and (b) shows a breakdown of adsorbed platelets in terms of their 
morphology where Figure 5.9 (a) shows the concentration of round cells, retaining 
their spherical shape with minimal radial protrusions (filopodia), and, Figure 5.9 (b) 
shows the concentration of spread platelets with well-developed actin fibres.  
 
Platelet adsorption on bare surfaces indicate that silicon facilitated the greatest 
number of round and spread platelets when compared to control TCPS even though 
TCPS showed a higher percentage of surface coverage. This may suggest the spread 
platelets on TCPS followed a larger morphology than silicon. A-C:H and ta-C 
surfaces, exhibited decreased levels of platelet adhesion and its subsequent spreading 
on all protein-pre-coated and bare surfaces and consequently, retaining its 
haemocompatible properties. TiO2 surfaces followed a similar trend to a-C:H and ta-
C substrates except for on albumin coated surfaces, while, control TCPS in the 
presence of fibrinogen and plasma proteins have been shown to increase spreading of 
platelets. The percentage of surface coverage on albumin pre-coated substrates was 
similar between the various surface chemistries, though, only silicon, a-C:H, ta-C 
and TCPS surfaces presented with similar levels of adhered platelets. Lower 
concentrations of platelets were found on TiO2 suggesting the degree of platelet 
spreading once adsorbed on TiO2 surfaces is greater than on the other albumin 
surfaces. When compared with the other fibrinogen pre-coated substrates, less 
platelets were found to adhere on fibrinogen coated a-C:H, even though a higher 
concentration of adsorbed fibrinogen with higher amounts of platelet binding 
domains exposed were reported (Chapter 4). This can suggest that, in the presence of 
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fibrinogen, the other surfaces promoted more non-fibrinogen dependent (or, non-
specific) adhesion of platelets to the surface.  
 
 
 
Figure 5.9 Concentration of a. round and b. spread platelets adsorbed  per square 
centimetre of test substrates, as calculated from rhodamine-phalloidin stained 
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fluorescence microscopy images. Platelets were exposed to nano-patterned silicon, 
TiO2, a-C:H, ta-C and TCPS flat test substrates without adsorbed proteins (DPBS) 
as well as albumin (BSA), fibrinogen (Fg), diluted plasma proteins (ratio 1:10, in 
DPBS) prior to incubation. Error bars: SD (n=3). 
 
Figure 5.10 shows the ratio of round versus spread platelets adsorbed on the protein 
coated and bare surfaces. No appreciable difference in ratio of adsorbed cells was 
noted on bare and fibrinogen-coated silicon, a-C:H, ta-C and TCPS test substrates.  
Albumin surfaces displayed slightly elevated cell ratios, while a significant increase 
were noted on plasma adsorbed surfaces. This reinforces the favourable interaction 
between platelets, and, plasma proteins other than fibrinogen and to some extent 
albumin in limiting the level of platelet spreading but not necessarily its attachment.  
 
 
Figure 5.10 Ratios of round vs. spread platelets calculated from fluorescence 
microscopy images of platelets exposed to protein pre-coated and bare silicon, TiO2, 
a-C:H, ta-C and TCPS flat substrates. Samples include Error bars: SD (n=3). 
 
While, TiO2 consistently exhibited a higher ratio of round cells on bare and surfaces 
coated with albumin and fibrinogen; plasma-coated silicon, followed by a-C:H and 
ta-C exhibited the highest ratio overall. In the presence of plasma proteins the ratio of 
0
5
10
15
20
25
30
35
40
DPBS BSA Fg Plasma
R
a
ti
o
 o
f 
R
o
u
n
d
 v
s
. 
S
p
re
a
d
 P
la
te
le
ts
 
Si TiO2 a-C:H Ta-C TCPS
Chapter 5: Platelet Morphology   198 
round cells versus spread cells on silicon increased by approximately 16-18 fold 
when compared with that of the bare surface. As such, the concentration of adhered 
cells and its breakdown, along with the cell ratio analysis indicates the marked 
influence plasma proteins play in decreasing the propensity of platelet adhesion and 
its subsequent spreading on specific surface chemistries, such as a-C:H and ta-C.  
 
 
5.2.1.2 Role of αIIbβ3 integrins in platelet adhesion 
 
The involvement of αIIbβ3 receptors in platelet-fibrinogen binding events was 
investigated by visualising the cytoskeletal developments of platelets attached on 
protein pre-coated surfaces and surfaces devoid of proteins in the presence of anti- 
αIIbβ3 antibodies. In this study, freshly prepared human platelets were incubated with 
an anti-human αIIbβ3 antibody, Abciximab (Reopro) for 1 hour before being exposed 
to protein pre-coated flat surfaces. Flat silicon, TiO2, a-C:H and ta-C surfaces were 
pre-incubated with 50µg/ml of albumin (BSA), fibrinogen (Fg) and diluted plasma 
(ratio 1:10, in DPBS) prior to platelet binding. After washing, the adhered platelets 
were fixed and stained and then imaged using fluorescence microscopy.  
 
Figure 5.11 shows human platelet response to the protein pre-coated and bare 
surfaces in the presence of anti-αIIbβ3 antibody. The number of platelets adhered to 
the substrates were significantly reduced in the presence of Reopro when compared 
with normal platelets in absence of the anti-integrin antibody (section 5.2.1.1).  The 
level of platelet spreading was also noticeably reduced. The densities of platelets 
covered across various surface chemistries appear similar, making it difficult to 
discern between the silicon and TCPS positive controls from a-C:H, ta-C and TiO2 
substrates. Platelets typically followed a rounded morphology, some with protruding 
filopodia suggesting that Reopro molecules hinder the platelet’s ability to probe the 
surface for focal adhesion sites and consequently results in cells that are weakly 
adhered to the surface with a more rounded morphology and increased height. Small 
levels of platelet aggregation were evident on silicon and TCPS controls as well as 
albumin coated and bare TiO2 surfaces. Extensive spreading of the adhered cells was 
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evident on bare and, fibrinogen and plasma coated silicon. Similarly, spreading was 
also evident on bare and fibrinogen coated TCPS substrates. A-C:H and ta-C surfaces 
showed reduced platelet adhesion and spreading on all four pre-coated conditions.  
 
It was interesting to note that while Reopro suppressed the level of platelet adhesion 
and subsequent spreading to fibrinogen and other proteins from plasma such as, 
fibronectin and von Willebrand factor [472], it did not inhibit it completely. As such, 
it can be inferred the significant, although not exclusive, role αIIbβ3 receptors play in 
mediating the adhesion of platelets on biomaterial surfaces in the presence of serum 
proteins. Further, albumin and bare surfaces also showed reduced platelet adhesion 
which may suggest αIIbβ3 receptors are susceptible to non-ligand specific platelet 
adhesion on biomaterial surfaces, and decreased availability of αIIbβ3 integrins to 
substrate surface may reduce the likelihood of non-specific activation of αIIbβ3 
receptors for platelet-surface binding.  
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Figure 5.11 Fluorescence microscopy images of Reopro bound platelet cytoskeletons 
exposed to bare (DPBS) and protein pre-coated a. silicon; b. TiO2; c. a-C:H; d. ta-
C; and e. TCPS flat surfaces. Protein pre-coated surfaces include 50µg/ml albumin 
(BSA), fibrinogen (Fg) and plasma (diluted in ratio 1:10, in DPBS). Samples were 
imaged at 500x magnification.  
 
 
The concentration of Reopro bound platelets attached to protein pre-coated surfaces 
and the mean platelet coverage after 1 hour of incubation, as calculated from 
fluorescence microscopy images are shown in Figure 5.12 (a) and (b), respectively. 
There are no significant differences (p<0.01) between total concentration of Reopro 
bound platelets adhered to substrates under the four protein pre-coated conditions 
when compared with platelets not exposed to Reopro (Figure 5.8 (a)). Silicon and 
TCPS reaffirming their role as positive controls showed increased levels of platelet 
attachment across all four conditions, except for plasma coated silicon, which 
showed lower level of attachment than plasma pre-coated TiO2 surfaces. A-C:H and 
ta-C surfaces consistently supported lower concentrations of adhered platelets under 
each condition. This may suggest that the level of αIIbβ3 platelet receptor interaction 
with biomaterial surfaces varies on surface chemistry where adhered platelets are 
more likely to tether to biomaterial surfaces with specific chemistries such as a-C:H 
and ta-C, via its αIIbβ3 membrane integrins.  
 
Fibrinogen and plasma pre-coated surfaces appeared more responsive to Reopro 
antibody, showing lower levels of adhesion on the substrates than its corresponding 
bare and albumin coated surfaces. There was no significant difference (p<0.05) in 
platelet concentrations between a-C:H and ta-C surfaces under each condition. 
Fibrinogen and plasma coated a-C:H and ta-C surfaces supported similar 
concentrations of adsorbed platelets. TiO2 showed similar levels of platelet 
attachment as a-C:H surfaces except in the presence of plasma proteins where it 
exhibited increased platelet attachment, similar to TCPS control.    
 
A significant decrease (p<0.05) in the level of surface coverage was evident with 
Reopro-bound platelets, Figure 5.12 (b), when compared with platelets not exposed 
to Reopro (Figure 5.8 (b)). A-C:H and ta-C surfaces continually showed decreased 
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levels of surface coverage across all conditions, except for on fibrinogen pre-coated 
surfaces where they showed similar levels of coverage to TiO2 and control silicon.  
 
 
 
Figure 5.12 Comparison of a. Reopro bound platelet concentrations, per square 
centimetre, and b. mean surface coverage by the platelets, as percentage value, 
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calculated from rhodamine-phalloidin stained fluorescence microscopy images. Flat 
silicon, TiO2, a-C:H, ta-C and TCPS test substrates were pre-coated with albumin 
(BSA), fibrinogen (Fg) and diluted plasma (ratio 1:10, in DPBS) prior to platelet 
incubation. The results were compared with surfaces devoid of proteins (DPBS). 
Error bars: SD (n=3). 
 
A breakdown of the total number Reopro-bound platelets with rounded and spread 
morphology are shown in Figure 5.14 (a) and (b), respectively. The data was 
calculated from the fluorescence images in Figure 5.11.  
 
Figure 5.14 (a) shows fibrinogen and plasma pre-coated surfaces supported lower 
concentrations of attached round platelets when compared with albumin pre-coated 
and bare substrates. This trend was also noticed in Figure 5.12 (a) but not in the 
concentration of adhered spread platelets (Figure 5.14 (b)). Integrin receptors on 
adherent cells have been known to establish tight focal contacts that link the actin 
filaments in the cytoskeleton to material surfaces [472].  The adhesion strength 
between fibrinogen and αIIbβ3 integrins have been reported as high as 80-100pN, 
while non-specific platelet interactions have shown adhesion strengths below 30pN 
[473], suggesting that a significant decrease in platelet αIIbβ3 integrins available for 
surface binding explains the drastic reduction in platelet attachment and its 
subsequent spreading. AFM images of Reopro-bound platelets attached to fibrinogen 
pre-coated a-C:H surfaces, shown in Figure 5.13 (a) and (b), is synonymous with this 
result. 
 
The αIIbβ3 integrins adhere to fibrinogen and plasma coated surfaces via both the 
RGD and γ chain C-terminal -peptide sequence specific binding as well as from non-
ligand dependent binding found on albumin and bare surfaces. Consequently, an 
overall reduction in the number exposed αIIbβ3 receptors on circulating platelets may 
explain the significantly lower concentrations round platelets found on fibrinogen 
and plasma coated surfaces when compared with the bare and albumin surfaces.  
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Figure 5.13 AFM topographical images showing (a) 2D and (b) 3D plots of 
fibrinogen pre-coated a-C:H surfaces seeded with Reopro bound human platelets. 
Surfaces were analysed in tapping mode with scan rate of 0.2Hz, vertical scale range 
of 1.0µm and scan size of 5µm x 5µm2. Measurements we carried out in liquid mode 
and images corrected using Nanoscope analysis. 
  
a 
b 
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Figure 5.14 Concentration of a. round and b. spread Reopro-bound platelets 
adsorbed per square centimetre of test substrates, as calculated from fluorescence 
microscopy images. Platelets were exposed to nano-patterned silicon, TiO2, a-C:H, 
ta-C and TCPS flat test substrates without adsorbed proteins (DPBS) as well as 
albumin (BSA), fibrinogen (Fg), diluted plasma proteins (ratio 1:10, in DPBS) prior 
to incubation. Error bars: SD (n=3).Statistical analysis was carried out using 
Student T-Tests and ANOVA. 
0
5
10
15
20
25
30
35
40
45
50
DPBS BSA Fg Plasma
N
u
m
b
e
r 
o
f 
ro
u
n
d
 p
la
te
le
ts
 (
x
 1
0
0
0
0
/c
m
2
)
Si TiO2 a-C:H Ta-C TCPS
0
1
2
3
4
5
DPBS BSA Fg Plasma
N
u
m
b
e
r 
o
f 
s
p
re
a
d
 p
la
te
le
ts
 (
x
 1
0
0
0
0
/c
m
2
)
Si TiO2 a-C:H Ta-C TCPS
a 
b 
Chapter 5: Platelet Morphology   210 
 
A significant decrease (p<0.01) in the concentration of spread platelets across all four 
conditions was noticed when platelets were exposed to Reopro than platelets on 
albumin surfaces not exposed to Reopro (Figure 5.12 (b)). A-C:H surfaces showed 
decreased concentrations of spread platelets on plasma surfaces, when compared 
with fibrinogen and albumin pre-coated surfaces where it exhibited similar 
concentration of spread platelets to silicon and TiO2 surfaces. TCPS control surfaces, 
in general, facilitated the higher concentrations of spread platelets, while, Ta-C 
surfaces supported the lowest concentrations of spread platelets. Decreased levels of 
platelet spreading as noticed on a-C:H and ta-C surfaces in the presence of plasma 
proteins may suggest the beneficial and synergistic role surface chemistry, adsorbed 
plasma proteins and anti- αIIbβ3 antibodies like Reopro play in enhancing the 
haemocompatibility of biomaterial surfaces by limiting platelet adhesion and its 
subsequent spreading. 
 
 
5.2.1.3 Nano-patterned surfaces 
 
Platelet adhesion on the nano-patterned substrates was investigated to determine the 
synergistic influence of nano-topography and surface chemistry on the adsorption of 
platelets on protein pre-coated surfaces. Nano-patterned bare silicon, TiO2, a-C:H 
and ta-C surfaces as well as surfaces pre-coated with either 50µg/ml albumin, 
fibrinogen or diluted plasma proteins (diluted in DPBS, ratio 1:10) for 60 minutes 
were seeded with 1x107 platelets for an incubation period of 60 minutes at 37ºC to 
allow sufficient adsorption and adhesion of the platelets. Surface adsorbed platelets 
were visualised using fluorescence microscopy, by staining the actin filaments with 
rhodamine-phalloidin (red) stain to reveal cytoskeletal developments, as well as 
imaged using SEM.  
 
Figure 5.15 shows the conformation of platelets on the nano-patterned surfaces 60 
minutes post-seeding using fluorescence microscopy. Nano-patterns on the substrate 
surface had a significant (p<0.01) influence on modulating platelet behaviour and its 
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subsequent response. A general trend was observed in that a greater number of 
platelets, as shown by the surface coverage of platelets on both; the protein pre-
coated and bare test surfaces, was found on all nano-rough substrates when compared 
with the flat substrates from section 5.2.1.1. Some regions on each of the surfaces 
displayed higher concentrations, than others, indicating the formation of large 
platelet aggregates.  Very clear and distinct differences regarding the conformation 
of the adsorbed platelets were also noticed between the nano-patterned and flat 
surfaces. Platelets on the nano-patterned surfaces appeared extensively spread out 
and displayed multi-layer stacking on the surface when compared with the flat 
surfaces. The greater degree of spreading and consequent increase in surface 
coverage has led to considerable thinning of the platelet’s cross section. The nano-
structural components seem to act as topographical cues by significantly aiding in the 
spreading process. The nano-structures facilitated the platelet’s well defined 
filopodia to probe the nano-patterned surfaces for potential tethering sites and for 
favourable adhesion. Consequently enhanced cytoskeletal organisation as well as 
contact guidance was evident on the patterned surfaces where the platelets appear to 
be flat and well adhered to the surface with irregular morphologies.  
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Figure 5.15 Fluorescence microscopy images showing rhodamine-phalloidin stained 
actin filaments of surface bound platelet cytoskeleton on bare (DPBS) and protein 
pre-coated a. silicon; b. TiO2; c. a-C:H; and d. ta-C nano-patterned surfaces. 
Protein pre-coated surfaces include 50µg/ml albumin (BSA), fibrinogen (Fg) and 
plasma proteins (diluted in ratio 1:10, in DPBS). Samples were imaged at 500x 
magnification using Zeiss Axioskop microscope.  
 
High resolution SEM images of platelets adsorbed on nano-patterned surfaces, as 
shown in Figure 5.16 to 5.19, revealed similar results to fluorescence microscopy 
images, from Figure 5.15. The platelets exhibited spread morphologies with well-
developed actin fibres in the leading edge of the cytoplasmic cell membrane. Further, 
over-reaching of adjacent platelet filopodia to facilitate communication and 
activation of cell signalling pathways between nearby platelets was also evident on 
all surfaces. In some cases intermediary platelets redefine their shape into long 
bridges, as shown in Figure 5.16 (a) and (b), to support cross-communication 
between distant platelets. Significant levels of platelet aggregation were evident on 
all protein-precoated surfaces when compared with platelets on flat surfaces. Nano-
patterns cause nano-rough surfaces with numerous peaks and troughs in a pseudo-
regular fashion to provide a greater surface area and consequently an increase in 
potential tethering sites for platelet integrins and subsequent cytoskeletal 
developments. Platelets were shown to project longer filopodia and present well-
developed actin fibres increasing their cohesive adherence to the surface and 
subsequently their overall activity.  
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Figure 5.16 SEM images of platelets exposed to nano-patterned (a) silicon, (b) TiO2, 
(c) a-C:H and (d) ta-C on pre-coated with albumin (BSA) at 50µg/ml concentration. 
Samples were imaged using an InLens detector (10KV) at 30K X magnification and 
54 degrees stage tilt.  
 
  
  
Figure 5.17 SEM images of platelets exposed to nano-patterned (a) silicon, (b) TiO2, 
(c) a-C:H and (d) ta-C bare surfaces. Samples were imaged using an InLens detector 
(10KV) at 30K X magnification and 54 degrees stage tilt. 
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Figure 5.18 SEM images of platelets exposed to nano-patterned (a) silicon, (b) TiO2, 
(c) a-C:H and (d) ta-C on pre-coated with fibrinogen (Fg) at 50µg/ml concentration. 
Samples were imaged using an InLens detector (10KV) at 30K X magnification and 
54 degrees stage tilt. 
 
  
  
Figure 5.19 SEM images of platelets exposed to  nano-patterned (a) silicon, (b) TiO2, 
(c) a-C:H and (d) ta-C on pre-coated with diluted plasma (dilution factor 1:10, in 
DPBS). Samples were imaged using an InLens detector (10KV) at 30K X 
magnification and 54 degrees stage tilt. 
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AFM images of platelets exposed fibrinogen pre-coated a-C:H nano-patterned 
surfaces exposing the network of actin cytoskeleton in the platelet cytoplasm is 
shown in Figure 5.20 and Figure 5.21. Further, the intercommunication between 
adjacent platelets was visualised in high resolution in Figure 5.21. The dendritic 
network of  platelet filopodia on the adhered platelet shown in Figure 5.20 appears 
more prominent than on fibrinogen coated flat surfaces (Figure 5.7) reinforcing the 
micro-structural and nano-structural changes in platelet’s actin cytoskeleton when 
exposed to nano-rough surfaces. Stiffness of such protrusions have been shown to be 
similar to that of the active actin polymerisation sites at the edge of the cell [474] and 
their relative Young's modulus was determined as 46.5kPa [470]. 
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Figure 5.20 AFM topographical images showing (a) 2D and (b) 3D plots of platelets 
adhered to nano-patterned a-C:H surfaces pre-coated with fibrinogen. Surfaces were 
analysed in tapping mode with scan rate of 0.2Hz, vertical scale range of 0.4µm and 
scan size of 10µm x 10µm2. Measurements we carried out in liquid mode and images 
corrected using Nanoscope analysis. 
 
 
a 
b 
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Figure 5.21 AFM topographical images showing (a) 2D and (b) 3D plots of platelet 
cross-communication upon adhering to nano-patterned a-C:H surfaces pre-coated 
with fibrinogen. Surfaces were analysed in tapping mode with scan rate of 0.2Hz, 
vertical scale range of 0.55µm and scan size of 10µm x 10µm2. Measurements we 
carried out in liquid mode and images corrected using Nanoscope analysis. 
 
a 
b 
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Figure 5.22 (a) and (b) show the total concentration of adhered cells and degree of 
platelet spreading on the protein pre-coated nano-patterned surfaces, respectively. 
Enhanced cell adhesion and cytoskeletal developments (shown as mean surface 
coverage) was evident on the nano-patterned surfaces when compared with flat 
surfaces, suggesting that the specific spatial arrangement of the nano-structures 
formed by the block co-polymer method along with the altered surface chemistry 
from nano-patterning is conducive to enhanced remodelling of the actin-cytoskeleton 
architecture and subsequent platelet response. Fibrinogen followed by plasma coated 
surfaces exhibited elevated platelet concentrations and spreading when compared 
with albumin coated and un-coated surfaces. This reinforces that a monolayer of 
albumin minimises, although doesn’t completely inhibit, the adhesion and spreading 
of platelets and consequently reducing the likelihood of thrombus formation [117, 
475]. In comparison to a-C:H and ta-C surfaces, TiO2 presented higher platelet levels 
and spreading on all protein conditions except plasma proteins where a-C:H and ta-C 
surfaces displayed significantly elevated (p<0.01) platelet concentrations. When 
compared with the bare surfaces, adsorbed albumin decreased the overall platelet 
adhesion on both; a-C:H and ta-C surfaces, while fibrinogen and plasma proteins 
enhanced platelet adhesion. Plasma proteins other than fibrinogen, have been shown 
to reduce platelet attachment on flat a-C:H and ta-C surfaces when compared with 
the bare surfaces (section 5.2.1.1), while nano-structures increase the overall 
adhesion and spreading of platelets by reducing the ability of plasma proteins to 
resist platelet attachment. Conformation of the adsorbed proteins can be evaluated 
using platelet adhesion studies where surfaces with increased platelet concentrations 
may be used as a measure to indicate the likelihood of platelets to adhere to specific 
binding regions on adsorbed proteins. A general increase in platelet concentrations 
across all four conditions suggest an altered conformation of albumin, fibrinogen and 
plasma proteins on the nano-patterned surfaces such that the surfaces support higher 
levels of ligand-dependent and non-specific platelet adhesion. 
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Figure 5.22 Comparison of a. surface bound platelet concentrations, per square 
centimetre, and b. mean surface coverage by the platelets, as percentage value, 
calculated from rhodamine-phalloidin stained fluorescence microscopy images. 
Nano-patterned silicon, TiO2, a-C:H, ta-C and TCPS test substrates were pre-coated 
with albumin (BSA), fibrinogen (Fg) and diluted plasma (ratio 1:10, in DPBS) prior 
to platelet incubation. The results were compared with surfaces devoid of proteins 
(DPBS). Error bars: SD (n=3). 
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This may further explain why actin filaments are better tensioned on fibrinogen and 
plasma proteins adsorbed on nano-patterned surfaces while fewer filopodia is 
observed for platelets adhered on albumin coated and bare nano-patterned surfaces. 
As such these results further reinforce that both; surface chemistry, surface 
topography (as in increase in surface roughness in the nanoscale region) are 
important factors in influencing biological response.   
 
A breakdown of number of round cells, retaining their spherical shape with minimal 
radial protrusions (filopodia), and, spread platelets with well-developed actin fibres 
on nano-patterned surfaces are shown in Figure 5.23(a) and (b), respectively. 
Fibrinogen and plasma pre-coated surfaces showed decreased adhesion of round 
platelets and elevated levels of spread platelets, except for plasma coated TiO2 
surfaces which showed increased concentration of round platelets. On the other hand, 
surfaces devoid of proteins showed elevated levels of round platelets when compared 
with spread platelet concentrations. In the presence of plasma proteins, nano-
patterned silicon and TiO2 presented decreased levels of spread platelets, and 
consequently decreased percentage of mean surface coverage (Figure 5.22 (b)) than 
a-C:H and ta-C. However this was not the case on flat substrates (section 5.2.1.1) 
where plasma and fibrinogen coated silicon and TiO2 displayed increased adhesion 
round and spread platelets when compared with a-C:H and ta-C. Variances in platelet 
attachment between nano-patterned and un-patterned surfaces of the same material, 
in terms of concentrations of adsorbed cells as well as its morphology, reinforces that 
changes in nano-scale surface topography can markedly influence platelet-surface 
interactions and subsequent platelet activation to affect the overall 
haemocompatibility of a biomaterial surface.   
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Figure 5.23 Concentration of a. round and b. spread platelets adsorbed per square 
centimetre of nano-patterned substrates, as calculated from rhodamine-phalloidin 
stained fluorescence microscopy images. Platelets were exposed to nano-patterned 
silicon, TiO2, a-C:H, ta-C and TCPS nano-paterned test substrates without adsorbed 
proteins (DPBS) as well as albumin (BSA), fibrinogen (Fg), diluted plasma proteins 
(ratio 1:10, in DPBS) prior to incubation. Error bars: SD (n=3). 
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5.2.2 QCM-D studies 
 
Changes in frequency and dissipation as measured via QCM-D were also used to 
examine platelet adhesion. Typical change in dissipation versus change in frequency 
(ΔD/Δƒ) plots of platelet attachment on each of the bare surfaces or surfaces pre-
adsorbed with proteins were constructed to provide accurate measurements of 
changes in coupled mass and viscoelasticity, independent of the position on the 
electrode [476].  
 
QCM-D signals do not have a linear relationship with the concentration of cells 
attached on the resonator surface. Cells form a non-homogenous sub-monolayer, 
covering only a small proportion of the electrode surface, leaving a larger portion of 
the surface area still uncovered. Cell behaviour in situ can only be envisioned as 
small perturbation to the interfacial properties of the QCM crystal surface in liquid, 
and as such Sauerbrey equation cannot be used [477]. Further, the penetration depth 
of the shear wave from the surface of QCM sensors into the bulk, at 5MHz, is only 
150nm [463], which is much shorter than the average platelet diameter 
(approximately 2-4µm). Frequency shifts and subsequent changes in dissipation 
energies will appear diminished as they are representative of merely a fraction of the 
cell mass closest to the surface of sensor electrode. An increase in the thickness of 
the viscoelastic layer will also affect frequency shifts further diminishing the time 
dependent frequency and dissipation curves.  
 
As such Dƒ plots were ascribed for platelet studies because the lateral sensitivity of 
the QCM-D sensor in measuring changes in resonant frequency (Δƒ) and dissipation 
factor (ΔD) are both proportional to the oscillating amplitude and their sensitivities 
vary in relation to the Gaussian functions of their distance from the middle of the 
electrode[476]. ΔD/Δƒ plots have also paved way for analysing the dynamic nature 
of the adhesion process in QCM-D, such as; the time-wise deposition of mass and the 
evolvement of its viscoelastic properties and the internal cytoskeletal developments 
as well as the overall shape of individual cells as a function of time [476, 478].  
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Dƒ plots for platelets exposed to TiO2, a-C:H and control silica (SiO2) surfaces pre-
incubated with either 50µg/ml of albumin, DPBS, 50µg/ml of fibrinogen or diluted 
plasma proteins (ratio 1:10, in DPBS) are shown in Figure 5.24 (a), Figure 5.25(a), 
Figure 5.26(a) and Figure 5.27 (a), respectively. And, pre-incubation of platelets with 
anti-αIIbβ3 (Reopro) antibody prior to their exposure to resonator substrates pre-
coated with 50µg/ml of albumin, DPBS, 50µg/ml of fibrinogen or diluted plasma 
(ratio 1:10, in DPBS) are presented in Figure 5.24Figure 5.25(b), Figure 5.26(b) and 
Figure 5.27(b), respectively.  
 
Silicon has a high affinity for oxygen and has been known to rapidly oxidise in air to 
form a native oxide layer [479], and as such silicon QCM crystals with a 
homogenous thin coating of SiO2 were purchased as model control substrates to 
mimic similar platelet responses as on silicon surfaces from Section 5.2.1. TiO2 and 
a-C:H coated as a thin layer on the these control silica crystals were analysed 
previously in Sections 4.2and  4.3.4. Ta-C surfaces were not studied using QCM-D 
as the ta-C coating repeatedly delaminated off the silica surface rendering the 
surfaces unusable for experimentation. The arrows (where applicable) represent the 
time sequence of the data for the third overtone (n = 15Hz).  
 
Previous studies [480-482] have shown that major interactions between cells and the 
adhering surfaces is through integrin receptors and that frequency shifts are typically 
representative of specific adhesion, or integrin mediated response, between cells and 
surfaces of QCM sensors. Integrin receptors cluster at focal adhesions facilitating 
direct contact between the ventral plasma membrane and the resonator surface [483]. 
Direct contact is achieved through the actin cytoskeleton, as they bind the cell 
membrane to the end of the focal adhesion [483]. In cell studies, frequency shifts 
corrolate with changes in coupled mass, implying adhesion of cells to the resonator 
surface, while an increase in D suggest an increase in the number of cells adhered to 
the surface as well as the extent of their spreading [402]. However, decreases in D 
values with increasess in ƒ are also indicative of cell spreading and cytoskeletal 
changes.  Such changes to the D vs. ƒ gradient is representative of an increase in 
rigidity of the cellular adlayer possibly caused by changes in the thichness of the 
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adlayer, increase in focal contacts on the resonator surface or their viscoelastic 
properties [402, 484]. Non-interacting cells, resting on the resonator surface, have 
not been known to show any appreciable changes in ƒ and D [402, 485]. 
 
In Figure 5.24(a), the QCM-D response curve for platelets adhering to albumin 
coated TiO2 was different to albumin coated silica and a-C:H suggesting that 
platelets interacted differently on TiO2 sensors. Pure elastic mass response on a Dƒ 
plot occurs when ΔD = 0 while a pure liquid viscosity-density response transpires 
when a marked increase in the ΔD to ƒ ratio occurs. Rise in the D and ƒ ratio is also 
known as the viscosity-density effect and may suggest an absence of surface binding 
and only fluid above the crystal [485]. The region in-between the pure elastic and 
viscosity density region is known as the viscoelastic region where a proportional 
increase in D with decreasing ƒ is indicative of an increase in cellular point contacts 
and increased platelet adhesion. The exposure of platelets to TiO2 and a-C:H surfaces 
resulted in Dƒ plots that fell well within the viscoelastic region and as such platelet 
interactions on these surfaces behaved as viscoelastic materials during the incubation 
period of 60minutes. The Dƒ plots for platelets exposed to albumin coated silica 
continued to exhibit a decrease in ƒ and an increase in D throughout the 
measurement period, however, control silica surfaces deviated from the viscoelastic 
behaviour during the last 10 minutes of the incubation period, which correlates with 
increased platelet surface contact and consequently increased volume of platelets 
being sensed during the period of measurement. Corroborating with this was the 
increased concentrations of spread platelets found in Figure 5.9(b). Similar platelet 
responses on silicon and silica surfaces with deviation from the viscoelastic 
behaviour during the end stages of platelet incubation in QCM-D may be attributed 
to the development and polymerisation of the actin monomers in the platelet 
cytoskeleton to form actin-rich radial protrusions or filopodia. Platelets interacting 
with albumin coated a-C:H surfaces exhibited a steady decrease in ƒ with increasing 
D values, again suggesting an increase in focal adhesions but not necessarily cell 
spreading. Coupled with this was the increased numbers of round platelets than 
spread platelets found on a-C:H surfaces from Figure 5.9.  
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Figure 5.24 Dissipation versus frequency curves (third overtone; n=3; 15Hz) for 
albumin coated silica, TiO2 and a-C:H surfaces exposed to a. normal platelets b. 
platelets pre-incubated with anti-αIIbβ3  (Reopro) antibody, as determined by QCM-D. 
Red, blue and green arrows represent the direction of increasing time for silica, TiO2 
and a-C:H surfaces, respectively. 
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Interestingly, the response of platelets on albumin coated TiO2 surfaces, for the first 
30 minutes of incubation, showed little change in measurements after the initial 
platelet-surface contact. This resulted in frequency shifts of approximately -5Hz 
during the first half of the incubation process after which platelets on albumin coated 
TiO2 followed a viscoelastic behaviour, similar to that of albumin coated a-C:H 
substrates suggesting that even though smaller concentrations of platelets adhered on 
the resonator surface, their degree of spreading of the adhered platelets is greater 
than the platelets exposed to albumin coated a-C:H or silica surfaces. Further similar 
end frequency shifts could suggest that the same proportion of TiO2 surface was 
covered by platelets and/or their focal contacts as on a-C:H and silica. This 
corroborates with the % surface coverage data obtained from fluorescence 
microscopy (Figure 5.8(b)) further reinforcing that although albumin reduces platelet 
adhesion it does not completely eliminate platelet adhesion or its subsequent 
spreading.  
 
Pre-incubation of platelets with anti-αIIbβ3 (Reopro) antibody followed by exposure 
to albumin coated surfaces, as shown in Figure 5.24(b), presented time-wise decrease 
in frequency as dissipation increased. The resulting curve fell within the viscoelastic 
region of the Dƒ plot. Furthermore, the frequency shifts caused by Reopro-bound 
platelets are similar in nature between the three surfaces and are smaller than the 
frequency shifts recorded from their corresponding  normal platelet response (Figure 
5.24(a)) suggesting a reduction in platelet adhesion and spreading. These results are 
synonymous with fluorescent microscopy analysis from Section 5.2.1.2. 
 
In Figure 5.24(a), the QCM-D response curve for platelets exposed to bare surfaces 
was different to platelets exposed to albumin coated surfaces. The Dƒ plot was 
significantly greater for platelets exposed to bare surfaces even though the gradient 
of the D ƒ plot remained the same with maximum dissipation change were found to 
be 7.6 x 10-6, 7.1 x 10-6 and 6.8 x 10-6 and frequency shifts of -38Hz, -30Hz and -
31Hz for silica, TiO2 and a-C:H surfaces, respectively. The gradient for all three 
surfaces were found to be relatively linear with no major fluctuations suggesting that 
platelets were forming attachments on the biomaterial surface and their cytoskeleton 
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developed over time causing spreading across the surface. Platelets exposed to bare 
silica surfaces exhibited a greater frequency shift than platelets exposed to a-C:H and 
TiO2 suggesting that bare silica surfaces supported greater platelet adhesion than a-
C:H and TiO2 surfaces. These results are concurrent with fluorescence microscopy 
analysis shown in Figure 5.8 and Figure 5.9. Further, a greater frequency change for 
platelets exposed to bare surfaces than platelets exposed to albumin coated surfaces 
suggests that platelets exposed to bare surfaces present increase focal contacts, 
possibly due to increased cell attachment, and exhibit increased platelet spreading. 
These results are synonymous with fluoresce microscopy results explain in Section 
5.2.1.  
 
Pre-incubation of platelets with anti-αIIbβ3 (Reopro) antibody followed by exposure 
to bare surfaces, as shown in Figure 5.24(b), presented decreases in ƒ and increases 
in D with the resulting curve falling within the viscoelastic region of the Dƒ plot. The 
QCM-D responses between the three surfaces were quite different from each other, 
which suggest that platelets exposed on these surfaces interacted differently on each 
surface even though they supported the similar levels of platelet adhesion (Figure 
5.12(a)). And, the change in frequency of Reopro-bound platelets on silica, TiO2 and 
a-C:H surfaces were less than normal platelets exposed to these substrates suggesting 
lesser adhesion and subsequent spreading of cells, as found in Section 5.2.1. Reopro 
incubated platelets on TiO2 sensors did not change in dissipation values as frequency 
decreased during the first 15minutes of the measuring period after which a steady 
rate of increase in dissipation was noted, proportional to changes in frequency.  Cells 
have been known to adhere to the resonator surface within the 10 minutes after 
which any changes observed in ƒ are indicative of changes cause by cell’s surface 
contacts and/or due to protein remodelling [481].   
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Figure 5.25 Dissipation versus frequency curves (third overtone; n=3; 15Hz) for 
bare silica, TiO2 and a-C:H surfaces exposed to a. normal platelets b. platelets pre-
incubated with anti-αIIbβ3  (Reopro) antibody, as determined by QCM-D. 
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This suggests reopro-bound platelets exposed on TiO2 surfaces adhered to the 
surfaces within the first 15minutes of the incubation period during which they did not 
exhibit any remodelling of their actin cytoskeleton. Formation of tightly adhering 
filopods as well as changes in platelet architecture facilitating increased platelet 
spreading occured within the last 45 minutes of the incubation period. These results 
are synonymous with fluorescence microscopy images (Figure 5.12(a) and (b)) 
showing higher percentage of reopro-bound platelet-surface coverage and lesser 
concentrations of adhered reopro-bound platelets than the other substrates. 
 
Figure 5.26(a) shows the QCM-D response curve for platelets exposed to fibrinogen 
pre-coated silica, TiO2 and a-C:H surfaces.  The Dƒ plot was significantly greater for 
platelets exposed to fibrinogen pre-coated surfaces than platelets exposed to albumin 
coated surfaces. The gradient for all three surfaces were found to vary, with TiO2 and 
a-C:H surfaces sustaining relatively linear gradient while platelets exposed to 
fibrinogen coated silica surfaces sustained an exponential increase in dissipation 
during the last 25 minutes of the measuring period. This indicates that platelets 
adhered on fibrinogen pre-coated TiO2 and a-C:H surfaces formed focal contacts on 
the surface throughout the incubation period allowing its actin-cytoskeleton to 
polymerise forming radial protrusions on the surface, as shown in Figure 5.4. While, 
platelets exposed to fibrinogen pre-coated silica surfaces initially supported higher 
levels of focal contacts on the surface, forming a more rigid adlayer. Morphological 
changes within the tightly adhered platelets only occurred during the later stage of 
the incubation period supporting actin re-structuring and platelet spreading. 
Fibrinogen coated a-C:H surfaces presented lower dissipation values and frequency 
shift when compared with TiO2 and silica even though same level of platelets were 
found to be attached on the surface (Figure 5.8(a)). This could indicate that the 
number of focal adhesion made by each platelet on fibrinogen coated a-C:H surfaces 
is lesser than platelets exposed to the other substrates suggesting that platelets form 
weaker attachments on fibrinogen pre-coated a-C:H surfaces.  
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Figure 5.26 Dissipation versus frequency curves (third overtone; n=3; 15Hz) for 
fibrinogen coated silica, TiO2 and a-C:H surfaces exposed to a. normal platelets b. 
platelets pre-incubated with anti-αIIbβ3  (Reopro) antibody, as determined by QCM-D. 
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Fluorescence studies comparing the influence of fibrinogen, when pre-coated on 
substrates, in eliciting a strong platelet response than bare substrates (Figure 5.8(a)) 
found platelets exposed to fibrinogen proteins attached at lesser concentrations. 
However, when compared with bare substrates, QCM-D results showed a greater 
shift in frequency when platelets were exposed to fibrinogen, which is typically 
indicative of increased mass uptake. Deviation from the viscoelastic behaviour 
showing significant increase in dissipation values during the later stages of platelet 
exposure to fibrinogen proteins, as found in Figure 5.26(a), may suggest that the 
obtained Dƒ curves are indicative of a greater level of focal adhesion and cell 
spreading rather than an increase in platelet attachment. This may imply that 
fibrinogen not only plays an adhesive role in platelet-surface interactions but also an 
important role in potentiating restructuring of platelet cytoskeletal architecture and 
subsequently their spreading.  
 
Pre-incubation of platelets with anti-αIIbβ3 (Reopro) antibody followed by exposure 
to fibrinogen surfaces is shown in Figure 5.26 (b). The Dƒ plot presented decreases 
in ƒ and increases in D with resulting curves falling within the viscoelastic region for 
all three surfaces. Changes in frequency of Reopro-bound platelets on fibrinogen 
coated silica, TiO2 and a-C:H surfaces were less than normal platelets exposed to 
fibrinogen pre-coated substrates suggesting lesser adhesion and subsequent spreading 
of cells, as found in Section 5.2.1.  
 
Figure 5.27(a) shows the QCM-D response curve for platelets exposed to plasma 
coated silica, TiO2 and a-C:H surfaces.  Plasma was diluted in DPBS, in the ratio of 
1:10, to avoid time-wise clotting of the plasma proteins which could strongly 
influence dissipation values during the platelet incubation process. The obtained Dƒ 
plots show increases in D as ƒ decreases, however, the relationship appears non-
linear. Platelets exposed to plasma coated a-C:H and silica substrates exhibited 
viscoelastic behaviour, while TiO2 surfaces deviated from the viscoelastic region of 
the Dƒ plot during the last 5 minutes of platelet incubation. This indicates that 
platelets adhered on plasma pre-coated TiO2 facilitated greater amount of platelet 
spreading that a-C:H and silica substrates. Plasma coated surfaces presented lower 
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dissipation values and frequency shift when compared with fibrinogen pre-coated 
surfaces even though greater level of platelets were found to be attached on the 
surfaces (Figure 5.8(a)). This could indicate that platelets form less focal contacts 
and weaker attachments to plasma pre-coated substrates than fibrinogen pre-coated 
substrates. Pre-adsorbed plasma exhibit lesser concentrations of adsorbed fibrinogen, 
this could be a possible reason behind weaker adhesion between platelets and plasma 
coated surfaces. Furthermore, reduced fibrinogen adsorption from plasma during the 
protein incubation phase is indicative of the favourable role other plasma proteins 
play in reducing platelet interactions that can potentiate platelet spreading. These 
observations are synonymous with fluorescence studies, Figure 5.9, showing reduced 
platelet spreading on plasma pre-coated surfaces even though higher levels of platelet 
attachment was measured.  
 
The Dƒ plots showing the adhesion of platelets, pre-exposed to anti-αIIbβ3 (Reopro) 
antibody, prior to their  incubation on plasma pre-coated surfaces is shown in Figure 
5.27 (b). The curve presented a steady decrease in ƒ with increasing D with resulting 
gradient falling within the viscoelastic region for all three surfaces. Frequency shifts 
recorded for Reopro bound platelets on plasma pre-coated silica, TiO2 and a-C:H 
surfaces were less than the frequency shifts recorded for normal platelets exposed to 
fibrinogen pre-coated substrates. Once again, this suggests that Reopro antibodies 
block the αIIbβ3 integrins necessary for cellular adhesion and subsequent spreading, 
although, they do not completely inhibit platelet adhesion. These results corroborate 
with previous results (Section 5.2.1)  and reinforce the minor, yet effective, role other 
platelet integrins, such as; α2β1, α5β1, etc [486] play during platelet adhesion.  
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Figure 5.27 Dissipation versus frequency curves (third overtone; n=3; 15Hz) for 
diluted plasma (ratio 1:10, in DPBS) coated silica, TiO2 and a-C:H surfaces exposed 
to a. normal platelets b. platelets pre-incubated with anti-αIIbβ3  (Reopro) antibody, 
as determined by QCM-D. 
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5.3 Summary 
 
Platelet adhesion and morphological changes, such as; spreading and aggregation, on 
the flat test substrates varied primarily between the four protein conditions rather 
than the chemistry of the thin films deposited on the surfaces. Albumin coated 
surfaces supported high levels of platelet adhesion with little platelet spreading, 
while, fibrinogen pre-coated surfaces and surfaces devoid of proteins supported high 
levels of platelet spreading. Platelets that showed no spreading either; retained their 
rounded morphology without any actin-rich pseudopodia protruding radially from the 
platelet membrane, or, presented platelets with radial protrusions enclosing non-
filamentous actin. Platelets on albumin and bare surfaces were found to change in 
morphology from their rounded state to a spread state during the last stages of 
platelet incubation; this was especially true on albumin-coated silicon-based 
substrates. Spread platelets have been shown to contain actin rich, stellate shaped 
filopodia. Further, the degree of platelet spreading on TiO2 surfaces was reported 
higher than on a-C:H and silicon-based substrates. Platelets exposed to plasma 
surfaces showed very little spreading, when compared with albumin, bare and 
fibrinogen pre-coated surfaces and yet presented increased levels of platelet-platelet 
intercommunication (identified by the over-reaching of filopodia between adjacent 
platelets) than fibrinogen surfaces. High levels of platelet adhesion on bare and 
albumin coated surfaces suggest that platelet adhesion on biomaterial surfaces is 
dependent on non-specific interactions between platelet receptors and biomaterial 
surfaces as well as passivating proteins such as albumin. Pre-coating the surfaces 
with fibrinogen and plasma proteins have been shown to reduce the level of platelet 
adhesion when compared with platelets exposed to surfaces devoid of proteins 
suggesting a favourable interaction between serum proteins including fibrinogen, 
platelets and biomaterial surfaces in reducing platelet adhesion. Furthermore, when 
compared with silicon (Si), TiO2, a-C:H and ta-C surfaces were shown to support the 
least number of adhered round and spread platelets on fibrinogen and plasma 
surfaces. Platelets were shown to form focal contacts with fibrinogen pre-coated 
TiO2 and a-C:H surfaces throughout the incubation period where number of focal 
contacts formed on a-C:H surfaces was less than that of TiO2 suggesting that platelets 
adhered on fibrinogen coated a-C:H surfaces form weaker attachments than on the 
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other surfaces. Again, TiO2 surfaces exhibited greater levels of platelet spreading 
than a-C:H surfaces in the presence of plasma proteins, although the amount of focal 
contacts formed by platelets on plasma coated surfaces wereless than fibrinogen 
coated surfaces. 
 
Anti-αIIbβ3 integrin antibody (Reopro) treated platelets decreased the overall levels of 
platelet adhesion and spreading on flat test substrates and substrates exposed to 
albumin, fibrinogen and plasma proteins suggesting the important role of αIIbβ3 
integrins in platelet adhesion and spreading on all four conditions. Fibrinogen and 
plasma surfaces supported the lowest concentrations of Reopro-exposed platelets. 
The adhered platelets displayed rounded morphologies with limited filopodial 
extensions. While the concentrations of adhered platelets were lower in the presence 
of the anti-integrin antibody, it did not completely inhibit binding indicating that 
platelet adhesion is dependent on both αIIbβ3 ligand-dependent as well as non-specific 
interaction between platelet receptors and biomaterial surfaces. Albumin and bare 
surfaces also showed reduced platelet adhesion which implies that αIIbβ3 platelet 
integrins are susceptible to non-ligand specific activation and consequent binding of 
its receptors to the biomaterial surfaces and albumin proteins. A-C:H and ta-C 
surfaces continually supported decreased levels of anti- αIIbβ3 integrin treated 
platelets on all protein pre-coated and bare surfaces, although a-C:H surfaces showed 
higher levels of platelet spreading similar to TiO2 surfaces on albumin and fibrinogen 
coated surfaces. This reinforces the influence of surface chemistry as well as specific 
plasma proteins in affecting αIIbβ3 ligand activation for platelet-surface binding. 
Normal platelets exposed on nano-patterned surfaces exhibited high concentrations 
of adhesion as well as extensive levels of spreading. Platelets formed multi-level 
stacked aggregates on the surfaces when compared with the flat surfaces suggesting 
that the nano-patterns behaved as topographical cues, which act as potential tethering 
sites for platelet integrin adhesion. The dendritic network of actin cytoskeleton in the 
cytoplasm of platelets adhered on nano-patterned surfaces appeared more 
pronounced. TiO2 surfaces presented higher levels of platelet adhesion and spreading 
on all protein pre-coated and bare conditions, except on plasma pre-coated surfaces 
where a-C:H and ta-C surfaces supported higher platelet concentrations. On nano-
patterned surfaces both fibrinogen and plasma proteins were found to enhance 
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platelet adhesion and it’s spreading. This was especially noticeable on a-C:H and ta-
C nano-patterned surfaces which showed the highest level of platelet adhesion and 
spreading in the presence of fibrinogen and plasma proteins. 
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6   CLOTTING CASCADE AND PLATELET 
ACTIVATION 
 
 
6.1   Introduction 
 
Blood coagulation and thrombus formation on biomaterial surfaces in vivo is 
ultimately dependent on a sequence of plasma protein reactions causing the 
activation of fibrinogen to form fibrin induced primary haemostasis as well as tightly 
controlled intracellular reactions mediating platelet activation and consequently 
aggregation. These two events are inextricably coupled, and along with the activated 
platelet surface for clotting factor assembly and thrombin binding, functions as a 
potent agonist for circulating platelets.  While the haemocompatibility of a 
biomaterial is implicitly linked to its tribological properties, the extent to which it 
can influence these interactions remains unknown.  
 
In this study, the influence of surface chemistry, nano-topography and serum protein 
adsorption on fibrin clot formation and platelet activation was analysed. Plasma 
clotting experiments on flat surfaces, examined in Section 4.1, were investigated by a 
series of coagulation assays and the ability of these surfaces to modulate the activity 
of heparin, was further evaluated. The degree of platelet activation on flat and nano-
patterned surfaces was determined by the expression of activation markers: P-
selectin (CD-62P), activated αIIbβ3, and α2β1 integrins on the platelet membrane, 
using a combination of ELISA, flow cytometry and fluorescence. The results 
obtained were compared to serum pre-coated surfaces. 
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6.2 Results and Discussion 
 
 
6.2.1 Coagulation of Plasma Proteins 
 
The influence of various surface chemistries in modulating the coagulant properties 
of plasma proteins and the anti-coagulant properties of heparin was examined by 
comparing the time taken to induce fibrin-clot formation via the extrinsic and 
intrinsic coagulation pathways. This was determined by prothrombin (PT) and 
activated partial thromboplastin (aPTT) coagulation based assays, respectively. The 
ability of the contacting surfaces to denature fibrinogen, impairing its function and 
consequently delaying fibrin clot formation was evaluated using thombin time assay 
(TT). Clotting times were determined using heparinised and non-heparinised plasma 
on flat silicon, TiO2, a-C:H and ta-C surfaces and the results were compared with 
control TCPS. 
 
 
6.2.1.1 Prothrombin (PT) clotting assay 
 
The effect of surface chemistry on the extrinsic cascade was analysed using PT 
coagulation test. The time taken for fibrin-dependent clot formation to form was 
measured upon the addition of phospholin ES rich, ellagic-acid based aPTT reagent 
and calcium chloride on flat surfaces pre-incubated with plasma proteins. The 
negatively charged ellagic acid activator initiates the extrinsic cascade by activating 
coagulation factors XII and XI and subsequently the activation of factors IX and X 
before proceeding through the common pathway. Activation of factor X is the 
dominant mechanism that leads to clot formation. 
 
Figure 6.1 shows the clotting times measured by PT assay of the test substrates and 
control TCPS. Of the test substrates, ta-C surfaces prolonged clotting the most by 19 
seconds closely followed by a-C:H, silicon and TiO2 with 17, 16 and 15 seconds 
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respectively. Plasma proteins on the control TCPS surfaces clotted more readily 
within 14.5 seconds. This may suggest while the test surfaces prolong the activation 
of extrinsic clotting factors, the difference in time delay is not significant P(<0.1), 
with exception to ta-C, which exhibited a delay in clotting time by 31%.  
 
 
 
Figure 6.1 Anticoagulant activity of flat silicon, TiO2, a-C:H, ta-C and TCPS 
biomaterial surfaces in prolonging plasma protein coagulation via the extrinsic 
pathway, as measured using an rabbit brain based thromboplastin  PT clotting 
assay. Error bars: SD (n=3) 
 
The anticoagulant activity of heparin via the extrinsic pathway, at increasing 
concentrations, on the flat surfaces, was described in Figure 6.2. Heparin is a 
commercially available anti-coagulant that behaves as a catalyst by reversibly 
binding to antithrombin III (ATIII) which increases its affinity to activated 
coagulation factors IX, XI, XII, X and thrombin by 1000 fold. Consequently, the 
ATIII-heparin complex accelerates ATIII’s ability neutralise thrombin and inhibits 
the factors from participating in the coagulation cascade. The maximum therapeutic 
range for anti-factor Xa heparin concentration is 0.7U/ml where 0.1U is equivalent to 
1µg, calculated from the stock concentration of heparin used (180U/mg, H3393, 
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Sigma) [487-491]. As such, the concentration of heparin dissolved in plasma was 
titrated to 1-5µg per ml of plasma, within the therapeutic range.  
 
 
Figure 6.2 Changes in anti-coagulant activity of heparin, after incubation with 
plasma protein adsorbed flat silicon, TiO2, a-C:H, ta-C and control TCPS surfaces, 
as measured using an PT clotting assay. Error bars: SD (n=3)  
 
Fibrin clot formation, in the absence of heparin, occurs within 13-19seconds, while, 
at increased heparin concentrations, of 5µg/ml, range between 17-21 seconds. 
Silicon, TiO2, a-C:H and TCPS showed an increase of 4-5seconds while clotting 
times of ta-C surfaces remained unchanged. Since elevated heparin concentrations 
did not affect the clotting times significantly it can be deduced heparin plays a 
limited role in inhibiting the activation of extrinsic clotting factors. Further, similar 
clotting periods between the substrates suggests that activation of the extrinsic 
pathway may not be influenced by surface chemistry, however, whether it is 
dependent on the presence of a synthetic biomaterial remains unknown.  
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6.2.1.2 Activated partial thromboplastin (aPTT) clotting assay 
 
The effect of surface chemistry on the intrinsic cascade was experimentally analysed 
using aPTT clotting assay. The time taken for factor-dependent clot formation to 
form was measured upon the addition of phosphoplastin RL rich, rabbit brain based 
thromboplastin reagent on flat surfaces pre-incubated with plasma proteins. 
Thromboplastins are a combination of phospholipid membrane bound tissue factor 
(III) and calcium ions (IV). Membrane bound tissue factor activates the intrinsic 
cascade by coupling to coagulation factors VII and X, and subsequently activates 
factor IX followed by factor X before proceeding through the common pathway. The 
aPTT clotting assay results on the flat surfaces reinforces the role of surface 
chemistry in fibrin related clot formation. From Figure 6.3 it can be deduced that a-
C:H and silicon surfaces prolong clotting time the most, by 63 seconds and 57 
seconds, respectively, followed by TiO2 and ta-C surface by 52 and 53 seconds, 
respectively.  
 
 
Figure 6.3 Anticoagulant activity of flat silicon, TiO2, a-C:H, ta-C and TCPS 
biomaterial surfaces in prolonging plasma protein coagulation via the intrinsic 
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pathway, as measured using an ellagic acid based aPTT clotting assay. Error bars: 
SD (n=3) 
 
The prolonged response to the ellagic activator by a-C:H and silicon, when compared 
to the control surface, may indicate that these materials impede the intrinsic 
activation pathway more readily, by behaving as an inhibitor to factors VII, IX and 
XI. The anticoagulant activity of heparin via the intrinsic pathway, at increasing 
concentrations on the flat surfaces, is shown in Figure 6.4.  
 
 
Figure 6.4 Changes in anti-coagulant activity of heparin, after incubation with 
plasma protein adsorbed flat silicon, TiO2, a-C:H, ta-C and control TCPS surfaces, 
as measured using an aPTT clotting assay. Error bars: SD (n=3)  
 
As mentioned earlier, without heparin, fibrin clot formation via the intrinsic pathway 
occurs between approximately 45-65seconds. Increasing the heparin concentration 
extends the aPTT clotting times significantly in an exponential manner. This is 
especially evident on silicon, a-C:H and ta-C surfaces. However, TiO2 followed a 
plateauing trend similar to control TCPS showing minimal variances to increasing 
heparin concentrations. While minimal differences between silicon, a-C:H and ta-C 
was noticed at 1 and 2.5µg/ml, at 5µg/ml, the time taken to induce clots varied 
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significantly between surfaces. A-C:H (4 minutes and 53 seconds) was the most 
perceptive to heparin activity, followed by ta-C (3 minutes 47 seconds) and silicon (3 
minutes and 29 seconds). While these surfaces inevitably exhibited plasma clot 
formation; the results indicate that the synergistic effect between surface chemistry 
and heparin can be enhanced by modulating surface chemistry of a biomaterial, 
especially at higher therapeutic concentrations of heparin. 
 
 
6.2.1.3 Thrombin time (TT) clotting assay 
 
Ability of the contacting surfaces to severely impair fibrinogen’s structure, by 
denaturation, and consequently their function in forming fibrin clots was analysed 
using the thombin time assay (TT). The time taken for fibrin-dependent clot 
formation to form was measured upon the addition of excess thrombin and calcium 
chloride on flat surfaces pre-incubated with plasma proteins. The active thrombin 
enzyme acts on soluble fibrinogen to convert it to an insoluble fibrin mesh.  
 
The thrombin times shown in Figure 6.5 are the recorded time, in seconds, to clot 
formation after the addition of thrombin and calcium chloride ions. Concentrated 
thrombin enzymes were reconstituted with calcium chloride salt in 1% (w/v) albumin 
solution (in DPBS buffer) to a final ratio of 1: 1: 8 of thrombin: CaCl2: 1% albumin, 
respectively, to produce clotting times within the normal reference range. Silicon and 
a-C:H surfaces prolonged clotting the most by 21 seconds closely followed by TiO2 
and ta-C with 20 and 19 seconds respectively. Plasma proteins on control TCPS 
clotted more readily within 14 seconds. 
 
The results above show test substrates prolong clot formation by 5-7seconds (30-
50% increase), suggesting that the substrates denature fibrinogen more readily than 
TCPS and consequently impede its conversion to fibrin. While surface bound 
fibrinogen have been known to unfold upon adsorption, as shown in Section 4.3, the 
amount of suspended proteins, in solution, that have denatured is still uncertain. 
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Figure 6.5 TT clotting assay measuring the anticoagulant activity of flat silicon, 
TiO2, a-C:H, ta-C and TCPS biomaterial surfaces in prolonging plasma protein 
coagulation in the presence of excess thrombin and calcium chloride ions. Error 
bars: SD (n=3) 
 
 
6.2.2 Platelet Activation Studies 
 
Activation of circulating platelets upon contacting biomaterial surfaces, in vivo, is 
primarily mediated by platelet integrins, which trigger successive stages of outside-in 
and inside-out signalling processes. This results in the formation of a pro-coagulant 
platelet surface. The activated extracellular integrins increase the integrin affinity to 
biomaterial surfaces and extra cellular ligands which influences the strength of 
platelet adhesion, and ultimately, its aggregation. Activation caused from binding of 
extra cellular ligands, such as plasma proteins, promotes both, the translocation and 
expression of intracellular integrins on the extracellular surface (e.g. intracellular 
αIIbβ3 and p-selectin), and, a conformational change within extracellular integrins to 
their activated state (e.g. extracellular αIIbβ3 and α2β1). 
 
Ordinarily, resting platelets express un-activated αIIbβ3, α2β1, α5β1, α6β1, αVβ3 and 
small amounts of P-selectin (CD62P) receptors on the plasma membrane of which 
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αIIbβ3 is the most abundant. During the initial stages of activation, α2β1 activates in 
the presence of circulating and exposed collagen from the sub-endothelium, while, 
the αIIbβ3 receptor activates upon binding to surface adsorbed fibrinogen proteins. In 
addition, fibrinogen circulating in plasma binds to and cross-links the activated αIIbβ3 
receptors on two different platelets which can lead to platelet aggregation. Apart 
from fibrinogen, other adhesive plasma proteins, such as von Willebrand factor, 
thrombospondin, fibronectin and vitronectin, containing RGD sequences can also 
bind to activated αIIbβ3. Therefore, activated αIIbβ3 and α2β1 receptors serves as a 
strong biomarker for initial platelet activation. Upon activation, the α-granule docks 
on the platelet membrane causing the translocation of intracellular P-selectin 
(CD62P) to the extracellular membrane, at high concentrations. As such detection of 
P-selectin (CD62P) on the membranes of adsorbed platelets can pose as an indication 
of end stage activation. Further, when platelets spread as a result of activation, they 
lose their discoid shape and release granular contents of their secretory organelles, 
which in turn act as agonists to platelet activation, and subsequently, aggregation. 
 
As such, the activation of attached platelets on serum-pre-coated flat substrates was 
evaluated, in vitro, for the surface expression of activated αIIbβ3 and α2β1 receptors, 
using ELISA. The expression of P-selectin (CD62P) and αIIbβ3 from circulating 
platelets on flat and nano-patterned surfaces was evaluated using flow cytometry. 
Lastly, the presence of activated αIIbβ3 and P-selectin (CD62P) and the localisation of 
activation markers on the surface membrane of adsorbed platelets was analysed using 
fluorescence microscopy.  
 
 
6.2.2.1 ELISA 
 
Expression of activated αIIbβ3 integrins on surface bound platelets was analysed using 
ELISA, in the manner described in Section 3.2.4.3.1. In brief, flat silicon, TiO2, a-
C:H, ta-C and TCPS surfaces were pre-adsorbed with albumin (BSA), fibrinogen 
(Fg) and diluted plasma proteins (ratio 1:10, in DPBS buffer). The results were 
compared to platelet integrin expression on bare surfaces. An anti-human αIIbβ3 
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antibody, Abciximab (ReoPro), was used to screen for αIIbβ3 integrins. The antibody 
bound platelets were incubated with peroxidase conjugated secondary antibodies 
followed by ABTS colorimetric dye. 
 
From Figure 6.6 it is evident the level of αIIbβ3 activation varied between the protein-
coated surfaces. While albumin coated surfaces served as a negative control for the 
assay by exhibiting reduced platelet activation, it did not however prevent the 
activation process. The bare surfaces presented increased activation when compared 
with albumin pre-coated surfaces. From this it could be inferred that adsorbed 
albumin molecules decrease the surface exposure to circulating platelets in solution 
and consequently reduce the surfaces overall activation.  Under static conditions, 
fibrinogen surfaces are known for being traditionally more responsive for αIIbβ3 
mediated platelet activation, and consequently showed substantially high receptor 
activation. Plasma coated surfaces, when compared to fibrinogen pre-coated 
surfaces, displayed reduced overall activation. This may suggest plasma proteins 
interact favourably with test substrates to reduce fibrinogen adsorption, or, by steric 
hindrance, reduce the overall exposure of adsorbed fibrinogen to circulating platelets 
in order to decrease αIIbβ3 mediated platelet activation.  
 
Comparing the different surface chemistries it is evident that TCPS served as the 
positive control by supporting the highest levels of platelet activation on bare and 
protein pre-coated conditions. Ta-C and TCPS coated with plasma exhibited reduced 
platelet activation than when coated with fibrinogen or devoid of proteins. This may 
suggest that adsorbed serum proteins decrease the overall surface exposure and 
present decreased surface-bound fibrinogen for platelet activation. Further, ta-C 
surfaces showed decreased activation when coated with plasma than with albumin. 
This may be due to greater surface coverage by non-activating serum proteins 
including; fibronectin, vitronectin, vonWillebrand factors, thrombospondin, laminins, 
etc, than by albumin. Silicon followed by TiO2 and a-C:H presented lower levels of 
activated αIIbβ3 on bare surfaces and higher levels on plasma pre-coated surfaces, 
when compared with ta-C. Plasma proteins adsorbed on a-C:H surfaces did not 
change the activation levels of the bare surfaces. Further, platelet activation on 
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plasma coated silicon and TiO2 was higher than on the bare surface, suggesting that 
unlike ta-C, plasma adsorbed on silicon and titania may exhibit pro-coagulant 
tendencies. 
 
Figure 6.6 Expression of activated αIIbβ3 receptors measured as absorbance from the 
attachment of ReoPro antibody to activated αIIbβ3 receptors on surface bound 
platelets, as determined by ELISA. Silicon, TiO2, a-C:H, ta-C and TCPS test 
substrates were pre-coated with 50µg/ml of albumin (BSA), 50µg/ml fibrinogen (Fg) 
and diluted plasma (ratio 1:10, in DPBS) before platelet incubation. The results 
were compared with surfaces devoid of proteins. Error bars: SD (n=3).  
 
It was interesting to note that the fibrinogen pre-coated substrates supported similar 
levels of αIIbβ3 activation even though a higher concentration of fibrinogen, with 
higher levels of its platelet binding domain was exposed on fibrinogen adsorbed on 
a-C:H (Chapter 4). It appears that even smaller amounts of adsorbed fibrinogen with 
less exposure of its platelet binding domain, as found with TiO2 and silicon, can 
mediate similar levels of platelet αIIbβ3 receptor activation. This could suggest that 
while the presence fibrinogen dictates αIIbβ3 activation, its relative concentration on 
the surface may not necessarily be a good indicator of the level of αIIbβ3 mediated 
activation. Other factors such as surface chemistry might be a contributing factor. 
Hence, the adsorption of specific plasma proteins, their interaction on the test 
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substrates as well as surface chemistry plays a significant role in the pro-coagulant 
activity of platelets via the αIIbβ3 mediated pathway.  
 
Figure 6.7 describes the expression of activated α2β1 integrins on surface adsorbed 
platelets using anti-α2β1 antibody, clone BHA2.1, as determined using ELISA. The 
flat surfaces were pre-adsorbed with albumin (BSA), fibrinogen (Fg), diluted plasma 
proteins (ratio 1:10, in DPBS buffer) and collagen, and the results were compared to 
platelet integrin expression on bare surfaces.  
 
Figure 6.7 Expression of activated α2β1 receptors measured as absorbance from the 
attachment of anti-α2β1 antibody to activated α2β1 receptors on surface bound 
platelets, as determined by ELISA. Silicon, TiO2, a-C:H, ta-C and TCPS test 
substrates were pre-coated with 50µg/ml of albumin (BSA), fibrinogen (Fg), diluted 
plasma (ratio 1:10, in DPBS)and collagen before platelet incubation. The results 
were compared with surfaces devoid of proteins. Error bars: SD (n=3). 
 
Absorbance values recorded for albumin coated surfaces are similar to that of the 
background indicating that the activation of α2β1 was inhibited in the presence of 
albumin. Fibrinogen, plasma and bare surfaces exhibit similar level of activation 
which is slightly higher than that of albumin but significantly lower than that of the 
positive control, collagen. Furthermore, there was a modest, but not statistically 
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significant increase in platelet integrin α2β1 activation in the presence of plasma, 
reinforcing that collagen behaves as a powerful agonist and supports the activation of 
α2β1 integrins while the bare surfaces and serum proteins do not. As such, α2β1 
mediated activation is not dependent on the surface chemistry of the test substrates or 
serum proteins, while, αIIbβ3 mediated activation is.  
 
 
6.2.2.2 Fluorescence Microscopy 
 
Fluorescence microscopy is not only a useful technique for elucidating the 
interactions of platelets with different substrata, as described in Section 5.2.1, but 
also allows visualisation of membrane functional activity through immuno-
cytochemical staining. In this study, platelets were seeded on bare and protein pre-
coated, flat and nano-patterned substrates, for 1 hour at 37 degrees. After washing 
the attached platelets were fixed and dual-labelled with RPE conjugated anti-CD62P-
selectin antibody, and, Reopro (human αIIbβ3 biomarker) followed by FITC 
conjugated secondary anti-human antibody. To observe the localisation of αIIbβ3 
integrins on the platelet membrane, platelets were visualised by fluorescence 
microscopy after staining these integrins and the actin cytoskeleton. Platelets 
exposed to flat and nano-patterned surfaces without absorbed proteins as well as pre-
coated with albumin, fibrinogen and diluted plasma (ratio 1:10, in DPBS) were 
imaged at 500x magnification. 
 
 
6.2.2.2.1 αIIbβ3 Activation and Actin staining on Nano-patterned Surfaces 
 
The localisation of platelet receptor αIIbβ3 on the platelet membrane was visualised by 
dual staining the attached platelets, on bare and protein pre-coated nano-patterned 
silicon, titania, a-C:H and ta-C surfaces. Rhodamine-phalloidin was used to stain for 
actin filaments and FITC conjugated antibody was used specifically to bind to the 
antibody that bound to activated αIIbβ3 platelet receptors. The results are shown in 
Figure 6.8 to 6.11.  
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Figure 6.8 Fluorescence microscopy images of platelet cytoskeletons (left, red rhodamine-phalloidin actin stain) and the membrane 
distribution of activated αIIbβ3 integrins (middle, green-FITC conjugated antibody to Reopro bound αIIbβ3 receptor)on platelets attached to 
albumin coated silicon, TiO2, a-C:H and ta-C nano-patterned surfaces. Samples were imaged at 500x magnification using Zeiss Axioskop.The 
arrows show platelets that do not present detectable levels of the activation marker. 
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Figure 6.9 Fluorescence microscopy images of platelet cytoskeletons (left, red rhodamine-phalloidin actin stain) and the membrane 
distribution of activated αIIbβ3 integrins (middle, green-FITC conjugated antibody to Reopro bound αIIbβ3 receptor)on platelets attached to 
bare silicon, TiO2, a-C:H and ta-C nano-patterned surfaces. Samples were imaged at 500x magnification using Zeiss Axioskop microscope.  
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 Figure 6.10 Fluorescence microscopy images of platelet cytoskeletons (left, red rhodamine-phalloidin actin stain) and the membrane 
distribution of activated αIIbβ3 integrins (middle, green-FITC conjugated antibody to Reopro bound αIIbβ3 receptor)on platelets attached to 
fibrinogen coated silicon, TiO2, a-C:H and ta-C nano-patterned surfaces. Samples were imaged at 500x magnification Zeiss Axioskop.  
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Figure 6.11 Fluorescence microscopy images of platelet cytoskeletons (left, red rhodamine-phalloidin actin stain) and activated membrane 
αIIbβ3 integrins (middle, green-FITC conjugated antibody to Reopro bound αIIbβ3 receptor)on platelets attached to plasma (dilution ratio 
1:10, in DPBS) coated silicon, TiO2, a-C:H and ta-C nano-patterned surfaces. Samples were imaged at 500x magnification. 
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Platelet attachment on albumin pre-coated nano-patterned surfaces is shown in 
Figure 6.8, where the morphology of the bound platelets, as elucidated from the actin 
cytoskeleton as well as the distribution of activated αIIbβ3 integrins are shown. 
Platelets exposed to albumin coated surfaces were rounded in morphology with αIIbβ3 
integrins present at high intensities. Especially on a-C:H surfaces, indicated by the 
arrows, certain platelets do not show detectable levels of the activation marker. This 
may suggest that the level of activation is independent of platelet morphology and 
that a platelet may remain in its rounded shape while exhibiting higher levels of 
activation. However, activation seemed ubiquitous on spread platelets, where, the 
degree of spreading (or, increase in a platelet’s surface coverage) is inversely 
proportional to the intensity of αIIbβ3 per unit area. This may be due to expansion of 
the platelet’s cytoplasm across the surface, which may stretch its membrane and 
consequently distribute the finite number of activation markers presented on the 
membrane.  
 
Furthermore, the level of activation varied drastically between the albumin pre-
coated nano-patterned substrates, primarily due to the number of attached platelets 
and their level of spreading. Platelets on TiO2 surfaces exhibited increased spreading 
while platelets on ta-C surfaces presented a rounded morphology with high degree of 
clumping. The level of activation per unit square appeared lower on a-C:H surfaces, 
which presented decreased platelet attachment and limited spreading.  
 
Activation of platelets on bare surfaces, as well as fibrinogen pre-coated and plasma 
pre-coated substrates are shown in Figure 6.9 to 6.11, respectively. Similar to 
albumin pre-coated surfaces, the level of activation observed on the various materials 
was dependent on platelet number and morphology of the adhered platelets. Not all 
round platelets displayed detectable levels of activation while spread platelets 
presented activated αIIbβ3 receptors at varying concentrations. Fibrinogen and plasma 
pre-coated surfaces exhibited increased platelet attachment, spreading and multi-
level stacking, and consequently presented higher activation levels than albumin or 
bare surfaces. This was especially evident on TiO2 and a-C:H surfaces. Furthermore, 
between plasma and fibrinogen surfaces, fibrinogen surfaces achieved higher levels 
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of activation where αIIbβ3 integrins appear more pronounced in the central region of 
the spread platelet while little or no actin was detected. This may suggest that the 
extracellularisation process of activated αIIbβ3 integrins, upon contacting the protein 
coated surface may occur centrally to facilitate platelet-platelet adhesion due to 
fibrinogen-mediated biological cues. Similar morphologies of spread platelets were 
evident on plasma coated surfaces, however, not to the same extent, suggesting a 
favourable interaction between plasma proteins and the nano-patterned surfaces.  
 
 
6.2.2.2.2 P-selectin and αIIbβ3 Activation on Flat Surfaces 
 
The distribution of platelet receptors; P-selectin and αIIbβ3, on the platelet membrane 
were visualised by dual labelling the attached platelets with RPE conjugated 
antibody specific for P-selectin (CD62P) and FITC conjugated secondary antibody 
specific to ReoPro bound αIIbβ3. Platelets were then incubated for 1 hour on bare and 
protein pre-coated flat silicon, Tio2, a-C:H and ta-C surfaces and the results shown in 
Figure 6.12, Figure 6.14 and Figure 6.15, correspond to activation of platelets on 
albumin, fibrinogen and diluted plasma (ratio 1:10, in DPBS) pre-coated substrates, 
respectively. These results were then compared with platelet activation on substrates 
devoid of proteins, as shown in Figure 6.13.  
 
Platelet activation on protein pre-coated and bare flat surfaces are shown in Figure 
6.12 to 6.15. The images show P-selectin (CD62P) activation on the membranes of 
bound platelets, activated αIIbβ3 integrins, and their co-localisation.  
The level of P-selectin activation varies between protein coats as well as surface 
substrates. In general, higher intensities of the P-selectin and greater number of 
activated cells were evident on fibrinogen followed by DPBS and plasma, with 
albumin supporting the lowest level of integrin activation. Silicon and ta-C surfaces 
facilitated a greater concentration of the activated cells when pre-coated with 
fibrinogen, where the concentration of cells activated in the presence of albumin is 
greater than when devoid of proteins, suggesting that P-selectin activation is not 
initiated by platelet interaction to the bare surfaces. 
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Figure 6.12 Fluorescence microscopy images showing membrane distribution of activated P-selectin (left, red-RPE conjugated anti-CD62 P-
selectin) and αIIbβ3 integrins (middle, green-FITC conjugated antibody to Reopro bound αIIbβ3 receptor)on platelets attached to albumin 
coated silicon, TiO2, a-C:H and ta-C flat surfaces. Samples were imaged at 500x zoom using Zeiss Axioskop microscope. 
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Figure 6.13 Fluorescence microscopy images showing membrane distribution of activated P-selectin (left, red-RPE conjugated anti-CD62 P-
selectin) and αIIbβ3 integrins (middle, green-FITC conjugated antibody to Reopro bound αIIbβ3 receptor)on platelets attached to bare silicon, 
TiO2, a-C:H and ta-C flat surfaces. Samples were imaged at 500x zoom using Zeiss Axioskop microscope. 
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Figure 6.14 Fluorescence microscopy images showing membrane distribution of activated P-selectin (left, red-RPE conjugated anti-CD62 P-
selectin) and αIIbβ3 integrins (middle, green-FITC conjugated antibody to Reopro bound αIIbβ3 receptor)on platelets attached to fibrinogen 
pre-coated silicon, TiO2, a-C:H and ta-C flat surfaces. Samples were imaged at 500x zoom using Zeiss Axioskop microscope. 
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Figure 6.15 Fluorescence microscopy images showing membrane distribution of activated P-selectin (left, red-RPE conjugated anti-CD62 P-
selectin) and αIIbβ3 integrins (middle, green-FITC conjugated antibody to Reopro bound αIIbβ3 receptor)on platelets attached to plasma pre-
coated silicon, TiO2, a-C:H and ta-C flat surfaces. Samples were imaged at 500x zoom using Zeiss Axioskop microscope. 
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Furthermore, while the level of activation on ta-C surfaces is decreased in the 
presence of plasma proteins than when compared with only fibrinogen, silicon 
responded adversely showing greater activation levels on plasma pre-coated surfaces. 
TiO2 and a-C:H surfaces supported increased concentrations of activated platelets 
when incubated on fibrinogen pre-coated surfaces followed by bare surfaces than on 
albumin. Furthermore, the number of activated platelets plummeted in the presence 
of plasma proteins than when compared with control albumin. This may suggest a 
favourable interaction between plasma proteins than TiO2 and a-C:H surfaces 
limiting P-selectin activation, while the surfaces alone promote non-ligand specific 
activation. It was interesting to note ta-C surfaces supported the least number of 
activated platelets on plasma-pre-coated surfaces. 
 
The activation of αIIbβ3 integrins followed a similar trend to the ELISA data reported 
in Section 6.3.1, with fibrinogen pre-coated surfaces supporting the highest 
concentration of activated platelets followed by plasma pre-coated surfaces and the 
bare surfaces. In general, a-C:H surfaces, supported the least amount of activated 
platelets and a-C:H and ta-C surfaces responded more favourably in the presence of 
plasma proteins than silicon and TiO2.  
 
Comparing the images on the right hand column, it is evident that platelets attached 
upon 1 hour of incubation, readily exhibit αIIbβ3 activation than when compared with 
P-selectin, and P-selectin activation only occurs in platelets that present activated 
αIIbβ3 receptors. This not only proves the significance of activated αIIbβ3 in P-selectin 
activation but also reinforces the role of P-selectin as an late stage activation marker. 
It was also interesting to note that activation of P-selectin was not dependent on the 
level of αIIbβ3 activation or platelet spreading. The presence of P-selectin was not 
limited to spread platelets, but also ones that retained their rounded morphology. 
Further, activated P-selectin was detected on platelets exhibiting high intensities of 
αIIbβ3 as well as lower intensities, suggesting that P-selectin activation is dependent 
although not limited to the level of αIIbβ3 activation.     
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6.2.2.2.3 P-selectin and αIIbβ3 Activation on Nano-patterned Surfaces 
 
The distribution of activated P-selectin and αIIbβ3 membrane receptors on surface 
bound platelets was visualised by dual labelling the integrins with RPE conjugated 
antibody specific for P-selectin (CD62P) and FITC conjugated secondary antibody 
specific to ReoPro bound αIIbβ3. Platelets were incubated on bare and protein pre-
coated nano-patterned surfaces. The results shown in Figure 6.16, Figure 6.18 and 
Figure 6.19 correspond to activation of platelets on albumin, fibrinogen and diluted 
plasma (ratio 1:10, in DPBS) pre-coated substrates, respectively. These results were 
compared with platelet activation on silicon, TiO2 a-C:H and ta-C substrates devoid 
of proteins, as shown in Figure 6.17.  
 
A greater level of P-selectin and αIIbβ3 activation was exhibited on nano-patterned 
surfaces than on flat surfaces. This was especially evident on albumin pre-coated 
surfaces (Figure 6.16), where higher concentrations of αIIbβ3 activated platelets 
presented P-selectin activation. Silicon surfaces supported higher levels of p-selectin 
activation while TiO2 surfaces showed increased αIIbβ3 activation. A-C:H surfaces 
presented lower levels of both markers, followed by ta-C. Further, it appears that 
while αIIbβ3 is highly aggregated in the central region of a spread platelet, P-selectin 
integrins are localised in such a way they not only appear as aggregates in the centre 
abut also form the outer pheripheral ring of a platelet, as indicated by the white 
arrows on silicon, a-C:H and ta-C of Figure 6.16.  
 
Figure 6.17 to 6.19 show platelet activation on bare, fibrinogen and diluted plasma 
(ratio 1:10, in DPBS) pre-coated surfaces, respectively. As can be seen, the level of 
P-selectin activation remains relatively the same on all four substrates on fibrinogen 
pre-coated and bare surfaces, except for ta-C bare surfaces which present lower 
concentrations of activated cells. Plasma pre-coated surfaces however display 
significantly lower levels of P-selectin activation, similar to plasma-pre-coated flat 
surfaces, suggesting that while nano-patterns increase P-selectin activation, plasma 
proteins interact to counteract the effect and restore activation levels of the flat 
surfaces.  
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Figure 6.16 Fluorescence microscopy images showing membrane distribution of activated P-selectin (left, red-RPE conjugated anti-CD62 P-
selectin) and αIIbβ3 integrins (middle, green-FITC conjugated antibody to Reopro bound αIIbβ3 receptor)on platelets attached to albumin pre-
coated silicon, TiO2, a-C:H and ta-C nano-patterned surfaces. Samples were imaged at 500x zoom using Zeiss Axioskop microscope. 
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Figure 6.17 Fluorescence microscopy images showing membrane distribution of activated P-selectin (left, red-RPE conjugated anti-CD62 P-
selectin) and αIIbβ3 integrins (middle, green-FITC conjugated antibody to Reopro bound αIIbβ3 receptor)on platelets attached to bare silicon, 
TiO2, a-C:H and ta-C nano-patterned surfaces. Samples were imaged at 500x zoom using Zeiss Axioskop microscope. 
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Figure 6.18 Fluorescence microscopy images showing membrane distribution of activated P-selectin (left, red-RPE conjugated anti-CD62 P-
selectin) and αIIbβ3 integrins (middle, green-FITC conjugated antibody to Reopro bound αIIbβ3 receptor)on platelets attached to fibrinogen 
pre-coated silicon, TiO2, a-C:H and ta-C nano-patterned surfaces. Samples were imaged at 500x zoom using Zeiss Axioskop microscope. 
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Figure 6.19 Fluorescence microscopy images showing membrane distribution of activated P-selectin (left, red-RPE conjugated anti-CD62 P-
selectin) and αIIbβ3 integrins (middle, green-FITC conjugated antibody to Reopro bound αIIbβ3 receptor)on platelets attached to plasma coated 
silicon, TiO2, a-C:H and ta-C nano-patterned surfaces. Samples were imaged at 500x zoom using Zeiss Axioskop microscope.
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The level of αIIbβ3 activation on fibrinogen coated and bare nano-patterned substrates 
was significantly greater than the corresponding flat surfaces. This may be due to 
increased platelet spreading. A-C:H and ta-C bare surfaces showed decreased levels 
of platelet activation when compared with silicon and titania, while TiO2 and a-C:H 
fibrinogen pre-coated surfaces showed decreased activation when compared with 
silicon and ta-C substrates. Although it was difficult to discern between the test 
substrates, the level of activation on plasma proteins was substantially lower, 
suggesting that either; these surfaces preferentially adsorb proteins not involved in 
activation, and/or, the conformation of proteins are altered after adsorbing on these 
surfaces such that they limit platelet activation. Again, this reinforces the overall 
favourable interaction between plasma proteins and nano-patterned surfaces limiting 
the overall αIIbβ3 activation.  
 
 
6.2.2.3 Flow Cytometry 
 
Activation of unattached platelets in response to exposure to silicon, TiO2, a-C:H and 
ta-C surfaces, and, serum proteins including albumin, fibrinogen and diluted plasma, 
was evaluated after exposing the platelet suspension to fluorescently tagged 
antibodies specific to activated αIIbβ3 and P-selectin expression and measured using a 
flow cytometer.  
 
The one parameter histograms showing cellular fluorescent intensities as fold 
increase using the FL-1 channel (Figure 6.20) was used to determine the presence of 
activated αIIbβ3 receptors. Reopro antibody was used to probe for activated αIIbβ3 
integrins and detected using an anti-human antibody conjugated with FITC. Bare 
silicon and plasma pre-coated ta-C, showed decreased activated αIIbβ3 in solution. 
While a difference in receptor activation was observed on some bare and plasma 
substrates, no appreciable difference were detected between flat substrates and 
control TCPS pre-coated with albumin and fibrinogen. The nano-patterned surfaces 
showed the same level of activation between protein pre-coated surfaces as well as 
surface chemistry. Further, the fluorescent levels on the nano-patterned surfaces were 
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similar to that of the flat surfaces, suggesting that varying the underlying nano-
topography of the surface had no effect on αIIbβ3 activation in solution for non-
adherent platelets. Figure 6.21 shows P-selectin exposure on platelets from solution. 
Apart from plasma pre-coated ta-C, which showed a decrease in P-selectin 
expression, activation levels followed a similar trend to αIIbβ3, where they did not 
vary between surfaces, protein pre-coated surfaces and nano-topography. 
 
Overall, it is evident that the above mentioned surface chemistries, nano-topography 
and adsorbed proteins do not markedly mediate ligand or integrin conformation in 
solution but rather exerts its influence upon surface contact (as shown in 
Section6.2.2.1 and 6.2.2.2), in vitro.  
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Figure 6.20 Flow cytometric analysis of αIIbβ3 expression on platelet membranes on 
flat and nano-patterned Si, TiO2, a-C:H and Ta-C surfaces either devoid of proteins 
(DPBS), or, in the presence of proteins including albumin (BSA), fibrinogen (Fg), or 
diluted plasma (ratio 1:10, in DPBS). The results from the flat surfaces were 
compared with control TCPS. The profiles are representative of three experiments 
for each condition. 
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Figure 6.21 Flow cytometric analysis of P-selectin (CD62P) expression on platelet 
membranes on flat and nano-patterned Si, TiO2, a-C:H and Ta-C surfaces either 
devoid of proteins (DPBS), or, in the presence of proteins including albumin (BSA), 
fibrinogen (Fg), or diluted plasma (ratio 1:10, in DPBS). The results from the flat 
surfaces were compared with control TCPS. The profiles are representative of three 
experiments for each condition. 
 
 
6.3 Summary 
 
The time taken for the polymerisation of fibrin monomers into fibrin clots on the test 
substrates was delayed when the test surfaces were pre-exposed to plasma proteins. 
A-C:H has shown the longest delay, especially when the plasma proteins were 
diluted with higher concentrations of heparin. The intrinsic and common pathways 
have been proven accountable for this response. Intrinsic factors are readily 
influenced by biomaterial surfaces; causing the inhibition of their function. The 
samples also impede the conversion of fibrinogen to fibrin, by denaturing the protein 
and consequently temporarily retarding the clotting process. 
 
The level of platelet activation was reduced on plasma pre-coated surfaces. Plasma 
proteins, other than fibrinogen, not only reduce the overall exposure of the bare 
surfaces but also reduce the binding of fibrinogen to the surface either by; steric 
hindrance or by reducing the overall exposure of adsorbed fibrinogen to circulating 
platelets in order to decrease αIIbβ3 mediated platelet activation. This was especially 
evident on a-C:H and ta-C substrates. There was no activated α2β1 receptors detected 
on bare and protein-pre-coated flat substrates. P-selectin activation was not 
dependent on the chemistry of the bare surfaces, but rather dependent on whether the 
platelets exhibit activated αIIbβ3 receptors. The level of activation between the various 
materials was dependent on concentration of adsorbed platelets and their respective 
morphology. Not all platelets with a rounded morphology displayed detectable levels 
of activation while spread platelets presented activated receptors at varying 
concentrations. 
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Nano-patterned surfaces exhibited increased activated P-selectin and αIIbβ3 integrins 
and again, a favourable interaction between plasma proteins and patterned surfaces 
reduced the overall activation levels of the bare and fibrinogen pre-coated substrates. 
Although it was difficult to discern between the various surface chemistries, it was 
clearly evident that nano-patterns decreased the overall haemocompatibility of a 
given biomaterial surface.  
 
While platelet activation studies using ELISA and fluorescence microscopy show 
surface chemistry, nano-topography and adsorbed proteins mediate ligand or integrin 
conformation on surface adsorbed platelets; flow cytometry experiments indicated 
platelets suspended in solution remain uninfluenced by varying chemical and 
physical properties of a-C:H, ta-C and titania thin films.  
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7 OVERALL DISCUSSION 
Driven by the increasing economic and social burden associated with thrombus 
development on blood-contacting medical devices, and despite over half a century of 
progress in understanding the interactions at play at the blood-biomaterial interface 
[5, 219, 220], the level of knowledge required to design and develop 
haemocompatible materials has not yet been attained. In fact, Ratner has stated that a 
truly blood compatible surface is still yet to be produced after 60 years of research 
into haemocompatibility and numerous approaches to solving the blood-biomaterial 
dilemma [5].  
 
The haemocompatibility of a material is essentially the tolerance of blood to the 
surface of blood contacting devices and is of great importance as blood is the first 
bodily fluid that contacts artificial surfaces. Blood is in contact with artificial 
surfaces during many modern health care treatment and diagnostic procedures such 
as: venous catheters, stents, vena cava filters, vascular grafts, LVAD’s and prosthetic 
heart valve implants, cardiopulmonary bypass, dialysis, and blood transfusions and 
even when blood is drawn for commonly run blood tests. Approaches such as surface 
coating and surface modification have been recently undertaken in an effort to 
improve blood compatibility. Modification of the biomaterial surface to minimise the 
overall blood-biomaterial interactions (by chemically modifying the surface of the 
biomaterial with anti-coagulant and anti-thrombotic drugs or seeding with 
endothelial cells) are still far from perfect. Such surface modifications are not 
economically viable; rather, they require complex experimental procedures and are 
likely to endure potential regulatory-approval complications downstream [439, 492]. 
Further, these surfaces require long term stability from delamination under shear 
stress. Modulating the surfaces with endothelial cells can be beneficial as it mimics 
the inner surface of blood vessel walls, however the adhesion and proliferation of 
endothelial cells on implant surfaces is a complicated task and occurs only with a 
long turn over time, therefore rending this option unviable during emergency 
situations requiring immediate implantation. Surface coatings such as inorganic 
coatings (carbon based) [493] or passivating the surface by forming covalently linked 
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oxidised surface adlayer [331] are also options, but the interaction between blood and 
biomaterial surfaces is multi-staged and complex - it is an interlinked process 
involving protein adsorption, platelet adhesion and activation, involving several 
factors including surface chemical composition, charge, flexibility, wettability and 
conditions of blood flow [494-497] – and the exact mechanism of selective 
adsorption of plasma proteins and the adhesion, spreading and activation of platelets 
at the blood-biomaterial interface still remains unknown. 
 
Therefore, this study investigated the influence of surface chemistry, nano-roughness 
and adsorption of specific plasma proteins on human platelet interactions. The 
impact of surface chemistry was tested by changing the biomaterial thin film coating 
applied, while the surface nano-topography was altered by engineering pseudo-
regular surface nano-patterns. Surface engineering was carried out on silicon wafers 
as these substrates presented an ultra-flat surface with topographical features, if any, 
only in the sub-nano-meter range. Further, the influence of plasma proteins was 
evaluated by allowing specific adsorption of albumin and fibrinogen as well as 
plasma on the surface engineered biomaterial surfaces. The results were then 
compared with surfaces devoid of proteins.  
 
 
7.1 Influence of Surface Chemistry on Plasma Protein Adsorption 
and Coagulation Cascade Activation 
 
Blood plasma is mainly constituted of proteins and so far over 300 different proteins 
have been documented. These proteins have contained plasma concentrations 
ranging from 35-50 mg/mL for serum albumin to only 0-5 pg/mL for interleukin 6 
[179]. In the process of developing new haemocompatible materials, hundreds of 
surface coatings and bulk materials have been evaluated with regard to their 
interactions with proteins such as fibrinogen, fibronectin, von Willebrand factor, and 
albumin etc; although overall plasma protein compatibility has been assessed less 
often. Protein adsorption from plasma is far more complicated than from a single 
protein solution [498]. Blood plasma is a multi-protein solution, which is 
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concentrated with various proteins at varying concentrations. Adsorption is regarded 
as a selective and competitive process with adsorbed proteins not always bound 
indefinitely to the surface. The composition of adsorbed proteins is subject to change 
over time in a phenomenon known as the Vroman effect [184]. This phenomenon 
covers a monolayer on the surface with a thickness of 2-10 nm [185]. Surfaces 
resistant to protein adsorption, as found with non-fouling surfaces, have generally 
been evaluated from experiments involving single-protein solutions. Such surfaces 
may not necessarily present a similarly high efficiency in resisting protein adsorption 
from plasma [498]. When fibrinogen and albumin were in a solution by themselves, 
ultra-flat test substrates with surface roughness in the sub-nano-meter range, have 
been shown to exhibit a higher affinity to albumin than fibrinogen.  
 
Biomaterial substrates used in this study include: flat (un-patterned) silicon wafers 
coated with either a-C:H (hydrogenated amorphous carbon) and ta-C (tetrahedral 
amorphous carbon) diamond like carbon or crystalline TiO2 (titania). 
 
Commercially used a-C:H and ta-C diamond like carbon (DLC) coatings were 
studied as these materials have exhibited excellent biocompatible, haemocompatible, 
anti-thrombogenic and non-cytotoxic  properties, when compared with pyrolytic 
carbon, stainless steel and polyurethane [315, 499]. DLC is a hydrophobic material 
with reported surface energies ranging between 40-54mNm-1 and contact angles 
between 55-70º [304, 305, 500-502]. As a surface coating, DLC has been proven to 
be wear resistant, chemically inert and low friction, reducing the surface energy of 
the underlying biomaterial by reducing the number of free bonds which are known to 
cost energy [270].  
 
TiO2 coatings were studied in this project as opposed to the titanium surfaces which 
are commercially used in the biomedical industry because TiO2 has shown better 
haemocompatibility than the bulk titanium. Titanium and its alloys are highly 
regarded and often used  due to the excellent corrosion resistive properties of the 
native oxide layer formed on the bulk material [329-331]. The native oxide layer 
primarily consists of amorphous titanium dioxide (TiO2) [333-336]. This protective 
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and highly stable, passive film is, in effect, the surface that will interact with the in 
vivo environment and is therefore of huge importance when considering cell-surface 
interactions. A study conducted by Sunny et al. [344] found the ratio of adsorbed 
albumin to fibrinogen (albumin/fibrinogen ratio) increased 7 fold when the thickness 
of the coated TiO2 layer increased by 180nm. Furthermore, the adsorption of serum 
proteins on TiO2 substrates were found to occur through calcium binding sites in a  
similar manner to the adhesion of hydroxyapatite crystals [369]. Another study 
conducted by Smith et al. [503] found a decrease in overall thrombogenic effects of 
TiO2 nano-tube arrays when compared with biomedical grade titanium after 2 hours 
of contact with whole blood plasma. While the native oxide layer has increased the 
overall corrosion resistance of the biomaterial, the oxide layer formed is only a few 
nanometres thick, failing to prevent the  leaching of titanium ions and allowing the 
diffusion of oxygen ions into adjacent tissues, in vivo [504, 505]. As such, there is a 
growing interest in the development of thicker TiO2 coatings for biological 
applications. The TiO2 coated substrates studied in this project were deposited using 
filtered arc deposition and the surface energy and contact angle values of the 
hydrophilic substrates were previously reported to be 50J/m2 and 70º, respectively, 
by Randeniya et al. [501] and Ismail et al. [500].  
 
So far, the haemocompatibility of a biomaterial has been dictated by the ratio of 
adsorbed albumin and fibrinogen. A high ratio of albumin to fibrinogen proteins 
adsorbed on an implant can be correlated with a low number of adhering platelets, 
and therefore with low tendency of thrombus formation. A study conducted by 
Weber et al. [197] showed that fibrinogen, even at less than physiological 
concentrations, can sufficiently initiate full-scale platelet activation. However, other 
plasma proteins such as fibronectin, at ten times the physiological concentration of 
albumin, cannot mediate the same response [198].  In single protein solution studies, 
the albumin to fibrinogen ratio was approximately 1 for TiO2 and 1.1 for a-C:H 
surfaces. This can be compared to ta-C surfaces that exhibited a protein ratio greater 
than 3.5. The ratios obtained for both TiO2 and a-C:H were similar to the results 
obtained by Jones et al. [387] and Dion et al. [255]. However, when albumin was in a 
competitive solution with fibrinogen at physiological concentrations (ratio 10:1, 
albumin to fibrinogen), not only was there a decrease in adsorption of both proteins, 
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but albumin’s affinity to the test surfaces became less than that of fibrinogen. This 
was especially evident on ta-C and a-C:H surfaces, which displayed only a small 
decrease in fibrinogen adsorption but a significant drop in albumin adsorption, 
resulting in an overall decrease in albumin to fibrinogen ratio during competitive 
binding. Conversely, the ratio of albumin to fibrinogen adsorbed on TiO2 surfaces 
remained unaltered. This shows that the adsorption of selective proteins is implicitly 
linked to the surface chemistry of the biomaterial.  
 
Whilst the adsorption of albumin retards the adhesion and activation of platelets; the 
adsorption of fibrinogen, with a conformation that exhibits increased availability of 
its platelet binding domain, promotes platelet adhesion and activation. The level of 
platelet binding region presented on fibrinogen from single protein solutions was 
similar to the complex solution, notwithstanding, the concentration of adsorbed 
fibrinogen decreased in the presence of albumin.  Fibrinogen adsorbed on flat 
surfaces was shown to align flat against the surface, following side on and bent 
conformation. The conformation of fibrinogen on TiO2 was similar to the 
conformation suggested by Hemmersam and Foss [460] and Moseke et al [462] 
using QCM-D and ELISA. Conversely, plasma proteins formed a dense and highly 
viscous layer on the flat substrates when compared with the rigid albumin and 
fibrinogen protein coated surfaces.   
 
When comparing the kinetics of fibrinogen and plasma protein adsorption, it was 
evident that fibrinogen and other plasma proteins adsorbed more rapidly on a-C:H 
surfaces than TiO2 during the initial stages of protein adsorption. This indicated a 
higher binding affinity between the proteins and a-C:H. During the latter stages of 
adsorption however it was noticed that the rate of protein adhesion decreased to near 
zero while adsorbed mass continued to increase. This phenomenon suggested a 
dynamic interaction between the surface and fibrinogen and/or plasma proteins 
causing the rearrangement of the proteins upon adsorption. Furthermore, it was 
observed that the adsorbed fibrinogen may have denatured and formed a rigid dense 
layer on the surface with only a small fraction of incorporated water. This 
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assumption correlates with Moseke and Ewald’s [462] analysis of fibrinogen 
adsorption on TiO2 surfaces.  
 
The adsorption of the vastly overlooked apolipoprotein A1 proteins, other high 
molecular weight HDL’s [506, 507] and plasma proteins such as: fibronectin, von 
Willebrand factor, viteronectin, etc [116], may explain the drastically reduced 
availability of platelet binding domains exposed on fibrinogen proteins that are 
adsorbed from plasma. This implies a favourable interaction between plasma proteins 
and biomaterial surfaces in reducing the exposure of fibrinogen’s platelet binding 
domain for platelet αIIbβ3 receptor binding. The exposure of fibrinogen α-chain and γ-
chain was also affected by the presence of other plasma proteins as well as surface 
chemistry. This indicated that the denaturing of the fibrinogen protein on the 
adsorbed surfaces and its assumed conformation for platelet binding was typically 
dependent on a combination of surface chemistry, surface nano-topography and its 
interaction with other plasma proteins.  
 
Furthermore, the thrombin time (TT), prothrombin time (PT), and activated partial 
prothrombin time (APTT) maintain the anticoagulation mechanism, as found in 
physiology. They also regulate the plasma coagulation defects. Specifically, the 
APTT test governs how the biomaterial affects coagulation time while both PT and 
APTT tests account for the enzymatic activities which lead to clot formation. The 
measured anti-coagulant activity of the surfaces show that TiO2 and a-C:H and ta-C 
substrates behave favourably with plasma in delaying the time taken to form fibrin 
clots when compared with control TCPS. The intrinsic and common pathways have 
been proven accountable for this response. These factors are readily influenced by 
biomaterial surfaces causing the inhibition of their function. The samples also 
impede the conversion of fibrinogen to fibrin by denaturing the protein and 
temporarily retarding the clotting process. 
 
While previous studies have conducted similar tests with results corroborating with 
the APTT times found on a-C:H surfaces [319, 320, 327, 508], no one study has 
looked at the effect of surface chemistry of DLC and TiO2 in influencing clotting 
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times in the presence of anticoagulant therapies such as heparin. Heparin is an 
anticoagulant ('blood thinner') which works by decreasing the clotting ability of the 
blood through binding to anti-thrombin III. When serum plasma diluted with heparin 
was administered on the test substrates, as expected, their subsequent clotting times 
increased with increasing heparin concentrations. However, it was interesting to note 
that a-C:H surfaces delayed clot formation the longest when compared with TiO2 and 
ta-C. This suggests that surface chemistry of blood contacting devices can influence 
the functionality of heparin molecules in turn affecting their interaction with plasma 
proteins. 
 
 
7.2 Influence of Plasma Proteins on Platelet Interactions 
 
Although the studies mentioned above are considered to be important to evaluate the 
entire haemocompatibility of the test substrates, platelet adhesion may be considered 
to be the primary issue in the blood-biomaterial dilemma as it directly influences 
platelet-related coagulation and thrombosis. Platelet adhesion receptors recognise 
and bind to surface-adsorbed key adhesive proteins such as fibrinogen, and 
supporting proteins such as fibronectin, vitronectin, immunoglobulins and von 
Willebrand factor. This leads to the adhesion of circulating platelets onto biomaterial 
surfaces as well as its subsequent spreading and activation. As such, it was necessary 
to analyse the anti-platelet effects of surface chemistry and the adsorption of specific 
plasma proteins in this study.   
 
Prolonged exposure of platelets in blood to non-haemocompatible thrombogenic 
materials in vivo has showed that platelet numbers in blood decrease with surface 
exposure time. Lee et al. [496] showed platelets in plasma adhered in increasing 
numbers with decreasing wettability of surfaces. Since fibrinogen is known to 
preferentially adsorb on hydrophobic rather than hydrophilic surfaces, it could imply 
that platelet adhesion on hydrophobic surfaces is dictated by increasing 
concentrations of adsorbed fibrinogen.  
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Platelet adhesion and morphological changes, such as spreading and aggregation on 
the flat test substrates, varied drastically between the four protein conditions when 
compared with small differences found between the chemistries of the thin films 
deposited on the surfaces. This in understandable as TiO2, a-C:H and ta-C exhibit 
similar surface energies and hydrophobic tendencies. In general, albumin coated 
surfaces supported high levels of platelet adhesion with little platelet spreading, 
while fibrinogen pre-coated surfaces and surfaces devoid of proteins supported high 
levels of platelet spreading. This shows that platelet adhesion and subsequent 
spreading is not only depend on ligand mediated platelet interactions but also 
because of non-specific activation of platelet adhesive receptors on biomaterial 
surfaces. Platelets that showed no spreading either retained their rounded 
morphology without any actin-rich pseudopodia protruding radially from the platelet 
membrane, or, presented platelets with radial protrusions enclosing non-filamentous 
actin.  
 
The kinetics of platelet adhesion studied by Yayapour et al. [509] shows that 
platelets adsorb rapidly within the first few seconds of incubation on hydrophobic 
surfaces. This is in comparison to the time taken to adhere on hydrophilic surfaces 
(more than 30 seconds). Considering the intrinsic nature of circulating platelets in 
blood this is not surprising given that the main role of platelets is to rapidly adhere 
and aggregate at the site of blood vessel injury. In this study, platelets on bare 
surfaces were shown to rapidly adhere within the first few seconds of incubation 
followed by a slow decline in the rate of platelet adhesion before saturation. This 
reinforces the hydrophobic nature of the test substrates. Furthermore, the adsorbed 
platelets were found to change in morphology from their rounded state to a spread 
state during the last stages of incubation.  
 
Spread platelets have been shown to contain actin-rich, stellate shaped filopodia. The 
degree of platelet spreading on plasma pre-coated TiO2 surfaces was reported to be 
higher than on plasma coated a-C:H substrates, even though QCM-D data showed a-
C:H surfaces supported higher concentrations than TiO2. Nan et al [267] was able to 
show that TiO2 surfaces performed better than pyrolytic carbon (a biomaterial 
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commonly used in heart valves) when exposed to plasma containing both plasma 
proteins and platelets. Platelets exposed to plasma surfaces showed very little 
spreading when compared with albumin, bare and fibrinogen pre-coated surfaces, yet 
these platelets presented increased levels of platelet-platelet intercommunication than 
fibrinogen surfaces (identified by the over-reaching of filopodia between adjacent 
platelets).  
 
Though albumin proteins reduced the levels of platelet spreading found on bare 
surfaces, it did not limit platelet adhesion. Albumin is known to be the most 
abundantly available plasma protein and is often used to passivate biomaterials from 
platelet interaction due to its anti-thrombotic characteristics. This is because albumin 
proteins lack any known amino acid sequences necessary for binding platelet 
adhesive receptors. However, once adsorbed on artificial surfaces, albumin has been 
proven to undergo conformational change and unfold at the surface interface. When 
the degree of unfolding of albumin proteins exceeded a 34% loss in its α-helical 
structure, surface adsorbed albumin proteins were found to adhere to Arg-Gly-Asp 
(RGD) specific platelet receptors (αIIbβ3 integrins) [510, 511]. Furthermore, platelet 
adhesion response was shown to increase with further unfolding of albumin just as 
strongly as that which was observed for adsorbed fibrinogen. Sivaraman and 
colleagues [510, 511] further found that it is the exposed Arg residue in the unfolded 
protein that plays a prominent role in mediating platelet adhesion to albumin 
proteins. Therefore, high levels of platelet adhesion on bare and albumin coated 
surfaces found in this study, suggest that platelet adhesion on biomaterial surfaces is 
not only dependent on non-specific interactions between platelet receptors and bare 
and albumin coated biomaterial surfaces, but may also be influenced by RGD 
specific platelet receptor-albumin interactions. 
 
Pre-coating the surfaces with fibrinogen and plasma proteins have been shown to 
reduce the level of platelet adhesion as compared to platelets exposed to surfaces 
devoid of proteins. This suggests a favourable interaction between serum proteins 
including fibrinogen, platelets and biomaterial surfaces in reducing platelet adhesion. 
Furthermore, TiO2, a-C:H and ta-C surfaces were shown to support the least number 
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of adhered round and spread platelets when compared with control silicon substrates, 
on fibrinogen and plasma coated surfaces. Platelets formed focal contacts with 
fibrinogen pre-coated TiO2 and a-C:H surfaces throughout the incubation period 
where the number of focal contacts formed on a-C:H surfaces was less than that of 
TiO2. This suggests that platelets adhered on fibrinogen coated a-C:H surfaces form 
weaker attachments than on the other surfaces.  
 
TiO2 surfaces exhibited greater levels of platelet spreading than a-C:H surfaces in the 
presence of plasma proteins, although the amount of focal contacts formed by 
platelets on plasma coated surfaces were less than fibrinogen coated surfaces. When 
an in vivo investigation involving the implantation of pyrolytic carbon and TiO2 
coated pyrolytic carbon into the ventral aorta of a dog (for the duration of two weeks) 
was conducted by Zhang et al. [512], the results showed that the amount of thrombus 
on TiO2 coated valve was only 1/8 compared to that of pyrolytic carbon. This 
suggests that though spreading was evident on all plasma coated substrates, the level 
of adhesion and spreading is significantly lower than what is available commercially. 
Furthermore, when compared with TiO2, a-C:H and ta-C surfaces, exhibited higher 
levels of platelet binding region exposure from fibrinogen adsorbed from plasma. 
However, both plasma coated a-C:H and ta-C displayed reduced levels of platelet 
binding and spreading than plasma coated TiO2. This suggests a higher level of 
adsorption of denatured albumin and von Willebrand factor, fibronectin, and other 
plasma proteins on TiO2 substrates mitigating platelet adhesion. Therefore, it is 
sufficient to conclude that a-C:H and ta-C surfaces are more haemocompatible than 
TiO2 substrates, although the delamination of ta-C coating over time can be a limiting 
factor on using ta-C coated substrates in cardiovascular implantation. A-C:H’s 
excellent haemocompatibility when exposed to plasma proteins and platelets was 
also exhibited in studies conducted by Jones et al. [387]. 
 
Platelet activation studies conducted in this project show that plasma proteins interact 
favourably with test substrates, especially a-C:H and ta-C when compared with TiO2. 
This was shown to reduce the overall bare surface exposure and reduce fibrinogen 
adsorption either by steric hindrance or by reducing the overall exposure of adsorbed 
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fibrinogen to circulating platelets in order to decrease αIIbβ3 mediated platelet 
activation. There were no activated α2β1 receptors detected on bare and protein-pre-
coated flat substrates. Leistikow et al [513] revealed that the αIIbβ3 integrin moves 
from the platelet membrane surface towards the outer cytoplasm in the activation 
process using cross-sectional images of platelets that adhered to formvar-coated 
grids. The αIIbβ3 integrin found on the protein pre-coated and bare substrates 
appeared more pronounced in the central region of the spread platelets where little 
actin filaments were detected. This suggests that the expression of activated αIIbβ3  
integrins upon contacting the protein coated surface may occur more centrally before 
distributing to the periphery. P-selectin activation was not dependent on the 
chemistry of the bare surfaces, but rather dependent on whether the platelets exhibit 
activated αIIbβ3 receptors.  
 
The level of activation between the various materials was dependent on 
concentration of adsorbed platelets and their respective morphology. Not all platelets 
with a rounded morphology displayed detectable levels of activation while spread 
platelets presented activated receptors at varying concentrations. A study conducted 
by Gutensohn et al [383] (using platelet-rich-plasma in a dynamic flow condition) 
revealed that the fluorescence intensity of the activation-dependent antigens P-
selectin (CD62P) showed higher levels in non-coated 316L stainless steel than DLC-
coated stents. Since 316L stainless steel is a commonly used cardiovascular material, 
a lower level of platelet activation detected on a-CH is indicative of a more 
haemocompatible material. Though a similar level of activation was detected on 
plasma pre-coated TiO2, a-C:H and ta-C surfaces, it can be concluded that all three 
substrates possess good haemocompatibility. Furthermore, while it is evident that 
under static conditions surface chemistry and adsorbed proteins mediate ligand or 
integrin conformation on surface adsorbed platelets, they do not exhibit any 
influence on platelets suspended in solution.  
 
Anti-αIIbβ3 integrin antibody (Reopro) treated platelets decreased the overall levels of 
platelet adhesion and spreading on flat test substrates and substrates exposed to 
albumin, fibrinogen and plasma proteins. This suggests the important role of αIIbβ3 
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integrins in platelet adhesion and spreading on all four conditions. Fibrinogen and 
plasma surfaces supported the lowest concentrations of Reopro-exposed platelets. 
The adhered platelets displayed rounded morphologies with limited filopodial 
extensions. While the concentrations of adhered platelets were lower in the presence 
of the anti-integrin antibody it did not completely inhibit binding. This indicated that 
platelet adhesion is dependent on both αIIbβ3 ligand-dependent as well as non-specific 
interaction between platelet receptors and biomaterial surfaces. Albumin and bare 
surfaces also showed reduced platelet adhesion which implies that αIIbβ3 platelet 
integrins are susceptible to non-ligand specific activation and consequent binding of 
its receptors to the biomaterial surfaces and albumin proteins. A-C:H and ta-C 
surfaces continually supported decreased levels of anti- αIIbβ3 integrin treated 
platelets on all protein pre-coated and bare surfaces. However, a-C:H surfaces 
showed higher levels of platelet spreading similar to TiO2 surfaces on albumin and 
fibrinogen coated surfaces. Further, it was interesting to note that the fibrinogen pre-
coated substrates supported similar levels of αIIbβ3 activation even though a higher 
concentration of fibrinogen with increased exposure of its platelet binding domain 
was evident on fibrinogen adsorbed on a-C:H. It appears that even smaller amounts 
of adsorbed fibrinogen with less exposure of its platelet binding domain, as found on 
fibrinogen pre-coated TiO2 and silicon, can mediate similar levels of platelet αIIbβ3 
receptor activation. This could suggest that while the presence fibrinogen dictates 
αIIbβ3 activation, its relative concentration on the surface may not necessarily be a an 
indicator of αIIbβ3 mediated platelet activation levels. Other factors such as surface 
chemistry might be a contributing factor. This reinforces the influence of surface 
chemistry as well as specific plasma proteins in affecting αIIbβ3 ligand activation for 
platelet-surface binding.  
 
 
7.3 Influence of Surface Nano-topography on Protein Adsorption 
and Platelet Interactions 
 
One of the goals of this study was to substantiate, with experimental evidence, the 
case for introducing nano-scale topographical changes to commercially used DLC 
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and TiO2 surface coatings in an effort to improve the haemocompatibility of currently 
used biomaterials. Many studies have assessed the biocompatibility and 
haemocompatibility of DLC and TiO2 surfaces however there is limited knowledge 
and study on presenting the effects of defined nano-topography of such surface 
coatings and their effect on protein adsorption and platelet interactions. As such it 
was necessary to investigate the influence of surface nano-topography on protein 
adsorption and platelet interactions.   
 
Nano-structures are fabricated on the silicon substrates with two or more polymers 
using the block co-polymer method. Through phase separation the polymers tend to 
organise themselves into laterally ordered, periodic arrays of self-assembled features 
in the order of 3-50nm [514-516]. The original block co-polymers are etched away 
after the films are exposed to metal salts, resulting in a pattern of metal nano-
structures on the surface replicating the pattern of the phase-separated block co-
polymer features. The size of the particles, its relative pitch, and regularity of the 
organised nano-arrays, are determined by block lengths within the block co-polymer 
as well as a suitable energy source. Under the right conditions this can cause the 
block co-polymer film to heat and arrange themselves into organised domains [435, 
436]. By varying the polymers, many different arrangements involving changes in 
nano-particle size, shape and pitch between adjacent particles can be achieved on the 
substrate surface. The directed self-assembly (DSA) of block co-copolymers offer 
several advantages over the commercially used nano-lithographic techniques. These 
advantages include precision of nano-scale patterning, ultrafine line edge roughness 
(LER), dense area of packing of nano-domains, low cost of processing, and large 
area scalable nano-patterning [517]. Furthermore, block co-polymer is a reproducible 
method for producing high quantities of pseudo-identical substrates of larger surface 
areas.  
 
In this study, nano-patterns were formed on ultra-flat silicon wafers using gold (Au) 
nano-particles on polystyrene and polyvinylpyridine (PVP) block co-polymer film. 
The flat substrates were then coated with either a-C:H (hydrogenated amorphous 
carbon) and ta-C (tetrahedral amorphous carbon) diamond like carbon or crystalline 
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TiO2 (titania). The nano-roughness (RMS) of the block co-polymer modified flat 
substrates were measured to be in the 5-10nm scale. 
 
The hydrophilic or hydrophobic nature of a surface, also known as surface 
wettability, is identified by the static contact angle formed between a water droplet 
and the substrate surface. A hydrophilic surface is one that embodies a contact angle 
value less than 65ºand a hydrophobic surface exhibits a contact angle greater than 
65º. Surfaces with contact angle between 65-90º are considered to be intermediate 
hydrophobic surfaces [518-520]. Increasing the surface roughness of the surface has 
been shown to enhance the hydrophobic nature of the surface and decrease its surface 
energy [521-524].  
 
Curtis et al. [443] suggested an increase in the van der Waals interaction caused by 
the closely packed nano-structures prevents the wetting of surfaces and consequently 
increases the overall hydrophobic characteristics of nano-patterned surfaces. Higher 
adsorption of fibrinogen protein is thought to have been influenced by hydrophobic 
surfaces [387]. However, an increase in surface hydrophillicity has been known to 
elevate albumin adsorption. As such, changing surface nano-roughness has been 
shown to increase fibrinogen and other plasma protein adsorption, consequently 
increasing human platelet adhesion. This is synonymous to the results found in this 
study, where changing the surface nano-topography by adding nano-patterns that 
increased the overall surface roughness of the test substrates to 5-10nm caused an 
increase in the adsorption of fibrinogen and plasma proteins.  
 
Previous studies [525-527] have shown that although highly hydrophobic surfaces 
initially promote the adsorption of large amounts of proteins due to hydrophobic 
interaction, they nevertheless become easily desorbed because of low surface energy. 
This was not found to be the case on nano-patterned surfaces. The proteins were 
found to form multiple layers, saturating in the grooves between the peaks formed by 
the nano-patterns. While it was evident that the morphology of adsorbed proteins 
were not confined to a particular conformation, the tri-nodular structure of fibrinogen 
was retained. Once adsorbed on nano-patterned surfaces, fibrinogen predominantly 
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aligned itself against the slope of the nano-patterns decreasing the overall surface 
roughness. Even after several washes the majority of the proteins did not desorb off 
the surface suggesting that nano-patterns act as topographical cues for protein 
adsorption. Furthermore, fibrinogen proteins adsorbed on nano-patterned surfaces 
presented increased levels of platelet binding domains, where a-C:H and ta-C 
exhibited the highest % increase when compared with TiO2.  
 
The two ideal responses from platelets upon interacting with biomaterial surfaces are 
either, the formation of a passivating film of platelets or total non-adherence of 
platelets (such that platelets remain in their non-activated state) [528, 529]. Ratner et 
al. [529] have shown platelets to initially adhere and activate when forming a 
passivating layer, and only spread to form a thin stable layer on the biomaterial 
surface afterwards. However, the continual adherence of platelets tend to form an 
unstable covering which over time breaks off into emboli. This leads to tissue and 
organ failure and ultimately death [528, 529]. As such, quantification of adhered 
platelet numbers, their morphology and the degree of surface coverage by platelets 
on the biomaterial was necessary. Normal platelets exposed on nano-patterned 
surfaces exhibited high concentrations of adhesion as well as extensive levels of 
spreading. Platelets formed multi-level stacked aggregates on the surfaces when 
compared with the flat surfaces suggesting that the nano-patterns behaved as 
topographical cues acting as potential tethering sites for platelet integrin adhesion. 
The dendritic network of actin cytoskeleton in the cytoplasm of platelets adhered on 
nano-patterned surfaces appeared more pronounced. TiO2 surfaces presented higher 
levels of platelet adhesion and spreading on all protein pre-coated and bare 
conditions. The exception to this was on plasma pre-coated surfaces where a-C:H 
and ta-C surfaces supported higher platelet concentrations. On nano-patterned 
surfaces, both fibrinogen and plasma proteins were found to enhance platelet 
adhesion and its spreading, while this was not the case on flat substrates. However, 
Smith et al. [503] was able to show improved blood-compatibility of TiO2 due to 
nano-tube array surface patterning after incubating the samples in blood plasma for 
over two hours. He identified that the nano-architecture of the nano-tube arrays was 
the key in potentiating an optimal interface for promoting non-thrombogenic 
response. From the multi-layering of platelets, as found in the in-vitro experiments 
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performed in this study, it can be inferred that within the time scale examined 
platelets do form an unstable covering on the block co-polymer modified substrates.  
 
With respect to platelet activation, platelets attached on nano-patterned surfaces 
exhibited increased levels of activated P-selectin and αIIbβ3 integrins, while platelets 
suspended in solution did not exhibit changes in P-selectin and αIIbβ3 integrin 
activation when compared with flat substrates. The level of platelet activation was 
lower on plasma coated nano-patterned surfaces than fibrinogen pre-coated and bare 
nano-patterned surfaces. This suggested a favourable interaction between plasma 
proteins and nano-patterned surfaces in reducing the overall activation levels of the 
bare and fibrinogen pre-coated substrates. While surface chemistry played a 
dominant role on platelet adhesion and activation on the flat surfaces, it was difficult 
to discern the levels of platelet activation between the various surface chemistries of 
the nano-patterned surfaces. This suggested that nano-features are able to overcome 
chemical influence. A similar notion was reported by Koh et al. [530] where the level 
of platelet interaction was severely altered in the presence nano-pillars when 
compared with their unstructured substrates, even though the difference in platelet 
response between the nano-patterned substrates did not vary. Hence, tailoring 
substrate surfaces with suitable nano-topographical features in addition to specific 
surface chemistry can remarkably influence the overall platelet response. As with 
changing the surface nano-roughness by 5-10nm and pitch between 50-150nm, it was 
evident that nano-patterns decreased the overall haemocompatibility of a given 
biomaterial surface by increasing the availability of platelet binding domain on 
fibrinogen adsorbed on the surface, and enhancing the adhesion, spreading and 
overall surface activation of platelets. Though previous studies have been able to 
demonstrate a decrease in platelet adhesion and its subsequent activation by 
introducing nano-patterns on the surfaces, it has become more evident over the last 
few years that structures of 200-800nm height/depth, 100-200nm width and 
interspacing less than 200nm [530, 531] have been shown to reduce platelet adhesion 
and subsequent activation in vitro. This is despite its ability under shear flow that still 
remains unknown. Further, the nano-topography presented in this study may show 
increased levels of platelet adhesion under static mode, however, in the presence of 
shear flow the blood platelets might respond differently. 
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Therefore, to deepen the overall understanding of the haemocompatibility of a 
biomaterial, in an effort to be able to design and develop biomaterials with improved 
haemocompatibilities, this study was able to show the significance of surface 
chemistry, surface nano-topography and adsorption of specific plasma proteins in 
modulating platelet response on biomaterial surfaces. Modifying one aspect alone is 
insufficient, as each factor is dependent on another and it is the dynamic interplay 
between topographical, chemical and biological cues that can aid in the minimisation 
of the adhesion and activation of platelets for thrombus clot development.   
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8 CONCLUSIONS 
 
The future success of fabricating a truly haemocompatible biomaterial implicitly 
depends on understanding the mechanisms involved within the dynamic interactions 
between platelets, plasma proteins and biomaterial surfaces. In this study, the 
influence of different surfaces chemistries and nano-topographies on protein 
adsorption and conformation as well as the resulting platelet responses was 
investigated in vitro. From each of these studies the hypothesis that surfaces 
modulate protein-surface, platelet-surface and platelet-protein-surface interactions 
has been demonstrated through numerous conclusions, which have been listed below: 
 
 Surfaces only exhibit a high affinity for albumin, when albumin is in a 
solution by itself. At physiological ratio’s, surfaces present a higher binding 
affinity for fibrinogen when compared with albumin. When binding 
competitively, DLC (a-C:H and ta-C) surfaces presented severely reduced 
albumin/fibrinogen binding ratio which was primarily owed to a significant 
drop in adsorbed albumin. 
 A-C:H surfaces support higher concentrations of fibrinogen and plasma 
protein adsorption when compared with TiO2 
 Fibrinogen binding on DLC occurs over a constant dynamic interaction, 
while fibrinogen on TiO2 initially forms a proteinacious layer that is highly 
viscous after which is followed by dispelling of water molecules to form a 
rigid protein layer. Fibrinogen adsorbed on ta-C surfaces exhibited a side on 
conformation to align flat against the surface, while, fibrinogen on TiO2 
surfaces followed a bent conformation.  
 Surface chemistry was not the only deciding factor on the conformation of 
adsorbed fibrinogen. The conformation of adsorbed fibrinogen was severely 
altered when exposed to albumin even though DLC and TiO2 surfaces 
presented similar levels of platelet binding region on fibrinogen from single 
protein solutions and complex solutions. 
 DLC and TiO2 surfaces presented reduced platelet binding domains exposed 
on fibrinogen proteins adsorbed from plasma. Plasma proteins were found to 
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reduce the overall bare surface exposure and reduce fibrinogen adsorption 
either by steric hindrance or by reducing the overall exposure of adsorbed 
fibrinogen to circulating platelets. 
 TiO2 and a-C:H and ta-C substrates behaved favourably with plasma in 
delaying the time taken to form fibrin clots. When compared with ta-C and 
TiO2, a-C:H surfaces exhibited enhanced anti-coagulant  properties with 
increasing heparin concentrations. 
 Platelet adhesion on biomaterial surfaces is primarily dependent on integrin 
αIIbβ3-ligand mediated binding, although, non-specific binding to the surface, 
through covalent interactions between platelets and localised sites on the 
biomaterial surface devoid of proteins, is also evident.  
 Platelets were found to adhere rapidly on hydrophobic surfaces; and integrin 
αIIbβ3 was identified in mediating platelet adhesion as well as platelet 
spreading on biomaterial surfaces.  
 Platelet adhesion and spreading was reduced but not inhibited on albumin 
coated biomaterials. Generally, platelets on albumin coated biomaterials 
presented a rounded morphology, however, platelets on albumin coated TiO2 
surfaces presented increased spreading when compared with a-C:H and ta-C.  
  TiO2 surfaces exposed to fibrinogen supported increased concentrations of 
adhered platelets when compared with a-C:H and ta-C surfaces primarily 
because of elevated non-specific platelet interactions between platelets and 
TiO2 surfaces. When compared with fibrinogen, other plasma proteins 
interact favourably with DLC and TiO2 surfaces in reducing the material’s 
inherent thrombogenic response by reducing platelet attachment and their 
subsequent spreading. 
 While fibrinogen is necessary for αIIbβ3 activation, its relative concentration 
does not play a ubiquitous role in its activation levels. Even small 
concentrations of fibrinogen can elicit high levels of αIIbβ3 activation. 
 Not all platelets with a rounded morphology displayed detectable levels of 
activation while spread platelets presented activated receptors at varying 
concentrations. Integrin αIIbβ3  were found to occur more centrally before 
distributing to the periphery receptors. 
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 The surface chemistry of DLC and TiO2 was found to elicit a stronger 
activation of αIIbβ3 receptors than plasma proteins. P-selectin activation was 
not dependent on the chemistry of the bare surfaces, but rather dependent on 
whether the platelets exhibit activated αIIbβ3 receptors.  
 DLC and TiO2 surfaces did not induce activation of collagen receptor α2β1.  
 Block co-polymer fabrication method along with well established coating 
deposition techniques were an effective means of assessing protein adsorption 
and their respective conformation, as well as platelet interactions. 
 Nano-topography in the roughness scale of 5-10nm was found to promote the 
adsorption of large amount of proteins. The nano-patterns behaved as 
topographical cues to enhance protein adsorption. The proteins formed 
multiple layers, saturating in the grooves of the nano-patterns.  
 When compared with TiO2, nano-patterns increased the overall thrombogenic 
response of a-C:H and ta-C surfaces. When compared with flat surfaces, 
adsorbed fibrinogen on nano-patterned surfaces presented increased platelet 
binding domains for platelet binding. Platelets adhered at high concentrations, 
developed a stiff structure and displayed extensive levels of spreading and 
aggregation. The level of thrombogenic was further aggravated by fibrinogen 
and plasma protein adsorption. 
 It was difficult to discern the levels of platelet activation between the various 
surface chemistries of the nano-patterned surfaces. Nano-patterns exacerbated 
the activated P-selectin and αIIbβ3 integrins such that nano-features were able 
to overcome chemical influence. 
 
Overall this study illustrated that in vitro plasma protein and platelet responses can 
be modulated by altering topographical and chemical parameters of a biomaterial, 
and the specific adsorption of serum proteins. The ongoing challenge lies in 
completely understanding the mechanisms involved in platelet-protein-surface 
interactions which will allow development of materials that will elicit desired 
haemocompatible responses.  
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Recommendations 
 
Present research has introduced the effect of specific plasma proteins, surface 
chemistry and nano-features in eliciting thrombogenic response, in vitro. An almost 
natural next step in this field would be to transition into developing and optimising 
various nano-patterning techniques that can produce a range of nano-topographies to 
study the influence of nano-topographies on plasma protein and platelet interactions.  
Engineering biomaterial surfaces with well-defined nanoscale topographies and 
roughness has become a significant step towards modulating biological responses on 
bio-surfaces. The adsorption of nano-sized proteins, their binding affinity, 
conformation and spatial distribution is a result of complex processes influenced by 
surface wettability, surface chemistry, and surface topography. Altering the nano-
topography of surfaces changes the surface properties such as surface wettability and 
surface contact, and as such can greatly influence the way in which proteins interact 
with the bio-surface without compromising on surface chemistry or mechanical 
properties of the bulk material. Further, modulating nano-topographies have been 
shown to influence platelet adhesion, where the nano-features mimic the 
conformation of proteins and consequently behave as physical cues which dictate 
platelet adhesion, their spreading, activation and aggregation. Therefore it would be 
of great interest to optimise physical features, such as size, shape and pitch, on an 
implant surface such that it can greatly reduce haemostatic responses. Present nano-
patterning techniques are limited by their inability to produce homogenous, regular 
features with well-defined pitch and size within the 1-10nm range over large surface 
areas, required for commercial applications. The shape of nano-structures produced 
also need to be optimised to design hetero-structures that mimic the nano-sized 
conformation of platelet-repelling proteins that line the endothelial cells of the 
vascular wall, or the conformational state of circulating proteins when they illicit an -
thrombotic responses.  
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10  APPENDIX A 
 
10.1 Experimental Techniques 
 
Theoretical aspects behind the various experimental techniques used in this study are 
detailed below. 
 
 
10.1.1 X-ray Photoelectron Spectroscopy (XPS) 
 
XPS is an essential tool used to identify the chemistry and physics of the material 
surface, which aids greatly in understanding the interactions that occur on the top 
layer of the material as it interfaces with biology. It uses Einstein’s principle of the 
Photoelectric Effect to identify the elemental components on a material surface. 
Beams of x-rays are bombarded at the solid surface, as a result of the photoemission 
process, irradiates a small surface area to liberate electrons from the core and valence 
bands of the interfacial atoms. Even though the x-ray photons, emitted from an Al-Kα 
or Mg-Kα primary source, penetrate up to 10µm within the solid material, the X-ray 
spectrometer only detects electrons emitted within the top 10-15 nm, as shown in  
 
Figure 10.1Figure 10.1. This is because the deeper photo-emitted ‘Auger’ electrons 
are either recaptured or trapped at various excited states within the substrate material 
[532].  
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The kinetic energy of the emitted photoelectrons can be estimated by; 
 
EKIN = hυ - EB + ϕ                                                    eq 3 
 
where  
hυ is the energy of the photon 
EB is the binding energy of the core level electrons in an atom respective to        
      their highest occupied electron level in the solid 
ϕ is the spectrometer work function  
 
While hυ and ϕ are known constants dependent on the primary x-ray source, EB, 
which is characteristic of the electronic structure of each element at a particular 
oxidation state, can be deduced from measuring the kinetic energy of the photons 
[533].  
 
This process occurs in vacuum to avoid cross contamination and erroneous detection 
of elements found in air. Each element with respect to its oxidation state produces a 
unique sequence of peaks at specific EB values in the XPS spectrum, which is used to 
identify the individual elements present as well as to the species to which it is bonded 
on the material surface. Further, the concentration of detected electrons in each 
characteristic EB peaks can be used to determine the elemental composition within 
the irradiated area [532].  
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Figure 10.1 Schematic diagram of the X-ray photoelectron spectroscopy and 
principle behind the photoemission process[534]. 
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10.1.2 Scanning Electron Microscopy (SEM) 
 
SEM’s are microscopes that uses focused beam of high energy electrons to generate 
images representing morphological features and compositional analyses of inorganic 
and organic specimens on solid surfaces. The SEM produces high resolution, stable 
and noise-free images using beam of electrons projected from an electron gun, which 
follows a vertical pathway within a highly vacuumised environment of the 
microscope. The electron gun either uses heated tungsten or LaB6 filament for 
thermionic emission [535]. Electromagnetic fields assist in the deflection for 
electrons and the lenses allow the direction of the electrons to remain parallel to the 
magnetic field to optimise the position of the electron beam and to focus the beam 
directly towards a small rectangular scanning region on the sample [535].  Once the 
beam is in contact with the sample, the beam interacts with the material such that 
light, electrons and X-rays from the atoms of the interfacial layers of the surface are 
ejected, as shown in Figure 10.2.  
 
 
Figure 10.2 Complex interactions between the beam electrons of an SEM with 
material surfaces [536] 
 
Electrons travel in air only for short distances and therefore require a vacuum 
environment to operate successfully. X-ray, secondary electron (SE) and electron 
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backscattered (EsB) detectors capture the X-rays, backscattered electrons and 
secondary electrons, respectively, from the range of signals collected and are 
modulated to produce topographical images and elemental analyses (EsB detectors 
only) of the surface. 
 
 
 
 
10.1.3 Focused Ion Beam (FIB) Microscopy 
 
FIB microscope was used to sequester a slice of the surface’s cross section to 
determine the overall coverage of the deposited layer and the thickness of each 
coating. FIB functions along the same principle as the SEM, however, instead of 
electrons the charged particle beam projected within the column consists of 
positively charged ions, Figure 10.3.  
 
 
Figure 10.3 Schematic diagram of the FIB column [536] 
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Essentially a beam of charged particles rasters across a specified rectangular area and 
the captured signals from each raster position is plotted to form an image. The FIB 
produces high-current density beams from high-brightness ion sources for in-situ 
sectioning. Signals from the secondary sputtered electrons were detected by the 
InLens detector of the SEM to image the cross-section. The SEM system is operated 
with column pressures in the range of 10−5 Pa with pressures between 10−4 and 
10−3 Pa in the working chamber with the stage tilted at an angle of 53.8 degrees from 
the horizontal. A schematic diagram of the etching process is shown in Figure 10.4. 
 
Figure 10.4 Focused ion beam induced milling [536] 
 
 
10.1.4 Atomic Force Microscopy (AFM) 
 
The AFM is a three dimensional imaging tool often used to measure the micro and 
nano-topography of any solid surfaces. Apart from surface imaging, it can also be 
used to measure interfacial material properties and colloidal scale interactions forces 
in air and liquid medium.  
 
The AFM is essentially composed of a stage where samples are mounted using a 
nano-positioning system, and a thin metallic tip, attached to a cantilever, that scans 
across the surface at a pre-set scan rate. The cantilever is mounted on a piezoelectric 
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scanner which allows for 3-D positioning of the pyramid shaped nano-tip at high 
resolution, as shown in Figure 10.5. In tapping mode, a laser beam is reflected onto 
the point where the tip is mounted on the cantilever and the cantilever acts as a 
spring as it taps across the material surface. The force of attraction between the tip 
and the surface as the tip approaches the surface causes the cantilever beam to deflect 
in the x-y-z plane. The angular deflection of the reflected laser beam, caused by the 
angular deflection of the cantilever, is focused onto two side-by-side position-
sensitive photodiodes of a photo detector. The estimated difference in signals 
between the two photodiodes dictates the positioning of the laser spot on the detector 
and consequently, the angular deflection of the cantilever. The measurements across 
a specified scan area are recorded as 3-D images. 
 
Figure 10.5 Principle of AFM operation [537] 
 
 
10.1.5 Enzyme-Linked Immunosorbant Assay (ELISA) 
 
ELISA is a technique that is commonly used in in-vitro studies to indirectly quantify 
the adsorption of proteins or the adhesion of cells/platelets on biomaterial surfaces as 
well as the conformation of surface adsorbed proteins, or, expression of specific cell-
receptor proteins localised on the plasma membrane.  This is done using antibodies 
specific to the antigen. Both monoclonal and polyclonal antibodies, specific for 
various epitopes on proteins can be used for quantification purposes.  
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Essentially, several molecular complexes are adhered onto the adsorbed protein in a 
sequential manner followed by an end-stage enzymatic reaction before enabling their 
detection using a colorimetric, fluorescent or luminescent dye [538].  The enzyme 
label, Horseradish peroxidase (HRP), is often used in combination with 2,2’-azino-
di(3-ethylbenthiazoline) sulfonate (ABTS) colorimetric substrate. Proteins can also 
be probed after their extraction from the surface; however, the sensitivity of the 
technique is limited by the efficiency of the extraction process.  Direct ELISA’s can 
usually be executed on tissue culture plates, which have been incubated with test 
proteins or cells/platelets in the presence or absence of a biomaterial surface. 
However, the surface area of the sample biomaterial must comply with the linear 
relation between optical density and surface area for optimum measurements [538].  
 
 
10.1.6 Fluorescence Microscopy 
 
A fluorescence microscope is an optical microscope that uses fluorescence and 
phosphorescence in addition to reflection and absorption to allow visualisation of 
cells on non-transparent, opaque surfaces during cell-surface interactions. Typically 
the sample of interest is labelled with a fluorochrome (also termed fluorophore), 
which are excited by specific wavelengths of irradiating light. Fluorophores are 
stains that bind to visible and sub-cellular structures, such as proteins and actin 
filaments on platelet cytoskeleton, and are often highly specific for their target. They 
have a significant quantum yield (the ratio of photon absorption to emission) and as 
such can emit light of defined and useful intensity [539]. Common fluorophore labels 
include FITC (green), Alexa Fluor 488 (green) [540] and rhodamine (red). Phalloidin 
molecules bind to actin filaments and usually conjugated with rhodamine to enable 
direct labelling and visualisation of sub-cellular structures of cells, however this 
requires the cells to be fixed prior to staining [541, 542].  
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10.1.7 Quartz Crystal Microbalance with Dissipation monitoring (QCM-
D) 
 
Quartz Crystal Microbalance (QCM) is an ultra-sensitive weighing balance often 
used to measure the mass of deposited films. Until the 1980’s QCM was exclusively 
used in vacuum or gaseous environments [543]. It was used in the monitoring of 
metal plating in vacuum deposition systems, in measuring dry etch rates and 
oxidation rates of metal surfaces, and in measuring the degree of gas adsorption and 
desorption for various applications.  
 
It was not until 1982 however when Nomura and Okuhara [544] proved that a quartz 
crystal when immersed in solution can also oscillate in a stable mode, that the liquid 
application of QCM technology expanded. Nomura and Okuhara established that a 
change in frequency of the dry and wet crystal is dependent on density and the 
viscosity of the highly damped liquid media, not its dielectric constant [544]. Since 
then the use of QCM in liquid environments has been increasing rapidly, especially 
in the characterisation of bio-interfaces. The inclusion of dissipation monitoring 
provides information about visco-elastic properties of biofilms adsorbed to the metal 
coated quartz crystal. The implementation of the QCM-D setup as a liquid flow 
system provides the possibility of time-resolved observation of multi-stage 
adsorption processes from peptides to proteins to cell attachments. The versatility of 
QCM has enabled several biochemically oriented studies [545].  
 
The QCM-D technique, described in detail by Rodahl [543], is an highly-sensitive (< 
1ng/cm2) microgravimetric device that uses AT-cut quartz crystals that oscillates in 
thickness shear mode. In liquid mode resonant frequency drift is approximately zero 
at ‘near ambient’ temperatures, and consequently any small shift in resonant 
frequency is associated with induced mass change per area from adsorbed particles, 
such as proteins in solution. Change in frequency (Δƒ) can be quantitatively 
represented as change in mass using the Sauerbrey relation [477]; 
 
                                                       ∆m = (C/n) ∆f                                                    eq 4 
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where  
n is the frequency overtone number (n= 1,2,3,…), and 
C is the mass sensitivity constant  
 
                                                        C = (tqρq)/fo                                                       eq 5  
 
where  
tq is the thickness of quartz, and 
ρq , the density of the quartz 
 
For a 5-MHz crystal the mass sensitivity constant is ~ -17.7 Hz ng/cm2. This 
relationship however will only hold true if the adsorbed mass is evenly distributed 
over an active region of the crystal surface and is a small fraction compared to the 
mass of the quartz crystal, the adsorbed layer is thin and is rigidly attached to the 
crystal surface in such a way that no slip or deformation occurs during oscillation 
[477, 546, 547]. 
 
Frequency measurements at several overtones are a good indication of the viscosity 
of the adsorbed layer. If the upper most region of the adsorbed layer is soft, this layer 
furthest away from the quartz crystal surface, would not couple to the oscillation of 
the crystal sensor. In such cases Sauerbrey’s relation will underestimate the mass of 
the adsorbed layer. However, by measuring energy dissipated by this soft adlayer at 
several harmonics one can estimate visco-elastic properties and even film thickness 
and film density in the case of soft films such as protein adnd cell layers. The QCM-
D (QCM with dissipation monitoring) achieves this. It provides information on 
energy dissipated during the pulsed, forced oscillation of the QCM crystal [547]. The 
rate of dissipation is related to the properties of the crystal and the adsorbed layer. A 
viscous layer is intrinsically soft and will not oscillate along with the sensor exactly. 
Friction consequently arises within the adlayer causing dissipation and formation of a 
rigid film on the crystal therefore indicates little viscoelastic coupling and longer 
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decay time, while a non-rigid surface demonstrates increased viscoelastic coupling 
and a significant decrease in decay time [546, 547]. In the case of proteins, changes 
in dissipation upon adsorption have been predominantly attributed to increased inter-
layer density due to water adsorption, with minimal contributions from changes in 
surface roughness. Dissipation curves can be used to measure properties related to 
the viscoelastic properties of the protein layer. The dissipation rate for a system is 
related to the crystal’s electrical parameters and the ratio of dissipated and stored 
energy: 
 
                                                                                    
                                                                                                 . eq 6
 
where  
R and L are the resistance and inductance value of the crystal, respectively, and 
Edissipated and Estored are the dissipated and stored energy during each period of 
oscillation  
 
By measuring and analysing the frequency spectrum it is possible to measure the 
degree and rate of the protein mass attached to the surface, as well as any changes in 
the attached mass. However, the estimates of adsorbed mass measurements are based 
on the assumption that the system maintains uniform density throughout the process 
[548]. In reality, this is not true. The adhesion and adsorption of biomolecules tend to 
form an incomplete coverage on the surface or cause changes in material density 
limiting the application of the linear Sauerbrey relationship [546]. In such 
circumstances, the raw data obtained for multiple harmonics (n = 1, 3, 5, 7, 9, 11 and 
13) can be modelled into Voigt-based visco-elastic solid; or, Maxwell-based 
viscoelastic liquid models for meaningful parameters such as shear viscosity (η), 
thickness  (h) and mass (m)  [549].  Protein surface interactions are best described by 
the Voigt model, which assume that the adhered film is of uniform thickness and 
density. The fitted ƒ and D values, as well as mass m, calculated using Voigt based 
models [549-551] is shown below: 
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                               eq 7 
                        eq 8 
          eq 9 
where: m is the mass, ρ is the density, η is the viscosity, µ is the shear elastic 
modulus, ω is the angular frequency, h is the thickness, and, δ is the penetration 
depth of the acoustic shear wave into the bulk of the adsorbed layer. Furthermore, 
subscripts 1, 2 and q represent layer 1, layer 2 and the quartz crystal, respectively.  
 
The homogenous distribution of the protein layer is identified by solving for 4 
unknown parameters: ρ, h, µand η [548]. A unique solution can only be obtained by 
using two or more harmonics, as ƒ and D values for one overtone is insufficient to 
solve for four parameters. 
 
Furthermore, cell adhesion also cannot be analysed using Sauerbrey relation, as cells 
do not behave as rigid masses on the sensor surface and the entire cell cannot be 
sensed as their sizes are significantly larger than the penetration depth of the shear 
wave [551, 552]. The penetration depth of a shear wave from the crystal surface into 
the bulk is determined by the oscillation frequency as well as density and viscosity of 
the contacting liquid [549]: 
                                                     eq 10 
where: δ is the penetration depth, η, ρ and ƒ are the viscosity, density and frequency 
of the fluid. 
 
To investigate mechanical properties of adhered cells on QCM sensors, it is crucial 
to analyse cell adhesion using an appropriate model with adjustable parameters 
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dependent on the physical properties of the cell. For this, it is necessary to 
understand the specific parts of the cellular body that contribute to the measured 
QCM-D response [549]. The lateral sensitivity of the QCM-D for changes in both f 
and D are proportional to the oscillating amplitude and vary according to Gaussian 
functions of the same width, centred at the middle of the active electrode. Hence, the 
ratio between ΔD and Δƒ can be used to characterise the cell adhesion, independent 
of position on the electrode [549]. The time dependant changes to ΔD/Δƒ will 
depend on the mass that is deposited on the surface; the adlayer’s viscoelastic 
properties; physical properties of the cell such as: its internal structure and shape; 
and, how these features evolve over time during interactions with a surface [549, 
552]. QCM-D can be used as a high sensitivity technique to monitor and analyse the 
region where actual adhesion occur and the possibility to dynamically probe effects 
involving the adsorbing surface, surface adhesion proteins, the membrane and 
changes in cytoskeleton as cells spread from their rounded shape [552]. 
 
 
10.1.8 Flow-cytometry 
 
A flow cytometer is a laser based biophysical technique that utilises an optical to 
electronic coupling system to measure and analyse multiple physical characteristics 
of single cell suspensions as they flow in a fluidic stream. Ideally cells are tagged 
with a fluorophore specifically targeted to the cell or sub-cellular components, such 
as integrins, and the solution is passed through a fluidic system called the ‘sample 
core’. Lenses and detectors in the flow cytometer’s electronic system collect and 
measure the fluorescent light emitted as well as the scattered incident rays caused by 
the cells as they are taken up into the system to provide information such as the 
relative size and granularity of the cell and relative fluorescent intensity [553, 554]. 
This is shown in Figure 10.6. 
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Figure 10.6 Basic principles behind flow cytometry[555] 
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